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Abstract 
 
Background: Pain is the one of the most prevalent symptoms in people living with 
Human Immunodeficiency Virus/Acquired Immune Disease Syndrome (HIV/AIDS) and 
is largely undermanaged. In urban amaXhosa women living with HIV/AIDS (LWHA), 
the ‘Positive Living’ (PL) programme has been identified as an effective non-
pharmacological intervention for managing pain and may be affected by an 
empathetic therapeutic relationship. As a high prevalence of pain is likely to exist in 
rural amaXhosa women LWHA in South Africa, research is warranted on these two 
interventions amongst this population. 
Aim: To determine the effect of the combined PL programme and therapeutic 
relationship intervention (PL intervention), in comparison to a therapeutic 
relationship intervention (TR intervention) alone on pain severity, pain interference, 
symptoms of depression, health-related quality of life (HRQoL), self-efficacy and 
physical function in rural amaXhosa women LWHA. 
Method: A single-blind randomised trial was conducted using a sample of 
convenience. Interviewer administered questionnaires and functional tests at 
Baseline and at Weeks 4, 8, 12 and 24 were collected for the PL and TR intervention 
groups. Regression analysis determined the change of the primary outcomes, pain 
severity and interference, and secondary outcomes over the 24 weeks of the study. 
Results: Forty-nine amaXhosa women LWHA participated in the study. The PL 
programme and the data collection points were poorly attended by both groups. The 
pain severity and pain interference scores improved significantly in the PL (n = 26) 
and TR (n = 23) intervention groups over the 24 weeks of the study, with no 
significant differences between intervention groups. Symptoms of depression, 
HRQoL, self-efficacy and six of eight physical function tests were also significantly 
improved in the PL and TR intervention groups and, with the exception of self-
efficacy, no significant differences existed between intervention groups. 
Conclusion: The therapeutic relationship appears to be sufficient to manage pain in 
rural amaXhosa women LWHA and should therefore be recognised as a necessary 
intervention to provide effective and adequate pain management. 
1 
 
1 Chapter One: Introduction 
South Africa is home to the largest Human Immunodeficiency Virus/Acquired 
Immune Disease Syndrome (HIV/AIDS) population internationally1. Amongst people 
living with HIV/AIDS (PLWHA) pain is one of the most prevalent symptoms2–5, which 
is also true for PLWHA in the Eastern Cape, South Africa, part of the Sub-Saharan 
area6. The Eastern Cape, where this study was conducted, is largely populated by 
rural amaXhosa people, among whom the prevalence of pain in PLWHA is unknown. 
The prevalence of pain in rural amaXhosa women living with HIV/AIDS (LWHA) is 
unlikely to be vastly different from urban amaXhosa women LWHA, whose 
prevalence of pain is 74%7,8.  
 
As HIV/AIDS transforms from being regarded as a terminal illness to a chronic 
debilitating illness9, lengthening the life expectancy in PLWHA10–12, health-related 
quality of life (HRQoL)13–15, and poor pain management, have become bigger 
concerns9,16,17. Despite the high prevalence of pain amongst PLWHA, pain is largely 
undermanaged2,18–25. A need exists for effective pain management for amaXhosa 
women LWHA, given the likelihood of a high prevalence of pain7,8, which negatively 
affects physical and psychological functioning and HRQoL9,16,17, particularly in 
women20,26–28.  
  
2 
 
1.1 South African context of HIV/AIDS  
South Africa has an estimated 6.19 million HIV+ people29, making up the largest 
proportion of the worldwide HIV+ population of 35 million1,30. Life expectancy for 
PLWHA in South Africa has increased with the introduction of anti-retroviral therapy 
(ART) into the public health sector in 200410–12,30. AIDS-related deaths in South Africa 
nearly halved from 380 000 in 2005 to 200 000 in 2013. In South African populations, 
PLWHA, receiving ART before their CD4 T-cell count drops below 200cell/l, have 
near normal life expectancy12. Further, a higher baseline CD4 T-cell count prior to 
ART initiation, longer duration of ART, and being female all increase life expectancy 
in PLWHA in South Africa10–12. Consequently, HIV/AIDS has become viewed as a 
chronic debilitating disease rather than a terminal one9. 
 
The number of PLWHA on ART in South Africa, and in the Eastern Cape, has risen 
dramatically, from 47 500 (95% CI 42 900 – 51 800) in mid-2004 to 1.79 million (95% 
CI 1.65 - 1.93 million) mid-2011, and 5 300 in mid-2004 to 187 000 in 2011, 
respectively10. The South African National Strategic Plan was largely met as 80% of 
PLWHA who qualified for ART, using the initial criteria for starting ART, received 
treatment between 2007 and 201110,31.  
 
As a consequence of the successful ART rollout, the prevalence of HIV is rising 
annually despite the incidence reducing30, maintaining a high prevalence of HIV/AIDS 
in South Africa, and in the Eastern Cape30. Therefore, improving pain management in 
PLWHA in South Africa and the Eastern Cape, needs to become a higher priority. As 
the experience of pain and its management differs between cultures6,8,32–34, 
understanding rural amaXhosa women and their cultural and economic context is 
valuable in developing effective pain management strategies for this population35–39. 
  
3 
 
1.2 Research setting 
This study is concerned with evaluating the efficacy of pain management 
interventions and the ‘Positive Living’ (PL) programme, amongst rural amaXhosa 
women.  The response of rural amaXhosa women may differ from urban amaXhosa 
women40–45, for whom the PL programme was found to be feasible and effective46,47, 
as biopsychosocial differences exist between these populations32,33,35–39,48.  
 
The original PL programme, on which this study is based, was researched in an urban 
low-resource informal settlement outside of Cape Town, in the Western Cape44,46. 
The setting for the present study is Zithulele Hospital and the surrounding clinic 
areas, which is part of rural Eastern Cape45,49,50. Predominantly amaXhosa people live 
in this part of the rural Eastern Cape45. Many differences exist between these urban 
and rural environments regarding prevalence of HIV/AIDS, culture, terrain, 
economics, levels of education and health care, which need consideration in the 
implementation of treatment40–45,49,51,52. 
 
The prevalence of HIV is higher in the area of the present study than the previous 
study on the PL programme. In the Oliver Reginald Tambo (OR Tambo) District, which 
Zithulele Hospital and surround clinic areas are a part of, the prevalence of HIV was 
between nine and 12 percent in 2012, while the HIV prevalence in the City of Cape 
Town was between six and nine percent51.  
 
Zithulele Hospital provides services for 130 000 people in an area of just under 1000 
square kilometres, meaning that a patient may have to drive for over 45km of poor 
quality dirt road in a hilly terrain to reach the district hospital, or walk if the patient 
does not have finances for transport49,50. This journey by car takes about one hour49. 
Only 3 785 people in this area served by Zithulele Hospital were receiving ART in 
October 201353. There is a paucity of publicly available information regarding the 
prevalence of HIV/AIDS in this catchment area and how many people may have been 
untested and untreated at this time.  
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1.2.1 AmaXhosa culture 
The amaXhosa culture is the most prominent within Zithulele and its surrounding 
areas45, making it unsurprising that amaXhosa women living in these rural areas are 
much less influenced by other cultures40. In comparison, amaXhosa women living in 
urban areas are far more influenced by other cultures with whom they live in close 
proximity and integrate with40,44,45. Therefore, amaXhosa people living in rural areas 
live far more traditionally than those in urban areas40. However, although the heads 
of the homestead are traditionally men, migration of men to the urban areas has 
meant that women commonly perform this role within a family42,43. 
 
AmaXhosa women commonly live a transient life, visiting their husbands in urban 
areas or searching for work opportunities themselves40. As unemployment is a reality 
for many who live in Zithulele and its surrounding areas45, financial provision for 
many rural amaXhosa families is from family grants or pensions, and subsistence 
farming of crops and livestock43,45.  
 
In Zithulele and its surrounding areas, access to water and electricity is poor45 and 
women are required to walk to rivers to fetch water43. Further, subsistence farming 
is common for amaXhosa people, which requires manual work45. This context is 
therefore disabling for rural women LWHA, for whom decreased physical function is 
a common experience24,54, as physical functioning is essential for survival and 
participation in daily community life43. 
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1.2.2 Health care services 
Public health-services are poorly managed in the Eastern Cape according to the 
Eastern Cape Health Action Crisis Coalition, the Treatment Action Campaign and 
SECTION27 organisations55,56. Reports on the Eastern Cape highlight a lack of 
planning, infrastructure and maintenance55,56. There are often stock-outsa or 
shortages of medicine for HIV treatment and staff shortages are a reality53,55,57. This 
is the system in which Zithulele Hospital and its surrounding clinics provide health 
care. However, in spite of this, the Zithulele ART programme is well-managed53. That 
PLWHA on the Zithulele ART programme, which serves the hospital and surrounding 
clinics, always receive a full regimen of ART at each follow-up is a testimony to the 
well-managed service53.  
 
Access to health care for rural amaXhosa women accessing ART at Zithulele Hospital 
or the surrounding clinics, is reduced by limited transport and lack of finances. The 
distances between homesteads and clinics or the hospital, and the hilly terrain 
creates difficulties for viable transport options58,59, further the finances for transport 
are costly in relation to an average monthly income, particularly if there is poor food 
security6,43,45,57. 
 
As pain is a biopsychosocial construct32,33,37,48, this specific context of rural amaXhosa 
women in OR Tambo, Eastern Cape, has potential to influence pain and its 
management in this cohort. Further, with the existent health care challenges, pain 
management interventions need to be feasible and sustainable.  
  
                                                     
a An event where a particular medication is exhausted or out of stock at any health 
care facility at the time of it being necessary for treatment of a patient. 
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1.3 A theoretical framework of pain – the biopsychosocial model 
Pain is a biopsychosocial experience35–39, within which numerous factors 
interact32,33,37,48,60. Initially, the biomedical model of pain was widely accepted. In this 
model, the body is regarded as a machine, which could be fixed by addressing 
biological problems or tissue damage. The biomedical model neglects the role of the 
mind and brain in altering the pain experience, establishing a mind-body split, and 
explaining variance in pain by the extent of biological damage or pathology61. 
However, consistently the pain experience does not match the extent of damage62. 
By not recognising the processes of the brain and psychological, sociocultural and 
behavioural factors as contributors to pain, this model had limitations60,61.  
 
In response to these limitations and current knowledge, the biopsychosocial model is 
widely accepted as the most heuristic model to explain pain. Various models of pain 
have been developed under the biopsychosocial model of pain due to improved 
understanding of the pain experience and the involvement of the brain60,63. One 
example is the gate control theory of pain64. The theory described the influence of 
the peripheral nerve function and central processes, pattern recognition on the 
experience of pain, highlighted cognitive and emotional involvement in modulating 
the pain experience and indicated that pain was not proportionate to tissue 
damage64.  
 
A second example is Melzack’s pain neuromatrix, which recognises that pain can 
occur without a noxious stimulus65. The neuromatrix model of pain views pain as a 
higher order somatosensory construct, which is multidimensional and produced by a 
widely distributed neural network. The evaluative, affective and sensory dimensions 
of pain are each affected by multiple determinants and together affect pain 
perception and behaviour65,66.  
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Pain is now understood to be complex, and is described by the International 
Association for the Study of Pain as “an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage or described in terms 
of such damage”67. In this description, pain is recognised to be associated with actual 
or potential damage but not caused directly by it63,67. Although noxious stimuli may 
contribute towards pain, it is modulated by many factors65. 
 
The central role of the brain, and biological and psychological factors have been 
focused on in many models of pain. Cognitive involvement, such as fear-avoidance 
and catastrophising, which hinders pain reduction, have been recognised60,68,69. 
However, social factors, although acknowledged, initially did not receive as much 
attention. Social factors are highlighted more clearly in the social communications 
model of pain70, which highlights the effect of varied social interactions on pain 
perception and pain expression71. Behavioural changes allow observers to recognise 
an individual’s painful experience during social interaction63. Additionally, the 
observers response to pain expressions brings about a vicarious effect and 
adaptation to noxious responses, which may be moderated by empathy towards 
another individual in pain71. Social factors, therefore, have differing effects on pain 
experience and vice versa63,71.  
 
Consequently, effective pain management necessitates a broad assessment of 
biological, psychological and social factors, to comprehensively understand 
contributors to, and causes of, pain48,61. Furthermore, as a result of the 
biopsychosocial nature of pain, pain is inter-related with various elements of health, 
including depression, HRQoL, self-efficacy and function, which are necessary to 
assess in the presence of pain2,4,6,9,16,17,38,41,60,72–79. 
 
Establishing effective pain management, based on the biopsychosocial model of 
pain32,33,35–39,48,60, is necessary to address the burden of pain amongst 
PLWHA2,21,22,25,80. 
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1.4 Aim and Objectives 
1.4.1 Aim of the study 
To determine the effect of the PL programme and therapeutic relationship (TR) 
combined intervention (PL intervention), in comparison to a therapeutic relationship 
intervention (TR intervention) on primary outcomes, pain severity and pain 
interference, and secondary outcomes, symptoms of depression, HRQoL, self-
efficacy and physical function, in rural amaXhosa women LWHA. 
 
1.4.2 Objectives of the study 
In rural amaXhosa women LWHA, to determine the effectiveness of the PL 
intervention, in comparison with a TR intervention, with regards to: 
 
Primary objectives: 
- Pain severity, measured by the Brief Pain Inventory-Xhosa (BPI-Xhosa). 
- Pain interference, measured by the BPI-Xhosa. 
 
Secondary objectives: 
- Symptoms of depression, measured by the Beck Depression Inventory-
Xhosa (BDI-Xhosa). 
- HRQoL, measured by the EuroQol 5-Dimensional outcome questionnaire-
Xhosa (EQ-5D-Xhosa). 
- Self-efficacy, measured by the Self-efficacy for Managing Chronic Disease 
6-Item Scale (SE-6-Xhosa). 
- Physical function, measured by the physical performance task battery 
(PPTB). 
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To determine the aim and objectives, the next chapter will further introduce 
literature on psychosocial differences between cultures and its impact on the pain 
experience, the impact of pain experiences of PLWHA and the available management 
thereof. The literature review includes evaluation of outcome measurement choice. 
The third chapter explains how the trial comparing the efficacy of the PL programme 
combined with the therapeutic relationship, to the therapeutic relationship alone, 
was conducted and provides a detailed description of the two interventions (the PL 
programme and the therapeutic relationship). The results are presented in Chapter 
Four for the study sample (both intervention groups), the PL intervention group and 
the therapeutic relationship intervention group respectively. Here, results on the 
sample, demographics, clinical characteristics and the objectives of the study are 
presented. A qualitative aspect is thereafter presented, by means of post-study 
structured interviews. The discussion follows in Chapter Five, which discusses the 
results in relation to the objectives of the study. Finally, the conclusion is presented 
in Chapter Six.  
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2 Chapter Two: Literature Review 
2.1 Introduction 
The literature review introduces the psychosocial variables which contribute to pain. 
It then explores the prevalence, causes, characteristics of pain in PLWHA and 
discusses the influences of biomedical contributors and psychosocial factors on pain. 
The management of pain in PLWHA, using pharmacological and non-pharmacological 
interventions and their benefits and limitations, are then discussed. Lastly, outcome 
measures appropriate for use in research on interventions for pain in PLWHA will be 
discussed. 
 
The literature for this review was built from searches in the following databases: 
Pubmed, Pubmed Central and EBSCO search engines: Africa-Wide Information, 
CINAHL, ERIC, General Science Abstracts, Health Source, Medline, PsychARTICLES, 
PsychINFO and SocINDEX. Relevant literature was identified using these key words: 
Human Immunodeficiency Virus/Acquired Immune Disease Syndrome (HIV/AIDS), 
pain, health-related quality of life, self-efficacy, depression, function, 
biopsychosocial, South Africa, amaXhosa culture, self-management programs, 
exercise. Still further appropriate information was sourced via relevant websites, 
including StatsSA. The literature was limited to English literature only.  
 
2.2 Psychosocial variables contributing to Pain  
As Chapter 1.3 (p.6) describes, pain is an individual biopsychosocial experience35–
39,60,63,65. Therefore psychosocial constructs which differ between the urban and rural 
amaXhosa population, such as culture, gender, level of education and health literacy 
may affect the experience of pain18,20,27.  
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2.2.1 Influence of cultural factors on pain  
Pain intensity, tolerance and threshold can be influenced by culture and race. The 
influence of culture and race on pain has been researched in the United States of 
America (USA) primarily, and between European and Asian cultures32,33,54,81,82. 
Further, a disparity in pain intensity and pain interference in PLWHA has been 
reported between cohorts from sub-Saharan Africa and the USA8,22,54. In a systematic 
review by Parker and colleagues24 on pain in PLWHA, pain interference was reported 
in six cohorts, of which the two South African cohorts reported minimal pain 
interference while the four from the USA reported moderate pain interference. The 
lowest pain interference was reported by a South African cohort with moderate pain 
intensity whilst the highest pain interference was experienced in a cohort from the 
USA with only mild pain intensity8,24,54.  
 
This systematic review by Parker and colleagues24 will be frequently reported from in 
this literature review, as it is the highest quality of evidence and there are no other 
systematic review reports on the subject of pain in PLWHA. It should be noted that 
results of the systematic review poorly represent women due to less female subjects 
in articles relating to the subject at the time of the systematic review24. This 
systematic review was well conducted and included 28 studies, which were carefully 
selected for review from 61 studies which met inclusion criteria. Relevant inclusion 
of studies of a good quality for the systematic review was ensured by the use of a 
critical appraisal tool. Of the studies, which met inclusion criteria, studies scoring 
greater than or equal to the mean score, determined by the critical appraisal tool 
(68%), were reviewed. The 28 studies in the final review each scored above 70%, 
which is the minimum percentage suggested by Louw and colleagues83 to represent 
good quality prevalence studies84–86. The review was restricted to English only, 
possibly excluding other relevant data from studies done in other languages24. 
Additionally, as a result of the use of an electronic database search and not using 
papers which were unpublished, the author commented that publication bias may be 
present24. Bias may also have been created by the method of one reviewer doing the 
study appraisal24. 
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In literature, South African and black people have repeatedly been described as 
having stoic behaviour despite experiencing moderate or severe pain 
intensity8,22,24,54. This may result from the need to maintain function for survival in 
the South African context43 as the South African cohorts in the systematic review 
were predominantly poor, had high levels of unemployment with over half receiving 
no income, and had low levels of education8. Both South African cohorts in the 
systematic review by Parker and colleagues24 had poor pain management8, according 
to the Pain Management Index (PMI), which determines whether pain management 
is adequate or not by measuring pain severity against the pain medication 
prescribed87,88. However, of participants in the South African cohorts who received 
pain medication, a higher percentage than expected, of about 50% pain relief, was 
experienced8.  
 
Within South Africa, in a study by Mphahlele, Mitchell and Kamerman8, amongst 
ambulant and predominantly female black PLWHA, the prevalence of pain at the 
time of the interview was significantly higher in rural participants compared with 
urban participants. The difference in prevalence of pain indicates that within South 
Africa, different sub-cultures, may also contribute to pain prevalence. The rural 
participants were more impoverished with lower education levels than the urban 
participants. Both poverty and lower levels of education are risk factors of HIV-
related pain, which may have contributed to a higher prevalence of pain in the rural 
participants compared with the urban participants8,81,89. Despite this, at the time of 
diagnosis, the rural participants had a lower pain prevalence and fewer attended a 
clinic or hospital due to pain. Authors suggested that this may have been influenced 
by longer travelling distances to the clinic in rural areas and recall bias8. 
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Further differences were found as risk factors for the presence of pain between rural 
and urban participants in the study by Mphahlele, Mitchell and Kamerman8. In the 
rural cohort increasing age and higher CD4 T-cell counts increased the risk of pain 
presence, and being on ART and increasing level of education lowered the risk of 
pain presence. However, in the urban cohort being female and acquiring a tertiary 
education increased the risk of pain presence and the effect of increasing age was 
smaller than in the rural cohort8.  
 
The study by Mphahlele, Mitchell and Kamerman8 appears to be well conducted, 
with a moderately large sample. The study makes a useful comparison between 
urban and rural South African cohorts, indicating that differences in the experience 
of pain may exist between localities. One limitation of the study may be that the 
rural cohort only represents one sub-culture of rural South Africa, the Vatsonga 
people. 
 
Apart from the study by Mphahlele, Mitchell and Kamerman8 , a dearth of research is 
available which compares people from South African rural and urban environments 
regarding pain. Further, the amaXhosa people are not represented in the available 
research, except indirectly through the rural Vatsonga people, with whom the 
amaXhosa people share the Nguni culture34. Although similarities may exist due to 
the cultural link, the results cannot be applied directly from rural Vatsonga people to 
rural amaXhosa women34.   
 
In addition to a disparity in pain severity and pain interference between cultures in 
general, the perceived need for pain management differs between cultures, 
influenced by the hierarchy of other needs5. In a Rwandan cohort of PLWHA, only 
43% of participants recognised pain management as a need, despite a high 
prevalence of pain (72%) and 75% of participants with pain receiving inadequate pain 
management. Access to ART, financial assistance, home-based care and nutritional 
support, were perceived to be greater needs than pain management, implying a 
choice to endure pain in light of more pressing needs5. 
14 
 
Although all of the literature explored in this section does not directly apply to rural 
or urban amaXhosa people, it shows that people in different cultures and localities 
may experience pain differently6,8,34. Additionally, other social factors such as 
gender90–93, levels of education18,27, and health-literacy94–96 influence pain and its 
management. 
 
2.2.2 Influence of gender, levels of education, health literacy on pain 
Generally, literature on gender and pain syndromes indicate that women experience 
pain differently to men due to biological differences90–93. A difference in sex 
hormones affects the prevalence of pain and intensity of pain experience in men and 
women93. Therefore, women might respond differently to men, if given the same 
pain management, which provides an indication for researching pain management 
according to gender.   
 
Lower levels of education are associated with higher pain prevalence in cohorts of 
PLWHA18,27. Access to education in urban environments is greater than rural 
environments44,45. Despite a lack of research comparing education specifically of 
amaXhosa learners in urban areas to that in rural areas, the percentage of learners 
enrolled in schools and completing levels at each stage of schooling is known to be 
less in predominantly rural areas, such as in the areas around Zithulele, than those in 
urban areas, such as the City of Cape Town41,44,45. With marked differences between 
rural and urban education levels, the prevalence of pain in rural areas is likely to be 
higher than in urban areas. 
  
15 
 
Health literacy, which is the ability to seek, understand and use health care and 
information and is contributed to by education, plays a role in pain and its 
management, and changes the effect of self-management interventions on 
outcomes94–96. A well conducted study by Sperber and colleagues94, with a large 
sample size, indicated that participation in a self-management intervention was 
more effective and improved pain and mobility more in people with low health 
literacy, who were unable to read health-related words, than those with high health 
literacy. The results of the study by Sperber and colleagues94 were from a 
randomised control trial but are limited because the study sample included only 
veterans from the USA who were living with osteoarthritis, reducing the 
generalisability to other cohorts. With low levels of education in the area around 
Zithulele45, health literacy may also be low amongst the amaXhosa women included 
in the present study97. If this is found, and the results from Sperber and colleagues94 
are an indication of a general response of people living with chronic diseases to self-
management interventions, then the present study should be more effective than 
cohorts with a higher health literacy.   
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An individual’s lack of ability to act on positive health behaviours is an important 
contributor towards chronic pain96. A study by Briggs and colleagues96, which studied 
people with chronic lower back pain found that health literacy (determined by the 
Short-form Test of Functional Health Literacy in Adults (S-TOFHLA)), as well as pain 
intensity, were not correlated to outcomes of disability. Using mixed methods in the 
study by Briggs and colleagues96, provided greater depth to the study by including 
interviews, which determined that back pain-related beliefs and fear avoidance 
behaviour are associated with disability in the presence of chronic lower back pain96. 
The study had a moderately large sample size and was represented by low and high 
functioning people living with chronic lower back pain. However, the range of socio-
economic status of participants may have reduced the variability in health literacy, as 
every participant scored well for health-literacy. Varied health-literacy between 
participants would have helped to determine a better reflection of whether 
differences in health-literacy has on pain and its impact. Further, being an Australian 
study limits the relevance of these results in varied settings96.  
 
2.2.3 Sociocultural factors and HRQoL 
Literature indicates that sociocultural factors affect pain and other health outcomes, 
such as HRQoL, differently, which implies that it is relevant to investigate the effect 
of these sociocultural factors across different groups of people41,98,99. However, a 
paucity of research on sociocultural factors affecting pain and HRQoL in rural and 
urban amaXhosa PLWHA exists. 
 
In a large cohort population-based study by Jelsma and colleagues41, rural amaXhosa 
people living with disability (PWD) compared to urban amaXhosa PWD with the same 
functional limitation had a reduced HRQoL on multiple regression analysis41. Pain and 
mobility scores, which differed between rural and urban amaXhosa PWD, had the 
biggest influence on HRQoL41. Despite the limitation of using convenience sampling, 
reducing generalisability, the study was well conducted41. 
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In a large sample of 1159 urban South African participants, which was culturally, 
ethnically and economically diverse, the EQ-5D Visual Analogue Scale (VAS) score, a 
measure of a participant’s present state of health, was significantly affected by many 
factors98. These factors included age, presence of disability, low income, 
unemployment and each EQ-5D domain (mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression)98. As people living in the areas around 
Zithulele have low income and employment, a lower HRQoL VAS score may therefore 
be expected44,45,98. It is important to be aware that although the study was well-
conducted, the results may have been subject to a non-response bias as over 50% of 
the households in the sample population were not interviewed as they were not 
home at the time of the data collection98.   
 
Two studies described differences in responses to pain (a domain of HRQoL), 
between cultures34,41. In contrast and surprisingly, no correlation was found between 
ethnicity and gender, and HRQoL (measured by the EQ-5D VAS) in the study by 
Jelsma and Ferguson98. Therefore, it is relevant to investigate the effect of different 
cultures and environments on HRQoL and pain as differences in culture depending 
on environment may or may not affect pain and HRQoL34,41,98. 
 
The stoic behaviour in people in sub-Saharan Africa appears to influence quality of 
life (QoL), in addition to pain. A study by Phaladze and colleagues99, with a large 
convenience sample (743 participants), determined that a relatively high QoL score 
of three and a half (on a scale of 1-5, where five represents the highest QoL) was 
reported by a sub-Saharan cohort of PLWHA, taking into account the numerous 
symptoms (an average of 17.58 symptoms) and low functioning of the participants. 
Further, in this cohort 60% had an AIDS diagnosis and a third had a co-morbidity99.  
The outcome measures were reliable and validated for use amongst PLWHA but 
were not empirically validated or reliable for the settings or the language in which 
each was used, which may have caused error in the results, although they were 
deemed adequate and to have content validity by the authors and researchers99. 
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Pain and HRQoL, are also inter-related9,16,17, and both are influenced by sociocultural 
factors41,98,99. Various sociocultural influences must therefore be taken into account 
to better understand pain in PLWHA and the management thereof, as the 
prevalence, causes and characteristics of pain in PLWHA as well as the contributors 
to pain are likely to be influenced by sociocultural factors8,22,54,60. 
 
2.3 Pain in PLWHA 
2.3.1 Prevalence of pain in People Living with HIV/AIDS 
Pain is one of the most prevalent symptoms in PLWHA2–4. In two cohorts of PLWHA2,5 
pain was the most common symptom reported. Further, pain, causing enough 
concern to cause health care seeking behaviour, was the first reported symptom, at 
the time of diagnosis, in over 60% of a cohort of PLWHA in a study by Namisango and 
colleagues25. The study by Namisango and colleagues25 was generally well conducted 
and representative of both urban and rural PLWHA in Uganda. Other well conducted 
studies with large samples, which were inclusive of diverse areas (including rural and 
urban areas) in Southern Africa, and the Eastern Cape specifically, also report that 
pain is one of the most prevalent and concerning physical and psychological 
symptoms of HIV/AIDS2,6,100. A limitation in one of the other studies in agreement 
with pain being the most prevalent symptom, despite using a well validated outcome 
measure and establishing content validity of translated versions, was not conducting 
forward and back translation to ensure semantics and not validating the outcome 
measure in Africa. Although, the outcome measure had been used before in 
populations of PLWHA in Africa2. 
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A recent systematic review on pain in PLWHA by Parker and colleagues24 (described 
earlier in Chapter 2.2.1; p.11), with articles published between March 1982 and 
March 2012, found 24 samples from 28 articles representing 6814 PLWHA24. This 
systematic review showed that the prevalence of pain, which was 54% at point 
prevalence and 83% over a three-month recall period, has not decreased in the past 
30 years. Thus, the prevalence of pain has been a consistent problem despite the 
introduction of ART10,31.  
 
Within the range of prevalence rates reported in the systematic review, was a one 
week (55%), two week (58%), one month (68%), and six month (72%) recall period24. 
In contrast to these prevalence rates, one article, with a sample from Nigeria of 
PLWHA, reported a much lower prevalence of 27.8%, for a two-week recall period. 
This prevalence is far below the mean of the other four studies which reported a two 
week recall prevalence16–18,27,101–103. However, the prevalence reported in this cohort 
is open to bias. This study by Wahab and Salami101, a descriptive cross-sectional 
study, received one of the lowest scores (73%) in the methodological appraisal of the 
study, as the sample did not represent the entire target population, was not 
described in terms of ethnicity or ART status, and there was no response rate or non-
responders noted24,101. Furthermore, the number of participants was 79, much lower 
compared to the other samples24,101. Further, the inter-rater reliability was 
questionable, given the semi-structured interview, by which the prevalence was 
determined, was done by a number of medical professions101. To understand the low 
prevalence, and mild pain intensity reported in 70% of those who experienced pain, 
the authors questioned whether pain was thought, amongst the participants, to be a 
symptom accepted as part of LWHA, to be quietly endured, and not necessary to 
make complaint of101. 
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Another study, published after the systematic review by Parker and colleagues24 and 
done in the United Kingdom, with 859 participants, found a point prevalence of pain 
of 63% of participants at the time of interview104. This prevalence of pain falls within 
the range of prevalence of pain found in the systematic review24. The sample was 
poorly represented by women (less than ten percent were female participants). This 
was in keeping with the systematic review, in which most papers were from outside 
of Africa and mostly had poor female representation24,104. Conversely, men were 
mostly poorly represented in the papers from Africa in the systematic review 
relatively speaking, while women were well represented24. 
 
In a study in the USA determining the prevalence of joint pain, 50% of participants 
with HIV/AIDS only and 56% of participants with HIV/AIDS and Hepatitis C coinfection 
experienced joint pain respectively. The prevalence of joint pain alone amongst this 
cohort was high, without factoring in other types of pain105.  
 
Returning to the pooled prevalence of pain, the systematic review by Parker and 
colleagues24 indicated that pain in PLWHA is a consistent problem24. These results 
predominantly came from urban areas and the systematic review identified a lack of 
data from rural settings internationally, limiting the generalisability of the results24. A 
further limitation is that a low percentage, just under a third of the articles included 
in the systematic review24 were from lower income countries4,8,9,17,18,24,72,101,106,107. 
Five of these were South African, two of which shared a data set72,106. As noted 
earlier in Chapter 2.2.1 (p.11), only one article reflected an urban and rural 
environment, but the Vatsonga was the only ethnicity represented in the rural 
sample4,8,17,72,106. None of the South Africa studies had nationally representative 
samples24. This systematic review shows that despite the large burden of HIV/AIDS in 
South Africa, there is a dearth of literature on specific populations in South Africa1,24. 
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There is a dearth of research on pain prevalence amongst amaXhosa populations. 
The literature available reports the prevalence of pain for ambulant urban amaXhosa 
women LWHA to be 74% for a one week recall period7. No comparative studies on 
the prevalence of pain in PLWHA have been done in other urban amaXhosa societies 
or amongst rural amaXhosa populations. In the only article in the systematic review 
to compare ambulant and predominantly Black African women from rural and urban 
settings, Mphahlele, Mitchell and Kamerman8, reported the prevalence of present 
pain as greater in the rural sample (72%) compared to the urban sample (56%). Rural 
amaXhosa women may therefore also have a greater prevalence of pain to their 
urban counterparts8,34. 
 
Despite the paucity of literature specific to women and rural localities in South 
Africa, specifically rural amaXhosa people, the current literature suggests that the 
prevalence of pain is higher in women and people living in poorer 
communities73,74,108–110 and higher in rural compared to urban cohorts8. Therefore, 
the prevalence of pain in rural amaXhosa people is likely to be higher than the 74% 
prevalence found in an urban cohort of amaXhosa women24. 
 
2.3.2 Causes of pain in HIV/AIDS 
HIV-associated pain is multi-factorial, and can be neuropathic and/or nociceptive in 
nature19,20, varying in type and cause24. This is due to multiple possible causes of pain 
including the direct effect of the HI virus itself on the central or peripheral nervous 
system, opportunistic infections secondary to immunosuppression, and ART side-
effects2,8,18,20,25,54,111–113. Headaches, pain in the gastrointestinal tract, neuropathic 
pain, musculoskeletal pain and gynaecological pain are common types of pain 
experienced by PLWHA7. Pain is sometimes idiopathic28, or unrecognised, as 
indicated in an Italian sample, where 70% of pain syndromes were not identified 
during admission to the ward or day-care investigations112. Additionally, PLWHA 
experience pain which is not associated with or as a result of HIV22.  
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2.3.3 Characteristics of pain in HIV/AIDS 
There are various descriptions given to pain to help health care professionals (HCPs) 
understand pain, its causes and effects. Two descriptors of pain are its intensity and 
site. 
 
2.3.3.1 Pain intensity and its impact 
Moderate to severe pain intensity is most common amongst PLWHA24. An urban 
amaXhosa female sample had similar pain intensity, with Pain Severity Scores (PSS) 
of 7.52 for worst pain, 4.65 for average pain, 4.14 for present pain, and 3.93 for least 
pain7. In urban and rural South African cohorts, moderate to severe pain intensity 
was reported by around 60% of participants8. In a more recent study in urban South 
Africa, with women making up over 80% of the participants, the median pain severity 
at baseline was 6 on an 11-point scale, also representative of moderate pain in this 
cohort114. The results in another recent study by Lawson and colleagues104 of 
participants in the United Kingdom, were similar, yielding results of moderate pain 
severity, which was higher in women (6 on an 11-point scale) in comparison to men 
(5 on an 11-point scale). 
 
Pain intensity impacts on pain interference, symptoms of depression, HRQoL and 
function4,8,9,16,17,24,54,72–74,78. The impact of moderate to severe pain intensity differed 
between cohorts in South Africa and the USA, where minimal and moderate pain 
interference was reported respectively8,24,54. In PLWHA in the USA, a significant 
positive relationship between pain intensity and severity of depression was 
found16,73,74. As an association between pain and psychological symptoms exist, it is 
unsurprising that with the high prevalence of pain in PLWHA, psychological 
symptoms are prevalent too6,73,74,108,115. 
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2.3.3.2 Sites of pain 
In the aforementioned systematic review by Parker and colleagues24 on pain in 
PLWHA, anatomical sites of pain were reported in half of the 28 studies included and 
the number of sites of pain reported ranged between a median of 1, in a rural South 
African cohort, to a mean of 2.5 sites, in a cohort from the USA. A more recent study 
by Lawson and colleagues104 found that the median number of pain sites was 2, 
which falls inside the range found in the systematic review24.  
 
In South African cohorts it is common for PLWHA to experience multiple sites of 
pain8,116. The rural cohort in the South African study by Mphahlele and colleagues8 
had a smaller percentage of participants with multiple sites of pain (46%) in 
comparison to the percentage of urban participants with multiple sites of pain (61%). 
 
In the South African study by Mphahlele and colleagues8, the abdomen (rural: 30%; 
urban: 20%), chest (rural: 26%; urban: 30%) and head (rural: 19%; urban: 39%) were 
in the four most common sites of pain for both the rural and urban cohorts. The 
fourth site included in the most common sites differed between the rural and urban 
cohorts. In the rural cohort the genitals (19%) were common, whereas in the urban 
cohort the feet (33%) were common8. Another South African study by Hitchcock and 
colleagues17 reported that of PLWHA and neuropathic pain, 84% had pain in their 
lower limbs. The lower limbs was a commonly reported site of pain for PLWHA in the 
systematic review by Parker and colleagues24, and was reported by each study which 
reported sites of pain. This is unsurprising given that HIV–associated distal sensory 
neuropathy (HIV-SN) is a common cause of HIV-associated neuropathic pain17. 
Another frequently mentioned pain site in the systematic review was the head24. 
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Where more than one site of pain occurs simultaneously, in an individual, as is 
commonly the case in HIV/AIDS, it could infer two things24. One, that multiple 
pathological processes are occurring simultaneously, or that the person may be 
suffering from a central sensitisation disorder, which causes widespread pain due to 
changes in the nociceptive sensory neuron pathways in the central nervous system, 
which become more responsive to the normal or subthreshold level of excitatory 
input24,67,117,118. With such a wide variety of sources and influences of pain, it is not 
surprising that many PLWHA experience pain in multiple anatomical sites and that 
pain intensity differs between individuals24. For this reason, a variety of treatments 
are used to manage pain in PLWHA as treatment needs to target different causes and 
influences of pain, including different parts of the nervous system46,60,117. 
 
2.3.4 Biomedical contributors to pain in HIV/AIDS 
This section will further explore the biopsychosocial nature of pain, with regards to 
biomedical factors affecting pain in PLWHA. The impact of CD4 T-cell count, stage of 
disease, ART and gender on the experience of pain will be addressed. 
 
2.3.4.1 CD4 T-cell count and stage of disease in HIV/AIDS 
The relationship between stage of disease or CD4 T-cell count, and pain prevalence 
or pain intensity is unclear24,54,73,82. Pain is common at all stages of HIV/AIDS. Three 
studies in the previously cited systematic review by Parker and colleagues24 found 
that stage of disease, or CD4 T-cell count did not affect the prevalence of 
pain24,54,101,112. However, another two articles in the systematic review found an 
increased prevalence of pain with the later stages of disease9,81. The association of 
an advanced stage of disease with a higher prevalence of pain was also found in the 
recent study Lawson and colleagues104. Further, in two more studies, which used 
regression analysis, the risk of the presence of pain was found to increase as CD4 T-
cell count decreased24,73,82 and one more study found association between the 
presence of pain and having a history of AIDS defining illness54.  
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Higher pain intensity has been associated with a lower CD4 T-cell count in one study 
by Richardson and colleagues73. However, pain intensity in this sample was not 
associated with a history of AIDS defining illness. The participants in the study by 
Richardson and colleagues73 had all previously had a CD4 T-cell count below 200 
cells/l. 
 
As previously noted, the majority of these studies were done in high income 
countries54,73,82,104. Therefore, the results of these studies, on the relationship 
between stage of disease or CD4 T-cell count, and pain prevalence or pain intensity, 
should be interpreted with caution considering that the context of the present study 
differs. 
 
2.3.4.2 ART in HIV/AIDS 
The systematic review by Parker and colleagues24 reported conflicting findings on the 
relationship between being on ART and the prevalence of pain, as indicated in Table 
2-1. A study from the United Kingdom by Lawson and colleagues104 found, in contrast 
to the other studies presented in Table 2-1, that being on ART or having previously 
been on ART was a risk factor for the presence of pain8,54,106,114. It is noted that the 
cohort in Lawson and colleagues104 was comparatively much healthier based on CD4 
T-cell count results than the other cohorts from the studies, which found that ART 
was associated with reduced presence of pain or prevalence of pain8,54,114. The 
cohorts in other studies had average CD4 T-cell counts of equal or less than 200 
cells/l or over half the participants had a CD4 T-cell count of less or equal to 200 
cells/l. This may imply that for PLWHA with a low CD4 T-cell count, ART may be 
associated with reduced risk of pain presence and for PLWHA with high CD4 T-cell 
counts that being on ART increases the risk of pain presence104. It should be noted 
that as pain is contributed to by psychosocial elements, the fear of mortality, which 
may lessen with the use of ART, may contribute to lowering the risk of pain65,66. 
However, the relationship being ART and pain prevalence is uncertain given the 
conflicting results8,24,54,73,104,106,114. 
26 
 
Table 2-1: Associations between ART and the prevalence of pain in PLWHA 
Author  
(year) reference 
Setting Sample size 
(number) 
Percentage 
on ART 
(%) 
Regimen CD4 T-cell 
count 
(cells/l) 
Association between 
ART and pain 
Mphahlele, 
Mitchell and 
Kamerman   
(2012)8 
South Africa (rural) 125 53 stavudine or didanosine 
(d4T or ddl; 95%) 
199  
(median) 
Reduced risk of 
presence of pain with 
ART. 
Mphahlele, 
Mitchell and 
Kamerman 
(2012)8 
South Africa (urban) 396 68 
 
stavudine or didanosine 
(d4T or ddl; 91%) 
200 
(median) 
No difference in the 
risk of the presence of 
pain with or without 
ART. 
Breitbart and 
colleagues 
(1996)54  
United States of America  
(All participants had an AIDS 
diagnosis defined by 1993 
Centers for Disease Control HIV 
classification as CD4+ <200 or 
clinical category C) 
 
438 54 zidovudine (AZT; n = 
122, 28%), didanosine 
(ddl; n = 43, 9.9%), 
zalcitabine (ddC; n = 11, 
2.5%), and other or 
multiple (n = 59, 13.4%) 
150 
(median) 
Lowered risk of the 
presence of pain with 
ART. 
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Richardson and 
colleagues 
(2009)73 
United States of America (65% 
had clinical AIDS defined as 
CD4+ <200 by the 1993 Centers 
for Disease Control HIV 
classification) 
339 60 Not specified (58% had 
a CD4 
<200) 
No association to the 
prevalence of pain 
with ART. 
Lawson and 
colleagues 
(2016)104 
United Kingdom 859 77 Not specified 475 Increased risk of pain 
with ART or previous 
use of ART. 
Jelsma and 
colleagues 
(2005)106 
South Africa 
(urban Xhosa) 
(All World Health Organization 
stage 3 and 4 
clinical criteria as a result of a 
history of or current HIV-related 
illness, including tuberculosis; 
CD4 count less than 200/mm3) 
117 81  
(for the 
duration of 
the study) 
Not specified Not 
recorded 
Reduced prevalence 
over time on ART.  
Mphahlele, 
Kamerman and 
Mitchell (2015)114 
South African (urban) 92 65  
(on ART at 
baseline) 
Not specified (53% had 
a CD4 
<200) 
Reduced prevalence 
over time on ART. 
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This said, ART, especially neurotoxic anti-retrovirals (ARVs) such as stavudine, 
didanosine, and zalcitabine, are thought to contribute to the development of painful 
neuropathies113. Distal sensory polyneuropathy was correlated to use of ART and 
previous use of D4T in a South African cohort119. Further, pain, aching and burning 
are the most reported symptoms of sensory neuropathies, and are more common 
than numbness or pins and needles, in stavudine-exposed PLWHA119,120. 
 
The relationship between ART and prevalence of pain is inconclusive8,24,54,73,106. 
However, this is unsurprising given that there are many different regimens of ART121 
and many factors which influence pain as pain is a biopsychosocial experience65,66. 
 
2.3.4.3 Gender in HIV/AIDS 
Literature shows that women LWHA have a high prevalence of pain24,54,73,74,109. In the 
systematic review by Parker and colleagues24, a higher prevalence of pain was found 
in women than men LWHA in three studies54,74,81. The two studies in the systematic 
review of female only samples, reported a prevalence of pain of 63% at a one-month 
recall and of 83.5% at a six-month recall24,73,109. Parker and colleagues116 found a 74% 
prevalence of pain in urban amaXhosa women and Mphahlele, Kamerman and 
Mitchell114 found an 85% point prevalence of pain at baseline in a sample where 82% 
of participants were female, however a comparison for prevalence between women 
and men was not made. In a study by Lawson and colleagues104 the pain prevalence 
of women was always higher than the pain prevalence of men over time. 
 
Risk factors for pain differ for men and women LWHA. One study has shown that 
women are more at risk of new onset distal neuropathic pain than men122. Further, 
certain opportunistic infections are specific to women, such as cervical human 
papillomavirus infection, candida vaginitis and pelvic inflammatory disease, all of 
which present with pain89. 
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Literature on the differences in pain, not specific to any condition, between genders 
has indicated that for many pain modalities women are more sensitive to painful 
stimuli than men123. In one study, which evaluated the difference between genders 
on pain using a cold pressor experiment, showed that women reported higher 
intensity of pain compared to men124. In another experimental study by Sullivan, 
Tripp and Santor125 women also reported higher pain intensity than men. In this 
cohort Sullivan, Tripp and Santor125 found that fear was a predictor of pain intensity 
and behaviour for women, and that if pain catastrophising scores were statistically 
controlled there were no gender differences for pain and pain behaviour. Further 
there are a number of studies which indicate that females have a higher prevalence 
of pain for many conditions in comparison to men, including for neuropathic pain 
and musculoskeletal pain123. Therefore, for HIV-related pain may be more prevalent 
and of higher intensity amongst women in comparison to men. However, the impact 
of gender specifically on pain in PLWHA remains unclear24. 
 
From a psychosocial perspective women experience and respond to pain and pain 
management differently to men too20,89. Women have different pain behaviours to 
men125 and women LWHA are more commonly undertreated for pain28. Further, 
women LWHA experience depression more commonly than men LWHA, and 
depression negatively impacts on pain16,73,74,126,127. 
 
As pain and QoL in PLWHA are inter-related9,16,17 differences in QoL between genders 
may influence pain. The study by Sarna and colleagues128 demonstrates that women 
LWHA commonly experience concerns over finances, family, loss of relationship and 
disease progression, which reduces QoL128 and has the potential to impact on 
pain129.  Interestingly, pain was reported more commonly by women in this study 
compared to men128. In considering the results it should be noted that convenience 
sampling was used and the sample size was small128. In another study HRQoL was 
reported as lower in women than men and pain was one of the biggest contributors 
to the difference in HRQoL between men and women129.  
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This section on the effect of gender differences on pain has indicated that there is 
also an effect of psychosocial factors on pain in PLWHA20,28,89,128,129. The impact of 
psychosocial factors on pain in PLWHA will be discussed in more detail in the 
following section. 
 
2.3.5 Psychosocial factors and pain in PLWHA 
As a result of the focus of research frequently being on PLWHA from high-income 
countries and on men, there is less research to inform HCPs on the needs of PLWHA 
who are women, living in poorer communities, with low levels of education or rural 
contexts, or of amaXhosa culture24. The next section will explore the available 
research on the contribution of poverty and education on pain in PLWHA. 
 
2.3.5.1 Poverty and pain in PLWHA 
Current research indicates that pain prevalence is high in PLWHA living in poorer 
communities24,74,108,110. This was indicated by two samples in the systematic review 
by Parker and colleagues24, which focused on people from poorer communities in 
high-income countries74,108,110. Two papers were generated by one study and 
sample74,110. Both of these samples had a very high prevalence of pain in relation to 
the range of prevalence of pain reported in the systematic review by Parker and 
colleagues24,74,108,110. 
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In one of the samples (296 participants) of poorer communities in the systematic 
review a 91% prevalence of pain was reported at a one-week recall, using a cross-
sectional study design74,110. There was a high percentage of substance abuse in the 
sample and depression was experienced by almost half the sample. The high 
percentage of depression in this cohort suggests that depression may be more 
present within poor communities of PLWHA and as depression is associated with 
pain, pain is likely to be experienced quite commonly in poor communities74,110. The 
second sample (151 participants) in systematic review, which represented people 
who are from poorer communities and who had an advanced stage HIV or AIDS, the 
prevalence of pain was 83% over a three-month recall108. The basis of the advanced 
stage HIV or AIDS diagnosis was not included in the study methods. However, the 
study reported that the most recent CD4 T-cell count for 61% of the participants was 
equal to or under 200 cells/l, which indicates the low level of health in the sample. 
Both were well conducted studies with moderately large samples74,108,110. 
 
According to one study by Dobalian, Tsao and Duncan81, unemployment amongst 
PLWHA in the USA, a high-income country, was associated with higher pain intensity 
compared to employed participants. Interestingly, over 50% of the sample of PLWHA 
were unemployed81. This was a well conducted study with a sample size of over 2000 
PLWHA. Further, according to the study sampling and analytical weighting 
performed, the results of the study are nationally representative for the USA81. 
However, it is important to note that only PLWHA who received care participated in 
the study, therefore only representing those with sought out care81. In addition, in a 
study by Parker7, despite high unemployment percentage in a sample of amaXhosa 
women LWHA in South Africa (66%), a higher unemployment rate was found in 
PLWHA reporting pain than those without pain7. Parker7 used a cross-sectional 
design for the clinical analytical descriptive study, in which amaXhosa women LHWA 
attending a clinic were interviewed for the presence of pain, using the Brief Pain 
Inventory (BPI). 
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In poorer communities, where unemployment is common, such as the community of 
Zithulele and the surrounding areas 45, a high prevalence of pain and pain intensity in 
PLWHA, which impacts on function78, is likely to be found74,81,108,110. 
 
 
2.3.5.2 Education and pain in PLWHA 
Lower levels of education appear to be associated with higher pain prevalence and 
intensity in PLWHA, according to the systematic review by Parker and 
colleagues24,74,81. The association between level of education and various factors of 
pain, namely pain intensity, pain interference, and duration of pain or frequency of 
episodes, has also been described in other clinical populations, including cancer130, 
chronic pain131 and back pain132. With regards to people with cancer and back pain, 
the evidence is inconclusive although it suggests that an association between pain 
and level of education exists130,132. 
 
Cano, Mayo and Ventimiglia131 found a negative correlation between level of 
education and pain intensity and interference, where people living with chronic pain 
with higher levels of education reported lower pain intensity and interference. The 
sample in the study by Cano, Mayo and Ventimiglia131, included Caucasian and 
African American participants. Caucasian participants had a significantly higher level 
of education compared with the African American participants, and the pain intensity 
and interference amongst Caucasian participants was lower than that of the African 
American participants. The pain coping strategies were also different between these 
two groups. Further, the sample well represented each ethnicity with 62 Caucasian 
participants and 43 African American participants, and a total sample of hundred and 
five participants131. 
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Juarez, Ferrell and Borneman130, in a study in the USA suggest that differences in 
level of education, amongst other factors, influence the pain intensity reported by 
participants. A large difference in years of education between Hispanic participants 
(eight years of education) and Caucasian participants (14 years of education) was 
found, simultaneously with a significantly higher pain intensity in Hispanic 
participants compared to Caucasian participants130. However, no relationship 
between level of education and pain intensity was established in this study130. 
Further, of interest was the differences in beliefs and knowledge between the two 
ethnic groups on how to manage pain130. 
 
Support for the association between lower levels of education and higher pain 
intensity in PLWHA was found in a South African study by Peltzer and Phaswana-
Mafuya6. Peltzer and Phaswana-Mafuya6 found a relationship between lower levels 
of education and increased pain or symptom intensity in a large sample of 607 
PLWHA in the Eastern Cape, of which over half the participants were unemployed6. 
The sample was representative of people living in both urban and rural areas6. 
Convenience sampling was used, which may have caused bias in the results as the 
participants were found as a result of knowing an interviewer or being identified by 
key informants. However, the results are in agreement with the previous presented 
literature24,74,81. 
 
In contrast, another study in USA by Breitbart and colleagues54, found no correlation 
between education and the presence of pain or pain intensity54. The study by 
Breitbart and colleagues54 did not report on socioeconomic levels, which may be a 
contributing factor to the relationship between level of education and pain. In other 
cohorts where poverty and unemployment were predominant, the association 
between low levels of education and pain appears to be more apparent6,24,74,81. In 
the previous section Chapter 2.3.5.1 (p.30), high prevalence of pain and higher pain 
intensity has been described in the presence of poverty and unemployment 
respectively, in two samples from the USA24,74,81. 
 
34 
 
In South Africa, lower levels of education are more common in rural contexts8,45,133. 
Therefore, the sample of PLWHA in the present study is likely to have higher pain 
prevalence and intensity in comparison to the sample of amaXhosa women in the 
sample from Parker and colleagues46 mediated by education levels6,24,74,81. Despite 
the contradictory findings of literature on the association between pain and level of 
education, it would appear that low levels of education are of relevance for PLWHA 
experiencing pain6,24,74,81.  
 
So far, the literature review has focused on the prevalence, causes, characteristics 
and contributing factors of pain in PLWHA. This literature review will continue by 
exploring the management of pain in PLWHA. 
 
2.4 Management of pain in PLWHA 
Despite plenty of literature highlighting the prevalence, severity and interference of 
pain amongst PLWHA, pain is currently undermanaged in PLWHA, as confirmed by 
nine studies in the systematic review which measured pain management24. Women 
and people of lower levels of education are amongst the most undermanaged 
PLWHA18,20,26,27. 
 
Inadequate pharmacological treatment of pain in PLWHA is high, internationally and 
in South Africa24. Six studies in the systematic review by Parker and colleagues24, 
reported that between 66-100% of participants had received inadequate 
pharmacological treatment of pain4,8,18,21,24,103,134. The range of 66-100% of patients 
receiving poor pain management is the same for PLWHA in South Africa, as the two 
of the studies by Narasimooloo, Naidoo and Gaede4 and Mphahlele, Mitchell and 
Kamerman8, which represent the lower and upper range of inadequate management 
in the systematic review, are South African24. 
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Narasimooloo, Naidoo and Gaede4 found that 66% of inpatients in a government 
district hospital, situated in an urban setting, received inadequate pain management. 
Inadequate pain management was determined by a PMI score, which was calculated 
using the BPI and category of prescribed medication for pain. The study was a 
descriptive analytical study, which used convenience sampling and a sample of 100 
participants, most of whom were female. As women experience pain and pain 
management differently to men20,24,54,73,74,89,109, the results may be biased because 
the sample was predominantly female4. If a larger cohort of men, more equal to the 
number of female participants, were included in this study it would have limited this 
bias.  
 
The study by Mphahlele, Mitchell and Kamerman8, described in Chapter 2.2.1 (p.11) 
had a large sample established by convenience sampling, and included outpatients 
only. In comparison to the inadequate pain management reported in Narasimooloo, 
Naidoo and Gaede4 amongst inpatients, pain management for outpatients appears 
worse according to the results of Mphahlele, Mitchell and Kamerman8. Pain 
management was determined using the PMI in the study by Mphahlele, Mitchell and 
Kamerman8. In Mphahlele, Mitchell and Kamerman8, only 3% of the urban sample 
received weak opioids, while none of the rural sample did. In addition, no strong 
opioids were prescribed in either the urban or rural sample. All of the urban 
participants with severe pain and the vast majority of urban participants with 
moderate pain as well as all the rural participants with severe pain and moderate 
pain received inadequate pain management8. The results also indicated that in this 
study sample the urban sample had a higher percentage of adequate pain 
management compared with the rural sample but no statistical difference between 
the groups was evaluated8.  
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Another South African study by Mphahlele, Mitchell and Kamerman114, reported that 
in the sample of PLWHA no opioids were received by participants in severe pain114. 
The study was well conducted and assessed change in pain and its management over 
time (six months), using translated African language versions of the Wisconsin Brief 
Pain Questionnaire (WBPQ) and information on prescribed medication. A sample of 
convenience was taken of PLWHA attending a public-sector outpatient clinic114. At 
baseline, 95% of participants in pain at the time of the interview received no 
analgesics (neither nonsteroidal anti-inflammatory drugs (NSAIDS) or paracetamol) 
and six months later 75% of the participants in pain at the time of the interview. The 
prevalence of pain in the sample dropped over the six months, however, it does not 
appear that it was due to the use of pain medication as only one of the participants 
who no longer experienced pain was prescribed an analgesic114. It is evident that 
pain management with regards to pain medication was poor in this sample. Further, 
the results indicate that when pain medication were received, only paracetamol, 
NSAIDS and adjuvants were prescribed114. Therefore, if a PMI score had been 
calculated, it would provide information about the percentage and severity of 
inadequate pain management with regards to the prescription of pain medication. 
 
A further three studies reported that large percentages of PLWHA were given no 
treatment for pain. For the three studies, a range of 40-73% of participants received 
no treatment for pain9,101,135. Additionally, despite moderate to severe pain severity, 
no pain medication was administered in 60% of PLWHA in a cohort from a low-
income country (Nigeria)101. Although the Nigerian study by Wahab and Salami101 did 
have methodological flaws, as discussed earlier in Chapter 2.3.1 (p.18) the lack of 
pain medication, if accurately recorded, in a cohort with a low prevalence of pain still 
indicates a major problem with pain management in PLWHA, especially as the 
prevalence of pain may have been higher than reported. 
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Apart from pharmacological therapy22,80,136, existing interventions for managing pain 
in PLWHA include education137–140, self-management interventions141–143, cognitive 
behavioural therapy (CBT)144,145, physical exercise146–149, and a recently developed 
peer-led exercise and education intervention, the PL programme46,47. Literature on 
these interventions for managing pain with PLWHA follows. 
  
2.4.1 Pharmacological pain therapy 
Current evidence indicates limited efficacy of available pharmacological management 
for pain in PLWHA22,80. Partly due to this limited efficacy, a paucity of pain 
management guidelines and evidence for HIV-related pain, particularly HIV-SN, exist. 
Furthermore, many challenges such as inadequate knowledge of pain management 
for PLWHA and in the South African context the irregular availability of 
medication2,150–152 reduces the feasibility of using pharmacology alone in managing 
pain in HIV/AIDS. 
 
Current evidence recommends the World Health Organization’s pain ladder 
guidelines for adults153 as accepted practice for the management of pain in PLWHA 
despite these guidelines not being validated amongst the HIV+ population19,22,27,89,151. 
For neuropathic pain, which is commonly experienced in PLWHA80, the neuropathic 
pain treatment guidelines for South Africa are recommended22,80.  
 
Neuropathic pain is difficult to treat80 for a combination of reasons. It is often not 
well recognised in the clinic, its management is not well known, and the medication 
to treat it is limited in terms of both effect and availability80,150. For pain 
management of HIV-SN, a commonly experienced neuropathic pain in PLWHA17 
(Chapter 2.3.3.2; p.23), only high-dose topical capsaicin 8%, smoked cannabis, and 
recombinant human nerve growth factor (rhNGF) are more effective than placebo136. 
However, regular use of smoked cannabis as therapy is not recommended for legal 
reasons and for its adverse mental health effects154, rhNGF is not available for clinical 
therapy136 and topical capsaicin 8% is not available in South Africa80.   
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Despite the burden of pain amongst PLWHA there is currently no feasible 
pharmacological intervention which is more effective than placebo available in South 
Africa22,80. Current pharmacological guidelines have recommended the addition of 
non-pharmacological interventions to adequately manage pain22,80.  
 
2.4.2 Non-pharmacological pain therapy  
2.4.2.1 Education 
For people living with chronic diseases, self-management, facilitated by education is 
recognised as an important skill137. Interventions aimed at improving self-
management using various forms of education fall under the umbrella term self-
management support (SMS). SMS interventions focus on information provision, 
behaviour change, technical skills and self-efficacy to varying degrees making each 
different from one another137. Written education and didactic learning mostly focus 
on information provision and technical skills, whereas interventions including goal 
setting, group education with active participation and exercise focus more on change 
in behaviour and increasing self-efficacy137. A continuum showing the differences in 
the focus of self-management support (SMS) interventions, as shown on the next 
page in Figure 2-1, outlines various options in which education may be provided137. 
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Figure 2-1: A continuum showing the differences in the focus of self-management 
support interventions  
 
According to the literature review by the Health Foundation137, interventions for 
people living with chronic diseases, which focus on self-efficacy and behaviour 
change, are more beneficial for sustained health outcomes and quality of life137. 
However, the health outcomes were unspecified137. One meta-analysis of 17 studies 
found that the pooled data of SMS interventions had a small effect size for reducing 
pain in people with arthritis living in the USA155. Most of the interventions used were 
primarily based on the cognitive behavioural theory (n = 4) and/or the social 
cognitive theory (n = 9). The 17 studies differed in many aspects including the 
training of the facilitators (therapists, physicians or educators), frequency and 
duration of the educational sessions, whether education was given to a group or 
individuals, and the medium in which it was presented (face to face or over audio or 
video)155. It is important to note that with the variety of methods in the 17 studies, 
the results of the literature review reflected different effect sizes of SMS amongst 
the studies155.    
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It is understood that education by information provision alone may increase 
knowledge but is unlikely to be sufficient for improving self-efficacy and changing 
behaviour137. Although one study found that participants with acute pain, who were 
given written information explaining pain and knowledge for self-management, had 
more behaviour changes than those who received usual care in the short term, there 
were no significant differences after six-months. Furthermore, the change in 
behaviour did not translate into improved change in function. Taking into account 
the limited effects of education on participants’ health, the authors recommended 
that education should be provided along with other therapy138. 
 
Education by information provision alone appears to have a reduced effect on health 
outcomes in the long term139. For people living with arthritis, a programme which 
gave participants written information and follow-up information in the months 
thereafter tailored to personal factors such as demographics, health status and self-
efficacy, and a group self-management intervention (a programme designed to 
facilitate increased self-efficacy and improve self-management) had similar 
outcomes at two years post intervention baseline. The group self-management 
intervention was run by two trained leaders, one of whom was a peer-leader and 
neither of whom was a HCP. By the third year the participants in the self-
management intervention had significantly better scores for role function in HRQoL 
and significantly fewer doctor visits compared to the participants in the intervention 
giving tailored written information139. The tailored written information intervention 
with follow-up was 12 to 18 months in duration, and the self-management 
intervention was only six weeks. Therefore, the self-management intervention 
appears to be a more efficacious intervention than the tailored written information 
intervention139.   
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The above results are further supported by a study on elderly women who 
experienced pain for over three months75. Ersek and colleagues75 found that fewer 
pain management skills were reported in those who received an educational booklet 
compared with those who participated in a self-management intervention. Despite 
the difference in skills between groups, pain severity reduced significantly in both 
groups and no significant difference for reduced pain was found between the 
intervention groups at the three-month follow-up75. However, the long-term effects 
of the interventions and skills acquired on pain severity is unknown. In addition, the 
sample being of elderly women limits the generalisability of the findings75.  
 
An educational intervention for PLWHA experiencing pain in Malawi found that 
education reduced pain more significantly than usual care at eight weeks140. 
However, as the effect of education appears to reduce over time, the effect of the 
educational intervention may reduce in effect in the long term140. In this study, the 
educational intervention group received written information, a 30-minute face to 
face information session on managing pain, and a brief follow-up telephone 
conversation, which provided an opportunity for further questions. In contrast, the 
control group received routine care, with minimal information for pain 
management140. While the reduction in pain is an encouraging results, the 
improvement in pain at eight weeks in the educational intervention group may be 
biased by the additional attention received140. The development of a therapeutic 
relationship between the patient and health care provider was not controlled for in 
the study design introducing a potential source of bias156–159. A further study using 
three groups: usual care; educational intervention and a therapeutic relationship 
intervention with the additional contact than those in the educational intervention 
group receive, would control for this variable. 
  
42 
 
It appears that although education, in the form of didactic passive learning, may 
improve pain and help facilitate changes in behaviour; the effect in the long term is 
unclear138–140. Further, the long term effect of education in comparison to self-
management programmes on pain reduction remains unclear75,140. The research 
suggests that education should be used in conjunction with other forms of SMS to 
improve pain138. 
 
2.4.2.2 Self-management interventions 
Self-management interventions are more intricate than education alone, and include 
a combination of SMS interventions in a programme77,137,160–163. There appear to be 
long term effects of self-management interventions on pain and other health 
outcomes75,140. 
 
2.4.2.2.1 Theoretical Model 
Self-management interventions are based on social cognitive theory, which led to 
the self-efficacy theory, and CBT160,164,165. The focus of self-management 
interventions is on developing self-management skills, particularly increasing self-
efficacy, which facilitates active participation in chronic disease management. Self-
efficacy is integral to positively changing thought patterns and behaviours, having an 
impact on health outcomes77,160–163. These self-management skills help regulate or 
reduce the effects of the chronic disease on health despite changes occurring in the 
disease process165. 
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To achieve self-management, participants need to learn to manage three different 
areas: medical or behavioural, role, and emotional165. Managing medical and 
behavioural areas includes lifestyle modifications such as adhering to medication, a 
change of diet, and a change of activities and exercises. The roles people play in 
work, family and community life often need to change and modifications of one’s 
responsibilities or the technique, duration and frequency of tasks, which one 
performs to fulfil a role in society, need to be established. As change and living with a 
chronic disease is commonly met with emotion, learning how to manage various 
emotions is part of self-management of living with a chronic disease165. In addition, 
self-management is based on five skills: problem solving, decision making, resource 
utilisation, forming a patient-HCP partnership and taking action. In order for 
successful self-management to be learnt, the skills the patient trains in must be 
related to their particular needs and context165. 
 
In order to change behaviour, individuals need to have more than knowledge that it 
is beneficial to change. They need to believe that they are able to control and change 
their behaviour164. The social cognitive theory theorises that behaviour, thought, 
affective and external factors, which inter-relate with each other, also influence 
functioning of individuals and can be influenced by individuals themselves160. Self-
efficacy comes as a result of setting and obtaining goals by accomplishing 
performance tasks and becoming more confident in the ability to set and achieve 
goals and behaviour differently166. Self-efficacy increases as desired behaviour is 
developed and confidence is found in being able to behave as required in response 
to situations which arise. Closed groups provide a setting which stimulates change in 
behaviour and provides support and problem-solving around obstacles142,165. 
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Developing self-efficacy is enhanced by performance mastery, modelling, social 
persuasion and interpretation of symptoms, and physical and affective states164,165. 
Performance mastery is needed to change behaviour and develop confidence and a 
sense of control in self-management142,164,165. Successes are needed to build self-
efficacy, and therefore individuals need to overcome obstacles by problem-solving 
and perseverance. While failures undermine self-efficacy, if individuals learn from 
failures how to problem-solve and turn it into success, self-efficacy can be 
enhanced164.   
 
In self-management interventions, successes and increases in self-efficacy are 
achieved by contracting, a process of setting and accomplishing action plans towards 
desirable and attainable goals142. This involves problem solving, learning to manage 
areas of life which can be controlled, and adjusting behaviour and thoughts to 
improve symptoms and QoL163,167. Action plans must be concrete and specific and 
ones which participants feel confident they can achieve142. 
 
Successes early on in an intervention are optimal for increasing self-efficacy, 
however, self-efficacy can be learnt from failures at this stage too. Despite failures in 
early stages having a larger negative effect on self-efficacy, as confidence in self-
ability has not yet been established, participants who fail at action plans continue to 
problem-solve in a supported group setting until success is achieved, leading to 
perseverance and stronger self-efficacy164. Failure requires review and alteration of 
action plans to make them more suitable and achievable165. The group encourages, 
gives feedback and supports one another in problem-solving to adapt participant’s 
action plans to ensure future successes142. As self-efficacy increases, individuals may 
find confidence in increasingly difficult tasks and overcoming more obstacles which 
grow resilient self-efficacy164. 
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Modelling by successful self-managers, a peer-leader or group peers, facilitates 
participants’ belief in their capabilities. Peers model successes in health outcomes 
and assist one another with developing problem-solving142. Successes are heard of 
and observed in a group setting, which improves the efficacy of modelling164. As 
modelling only helps if it is of desired and valued outcomes164, successes by peer-
leaders and group members and the content in workbooks must represent and be 
relevant for the population for which it is intended165. 
 
Peer-leaders and group members help provide feedback through social persuasion 
when participants develop action plans142,164. Affirming individuals in their 
capabilities increases belief in themselves, increases persistence and effort, leading 
to higher competence and increased self-efficacy164. Relatively accurate social 
persuasion is important to not bring about unnecessary failure. Therefore, affirming 
individual abilities just beyond their ability is more likely to be effective because it is 
believable164. A closed group and social support have a positive effect on self-efficacy 
and problem-solving, facilitated by having a confidential space in which cohesion and 
companionship can form142,164. 
 
Additionally, self-efficacy is increased by participants’ ability to interpret symptoms 
and physiological and affective states, as individuals use physiological and affective 
states to help gauge health. If participants improve in physical functioning, manage 
stress and emotions better, and have more knowledge of common symptoms of 
chronic diseases or HIV/AIDS, it positively impacts on self-efficacy164,165. Symptoms of 
chronic illnesses commonly negatively influence self-efficacy and allow fear to 
develop when symptoms, which the sufferer does not recognise or understand, 
occur. As fear, anxiety and awareness of symptoms can exacerbate symptoms, if 
participants are trained in skills to recognise and respond to symptoms, symptoms 
can be managed more appropriately, leading to a greater sense of control, reduced 
fear and reduced symptoms142. Therefore, facilitating better problem-solving, 
recognition and management of symptoms, stress-management, physical functioning 
and management of medication are focused on in self-management interventions142.  
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These theories provide the basis for the structure and methods of implementation of 
self-management programmes, which increase self-efficacy, and thereby have a 
positive effect on health outcomes and pain, mediated by behaviour and thought 
changes161,162,167. 
 
2.4.2.2.2 Implementation/Structure 
Self-management interventions vary slightly in structure but all are based on the 
theories explored above. The structure includes a group of between 10-15 people, 
facilitated by a trained leader for either six or seven consecutive weeks of two-hour 
or two-and-a-half-hour sessions per week76,77,141–143. Components of group sessions 
include discussion around topics aimed at improving self-management, a form of 
goal setting and contracting called action planning, and relaxation training162. 
 
Topics covered frequently in self-management interventions include symptom 
management, medication, nutrition, stress management, exercise, communicating 
with family and HCPs and evaluating treatments76,162,167. Pain is rarely a topic which 
is covered but has been included in the Chronic Disease Self-Management 
Programme (CDSMP) content in some studies76,143. The topic of exercise is  
commonly part of the content of self-management interventions, such as CDSMP, 
however it is not performed in the group sessions76,143. 
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During the presentation of the topic of stress management participants are 
encouraged to learn ways to manage stress to help create a sense of control. For 
example this could involve practicing relaxation techniques, in order to be able to 
use relaxation techniques in different situations, including adverse situations such as 
whilst experiencing pain167. In the topic on exercise, participants are introduced to 
the concept of a ‘downward spiral’ and ‘upward spiral’, which occur when they 
either do or do not exercise, respectively. The ‘downward spiral’ leads to inactivity, 
resulting in weakness and sometimes pain, which leads to further inactivity and 
weakness as the lack of control over exercise continues. Alternatively, to gain control 
again, starting new exercise and activities is essential. As participants get stronger 
from activity they in turn might feel less pain and gain confidence to partake in more 
new activities and exercise167. 
 
The workbooks used to guide the process of becoming a successful self-manager, 
should be developed by HCPs in collaboration with people with the targeted 
condition to ensure that needs and concerns are addressed142,165. Further, a self-
management intervention developed specifically for PLWHA should therefore 
include the topic of pain as a high prevalence of pain in PLWHA exists2–4. 
 
2.4.2.2.3 Peer-led groups 
Peer-led facilitation is appropriate for self-management programs as it appears to 
have similar outcomes to HCP-led facilitation, and is a cost-effective alternative76,162. 
Self-management interventions for chronic diseases such as arthritis, HIV/AIDS and 
other chronic diseases, are commonly facilitated in peer-led groups47,76,77,141,162,168. 
To identify a suitable peer-educator for an intervention with PLWHA, consulting local 
structures in the community, including HCPs working with PLWHA and prominent 
leaders or members in community is common. After being appropriately selected, 
peer-leaders engage in training to run groups47,141, covering curriculum, practicing 
group facilitation and guiding action plans and receiving constructive feedback141,142. 
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Using a peer-leader has been received positively by participants in two studies57,141. 
Participants in these studies expressed that peer-led groups increased group 
participation and willingness to share experiences. Group participation brought 
about increased acceptance and identity and equipped people to cope better with 
LWHA57,141. Further, the culture and environment which groups create, has the 
potential to influence the psychosocial nature of pain16.  
 
2.4.2.2.4 Efficacy of self-management interventions 
Group participation in self-management interventions has been found to significantly 
reduce pain in people living with chronic disease76,77,162 and in PLWHA142,169,170. 
Additional benefits of self-management interventions include improvements in 
depression, QoL and function76,77,141,162. 
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Participating in self-management interventions appears to improve self-efficacy, 
which improve health outcomes77,142. In a study by Lorig, Gonzalez and Ritter77, 
people with osteoarthritis, participated in a self-management intervention. 
Differences between self-efficacy scores between baseline and a four-month follow-
up predicted improvements in health status, including pain and depression77. The 
results of the study have strength as the study design was a large longitudinal, 
randomised control study, which assessed changes over a year77. As a result, the 
study determined that earlier changes in self-efficacy can predict changes in pain77. 
The study was published over 15 years ago, which may render the results out of 
date77. Further, the study assessed the effect of a programme for people living with 
osteoarthritis only, which therefore means that the prediction of improvement in 
pain from change in self-efficacy may not apply in other clinical populations77. 
Nonetheless, it is a possible that changes in self-efficacy could predict change in pain 
in other chronic disease populations such as PLWHA participating in a self-
management programme, which is supported by the recent study by Parker and 
colleagues46. In the study by Parker and colleagues46 participants followed a 
programme tailored for PLWHA, which was partly based on a self-management 
programme, in which the self-efficacy scores and pain severity and interference 
significantly improved over time46. However, in this study the self-efficacy results did 
not predict the reduction in pain severity or interference46. 
 
In qualitative research by Gifford and Sengupta142, self-efficacy and playing an active 
role in management were identified as positive outcomes of participating in a self-
management intervention developed for PLWHA. The study used purposive sampling 
in order that the sample represented a range of responses to the intervention and 
conducted telephonic interviews from which topics were identified and explored142.    
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The effects of self-management interventions on pain are unclear. While Ory and 
colleagues76 found a significant improvement in pain, when participants from the 
USA took part in CDSMP (a self-management programme for a range of chronic 
diseases), Lorig and colleagues143 found no changes to pain. Both studies used similar 
methods. The two studies had peer-leaders who had a chronic disease, and for data 
collection, participants completed self-administered questionnaires76,143. However, 
the content differed between the interventions. Ory and colleagues76 specifically 
targeted pain in their intervention content, whereas the intervention in the study by 
Lorig and colleagues143 was more generic to chronic disease management. Therefore, 
it would appear that in order to have an impact on pain, an intervention needs to 
include pain specific content76,143.  
 
From the study by Ory and colleagues76, it appears that self-management 
interventions such as the CDSMP are better suited to participants who are less 
severely affected by their condition or whose outcomes improve during 
participation76. Those in the study with very poor health initially, tended to not 
complete the CDSMP or failed to return for follow-up tests. This suggests that self-
management interventions are not feasible or effective for people with poor health 
at baseline. It is noteworthy that the analysis of results in the study by Ory and 
colleagues76 considered the extent of missing data and used mixed methods to 
produce an unbiased  estimate of the effects of the intervention76. 
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Similar to the results of Lorig and colleagues from people living with chronic 
disease143, no effects on pain were found in men LWHA, who participated in the 
Positive Self-Management Programme (PSMP), which, despite the prevalence of pain 
in PLWHA2–4, also omitted pain specific content169. Additionally, the frequency of 
exercise in men LWHA, who participated in the PSMP (which included exercise as a 
topic but was not performed in the group), was not significantly different from the 
control group. However, participants of the PSMP group had significantly better self-
efficacy than the control group over time. This study had several limitations, 
including being restricted to men and following up for three months only, preventing 
information on the effect of PMSP and self-efficacy in the long term169.   
 
Other benefits of self-management programmes include significant improvements in 
QoL in CDSMP76. Further, Webel141 reported that two out of the nine subscales of the 
HIV/AIDS-targeted Quality of Life outcome measure were significantly better in 
urban women LWHA in the United States of America, who participated in PSMP 
compared with those receiving a workbook (not based on PSMP). However, these 
scales were also significantly different between groups at baseline. Therefore, the 
results do not necessarily reflect success of the intervention but could simply be a 
difference between the groups maintained over time141. The results may possibly be 
negatively affected as, participants reported that peer-leaders in this PSMP did not 
use the workbook effectively, despite training141.  
 
In people living with chronic diseases and PLWHA, the benefits of self-management 
interventions on pain and other outcomes are unclear. Therefore, more research is 
needed to assess its effect across various contexts. Many of these self-management 
interventions were developed and studied in the USA76,77,162, including the PSMP for 
PLWHA141,142. The biopsychosocial nature of pain may change the effectiveness of 
self-management interventions on pain, according to different socio-demographics 
and chronic disease35–39 indicating the need for culturally specific studies. 
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Research into the efficacy of self-management interventions in combination with 
other pain management strategies is indicated. Self-management has brought about 
a significant difference in pain in some studies76,77,162, but there is minimal research 
for its effect on pain in PLWHA169. Furthermore, the effect of self-management 
interventions and other pain management strategies have not been explored in 
combination among rural amaXhosa women. 
 
2.4.2.3 Cognitive Behavioural Therapy 
Cognitive behavioural therapy (CBT) is another intervention used for PLWHA 
experiencing chronic pain. Many self-management interventions are based on CBT 
and therefore there are many similarities between the approaches. For PLWHA 
experiencing chronic pain, pain management is one of the main focuses of CBT and 
covers cognitive reinterpretation of pain and learning skills of problem solving, goal 
setting, exercise, communication with health professionals and relaxation144,145,170.  
 
When CBT is delivered in a group setting, the group structure and content are similar 
to those used in self-management groups with some notable differences. 
Participation in CBT based management interventions involves twelve weeks of 90 
minute sessions led by clinical psychologists. Furthermore, the clinical psychologists 
are available outside of group sessions144,145 and may facilitate an improvement in 
pain management by working directly with physicians145. One study allowed rolling 
admissions, therefore allowing for a continuous change in the dynamics of the group 
compared with a closed group142,170.    
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The results of CBT include reduced pain intensity and pain-related impairment even 
with moderate attendance of group sessions, however no long-term effect after 
participating in CBT was recorded144,170. In one study, improvement in pain anxiety 
during treatment was found to play a role in helping pain acceptance that improved 
pain-related impairment144. Other results of CBT indicate that participants with 
higher pain anxiety at baseline showed greater improvements in pain related 
functional activity145. CBT has also been shown to facilitate improvement in 
depression144,170, which may also be mediated through increased pain acceptance, 
which itself is a result of participation in CBT144.  
 
Despite positive results for pain management in PLWHA and chronic pain, the CBT 
intervention is possibly less effective than self-management interventions, as CBT 
management interventions are lengthier and less cost-effective76,77,144,145,162. In 
addition, they are delivered by psychologists specifically trained in the treatment, 
which increases the resource requirements144,145 – a consideration for health care in 
resource constrained settings. 
 
2.4.2.4 Physical exercise 
Exercise can have a hypoalgesic effect on pain171–173. Further, the presence of pain is 
associated with reduced self-efficacy, QoL and physical function6,78,174, all of which 
can be improved with exercise146,148,149. Exercise significantly increases self-efficacy149 
and improves QoL146. However, a paucity of evidence exists for the long term 
effectiveness of exercise on pain in PLWHA148,175,176. 
 
Exercise was the most common strategy to self-manage pain, reported in qualitative 
research by ambulatory PLWHA from the USA experiencing chronic pain177. The 
median CD4 T-cell count of the sample was 571 cells/l, meaning that on average the 
participants had minimal immunosuppression and were not at high risk of 
opportunistic infection178. Forms of exercise included housework, walking for a set 
time or doing sets of exercise routines. Participants’ reported that exercise helped 
ease the pain and was helpful in accomplishing goals177. 
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Physical exercise is beneficial for treating pain as exercise increases the release of 
endogenous opioids, such as endorphins, which inhibit pain and increase pain 
tolerance173. A meta-analysis by Naugle, Fillingim and Riley179, on studies in which 
pain was experimentally induced, indicated that exercise is able to reduce the 
perception of pain in healthy populations. Additionally, in populations with chronic 
pain, on average a positive small effect size was found for pain reduction from 
aerobic exercise179. However, the results indicated that the effect of exercise on pain 
was more variable amongst people with chronic pain as hyperalgesia was also 
reported post exercise, although it was less common179. 
 
For PLWHA, aerobic and resistance exercise, of low to moderate intensity, is a safe 
and accepted intervention147,148, commonly used in the management of other 
chronic diseases146. Exercise is beneficial in alleviating HIV-associated symptoms, 
HIV-related muscle wasting, metabolic and cardiovascular impairments146,147,180. 
During the early stages of HIV, exercise may increase CD4 T-cell count and decrease 
viral load as well as delay symptom onset and decrease symptom severity147.  
 
Although exercise is safe for PLWHA148,149,181,182, PLWHA should be assessed before 
starting an exercise regime. Various conditions predispose PLWHA to responding 
differently to exercise, such as having decreased lung function, after pneumocystis 
pneumonia, or experiencing muscle cramps or cardiac dysrhythmias following 
diarrhoea or poor nutrient absorption147. Exercise routines should take into account 
the individual’s current amount of exercise and activity, stage of disease, HAART 
regime and side effects146. 
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2.4.2.4.1 Exercise-intensity 
Exercise-induced hypoalgesia was more effective with a higher intensity of aerobic 
exercise compared to moderate intensity amongst healthy participants from the 
USA, in a study by Naugle and colleagues171, in which 15 females and 12 males 
participated. Naugle and colleagues171 studied the impact of exercise on 
experimentally-induced pain pressure threshold, which was found to increase post 
aerobic exercise performed at 70% heart rate reserve171. Participants completed 
three sessions of 25 minutes each, which included higher intensity exercise 
(stationary cycling at 70% heart rate reserve), moderate intensity exercise (stationary 
cycling at 50% heart rate reserve) or rest. The order of sessions was randomised and 
before the three sessions commenced a training session took place to familiarise 
participants with the procedure of experimentally-induced pain testing 
procedures171.  
 
Moderate-intensity exercise, the most commonly advised intensity for PLWHA147, has 
no known negative effect and has been reported to be helpful in reducing symptoms 
of HIV infections and improving the immune system. Exercise of moderate intensity 
is safe for PLWHA with high viral loads as indicated by the immune response176. In a 
cohort of PLWHA, of predominantly deconditioned participants with high viral loads, 
exercise did not affect viral load in 22 of 25 participants. In three participants, post-
acute exercise, transient detectable HIV RNA was found despite having previously 
undetected HIV RNA176.  
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In a study of men who were HIV+ from the USA by Mustafa and colleagues175, 
exercise of moderate-intensity slowed progression of HIV to AIDS, bringing about a 
slower decline or increase in CD4 T-cell count in those who exercised regularly 
compared with those who did not175. Further, a slower progression to AIDS occurred 
in men who exercised three to four times weekly rather than daily175. The sample in 
the study included 415 men, of whom 156 were HIV+. This study, with four years of 
follow-up, shows long-term effect but as it was conducted in the late 1980s, prior to 
HAART, it is possibly outdated175.  
 
Another two studies, of which the study by Fillipas and colleagues149 is more recent 
than the possibly outdated study by Mustafa and colleagues175, found no effect of 
exercise on CD4 T-cell count or viral load149,181. In the study by Fillipas and 
colleagues149, which also only included men, the effect of exercise on CD4 T-cell 
count and viral load was assessed at six months, which limits evidence for the long-
term effect of exercise on these immune markers149. The three studies discussed 
here further validate that moderate-intensity exercise and slowly progressed 
exercise is safe for PLWHA and does not negatively affect the immune system in men 
LWHA149,175,181. A major limitation to the three studies is that they primarily focus on 
men. Two of the studies only had male participants149,175, while the third study had a 
sample of 60, with 52 males and eight females, and the sample was then equally 
divided for the study intervention groups181. 
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2.4.2.4.2 Aerobic and resistance exercise 
Aerobic exercise and resistance exercises are beneficial for reducing pain171,172. 
Additionally, Baiamonte and colleagues172 found that resistance exercises increase 
pain tolerance, which was tested by use of a mechanical nociceptive stimulus, 
however the pain threshold remained unchanged. Resistance exercises were done in 
a circuit of nine exercises, performed as three sets with 12 repetitions in each by 
participants who regularly participated in resistance training172. A large effect size for 
the increase in pain tolerance was found between the pre-exercise results compared 
to one minute post exercise172. The effect did not last long as from one minute to five 
minutes, there was a significant decrease in pain tolerance. The study results are 
limited though, as the results do not indicate the effects of exercise-induced 
hypoalgesia in people who do not regularly train172. 
 
In the study from Fillipas and colleagues149, PLWHA (over 18 years old) who took part 
in two 60 minute aerobic and resistance training sessions during a week over six 
months, had significantly better self-efficacy and cardiovascular fitness and increased 
HRQoL as compared with the control group149. The control group results stayed 
much the same as baseline, while the participants in the exercise intervention group 
did considerably better than their baseline149. The training programme took place 
over six months and followed guidelines of starting at 60% of maximal heart rate, 
using the Borg Relative Perceived Effort Scale183, and increasing to 75% as 
improvement occurred. Resistance training was initially at 60% of one repetition 
maximum, gradually increasing to 80% and were performed in three sets of ten 
repetitions and breaks were given between sets and exercises149. There was good 
adherence to the exercise program, which was supervised by a physiotherapist, 
which may have contributed to the effectiveness of the exercise programme. As 
mentioned previously, the study only included males, limiting application of the 
results to women and the length of follow-up time limits knowledge of the long-term 
effect149.  
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Similar to Fillipas and colleagues149, Hand and colleagues148, found that for PLWHA 
from the USA (over 18 years old) participating in aerobic and resistance training is 
safe and improves functional aerobic capacity148. As functional aerobic impairment 
may partly be due to deconditioning, which can result in pain167, the finding is useful 
in order to reduce deconditioning by increasing functional aerobic capacity in 
PLWHA148,182. No significant differences between participants on HAART or not on 
HAART were found148. The study was limited by a small sample size and a high drop-
out rate. About two-thirds in the exercise group and half in the control group 
completed the study. Additionally, women were not well represented as very few 
participated in the study148. Hand and colleagues148 found that women responded as 
well as men, indicating that both women and men benefit from aerobic and 
resistance training but the poor representation of women may limit the strength of 
these findings148. The study was well controlled, and excluded individuals who had an 
opportunistic infection, had previously used or were currently using hormone 
therapy, was an alcohol or substance abuser, or individuals for whom it was unsafe 
to exercise. Further, participants were excluded if they were participating in a 
structured exercise programme before participation in the study. In addition, 
dropouts were contacted to find out whether any adverse signs or symptoms 
occurred but none were reported148. 
 
Therefore, aerobic and resistance exercise should be part of the management of pain 
in PLWHA, as exercise is safe for PLWHA and brings about exercise-induced 
hypoalgesia148,149,171–173,181,182.  
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2.4.2.5 ‘Positive Living programme’: a multimodal intervention approach  
A multimodal ‘Positive Living’ six-week peer-led exercise and education intervention 
(PL programme) guided by a ‘Positive Living’ workbook (PL workbook), was found to 
be effective and feasible in managing pain in South African urban amaXhosa women 
LWHA46. The educational contents of the PL programme and workbook were 
developed by Parker and colleagues47, for specific use by PLWHA. The contents were 
carefully chosen from evidence-based educational material, developed by experts 
(researchers in health, doctors, physiotherapists and nurses), on managing living with 
chronic health conditions, including HIV/AIDS and chronic pain167,184–186. The self-
efficacy theory and principles from CBT160 were used to develop the PL programme47.  
 
The PL programme has similarities with other self-management interventions for 
people with chronic diseases76,77,162 but additionally incorporates performing 
exercise in the sessions, which facilitates core self-management skills acquisition and 
promotes self-efficacy47,165. The exercise routine was designed to maintain various 
body functions, which may decline in PLWHA, for example cardiovascular 
fitness47,149.  
 
The PL workbook is used to guide each peer-led session over six consecutive weeks47, 
which is an adequate amount of time to change behaviour165. Peer-led sessions 
facilitate aerobic and strengthening exercise, relevant topic discussions for 
amaXhosa women LWHA, development of action plans specific to the weekly topic, 
and relaxation training47. The peer-educators in Parker and colleagues were well 
familiarised with the content of the PL workbook and referred to the manual during 
groups sessions. It should be noted that the manual was not used as a script47. This 
manner of facilitating is necessary to clarify as participants of a self-management 
intervention in a study by Webel and colleagues141, felt that the peer-leader should 
have been better prepared and should not read directly from the manual. The study 
by Webel and colleagues141 used qualitative research to investigate the participants 
experiences of the intervention. 
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The workbook is designed to be used by participants as a resource outside of 
sessions. Examples of exercise and relaxation routines, symptom charts, and space to 
write goals are included in the workbook7,46,47. Symptom charts assist participants in 
selecting appropriate action to respond to symptoms, thereby improving self-efficacy 
with the use of the charts7. This model of symptom chart, used in the PSMP, was 
found to be useful by participants142. Additionally, the most important information in 
a workbook chapter is summarised in blocks, similar to other self-management 
books, to aid an increase in knowledge of self-management167. 
 
The relaxation routines aim to facilitate relaxation sessions (in the form of autogenic 
training)187. Relaxation techniques aim to assist behavioural change, which reduces 
pain, improves self-efficacy and helps with other health outcomes188,189. Practicing 
relaxation appears to enhance the physiological response of the parasympathetic 
system, whilst reducing the sympathetic reaction to the presence of pain189. 
 
The efficacy of the workbook on health outcomes may be impacted upon by 
participants’ health literacy190. Low health literacy is influenced by lower levels of 
education and rural living41,191. The literacy level of workbooks used in programmes 
needs to be considered within context. For example, the English version of the PL 
workbook has a Flesch Reading Ease Score of 72/100 and Flesch-Kincaid Grade Level 
of 7.8. This indicates that the workbook is appropriate for people with seven years of 
education7. For the urban amaXhosa participants of the study of Parker and 
colleagues46, the workbook was found to be appropriate and effective in reducing 
pain. However, an intervention using a workbook only might be impractical in 
settings where a high percentage of patients have lower levels of education such as 
Zithulele and the surrounding areas, where half the population either only had some 
primary schooling (less than seven years of education) or no schooling45. 
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Parker and colleagues46 found that an intervention group, who participated in the PL 
programme, and a comparison group, who received a PL workbook without group 
facilitation, both improved significantly in all outcomes over a 16 week follow up 
period. These outcomes included pain severity, pain interference, symptoms of 
depression, self-efficacy and HRQoL46. In all outcomes no significant difference 
between groups were found46. While this research applies to urban amaXhosa 
women LWHA46, it might not extend to their rural counterparts as a consequence of 
the differences in culture, educational level and socioeconomic factors discussed in 
Chapter 2.2 (p.10). 
 
A similar multimodal intervention, designed for people with osteoarthritis who were 
awaiting arthroplasty, was studied in urban South Africa192. This study found a 
moderate to large effect size on pain severity and pain interference in the 
intervention group in comparison to the control group192. The intervention included 
aspects of a self-management programme and incorporating education and 
exercise192. It appears that interventions of this type reduce pain in various chronic 
diseases but the extent to which it may benefit South African people in rural contexts 
is still unknown46,192. 
 
Parker and colleagues46, who studied the intervention designed for PLWHA, 
theorised that the improvement recorded in both intervention groups may have 
been due to an unintended effect of the study. Arguably an additional intervention46, 
a therapeutic relationship was developed by the consistent care, given by an 
empathetic HCP, at regular follow-ups. As the effect of a therapeutic relationship 
(TR) was not studied, the role of the TR on pain and health outcomes compared with 
the PL programme is unknown.  
 
The implication of the study from Parker and colleagues46 is that patients may just 
need to be followed up by the same empathetic HCP each time they visit the clinic. It 
is therefore relevant to consider the role of the therapeutic relationship on pain and 
health outcomes. 
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2.4.2.6 Therapeutic relationship 
Many studies have established that a therapeutic relationship is essential in 
optimising health outcomes in patients156–159. The therapeutic relationship has its 
own effect on outcomes and should therefore be regarded with value and attention 
during interactions between patient and HCPs193. Some researchers consider the 
therapeutic relationship as an essential platform for treatment, which must exist for 
change in outcomes to become possible194,195. However, the direction of the causal 
effect of the therapeutic relationship has been queried by some, who question if the 
outcomes may influence the therapeutic relationship196,197. Either way, fostering the 
therapeutic relationship appears to be important196.  
 
The therapeutic alliance between the patient and clinician, empathy from the 
clinician to the patient, and the expectations of treatment for the patient and 
clinician, all influence the therapeutic relationship156,195. Each factor interacts with 
another and has the ability to enhance or weaken the effect of an empathetic 
therapeutic relationship on outcome goals156,198. 
 
In this alliance, the character and behaviour of the therapists appear to have more 
influence on the therapeutic relationship than the patient. The patient’s perception 
of care contributes towards physiological changes, such as a release of endogenous 
opioids and neurophysiological changes, even in the absence of analgesic 
medication, as seen in placebo analgesic effects199–201. Patients perceive empathy 
from a HCP if they feel that they have been listened to and heard by their HCP. This is 
facilitated by HCPs reflecting their understanding back to the patient verbally, while 
showing compassion, for example with appropriate facial expressions and tone of 
voice. Health care professionals have an increased ability to show empathy if they 
can place themselves in the patient’s position202,203. Further, HCPs’ empathy towards 
the patient increases patients’ trust in HCPs, improves compliance with following 
medical advice and regimens (also found amongst PLWHA) and promotes healthy 
behaviour, which are all conducive to improved health204–207. 
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In a large study of PLWHA in the USA, a positive relationship between a HCP and 
patient was necessary to improve adherence to medication206. The association 
between better relationships and improved adherence to medication was 
strengthened further if the patient had self-efficacy in taking medication206. This 
finding was tested across categories such as race, gender and ART regimen by 
stratified sampling within the large study which found the finding was consistent. 
The study included people who were heterosexual, homosexual and bisexual and 
was 74% men. As the sample was over 2000 people, the data analysis is likely to 
represent both genders and other categories well206. 
 
Treating patients as individuals and establishing patient-centred care is important to 
develop a good clinician-patient relationship198. Communication, both verbal and 
non-verbal, is a key aspect of the therapeutic relationship and perception of care. 
Patients value being listened to, having their stories, opinions and choices heard, 
understood and believed198,208–210. Other interpersonal skills which are valued by 
patients include being friendly, confident, empathetic, encouraging and 
respectful198,211.  
 
Empathy and behaviours from health care professionals which develop a 
constructive therapeutic relationship can be improved with training and practice212–
214. Training, which focused on increasing the ability to be empathetic, improved 
physician’s empathy as perceived by patients in one study215. This training 
incorporated understanding emotions from a neurobiological and physiological 
perspective, practicing recognising emotion in people’s behaviour, practicing 
behaviour which illustrates empathy and care, and self-development skills, such as 
relaxation and mindfulness215. Further, self-reflection, personal resilience and having 
a balanced healthy life have contributed towards developing empathy and 
maintaining it216,217. 
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The existence of an empathetic, therapeutic relationship in treatment has primarily 
been found to significantly reduce psychological symptoms but in addition studies 
have also recorded improvement in physical outcomes as well156,197,207. For example, 
the therapeutic alliance scores was a predictor of reduced pain severity and 
improved function in people with chronic lower back pain receiving treatment of 
either exercises or spinal manipulation by physiotherapists in a study by Ferreira and 
colleagues218. This was a retrospective observational study, which was part of a 
randomised control trial of 182 participants with chronic lower back pain living in 
Australia218. Therapeutic alliance was assessed at second treatment session, while 
the outcome measures were assessed at baseline and eight weeks of treatment218. 
Treatments were run by experienced physiotherapists and monitored to maintain a 
high standard of practice to ensure a well conducted study218. Although the study 
was well designed, ending at eight weeks to ensure that the prediction was as 
accurate as possible, the limitation is therefore that the long term effects of the 
prediction are unknown218. 
 
A second study indicating improvements in physical outcomes arising from the 
therapeutic relationship was conducted by Fuentes and colleagues219. This study 
indicated that if active interferential current therapy was given in the presence of an 
enhanced therapeutic alliance for participants with chronic lower back pain, the 
result was a clinically meaningful improvement in pain intensity219. Fuentes and 
colleagues219 ran a four-group experimental controlled study with 117 participants, 
which was conducted with groups either receiving a limited or enhanced therapeutic 
alliance and active or sham interferential current therapy. Despite receiving either an 
active or sham interferential current therapy, both groups which received an 
enhanced therapeutic alliance yielded large effect sizes for pain intensity in 
comparison to the limited therapeutic alliance groups219. Pain intensity was assessed 
subjectively using a numeric rating scale and pain sensitivity (of the muscle) was 
assessed objectively using pressure pain threshold. Unfortunately, repeated 
measurements were done directly after the treatment only and therefore the long 
term effect is unknown219.  
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Improvements in patient’s health outcomes and change of behaviour appear to be as 
a response to being observed and cared for220. This is described as the Hawthorne 
effect, a non-specific element of treatment in trials, similar to the therapeutic 
relationship, which appears to improve outcomes220–222. It appears to primarily be 
the care, trust and attention received as a response to participating in a trial which 
impacts the outcomes positively197,221. Being in a clinical trial also improves 
researchers’ and HCPs’ behaviour towards participants, in comparison to routine 
care given222. The same care can therefore be intentionally given in patient’s 
treatment sessions in routine care212–214, having the same effect as in clinical trials199–
201,204,207. 
 
It is important to establish the extent to which the therapeutic relationship enhances 
the outcomes of effective treatments196. The PL programme by Parker and 
colleagues46 was found to be feasible and effective for pain, however the extent of 
the effect of the therapeutic relationship remains unknown46. Therefore, if an 
intervention to manage pain in PLWHA is researched, the effect of the therapeutic 
relationship needs to be considered and valid, reliable and appropriate measurement 
instruments need to be identified to record the efficacy of the interventions 
appropriately223. 
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2.5 Outcome measures 
It is recommended that studies evaluating the efficacy of interventions on pain, 
should use multiple outcome measures, to reflect the multidimensional nature of 
pain comprehensively, in order that clinically meaningful change in pain and inter-
related outcomes are determined224. The guidelines developed by the Initiative on 
Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) group 
recommend that pain studies consider measurement of pain, physical functioning, 
emotional functioning, participant rating of improvement and satisfaction with 
treatment, symptoms and adverse effects and participant disposition. Further, 
recommended outcome measures appropriate for these domains were chosen 
foremost on appropriateness of content, reliability and validity, responsiveness (an 
important aspect of validity for detecting change) and feasibility with regards to 
burden223.   
 
2.5.1 Pain 
In the systematic review by Parker et al.24 the most commonly used measurement 
instrument for pain in PLWHA was the Brief Pain Inventory (BPI), followed by the 
WBPQ and the Italian Pain Questionnaire (Italian version of the McGill Pain 
Questionnaire (MPQ))225–227. 
 
Although the MPQ is often used in pain studies, it has limitations as it does not 
measure pain interference226 and has low sensitivity to change over time in 
comparison with other scales, such as a VAS for pain  intensity measurement226,228. In 
comparison, the responsivity of the BPI in measuring change of pain over time is a 
strength of the BPI229. The BPI and the WBPQ measure pain intensity and pain 
interference, using different scoring for pain interference, and recalling pain over a 
week, and a month, respectively227,230. The BPI-Xhosa has been validated for use in 
amaXhosa women with HIV116, while the WBPQ has been translated into Xhosa, but 
due to insufficient participants has not been validated34. This suggests that the BPI is 
an appropriate assessment tool for assessing the efficacy of interventions on PSS and 
Pain Interference Scores (PIS). 
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The BPI, originally developed for assessment of pain in people with cancer227, has 
been found to be valid and reliable for use in many conditions related to pain, such 
as with arthritis, lower back pain or chronic pain229,231. Pain severity scores are an 
average of scores on four questions (pain at its worst, least, average and right now) 
and pain interference scores are determined by an average of scores of seven 
questions (seven domains of functional interference). Questions are scored by 
numeric rating scale from 0-10, where lower scores represent less pain severity and 
pain interference and higher scores represent higher pain severity and pain 
interference87,227.  
 
Additionally, the isiXhosa translation, the BPI-Xhosa, has good reproducibility of 
original semantics and was found valid and reliable, with good internal consistency, 
for amaXhosa PLWHA in urban areas116. The two-factor structure of the BPI-Xhosa, 
referring to pain intensity and pain interference, was also found in other South 
African languages for the WBPQ34,116. 
 
As per the English version, designed for research and endorsed by the IMMPACT 
guidelines for pain studies223,224, the BPI-Xhosa is an appropriate outcome measure 
of prevalence of pain, pain intensity and pain interference116. The BPI-Xhosa is 
therefore the outcome measure of choice for the primary outcomes, pain severity 
and pain interference, in the present study.  
 
The translation of the term “average” and the use of the scale had been identified as 
two difficulties of using the BPI-Xhosa116. The authors warned that this outcome 
measure should therefore be used with caution in studies, more so in rural areas 
where the BPI-Xhosa has not been tested. To account for this, the authors suggested 
that the BPI be calculated with and without the score for pain on “average” to check 
that the data has a similar structure116. 
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In addition to determining pain severity and pain interference, the BPI is also used to 
determine the adequacy of pain management, by a measurement called the 
PMI87,88,227. The PMI determines whether pain management is adequate by 
measuring pain severity against the pain medication prescribed87,88. The level of pain 
severity is categorised into no pain (zero points), mild pain (one point), moderate 
pain (two points) and severe pain (three points) using the BPI227. The categories for 
pain medication is as follows: no medication (zero points) mild opioids (one point), 
moderate opioids (two points) and strong opioids (three points)87,88,153. To calculate 
the PMI, the value of the pain severity is subtracted from the value of the strongest 
pain medication received. If the PMI score has a negative value then the medication 
was inadequate, while if the score is positive then it represents adequate pain 
management87,88. 
 
2.5.2 Symptoms of depression 
Two valid and reliable outcome measures frequently used in people with pain232, to 
assess symptoms of depression are the Beck Depression Inventory (BDI) and Center 
for Epidemiological Studies Depression Scale (CES-D)233,234. Further, the BDI is 
recommended by IMMPACT for pain studies224 as symptoms of depression are inter-
related with pain24,73,74,126. Both measurement instruments have advantages with 
regards to validity when assessing people experiencing pain. The BDI has better 
specificity in comparison to the CES-D, while the CES-D has better sensitivity 
compared to the BDI232. 
 
Due to its brevity and simple language, the BDI is easy and quick to administer, and is 
appropriate for people with low levels of education224. The BDI consists of 21 
questions, each with four possible responses of which one must be chosen. Each 
answer corresponds with a score (0 - 3), and the total BDI score is the sum of the 21 
scores234,235. The highest total score on the BDI is therefore 63, with a higher score 
indicating greater symptoms of depression234,235. 
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The BDI is a useful measure of symptoms of depression, and although it is not used 
for diagnostic purposes of major depressive disorder236 it is sufficient for assessing 
change in symptoms of depression in PLWHA232,236. Further, the BDI is a valid 
measurement outcome to use in populations with chronic pain232 and has been used 
in a South African cohort of amaXhosa women experiencing pain46. 
 
Two revisions have been made to the BDI, the second being the BDI-II237,238. The BDI-
II is a reliable outcome measure with initial construct validity, which was 
demonstrated in PLWHA receiving ART in South Africa236, amongst whom a high 
prevalence of pain was likely2–5,24. An isiXhosa version of the BDI-II was developed, 
the BDI-Xhosa and has been found to be valid and reliable238. It has subsequently 
been used amongst rural South African amaXhosa people in the Eastern Cape239 and 
urban amaXhosa women LWHA46.  
 
2.5.3 Health-related Quality of Life 
Health-related quality of life is commonly affected when people are suffering from 
pain9,16,17. Although many HRQoL measures exist, the Medical Outcome Study Short-
Form Health Survey (MOS-SF-36)240 and the EuroQol instrument (EQ-5D)241, have 
both been translated into isiXhosa to measure quality of life in amaXhosa 
PLWHA241,242. The translation of the MOS-SF-36 had overall good reliability and 
validity. However, there was poor reproducibility in some questions and the 
semantics were of concern. Therefore, the authors recommended more research is 
carried out on this translation242. 
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The EQ-5D243 was designed as a self-report measure of HRQoL for any disease across 
countries. It assesses five dimensions of health, comparing present state of health to 
previous state of health and a VAS assessment of current health state243. The five 
domains include mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. Each domain has three statements to describe participants’ 
current health, which are used to provide a single score, the EQ-5D Index score. 
Current health state is assessed using a scale where 0 is the ‘worst imaginable health 
state’ and 100 is the ‘best imaginable health state’ which provides an EQ-5D VAS 
score243.   
 
The EQ-5D has construct validity, test-retest reliability and responsiveness, 
particularly to health deterioration, and has been used in people with chronic 
pain244–246. Further the EQ-5D–Xhosa is reliable and validated241 and has been used in 
South African urban areas amongst amaXhosa PLWHA46,72. 
 
2.5.4 Self-efficacy  
In determining the effect of self-management programmes, measuring self-efficacy is 
necessary as it is believed to be integral to the programme’s success77. The Self-
efficacy for Managing Chronic Diseases Six-Item Scale (SE-6)162,247, Pain Self-Efficacy 
Questionnaire (PSEQ)248 and the HIV Symptom Management Self-Efficacy for Women 
Scale (HSM-SEWS)249 are three of many valid and reliable self-efficacy scales162,248,249. 
Although the PSEQ was developed for people with chronic pain248 and the HSM-
SEWS for women LWHA249, and therefore both appear appropriate for assessing 
change in self-efficacy in women LWHA with pain, isiXhosa versions of the 
instruments do not exist. Further, the HSM-SEWS, would be problematic for 
comparison of results between gender249. 
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As HIV/AIDS is a chronic disease, the SE-6162,247 is appropriate for use amongst 
PLWHA9. Further, it has been used in self-management programmes, such as the PL 
programme amongst PLWHA46,47,169, to measure change in self-efficacy162. The mean 
average of the six questions, making up the instrument, answered on a scale of one 
(not at all confident) to ten (totally confident) determines the total self-efficacy 
score247. The SE-6-Xhosa is validated and has single factor structure with good 
internal consistency7. For a combination of these reasons the SE-6-Xhosa is the 
measurement instrument of choice for evaluating self-efficacy changes in the 
present study. 
 
2.5.5 Physical function 
Pain changes individuals’ physical performance and their ability to participate in daily 
activities78,250. PLWHA, and experiencing pain, have lower performance levels than 
their healthy counterparts78,250. Recent Consolidated Standards for Reporting Trials 
(CONSORT) and Outcome Measures in Rheumatology (OMERACT) groups 
recommend that both patient reported measures and performance based outcomes 
should be used in pain studies as they are complementary and provide more 
comprehensive measurement of physical function. Additionally, a broader 
assessment of physical function should be made, assessing physical function in light 
of participation and other inter-related International Classification of Functioning, 
Disability and Health (ICF) elements251. 
 
The physical performance task battery (PPTB) is a performance based outcome 
measuring physical function using a set of familiar simple and complex physical 
function tasks measured in time, distance or speed78,252. The BPI, already chosen as 
an outcome measure for pain, provides a patient reported measure for physical 
function by measuring pain interference251. 
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The PPTB has been tested amongst people with back pain, people living with cancer 
and PLWHA and each test was reliable and valid78,252,253. The PPTB outcome measure 
is appropriate for specific conditions as the functional tests included in the battery 
differ depending on the condition it was tailored for78,251,252,254,255. The tests measure 
speed and co-ordination, balance, and endurance78,252 and have been used to 
identify differences in function between PLWHA and healthy people78. Testing 
different aspects of function with a variety of tests provides a broader assessment 
than if one test was performed independently, such as the six-minute walk test 
(6MWT), which is included in the PPTB251. Further, there is a moderate correlation 
between performance in the battery of tests and participants’ self-report on function 
(r = 0.25 - 0.51)252.  Of the self-report measures, the Functional Status Index yielded 
the strongest correlation252.  
 
As the functional tests are valid as individual tests, the battery can be tailored 
towards the context of participants and treatment (by omitting irrelevant or 
unhelpful tests), which is a further strength of the outcome251,252. As the coin test, 
was found to be the least consistent test in one study252 it was not included in the 
battery used for the present study. The sock test was also omitted as it measures 
dexterity and is therefore not a valuable test for measuring the effect of the exercise 
programme developed by Parker and colleagues46, which focused on endurance, 
strength and flexibility. Further, in a previous South African study by Saw and 
colleagues192, the sock test was not useful for determining the effect of a similar 
exercise programme on function. Although the PPTB is time consuming (between 20-
40 minutes depending on participants), it is accepted by patients, simple to execute 
and feasible in resource-poor settings, such as rural South Africa55,56, as few 
resources are required252.  
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For the purposes of the present study the PPTB included the following tests: 
- 15 metres (m) walking at preferred speed. For this test, subjects are timed 
as they walk 7.5m, turn around, and walk back to the starting position at 
their preferred walking speed. 
- 15 m walk at fastest speed. Subjects are again timed as they walk 7.5m, 
turn around, and walk back to the start as fast as they can. 
- Unloaded forward reach. For this test, subjects stand adjacent to a wall on 
which a tape measure is positioned horizontally at shoulder height. 
Subjects reach forward as far as they can and the distance reached is 
measured in centimetres (cm). 
- Timed, repeated sit-to-stand. Subjects sit in a standard chair and are then 
timed as they stand up and then sit back down, twice. The test is repeated 
after a brief rest and the average time of the two trials is used.  
- Loaded forward reach.  For this test, subjects stand adjacent to a wall on 
which a tape measure is positioned horizontally at shoulder height.  They 
hold a weighted bar (4.5 kg) with both hands close to their body and at 
shoulder height. They then reach forward as far as they can with the bar 
in a horizontal position, maintaining their hands at shoulder height. The 
reach distance is recorded in cm.  
- Timed, repeated reach-up. For this test, subjects stand facing a wall and 
reach up as high as they can with both hands. A mark is placed on the wall 
at the reached distance. Subjects then reach up and return their hands to 
their sides three times, as fast as they can. 
- Distance walked in 6 minutes. Subjects walk as far and as fast as they can 
for 6 minutes. The distance walked is measured in metres at 6 minutes. 
(Subjects are allowed to rest if and as necessary during the 6-minute 
period.)  
- Timed belt tie. Patients sit in a standard chair and are timed as they wrap 
a standard wrap bandage (approximately 1 meter long) around their waist 
and tie it in front of them. 
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2.5.6 Health Literacy 
The Rapid Estimate of Adult Literacy in Medicine (REALM) and the Test of Functional 
Health Literacy in Adults (TOFHLA) or S-TOFHLA are commonly used health literacy 
measures190. The S-TOFHLA has good reliability and validity and is the most 
appropriate for testing the understanding of information256.  
 
Individual questions and demographics were measured against the S-TOFHLA using 
regression analysis to determine the highest predictors of limited health literacy, of 
which three questions were identified97. The questions asked for self-reported 
reading ability, how much help was needed to read health materials and the level of 
education obtained. In response to these three questions, the answers more 
indicative of having limited health literacy were a low self-reported reading ability, 
needing help frequently when reading health materials (Single Item Literacy Screener 
(SILS)) or a low level of education. The combination of these three questions is more 
comprehensive than using the SILS alone, as all three questions are predictors of 
limited health literacy97. The three questions were used to develop a shorter 
outcome measure than the 36-item S-TOFHLA, called the “SOS” health literacy 
screening tool97. 
 
The acronym “SOS” is a helpful mnemonic to remember questions related to: 
‘Schooling level’, ‘Opinion of reading ability’ and ‘Support needed’97. Reporting a 
completion of high school or less, indicating a reading ability of ‘okay’ or worse and 
stating that help is ‘sometimes’ or more often required to understand information on 
health is indicative of having a limited health literacy97. Although the “SOS” health 
literacy screening tool has not been translated into isiXhosa or studied in an 
amaXhosa population it will be used to measure health literacy in the present study 
as it is quick to use, simple to administer and there are no foreseen problems with 
translation.  
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2.6 Conclusion 
The prevalence of pain amongst rural amaXhosa women LWHA is likely to be high, 
similar to the high prevalence of pain which exists for urban amaXhosa women 
LWHA7,8. As pain is largely undermanaged in PLWHA24, especially for women and 
people with lower levels of education18,20,26–28, and South Africa has the largest 
population of PLWHA internationally1, managing pain well in PLWHA should be of 
high concern in South Africa. The extent of this problem is increased by the rising 
prevalence of HIV despite the incidence reducing, a consequence of the successful 
ART rollout30 and HIV/AIDS becoming a chronic debilitating condition9. Further, is it 
not simply managing pain which needs research, but the effect pain has on various 
aspects of health, such as HRQoL, self-efficacy and depression, which also deserve 
attention2,4,6,9,16,17,38,41,60,72–79. 
 
Literature infers the lack of and need for effective pain management for 
PLWHA18,19,21–24,27. Turning primarily to non-pharmacological interventions to 
manage pain in PLWHA is vital, due to the limited efficacy of pharmacological 
interventions for managing pain in HIV/AIDS22,80 and the biopsychosocial dynamics of 
pain2,16,18,20,21,23,27,60,61,257.  
 
The PL programme, a combination of education and physical exercise, within a 
similar format to a self-management intervention and based on the principles of 
CBT46,47, appears to be an effective alternative for managing pain compared to other 
pharmacological and non-pharmacological interventions used alone75–77,138–
140,144,145,147,148,162,169,170,175–177. PLWHA who participate in the PL programme should 
benefit from knowledge acquisition, increased self-efficacy164,165 and moderate 
intensity exercise, which is safe for PLWHA147,148. All of these aspects of the 
programme may bring about pain reduction76,77,140,144,162,170,177. 
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The PL programme has been identified as an effective non-pharmacological 
intervention for managing pain in urban amaXhosa women LWHA46. In this cohort 
pain severity and pain interference was significantly improved. In addition, it appears 
to be feasible in a resource-poor, rural setting and has moderately long-term 
effects46. 
 
Further research is recommended to critically assess the effectiveness and feasibility 
of the PL programme in rural amaXhosa women LWHA46. Although, it is likely to be 
appropriate for rural amaXhosa women, who share parts of the urban amaXhosa 
culture40, rural amaXhosa women may respond differently as a result of 
biopsychosocial differences. As highlighted in the review, the differences between 
urban and rural amaXhosa women in culture, level of education and psychosocial 
constructs need to be considered34,40–45. Research also suggests that an empathetic 
therapeutic relationship may have added to the improvement in pain in urban 
amaXhosa women LWHA who participated in the PL programme but the extent of 
the effect of the therapeutic relationship on pain in PLWHA is unknown46.  
 
In conclusion, a study on the effectiveness of the PL programme is indicated in rural 
amaXhosa women LWHA. Secondly, the study needs to be designed to allow 
comparison of the combination of the PL programme with a therapeutic relationship 
and a therapeutic relationship alone to establish the extent of the effect of the 
therapeutic relationship on outcomes of the study in Parker and colleagues46. 
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3 Chapter Three: Methods  
This chapter outlines the methods for the study designed to explore the following 
aim: “To determine the effect of the PL programme and therapeutic relationship 
combined intervention (PL intervention), in comparison to a therapeutic relationship 
intervention (TR intervention) on primary outcomes, pain severity and pain 
interference, and secondary outcomes, symptoms of depression, HRQoL, self-
efficacy and physical function, in rural amaXhosa women LWHA.” 
 
3.1 Research design 
A two-group single-blind (by interviewer) stratified convenience trial, with 
interviewer administered questionnaires and functional tests at Baseline and at 
Weeks 4, 8, 12 and 24, was conducted.  
 
3.2 Sample  
The present study used a sample of convenience of amaXhosa women LWHA, aged 
between 18 and 40 years and either on consistent ART for three months and 
registered on the Zithulele Hospital ART database or being monitored for their 
condition. All amaXhosa women LWHA who attended on the day of the ARV 
outreach clinics of Zithulele Hospital, in the OR Tambo District, at Pumalanga Clinic 
and Ngcwanguba Community Health Centre (CHC) were invited to participate in the 
study. These clinics, Pumalanga Clinic and Ngcwanguba CHC, were chosen as each is 
well situated with frequent public transport services, facilitating patient access. The 
sample was not intended to represent all amaXhosa women LWHA in rural areas.  
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3.3 Sample size and power analysis 
Sample size was calculated using change in pain severity on the BPI, a primary 
outcome measure of the present study. The mean (M) and standard deviation (SD) 
scores of the PSS in the previous study using the PL programme by Parker and 
colleagues46 were used to calculate the present study sample size. The changes in 
PSS in the previous study by Parker and colleagues46 were recorded at baseline (5.32 
± 1.93), week 0 (5.55 ± 1.65), week 4 (3.81 ± 2.89), week 8 (3.1 ± 3.03), week 12 (2.79 
± 3.38) and week 16 (1.81 ± 2.87).  
 
A change of three points in pain severity (on a scale from 0 - 10) is regarded as a 
clinically significant improvement in pain224,258, hence a minimum detectable 
difference value of three was used to calculate the required sample size. A sample 
size of four, six and thirteen participants per intervention group for a SD of 1.6, 2 and 
3 respectively was calculated to be statistically significant (p < 0.05) and provide a 
93%, 92% or 91% power respectively, to detect a three out of ten change in pain 
severity. Therefore, the power analysis indicated that a sample of 13 participants per 
intervention group, using the conservative estimate SD value 3, would render 
adequately powered results.   
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The sample size was increased after the power analysis to account for potential 
dropout in the group. In the previous study by Parker and colleagues46, non-
attendance ranged between 8% and 25% of the participants at PL programme weeks 
and data collection points. The number of participants in the PL intervention group 
also needed to be increased in order to ensure that each group was large enough for 
an appropriately sized group of 12 participants46. Therefore, the present study 
needed 24 participants in the PL intervention group in order that two appropriately 
sized groups of 12 participants could be made for the PL programme. The combined 
PL intervention group aimed to consist of 24 participants, which allowed for attrition 
as well as two appropriately sized PL programme groups. An additional 24 
participants were therefore to be allocated to the TR intervention group, making the 
entire sample 48. The power estimates were re-calculated with 24 participants in 
each group. For SD scores 1.6, 2 and 3 the results would be adequately powered at 
100%, 100% and 98% respectively. 
 
3.4 Inclusion and exclusion criteria 
Women LWHA who met the criteria for participation in the study, outlined in Table 
3-1, were recruited to take part. As discussed in the literature review, PLWHA using 
or not using ART experience pain8,24, therefore both of these groups were included in 
the study. However, in order to ensure stability of participants at Baseline, if those 
included in the present study had not been on a consistent regimen for three 
months, they were excluded. Patients were not excluded based on CD4 T-cell count, 
stage of disease or pain medication use to increase generalisability. However, these 
parameters were recorded.  
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Table 3-1: Inclusion and exclusion criteria for participation in study 
Inclusion criteria 
Any woman who: 
Exclusion criteria 
Any woman who: 
1. is ambulant, HIV+, amaXhosa and 
aged 18-40 years.  
 
1. is on ART but has yet not been on 
his/her present treatment regime 
consistently for three months.   
2. attends Pumalanga Clinic or 
Ngcwanguba CHC for ART or is being 
monitored for their condition at the 
clinic. 
2. has previously participated in an 
education and/or exercise 
intervention to instil skills for 
managing pain. 
3. answers “yes” to the first question 
on the BPI: “Throughout our lives 
most of us have had pain from time 
to time (such as minor headaches, 
sprains, toothaches). Have you had 
pain other than these everyday kinds 
of pain during the last three 
months?”. 
3. is considered unfit for exercise 
according to the American College of 
Sports Medicine (ACSM) 
guidelines259,260.  
 4. has a cognitive impairment or 
moderate to severe intellectual 
disability as assessed by a medical- 
officer and occupational therapist 
using clinical judgement and the Mini 
Mental State Examination or Allen 
Cognitive Level Screen Assessment 
where appropriate. 
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3.5 Outcome measures 
A validated isiXhosa-translation of almost all outcome measures was used and 
interview administered. Only the “SOS” health literacy screening tool for the 
assessment of health literacy was not available in isiXhosa and was translated by the 
research interpreter to ensure consistency. The demographic questionnaire 
(Appendix A; p.234) and the “SOS” health literacy screening tool (Appendix B; p.236) 
were interview-administered at Baseline only, while all other measurement 
instruments were administered at Baseline and each follow-up interview.   
 
The primary outcome of pain was measured by the BPI, which generates a pain 
severity score and pain interference score (Appendix C/1; p.237)227. Symptoms of 
depression were measured with the BDI (Appendix C/2; p.241)235. Health-related 
quality of life was measured by the EQ-5D, which measures an EQ-5D Index score 
and an EQ-5D VAS score (Appendix C/3; p.245)243. Self-efficacy was measured with 
the SE-6 (Appendix C/4; p.253)247. Physical function was assessed by the PPTB, a 
physical performance battery of objective tests (Appendix C/5; p.255)254.  
 
The “SOS” health literacy screening tool was used as a health literacy screen in the 
present study. The “SOS” health literacy screening tool has not been translated into 
isiXhosa or studied in an amaXhosa population. This was partially addressed in the 
present study.  
 
3.6 The intervention 
The study included two intervention groups, the PL intervention group and the TR 
intervention group. The PL intervention group received two interventions, as they 
participated in the PL programme and the TR intervention. The TR intervention group 
only received the TR intervention. A diagram indicating the different roles and 
responsibilities for the implementation of the PL intervention group and TR 
intervention group can be found at the end of this section (Figure 3-1; p.91). 
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3.6.1 The ‘Positive Living’ programme 
Participants of the PL programme attended a peer-led group, which met over six 
consecutive weeks for two hours per week and was guided by the PL workbook 
(Appendix D; p.257). Each participant received both the English and isiXhosa versions 
of the workbook (printed in black and white), as participants in the previous study on 
the PL programme expressed that having both language versions improved 
comprehension7. Participant attendance was recorded on a register.  
 
Peer-leaders, who were HIV-positive, were identified by managers in the Zithulele 
Hospital ART programme. The two prospective peer-leaders identified were chosen 
as they were each well respected by community members, had dynamic, influential 
and encouraging characters, and had previous history of leadership in the ART 
programme. Both candidates had previously worked as peer-educators, educating 
peers on LWHA by spoken information provision during support groups. Once 
identified and chosen, both of the prospective peer-leaders were trained to facilitate 
the ‘Positive Living’ programme. One of the trained peer-leaders was unable to 
follow through on her commitment to the study and ‘Positive Living’ programme due 
to personal reasons. Therefore, the remaining trained peer-leader became the 
facilitator of the groups. 
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Training of the prospective peer-leaders was conducted by the researcher and took 
place in January and February 2015 over four weeks and incorporated 40 hours of 
training (ten hours per week). Before training began, the prospective peer-leaders 
were given the PL workbook to familiarise themselves with and an orientation into 
what would be required of them as peer-leaders in the study. The training was done 
at Zithulele Hospital and Pumalanga clinic, where the intervention would take place. 
As the researcher was not fluent in isiXhosa, two training assistants were chosen to 
help with training. The two training assistants each had the greatest amount of 
experience with interpreting out of the hospital staff. Additionally, one training 
assistant was an ARV clinic co-ordinator and had previous experience with training 
peer-leaders to facilitate groups. The role of the two training assistants was two-fold. 
One responsibility was to aid understanding between the researcher and the peer-
leaders in communication by interpreting when necessary. The second responsibility 
was to ensure that the content of the book and meaning of the message were not 
lost when the peer-leaders practiced the PL programme facilitation. 
 
As the prospective peer-leaders’ previous role as peer-educators had been more 
didactic in nature and additionally included some counselling, it was imperative that 
the peer-leaders first understood their new roles in the present study. The 
pedagogical approach in the PL programme was of facilitated experiential learning, 
which both candidates were able to demonstrate over the process of training.  
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Peer-leaders were trained to do group facilitation, use the workbook as a guide and 
be familiar with its contents. During this process the candidates learnt not to rely on 
previous knowledge from their role as a peer-educator or to use a didactic approach. 
Training covered how to start a session, facilitate discussion on workbook 
educational topics, lead exercise routines and recognise adverse symptoms of 
exercise, facilitate relaxation techniques, and facilitate action planning and its 
modification. During training, each week’s session was conducted by the researcher 
in English and observed by the peer-leaders, who afterwards would run the session 
in isiXhosa to practice until the standard of facilitation was high. Areas within the 
session would be revisited to allow for improvement. During facilitation by the peer-
leaders in isiXhosa, the training assistants’ role was essential for achieving a high 
standard of facilitation. 
 
The outline of topics, content and activities included in the PL programme for Weeks 
one to six are presented in Table 3-2. Week one of the PL programme commenced 
with a discussion on maintaining group confidentiality and signing contracts 
(Appendix E; p.328) to promote commitment to the group members and to 
attendance. After each session, the peer-leader was debriefed by the researcher to 
ensure content veracity and peer-leader skill maintenance by making 
recommendations for the following sessions. Further, the debriefing served as a time 
for the researcher to provide support to the peer-leader. 
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Table 3-2: Outline of the PL programme over Weeks one - six 
      
 
 
 
 
Discussion 
topic 
Content Action 
planning  
Exercise 
routine 
Relaxation 
Week one:  
Self-
management 
and exercise 
What is meant by “self-
management”? 
Self-management steps 
Action plans 
Exercise 
Types of exercise 
Steps to success with 
exercise 
An exercise routine 
Exercise - Included 
Week two: 
Managing 
common 
symptoms of 
HIV/AIDS 
Symptom management 
Action charts for common 
symptoms 
Coughing  
Depression 
Diarrhoea 
Fever 
Headache 
Eye 
Nausea and vomiting 
Shortness of breath 
Sore throat and mouth 
Skin problems 
Urination problems 
Managing 
symptoms + 
exercise 
20 
minutes  
Included 
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       46,47 
 
Each session had an educational discussion topic, on which participants would 
develop an action plan. The action plans facilitated skill development, which 
influences self-efficacy as described in the literature review (Chapter 2.4.2.2; p.42). 
For Week one an action plan was developed for exercise, which over the programme 
was reviewed and re-developed weekly. Other action plans corresponding to the 
topic focused on during a session were reviewed the week after the topic was 
discussed.  
  
Discussion 
topic 
Content Action 
planning  
Exercise 
routine 
Relaxation 
Week three:  
Stress 
management 
What is stress? 
Managing stress 
Sleep 
Communication with your 
health carer 
Relaxation skills 
Stress 
management 
+ exercise 
22 
minutes 
Included 
Week four:  
Pain 
Causes of pain in HIV/AIDS 
Pain self-management 
Pain + 
exercise 
24 
minutes 
Included 
Week five:  
Eating well 
Balanced nutrition 
Dealing with barriers to 
eating well 
Food safety 
Eating well + 
exercise 
26 
minutes 
Included 
Week six: 
Continuing as 
a successful 
self-manager 
Action planning for the 
future 
Reflection on changes 
Continuing as 
a successful 
self-manager 
28 
minutes 
Included 
87 
 
Participants took part in an exercise routine from Week two onwards, which 
followed the routine provided in the workbook and was amended weekly by adding 
two minutes of a new exercise. A relaxation session took place at each weekly 
session of the intervention to facilitate practicing relaxation using one of two 
relaxation strategies outlined in the workbook. The six-week course concluded with a 
certificate of graduation. 
 
3.6.2 The therapeutic relationship intervention 
Participants from both intervention groups were assessed by the same empathetic 
research assistant (RA) at data collection Weeks 0, 4, 8, 12 and 24. A therapeutic 
relationship developed during the interaction between participants and the RA, 
facilitated by the interview administered questionnaires. As the TR intervention 
group received this intervention only, the results from this group determined the 
effects of the therapeutic relationship independently on pain and other outcome 
measures.  
 
The RA was chosen because she possessed the ability to show empathy and develop 
a therapeutic relationship. The factors contributing towards a therapeutic 
relationship are outlined in the literature review (Chapter 2.4.2.6; p.62). Additional 
training helped the RA to understand and develop how to purposely generate a 
therapeutic relationship and to maintain the therapeutic relationship with 
participants over the study period.  
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Training was done by the researcher (a qualified physiotherapist) during January and 
February 2015. The RA was trained over 12 hours, during three sessions, before the 
intervention began. Thereafter, contact with the RA was made before and after each 
data collection day to review important aspects of the training and to address 
questions which the RA had, as well as to debrief the RA. The researcher was also 
available during the data collection days for any questions which arose. Training of 
the RA encompassed developing skills to perform the interview-administered 
questionnaires whilst displaying an empathetic relationship. To enhance the 
empathetic relationship, training included developing empathy, communication 
skills, interpersonal skills and self-awareness to enhance therapeutic relationship 
building with participants. 
 
The RA was trained to show care for the participants. This care included encouraging 
attendance at data collection appointments and showing interest in participants 
through phone calls for follow-up date reminders, and gently and kindly asking the 
reason when participants were unable to attend. Further, empathy was developed 
by training the RA to be able to shift perspective and develop understanding of the 
participant’s experience in order to reflect the participant’s experience back to the 
participant and respond appropriately. Part of this training included communication 
skills training. 
 
Improving communication skills plays a role in the perception of care. Being able to 
listen for verbal cues and observe and notice non-verbal cues developed the RA’s 
ability to improve the therapeutic relationship198,208–210. Further, aspects of the RA’s 
behaviour towards participants was focused on, ensuring that various interpersonal 
skills were enhanced such as being friendly, confident, empathetic, encouraging and 
respectful198,211. The RA was trained to appropriately greet participants on arrival in a 
friendly warm manner and by showing genuine interest in the participant which is 
appropriate for the amaXhosa culture. As the RA was amaXhosa herself, respectful 
greetings and conversations enquiring after the participant and their family and 
context came naturally to her.  
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The RA was also trained in the importance of building trust and facilitating trust by 
providing confidentiality, privacy and a non-judgmental space for the participant to 
express themselves. Training of this kind is valuable, as the character and behaviour 
of the RA, according to literature, have more influence on the TR than that of the 
patient195,197. 
 
It was imperative that the RA showed empathy to participants over the whole study 
period. In order to strengthen and maintain this, in the present study, debriefing 
occurred after each data collection date to provide a form of support as well as time 
for self-reflection to increase self-awareness216,217. Further, a social worker was also 
available for the RA for further debriefing as necessary. 
As the RA also conducted the interview-administered questionnaires, training 
included ensuring that the RA was familiar with the outcome measures. The 
researcher first went through each outcome measure with the RA. Thereafter, the RA 
practiced the outcome measures on the researcher, who acted as a participant, to 
ensure that the RA could perform all of the outcome measures with participants in a 
consistent manner and record data accurately. Various scenarios were played out in 
order to ensure that the RA could cope with different responses by participants and 
that the explanations provided by the RA were consistent despite different 
participants. The manner in which the data were collected was purposely thought 
through to achieve the perception of empathy by the study participants. Therefore, 
the data collection was not done only as a task to be completed but created an 
atmosphere for an empathetic therapeutic relationship and trust to be built. 
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With regards to the VAS in the BPI, more focus was placed in training how to explain 
the question if the VAS was not understood. Scenarios were played out by the 
researcher acting as a participant to train the RA to be able to problem-solve if 
participants found difficulty in answering questions such as the VAS in the BPI or 
picking only one answer of three options as necessary in the BDI. Training also 
addressed re-explaining and ensuring understanding if the numbers given for each 
question did not make sense in relation to other questions within the BPI, for 
example if the worst score for pain was a lower score than the average score for pain 
in the last week. The RA also practiced explaining the term “average” in order to 
have a consistent explanation if the question was not initially understood. For 
questions, such as in the BPI and the EQ-5D with multiple options, it was emphasised 
that only one option should be chosen by the participant and that therefore if the 
participant responded with two answers the RA would encourage them to choose 
one option. The PPTB was practiced multiple times in order to ensure that the set-up 
was equal at each data collection point and that accurate data recording, which was 
reliable, was collected. 
 
Participant attendance of data collection follow-ups were recorded by a register. Due 
to many difficulties with patient transport and community events being held on 
participants’ follow-up dates, participants were provided with a second date to 
attend within seven days of their original data collection date should they not be 
able to attend the original date. Participants who were unable to attend their follow-
up were given the option of doing a telephonic-based interview, in which all 
outcome measures were completed except the PPTB. 
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Figure 3-1: Roles and responsibilities for the implementation of the PL intervention group and TR intervention group 
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3.7 Procedure 
The procedure which was followed is illustrated in Figure 3-2 (p.93).  
 
Prior to sample recruitment, the RA, who conducted the interviewer-administered 
questionnaires for data collection, was trained on all outcome measures. Piloting was 
performed with five participants (>10% of the proposed sample) to establish whether 
the recruitment and data collection process was feasible and acceptable for rural 
amaXhosa women LWHA and it allowed for establishment of inter-rater reliability.  
 
Piloting of the recruitment process was done by the researcher, who was assisted by 
an interpreter throughout the study, and included the informed consent process and 
screening for inclusion and exclusion criteria. Thereafter demographic information 
was collected using the demographic questionnaire and the “SOS” health literacy 
screening tool was performed. On completion of screening, baseline outcome 
measures were obtained by the researcher with help from the interpreter for the 
participants who were piloted only. The outcome measures were repeated by the RA 
one the same day to establish inter-rater reliability. The results of the repeated 
outcomes were satisfactory for the most part but one problem was identified, which 
was that sometimes patients answered the pain severity ‘on average’ as higher or 
lower than the ‘at its worst’ score. This was noted for further analysis when the data 
collection was complete. In addition, training was done with the RA to develop 
standard explanations of the term ‘average’. 
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Figure 3-2: Procedure for the study 
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Thereafter, in February and March 2015, recruitment from ARV clinics at Pumalanga 
Clinic and Ngcwanguba CHC commenced. Medical officers, nursing staff and word-of-
mouth at the clinic directed women LWHA who indicated an interest in participating 
in the study to a consulting room for the recruitment process. The research 
interpreter who helped during piloting, interpreted for the researcher during the 
whole recruitment process. If participants had completed pre- and post-test 
counselling they were screened for inclusion and exclusion criteria, including 
completing a screening for exercise safety (Appendix F; p.330) and cognitive 
impairment. If they were eligible for the study they were invited to participate in the 
study and the informed consent process was completed. If consent was given the 
researcher completed a demographic questionnaire and “SOS” health literacy 
screening tool with each participant. History taking was performed and medical 
notes in clinical notes and files were reviewed to collect relevant clinical information.  
 
Participants from Pumalanga clinic were allocated to the PL intervention group, while 
participants from Ngcwanguba CHC were allocated to the TR intervention group. This 
approach was used to prevent contamination. The two clinics are located far apart 
geographically, around 20 kilometres of hilly terrain, therefore minimising the 
interaction between the two communities261. By road, either a dirt road of around 23 
kilometres or a tar road of 28 kilometres, separate the two clinics261. Pumalanga was 
chosen as the site for the PL intervention group as the setting had a separate venue 
where the PL programme could run while maintaining blinding of the RA.  
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Separate information sheets and consent forms were created for the two 
intervention groups, which were translated into isiXhosa via forward and back 
translation, to maintain the semantics of the English version. The English and 
isiXhosa versions are both provided in the appendices (Appendix G; p.331). The 
consent form was read out by the research interpreter to the prospective 
participants to ensure that reading ability didn’t create a barrier to their 
understanding the contents of the form. Prospective participants could also take the 
consent forms home to discuss and decide on participation with family, however no-
one took up this offer. The opportunity to ask questions and raise concerns was 
available during recruitment and at all times during the study.   
 
Participants were informed that all transport costs would be reimbursed as it was an 
extra expense incurred due to study involvement and the PL intervention group were 
informed that they would receive a graduation certificate at their final session. 
Additionally, at data collection points and during the PL programme sessions a small 
snack and a drink would be provided to help sustenance during the clinic visits.  
 
All participants were given a number by random number allocation, which protected 
their identity from being linked to data collected, maintaining confidentiality, and 
assisting with blinding. Participants were explicitly told to keep the intervention 
group they participated in unknown to the RA. The RA remained unaware of the 
venue and PL programme sessions and reported being unaware of the participants’ 
allocated intervention. 
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There were 26 participants recruited for the PL intervention group and 25 recruited 
for the TR intervention group. The PL intervention group was split into two groups of 
12 and 14 for the PL programme. This smaller group size was based on the number of 
participants in the PL programme group in the study by Parker and colleagues46,47, as 
explained in the section on sample size (Chapter 3.2; p.77). All study participants 
were provided with appointment cards and were reminded telephonically via a 
cellular phone by the research interpreter of the PL programme dates and by the RA 
for data collection point dates. Refer to Figure 3-3 (p.97) for procedure and timeline 
for the PL and TR intervention groups. 
 
After recruitment, participants’ baseline outcomes measures were obtained by the 
RA. Two participants did not arrive for their baseline outcome measures and 
dropped out of the study leaving 23 participants in the TR intervention group. A 
week after recruitment and baseline measures were completed the PL programme 
commenced. 
 
During the PL programme and data collection, if participants did not arrive they were 
contacted to encourage future participation and remind them of the next date. This 
helped to minimise missing data, ensure that participants were aware of the next 
date in order to facilitate continuity in the study, and contribute to developing the 
therapeutic relationship by indicating care when a follow-up date was missed. 
 
During the study, participants were observed, by the peer-leader and RA, for signs 
and symptoms of worsening condition, to ensure exercise was always safe or a 
timeous referral to a medical officer was made if necessary. The peer-leader and RA 
were trained to alert the researcher if any concerns arose, however no concerns 
regarding exercise and health deterioration arose. 
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Figure 3-3: Procedure and timeline for the PL and TR intervention groups 
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The researcher was alerted to any concerns raised by the RA regarding the BDI. The 
RA was trained to refer participants to a social worker if they presented with 
moderate to severe depression on the BDI. However, participants who answered “I 
would like to commit suicide” or “I would commit suicide if I got the chance” were 
escorted directly to the social worker. If these answers were given over telephone 
based interviews, then participants were asked to come into Zithulele Hospital and 
the social worker was given their details immediately to phone them and make a 
home visit if necessary. 
 
After the completion of the Week 24 data collection point, a post study structured 
interview was conducted by the research interpreter. The series of open-ended 
questions (Appendix H; p.358) were asked telephonically, over a cellular phone, and 
differed for the two intervention groups. The PL intervention group interview 
questions were relevant to understanding the impact of the PL programme and its 
workbook and assessing whether further development was needed. Additionally, the 
PL intervention group post-study interviews were done to discern whether any 
contamination had taken place. The TR intervention group post-study interview was 
structured to further identify if any information from the PL programme and 
workbook had been disseminated to participants in the TR intervention group. 
 
3.8 Ethical considerations 
Before study commencement ethical approval was obtained from the Faculty of 
Health Sciences, Human Research Ethics Committee, University of Cape Town (HREC 
REF: 932/201) (Appendix I/1; p.361) and the Eastern Cape Department of Health 
(Ref: EC_2015RP30_713) (Appendix I/2: p.363). Additionally, permission for this 
research was granted by the Chief Medical Officer at Zithulele Hospital (Appendix I/3: 
p.364). The researcher is a qualified physiotherapist, registered with the Health 
Professions Council of South Africa (registration number: PT0116360). Throughout 
the study, adherence to the principles of the Declaration of Helsinki was 
maintained262.  
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Participation was voluntary and the information sheet and informed consent form 
contents were verbally communicated to ensure that participants could fully 
understand irrespective of their reading ability or health literacy, in order to make an 
informed decision to participate. It was disclosed that participants would participate 
in one of two intervention groups and that on completion of the study, should it be 
found that one intervention group received a significantly inferior intervention, 
participants would be given access to the superior intervention. Participants were 
informed that they were always allowed to ask questions, raise concerns or 
withdraw from the study. The Flesch Reading Ease Scores for the information sheet 
and consent forms of the PL and TR intervention group were 70.1/100 and 71.6/100 
respectively. According to the Flesch-Kincaid Grade Level the contents of the 
informed consent forms for the PL and TR intervention group are readable at a grade 
8 and grade 7 level respectively.  
 
Patient confidentiality was maintained by the researcher, research interpreter, RA, 
peer-leader and participants and all people involved signed contracts to this effect. 
Only relevant and valuable information for the study were accessed from records 
and handheld clinic cards. Using coding for the data collection maintained patients’ 
anonymity and the RA sealed data in envelopes, which were only accessible by the 
researcher. To further protect participants’ confidentiality, participants were 
contacted telephonically over cellular phones instead of using a short messaging 
service, as some participants shared cellular phones with other people. At closure of 
the study all data are to be kept in a locked filing cabinet by the research supervisor 
for five years.   
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On occasion participants requested to be interviewed alongside another participant. 
As patient confidentiality is important to ensure and therefore a delicate matter, 
participants who came forward together requesting to have interviews done 
together were each asked if they consented to this. In order to ascertain if they were 
completely willing, participants were asked for their consent individually, and were 
not in the presence of any other participants at the time of this question. Careful 
consideration was taken to detect any hesitation disclosed by participants in verbal 
and/or non-verbal responses.  
 
As there was a risk of participants being recognised by community members as being 
HIV+ and thereafter experiencing HIV stigma, efforts were made to minimise this 
risk. The PL workbook’s cover had no obvious associations to HIV/AIDS and apart 
from ARV clinic days being used for recruitment, the venues were not clearly 
associated with HIV/AIDS. Furthermore, as mentioned previously, confidentiality was 
maintained throughout.  
 
Compensation was fully disclosed at recruitment and was not compelling in any way 
to persuade participants to participate in order to receive compensation. Participants 
were treated equally to all other patients when seeking health care services and 
given no privileges during standard health care treatment. Monetary compensation 
covered the exact cost of transport to and from the clinic, enabling those with 
limited finances to take part and not causing any financial burden.  
 
Participation did not interfere with standard health care treatment and referrals for 
extra health care were made as appropriate when identified during the course of the 
study. A social worker was available for those with moderate to severe depression 
according to the BDI and a plan was put in place for participants if they were at risk 
of suicide. Screening for exercise safety at recruitment ensured that all participants 
were safe to exercise and further, the peer-leader and the RA were trained to 
recognise symptoms of distress during exercise. The peer-leader also ensured the 
creation of safe action plans.  
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The intention of the study was to benefit amaXhosa women LWHA with the aim of 
decreasing pain severity and pain interference by facilitating participants in the PL 
programme groups towards becoming successful self-managers and to benefit 
participants by a TR intervention. Potential existed for further benefit by decreasing 
depression and improving HRQoL, function and self-efficacy. This study was built on 
previous work in managing pain in PLWHA, in urban amaXhosa women specifically46 
and intended to research options for feasible and effective pain management 
strategies for rural amaXhosa women LWHA. Furthermore, this research contributed 
to research establishing effective non-pharmacological pain management in PLWHA, 
especially in South Africa where the largest HIV+ population lives.  
 
3.9 Data management and statistical analysis 
The primary outcome of pain in this study, as measured by the Pain Severity Score 
and Pain Interference Score of the BPI, using an 11-point VAS, were regarded as ratio 
variables for groups263.  As ratio data, the difference between scores on the VAS are 
meaningful for groups, and the difference between a score of two and three on the 
VAS is of the same intensity, on average, as the difference between a score of five 
and six. If Pain Severity Scores have halved it means that pain, on average, is half the 
pain intensity experienced before263. To determine the type of analysis to be 
conducted, distribution of the primary outcome measure, was tested using the 
Kolmogorov-Smirnov test. Data were normally distributed (d = 0.08; p > 0.2) and 
therefore, parametric statistical analyses were conducted.   
 
Distribution of all other data sets at Baseline were also tested using the Kolmogorov-
Smirnov test. Data for age, CD4 T-cell count at diagnosis and recent CD4 T-cell count, 
symptoms of depression, HRQoL (EQ-5D VAS only), self-efficacy and physical function 
were all normally distributed. Only the EQ-5D Index data set was not normally 
distributed. 
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A pragmatic approach to statistical analysis was followed for ease of interpretation 
of results. In the pragmatic approach, the distribution of the primary outcome 
measure is used to guide the analysis across all data264. This approach meant that 
despite the EQ-5D Index data not being normally distributed, parametric tests were 
still used, guided by the normal distribution of the primary outcomes, and in keeping 
with the rest of the secondary outcomes. In addition, parametric testing was 
conducted on the CD4 T-cell counts, in keeping with the pragmatic approach264, 
despite CD4 T-cell counts being more commonly regarded as a non-parametric 
variable265,266. 
 
Accordingly, results are presented as means (M) and standard deviations (SD) 
throughout. Descriptive measures such as frequency tables, proportions and Pearson 
Chi-squared tests (χ2) were used to analyse categorical data. Box and whisker plots 
for pain severity and intensity, CD4 T-cell count at diagnosis, recent CD4 T-cell count, 
and the EQ-5D Index measure of HRQoL can be found in Appendix J (p.369) for depth 
of presentation. 
 
Mixed model regression was used to test the effects of group, time, and group and 
time interactions, on pain severity, pain interference, depression, HRQoL (EQ-5D VAS 
and EQ-5D Index), self-efficacy and independent timed and distance tests of the 
PPTB. Two-way analysis of variance (ANOVA) was not used to test for significance, as 
mixed model regression was favourable for repeated measures in the presence of 
missing data. 
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For the regression analysis, initial diagnostic tests were performed on individual data 
sets with missing data to determine that data were appropriate to use regression. If 
data were not normally distributed as a consequence of missing data, they were 
transformed as necessary. Regression was used to fit a null model, which each model 
was then compared with. Four models, which were group, time, group and time, and 
group and time with a random intercept and slope, were assessed. If significance in a 
model was found, family-wise p-value correction was performed to test for multiple 
comparisons and reduce inflation of significance. If multiple models remained 
significant after correction, comparisons were made using ANOVA to determine the 
best model. Thereafter, family-wise p-value corrections were repeated. If no 
significant model was found to be better, the simplest model was chosen. To 
illustrate change over time ANOVA tests were conducted to accompany the results of 
the multiple regression analysis. 
 
In cases where no model would fit, such as with the data for the EQ-5D Index and the 
timed repeated sit-to-stand, the repeated reach-up and the belt-tie tests, analyses 
was conducted with a t-test and a one-way ANOVA, in keeping with the parametric 
approach. 
 
Significance was accepted at p < 0.05. Analysis was by intention to treat. For mixed 
model regression and all other analyses, the original data set with missing data was 
used. All data were captured on a Microsoft Excel spreadsheet. R Version 3.1.2 was 
used for model regression analysis and included use of the ‘ordinal’, ‘lme4’, 
‘GAMLSS’ and ‘car’ packages267–271. The graphs were produced using GraphPad Prism 
Version 6272 and the remaining data were analysed by STATISTICA®273. The 
researcher completed all univariate analyses while mixed model regression was 
carried out by Associate Professor Peter Kamerman from the School of Physiology, 
University of Witwatersrand.  
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4 Chapter Four: Results 
This section will first present the sample. The attendance of participants at the PL 
programme and data collection points of the PL intervention group and TR 
intervention group will follow. Thereafter the socio-demographic and clinical 
characteristics of the participants, analysis of change of the primary outcome, pain, 
and secondary outcomes over time will be presented. Lastly, the responses to open-
ended post-study interviews will be presented. The results are presented for the 
sample (N = 49), the PL intervention group (n = 26) and the TR intervention group (n 
= 23).  
 
4.1 Sample 
The study took place from February 2015 and September 2015. In total, 84 women 
LWHA were screened at Pumalanga clinic (n = 43) and Ngcwanguba CHC (n = 41) for 
participation in the study. The procedure for recruitment and screening is illustrated 
in Figure 4-1.  
 
Of the 26 participants in the PL intervention group, the number of attendees 
fluctuated weekly (Figure 4-2). For data collection points, which all participants 
attended at Baseline and Weeks 4, 8, 12 and 24, attendance fluctuated for various 
reasons, as stated in Figure 4-2. There were six participants in the PL intervention 
group and eight in the TR intervention group who attended all of five data collection 
points.  
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Figure 4-1: Screening, recruitment and allocation procedure  
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Figure 4-2: Attendance of PL programme and data collection pointsb 
 
                                                     
b The expression ‘failed to attend’ refers to there being no known reason for non-
attendance, as sometimes participants were not reached when contacted.  
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The results represent the number of participants reported at each data collection 
point in Figure 4-2 (p.106), except where otherwise stated in the chapter. 
  
4.2 Socio-demographic characteristics  
Socio-demographic data were collected in the demographic questionnaire at 
recruitment.  
 
4.2.1 Age 
The mean age for the sample was 33 years (± 5). No significant difference between 
groups was found for age (t = 0.72; p = 0.48) between the PL intervention group (33 
years ± 5) and the TR intervention group (32 years ± 4). 
 
4.2.2 Employment, highest level of education and health literacy  
Unemployment, independent of reason, was the predominant employment status in 
the sample with over 80% unemployment levels in both groups. Of participants who 
were unemployed, over 50% were not looking for work. Over half the participants 
attended high school and the most common highest level of education (HLOE) 
category was eight to nine years of education (34.7%). All participants had limited 
health literacy. No significant differences were found between groups for 
employment status, HLOE and health literacy (Table 4-1). 
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Table 4-1: Employment status, highest level of education and health literacy of the 
participants and PL and TR intervention groups (N = 49) 
 Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Number (%) Number (%) Number (%) Significance 
Test 
Employment  N = 49 n = 26 n = 23 χ2 = 1.42; p = 
0.7 
     Unemployed   
     - not looking    
     for work 
23 (47) 12 (46) 11 (48)  
     Unemployed      
     – looking for  
     work 
17 (35) 9 (35) 8 (35)  
     Employed 8 (16) 5 (19) 3 (13)  
     Unable to  
     work –    
     disability  
     grant 
1 (2) 0 (0) 1 (4)  
     
Highest level of 
education  
N = 49 n = 26 n = 23 χ2 = 2.11; p = 
0.55 
     No schooling 4 (8) 1 (4) 3 (13)  
     Gr.1-7 15 (31) 7 (27) 8 (35)  
     Gr.8-9 17 (35) 10 (37) 7 (30)  
     Gr.10-12 13 (27) 8 (31) 5 (22)  
     
Health literacy N = 49 n = 26 n = 23  
    Limited health   
     literacy 
49 (100) 26 (100) 23 (100)  
     Adequate  
     health literacy 
0 (0) 0 (0) 0 (0)  
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4.3 Clinical characteristics 
4.3.1 Medical history 
Participants were all HIV positive, as required by the inclusion criteria, with a mean 
of 3.96 (± 3.25) years since diagnosis and no significant difference between the 
groups. The mean CD4 T-cell count at diagnosis for the sample was 232 cells/l (± 
95). A significant difference was found for CD4 T-cell count at diagnosis between the 
PL group (206 cells/l ± 73) and the TR group (269 cells/l ± 112; t = 2.13; p = 0.04). 
However, no significant difference existed between groups at the most recent CD4 T-
cell count, with a sample mean of 461 cells/l (± 239) (Table 4-2). 
 
Table 4-2: Years since diagnosis (N = 48), CD4 T-cell count at diagnosis (N = 39) and 
recent CD4 T-cell count of the participants and PL and TR intervention groups (N = 
45) 
 
 
 
Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Significance Test 
Years since 
diagnosis 
N = 47 n = 25 n = 22  
        Years 3.97 ± 3.25  
(0.25 - 13) 
4.33 ± 2.56 
(0.25 - 10) 
3.56 ± 3.92 
(0.25 - 13) 
t = 0.81; p = 
0.42  
     
CD4 T-cell 
count at 
diagnosis 
N = 39 n = 23 n = 16 t = 2.13; p = 
0.04* 
     Cells/l 232 ± 95 
(32 – 505) 
206 ± 73 
(32 – 336) 
269 ± 112 
(36 – 505) 
 
     
Recent CD4 T-
cell count 
N = 45 n = 25 n = 20 t = 0.52; p = 
0.61 
     Cells/l 461 ± 239 
(54 – 1120) 
478 ± 251 
(54 – 1038) 
441 ± 227 
(195 – 1120) 
 
* Indicates a significant difference between groups 
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4.3.2 HIV management 
The participants were primarily on first-line ART while few participants were being 
monitored (8.16%) or were on second-line ART (10.2%). There was no significant 
difference between the groups in HIV management (χ2 = 0.42; p = 0.81) (Table 4-3).  
 
Table 4-3: HIV management of the participants and PL and TR intervention groups (N 
= 49) 
 Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Number 
(%) 
Number 
(%) 
Number 
(%) 
Significance 
Test 
HIV 
management  
N = 49 n = 26 n = 23 χ2 = 0.42;  
p = 0.81 
     Monitoring  4 (8) 2 (8) 2 (9)  
     First-line 40 (82) 22 (85) 18 (78)  
     Second-line 5 (10) 2 (8) 3 (13)  
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4.3.3 History of opportunistic infections 
The most common opportunistic infection (OI) reported by participants was 
pulmonary tuberculosis. Commonly participants were unaware of other OIs and 
these were not recorded or specified in clinic card records. No significant difference 
existed between groups for prevalence of opportunistic infections (Table 4-4).  
 
Table 4-4: History of opportunistic infections of the participants and PL and TR 
intervention groups (N = 49) 
 Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Number 
(%) 
Number 
(%) 
Number 
(%) 
Significance 
Test 
Medical history 
of opportunistic 
infections   
N = 49 n = 26 n = 23 χ2 = 6.12; 
p = 0.47 
     Previous  
     pulmonary  
     tuberculosis 
10 (20) 2 (8) 8 (35)  
     Previous 
     extra-      
     pulmonary  
     tuberculosis 
1 (2) 1 (4) 0 (0)  
     None known  38 (78) 23 (88)  15 (65)  
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4.3.4 Co-morbidities 
Co-morbidities were infrequent amongst the participants. In the PL intervention 
group one participant had depression and another had hypertension. The TR 
intervention group had one participant with epilepsy. No significant difference was 
found between the groups (Table 4-5).  
 
Table 4-5: Co-morbidities of the participants and PL and TR intervention groups (N = 
49) 
 Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Number 
(%) 
Number 
(%) 
Number 
(%) 
Significance 
Test 
 Co-morbidities N = 49 n = 26 n = 23 χ2 = 2.91; p = 
0.41 
     Depression 1 (2) 1 (4) 0 (0)  
     Epilepsy 1 (2) 0 (0) 1 (4)  
     Hypertension 1 (2) 1 (4) 0 (0)  
     None known 46 (94) 24 (92) 22 (96)  
 
  
113 
 
4.3.5 Analgesics 
Over half the participants in each group reported not receiving any analgesics. 
Paracetamol was the most commonly used medication. There was no significant 
difference between the groups for the use of analgesics (Table 4-6).   
 
Table 4-6: Analgesic use of the participants and PL and TR intervention groups (N = 
49) 
 Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Number 
(%) 
Number 
(%) 
Number 
(%) 
Significance 
Test 
 Analgesics N = 49 n = 26 n = 23 χ2 = 3.12; p = 
0.54 
     Paracetamol 11 (22)  5 (19) 6 (26)  
     NSAIDS 1 (2) 0 (0) 1 (4)  
     Paracetamol  
     &     
     NSAIDS 
 6 (12)  4 (15) 2 (9)  
     Paracetamol,   
     mild opioids     
     &  
     NSAIDS 
1 (2) 0 (0) 1 (4)  
     None  30 (61) 17 (65) 13 (57)  
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4.4 Change in pain 
4.4.1 Prevalence of pain 
As per inclusion criteria all participants had experienced pain within the previous 
three months. All participants reported pain within the last week on the BPI at 
Baseline (100% prevalence of pain). By Week 4 the prevalence of pain for the 
participants had reduced to 63.27%. In the weeks to follow the prevalence of pain 
continued to reduce until under half of all the participants presented with pain 
(Figure 4-3). 
 
 
Figure 4-3: Change in prevalence of pain for the sample  
 
The prevalence of pain in the PL intervention group and TR intervention group 
lowered to 62% and 65% respectively at Week 4. In the PL intervention group, the 
prevalence of pain continued to reduce, remaining lower than the TR intervention 
group over Weeks 4 to 24. However, there was no statistical difference between the 
groups for prevalence of pain at Weeks 4 (χ2 = 0.07; p = 0.79), 8 (χ2 = 0.99; p = 0.32), 
12 (χ2 = 1.6; p = 0.21) and 24 (χ2 = 1.6; p = 0.21) (Figure 4-4). Carried forward data 
was used to determine the prevalence of pain results. 
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Figure 4-4: Change in prevalence of pain in PL and TR intervention groups over time  
 
4.4.2 Sites of pain 
The participants in each intervention group (the PL and TR group) reported a median 
of 3 (range: 1-6) sites of pain at Baseline. The number of body sites participants 
reported experiencing pain in are represented in Figure 4-5 and Figure 4-6.  
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Figure 4-5: Sites of pain in the PL intervention group at Baseline 
 
 
Figure 4-6: Sites of pain in the TR intervention group at Baseline 
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4.4.3 Pain Severity Scores 
The change in PSS over time is presented in Figure 4-7 and PSS at each time point are 
presented in Table 4-7. No significant difference between groups was found for PSS 
at Baseline (t = 1.22; p = 0.23) (Table 4-7). Change in PSS over time was analysed 
using a cumulative link mixed-model ordinal regression. Three models, including the 
effect of group, group and time, and group and time with random intercept and 
slope, were significant when compared with the null model. After family-wise p-
value correction the models for group and time, and group and time with random 
intercept and slope were significant and compared to each other. The best model 
was the effect of group and time with random intercepts and slopes. On evaluation 
of this model there was a significant effect of time over the 24 weeks of the study (p 
< 0.001), where over time PSS decreased, indicating improvement. There was no 
significant effect of group or group and time interaction. Both groups showed 
significant improvements in PSS over time. In addition, the improvements in PSS over 
time were also clinically meaningful263, as the improvement in each group was more 
than three points on the scale of 0-10 (Table 4-7). 
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Figure 4-7: Change in Pain Severity Scores for PL and TR intervention groups over 
time  
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Table 4-7: PSS for participants and PL and TR intervention groups at each time point 
(N = 49) 
 Participants 
 
 
Positive Living 
intervention group 
 
Therapeutic 
relationship 
intervention group 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Baseline N = 49 n = 26 n = 23 
     PSS 4.57 ± 1.59 
(2-9.5) 
4.31 ± 1.25 
(2-6.25) 
4.86 ± 1.89 
(2-9.5) 
    
Week 4 N = 32 n = 19 n = 13 
     PSS 1.7 ± 2.05  
(0 - 7.75) 
1.91 ± 2.23 
(0 - 7.75) 
1.4 ± 1.68 
(0 - 4.5) 
      
Week 8  N = 35 n = 15 n = 20 
     PSS 2.05 ± 2.61 
(0 -9) 
1.03 ± 1.84 
(0 – 5.5) 
2.81 ± 2.88 
(0 - 9) 
    
Week 12 N = 32 n = 18 n = 14 
     PSS 2.26 ± 2.85 
(0 - 10) 
1.33 ± 2.05 
(0 – 5.5) 
3.45 ± 3.35 
(0 - 10) 
      
Week 24  N = 27 n = 15 n = 12 
     PSS  1.13 ± 1.75 
(0 - 5.25) 
0.75 ± 1.57 
(0 – 4.75) 
1.6 ± 1.89 
(0 - 5.25) 
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Successful pain management, for which a clinically important reduction in pain 
severity is necessary, is regarded as a reduction of three points on a scale of 0-10263. 
There was no significant difference between groups in the number of participants 
having successful reduction in pain severity (Table 4-8). The percentage of 
participants with successful reduction in pain was 52% at Week 4 for the PL 
intervention group and by Week 8, after the completion of the PL programme, the 
percentage of participants with successful reduction in pain was 67%. Over the next 
two data collection points, Weeks 12 and 24, the percentage of participants with 
successful reduction in pain remained at 67%. The percentage of participants with 
successful reduction in pain at Week 4 for the TR intervention group was 77%, which 
then reduced to 45% by Week 8 and then reduced further at Week 12, when 36% of 
participants were found to have a successful reduction in pain. By Week 24 the 
percentage of participants in the TR intervention group with successful reduction in 
pain had improved to 67%, the same percentage which was found in the PL 
intervention group. This indicates that there was no difference in the efficacy of the 
PL programme and the TR intervention combined compared to the TR intervention 
alone, to bring about clinically meaningful changes in PSS. This finding is supported 
by the results of the mixed model regression analysis on PSS. 
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Table 4-8: Success of PL and TR intervention groups for change in PSS (N = 49) 
 Participants 
 
 
Positive Living 
intervention 
group 
 
Therapeutic 
relationship 
intervention 
group 
  
 Number 
 
Number Number Odds 
Ratio 
Significance test 
Baseline - 
Week 4 
N = 32 n = 19 n = 13 0.33 χ2 = 1.94; p = 0.16 
     Successful*  20 10 10   
     Not 
successful  
12 9 3   
      
Baseline - 
Week 8 
N= 35 n = 15 n = 20 2.44 χ2 = 1.62; p = 0.2 
     Successful  19 10 9   
     Not     
     successful  
16 5 11   
      
Baseline - 
Week 12 
N= 32 n = 18 n = 14 3.6 χ2 = 3.03; p = 0.8 
     Successful  17 12 5   
     Not     
     successful  
15 6 9   
      
Baseline - 
Week 24 
N= 27 n = 15 n = 12 1 χ2 = 0; p = 1  
     Successful  18 10 8   
     Not     
     successful  
9 5 4   
*Successful represents a decrease in PSS of ≥ 3/10224,258. 
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4.4.4 Pain Interference Scores  
The change in PIS over time is presented in Figure 4-8 and PIS at each time point are 
presented in Table 4-9. There was no significant difference between groups for Pain 
Interference Scores (PIS) at Baseline (t = 1.19; p = 0.24) (Table 4-9). A cumulative 
linked mixed-model ordinal regression was used to analyse change in PIS over time. 
In comparison with the null model, the models for the effect of time, group and time, 
and group and time with random intercepts and slope were significantly better. 
These models remained significant after correction, and the best model included 
time and group with random intercepts and slopes when compared with each other. 
Time was found to be an independent predictor of PIS over the 24 weeks of the 
study (p < 0.001), but group, and group and time interaction had no significant effect 
on PIS. Therefore, PIS reduced significantly over time in both groups, while receiving 
the therapeutic relationship. 
 
There is anecdotal evidence to indicate that a reduction in PIS ranging between one 
and three represents a clinically meaningful change in pain interference on the 
BPI224. As the PIS of both intervention groups reduced by more than three points, 
these results can be therefore be considered as clinically important changes in pain 
interference according to the IMMPACT recommendations in a study by Dworkin and 
colleagues224. 
 
One participant who was present at Baseline data collection did not complete the PIS 
section of the BPI questionnaire. Therefore the results on PIS represent one less 
participant (from the TR intervention group) than Figure 4-2 (p.106) reports. 
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Figure 4-8: Change in Pain Interference Scores for PL and TR intervention groups over 
time  
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Table 4-9: PIS for participants and PL and TR intervention groups at each time point 
(N = 49) 
 Participants 
 
 
Positive Living 
intervention group 
Therapeutic 
relationship 
intervention group 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Baseline N = 48 n = 26 n = 22 
     PIS 4.87 ± 2.28 
(0.29 – 9.71) 
4.51 ± 2.15 
(0.29 – 8.43) 
5.29 ± 2.41 
(0.43 – 9.71) 
    
Week 4 N = 32 n = 19 n = 13 
     PIS 1.87 ± 2.68 
(0 - 9) 
2.07 ± 3.01 
(0–9) 
1.57 ± 2.21 
(0 – 6) 
    
Week 8  N = 35 n = 15 n = 20 
     PIS 2.21 ± 2.89 
(0 - 8.43) 
0.87 ± 1.74 
(0 - 5.29) 
3.21 ± 3.19  
(0 – 8.4) 
    
Week 12 N = 32 n = 19 n = 13 
     PIS 1.88 ± 2.95 
(0 - 9.86) 
1.09 ± 2.25 
(0 - 7.14) 
3.04 ± 3.53 
(0 – 9.86) 
    
Week 24  N = 27 n = 15 n = 12 
     PIS 0.92 ± 1.86 
(0 - 7.14) 
0.79 ± 2.09 
(0-7.14) 
1.08 ± 1.6 
(0 – 4.71) 
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4.4.5 Pain Management Index (PMI) 
There was no significant difference for PMI scores between the PL intervention 
group (-0.69 ± 0.47) and the TR intervention group (-0.95 ± 0.58) at Baseline (t = -1.7; 
p = 0.09). The mean PMI score for the sample at Baseline was -0.81 (± 0.53), 
indicating inadequate pain management in both groups. PMI was analysed using a 
cumulative link mixed-model ordinal regression. All models were significant 
compared with the null model and after correction for multiple comparisons. The 
best model, when the four models were compared, included the effect of group and 
time with random intercepts and slopes. In this model, there was a significant effect 
of time over the 24 weeks of the study (p < 0.001) as the PMI score improved over 
time in participants regardless of group. There was no significant effect of group or 
group and time interaction. The change in PMI over time is presented in Figure 4-9, 
and indicates adequate management by Week 24 in both groups. Therefore, the PL 
and TR intervention groups had significantly better pain management over time, 
according to the PMI score. 
 
It is noteworthy that no change in participants’ analgesic prescription was reported 
over the study period by any participant. The change in PMI presented in Figure 4-9 
is therefore as a result of change in pain severity.  
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Figure 4-9: Change in Pain Management Index for PL and TR groups over time  
  
127 
 
4.5 Change in symptoms of depression 
No significant differences were found between groups for the scores on the BDI at 
Baseline (t = 1.3; p = 0.2). The mean scores at Baseline on the BDI for the sample, PL 
intervention group and TR intervention group were 25.73 (± 11.2), 23.8 (± 9.9) and 
27.91 (± 12.21) respectively. A linear mixed-model regression was used to analyse 
the BDI scores. Data were transformed using a square root as data were not normally 
distributed initially and were right skewed. All models were significant when 
compared with the null model and after correction for multiple comparisons. Once 
comparisons were made between the models, no model was better than another. 
Therefore, the simplest model was chosen, which included the effect of time (p < 
0.001). In this chosen best model, there was no significant effect of group, or group 
and time. There was a significant inverse relationship which existed between time 
and BDI score over the 24 weeks of the study. The results show that the BDI in both 
groups significantly improved over time and had few symptoms of depression by 
Week 24. The change in BDI scores over time are presented in Figure 4-10.  
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Figure 4-10: Change in scores on the Beck Depression Inventory over time  
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4.6 Change in health-related quality of life 
The PL intervention group scored significantly higher than the TR intervention group 
on HRQoL, measured by the EQ-5D VAS (t = 3.38; p < 0.01) and EQ-5D Index (t = 3.2; 
p < 0.01) at Baseline (Table 4-10). Figure 4-11 and Figure 4-12 show the changes over 
time for EQ-5D VAS and EQ-5D Index respectively.  
 
Table 4-10: EQ-5D VAS and EQ-5D Index scores at Baseline (N = 49) 
 Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Significance test 
Baseline N = 49 n = 26 n = 23  
     EQ-5D VAS 59.9 ± 16.6 
(20 – 90) 
66.73 ± 15.03 
(40 – 90) 
52.17 ± 15.06 
(20 – 80) 
t = 3.38; p < 0.01* 
     EQ-5D Index 0.6 ± 0.28 
(-0.32 – 0.8) 
0.71 ± 0.14 
(0.09 – 0.8) 
0.47 ± 0.34 
(-0.32 – 0.8) 
t = 3.2; p < 0.01* 
*Indicates a significant difference between groups 
 
4.6.1 EQ-5D VAS 
Data for the EQ-5D VAS were processed by dividing it into proportions before 
regression was performed. Following an initial attempt of a linear mixed-model 
regression to model the data, a general additive mixed-model (model with inflated 
beta distribution) (GAMLSS) was used for analysis.  
 
The models for the effect of group, time, group and time converged and comparisons 
were made using a likelihood ratio test for the nested GAMLSS model, for which the 
effect of time, and group and time were significant. After stepwise removal of terms, 
the best model included time. For the EQ-5D VAS there was a significant 
improvement over time during the 24 weeks of the study (p < 0.001). No effect of 
group or group and time interaction was found. Therefore, the EQ-5D VAS improved 
in both intervention groups. 
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Figure 4-11: Change in EQ-5D VAS scores over time  
 
4.6.2 EQ-5D Index  
For the EQ-5D Index, data could not be modelled using mixed-model regression. An 
appropriate model could not be generated using GAMLSS. The analysis was therefore 
done using t-tests and a one-way ANOVA. 
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There were significant differences between groups for the EQ-5D Index at Baseline (t 
= 3.32; p < 0.01) and Week 8 (t = 2.86; p < 0.01) (Table 4-11), where the PL 
intervention group had better EQ-5D Index scores than the TR intervention group. 
No significant differences between groups were found at Week 24 (t = 1.27; p = 0.22) 
(Table 4-11). Over the 24 weeks of the study, the EQ-5D Index scores of the 
participants improved significantly (F(4-48) = 13.84; p < 0.001) (Figure 4-12), indicating 
improvement in HRQoL.     
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Figure 4-12: Change in EQ-5D Index scores over time  
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Table 4-11: EQ-5D Index scores for PL and TR intervention groups over time (N = 49) 
 Participants 
 
 
Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Significance test 
Baseline N = 49 n = 26 n = 23 t = 3.32; p < 0.01* 
     EQ-5D Index 0.6 ± 0.28 
(-0.32 - 0.8) 
0.71 ± 0.14 
(0.01 - 0.8) 
0.47 ± 0.34 
(-0.32 - 0.8) 
 
     
Week 4 N = 32 n = 19 n = 13 t = 1.08.5; p = 
0.29 
     EQ-5D Index 0.75 ± 0.28 
(-0.14 - 1) 
0.8 ± 0.26 
(-0.14 - 1) 
0.69 ± 0.31 
(-0.2 - 1) 
 
     
Week 8 N = 34 n = 15 n = 19 t = 2.86; p < 0.01* 
     EQ-5D Index 0.78 ± 0.3 
(-0.38 - 1) 
0.93 ± 0.1 
(0.76 - 1) 
0.66 ± 0.35 
(-0.38 - 1) 
 
     
Week 12 N = 31 n = 19 n = 12 t = 2.02; p > 0.05 
     EQ-5D Index 0.84 ± 0.33 
(-0.59 - 1) 
0.93 ± 0.16 
(0.33 - 1) 
0.69 ± 0.47 
(-0.59 - 1) 
 
     
Week 24  N = 27 n = 15 n = 12 t = 1.27; p = 0.22 
     EQ-5D Index 0.95 ± 0.09 
(0.69 - 1) 
0.97 ± 0.07 
(0.8 - 1) 
0.93 ± 0.11 
(0.69 - 1) 
 
* Indicates a significant difference between groups 
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4.7 Change in self-efficacy 
Self-efficacy scores were not significantly different between the groups at Baseline (t 
= 0.94; p = 0.35). The mean self-efficacy scores for the sample, PL intervention group 
and TR intervention group at Baseline were 6.15 (± 2.28), 6.44 (± 1.9) and 5.83 (± 
2.65). For analysis of self-efficacy scores, a linear mixed-model regression was 
performed to test for effect after transforming the data by squaring it, due to it being 
right skewed. The group, group and time, and group and time with random 
intercepts and slopes models were significant compared with the null model. After 
correction, group, group and time, and group and time with random intercepts and 
slopes remained significant. Comparisons between these models found that the 
effect of group and time with random intercepts and slopes was the best model. The 
model showed that regardless of group, the self-efficacy scores in all participants 
significantly increased over time (p < 0.001). The group was also an independent 
predictor as there was a significant difference between groups (p < 0.5), possibly 
from differences between groups around Week 8, and therefore there may not be a 
significant difference between groups for self-efficacy at Week 24. There was no 
significant effect of the group and time interaction, indicating that the intervention 
groups were improving at similar rates over time. Although, the PL intervention 
group had significantly better self-efficacy scores than the TR intervention group 
over the 24 weeks of the study, both groups improved significantly in self-efficacy 
scores. The change over time for self-efficacy is presented in Figure 4-13.  
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Figure 4-13: Change in self-efficacy scores over time  
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4.8 Change in function over time  
No significant differences were found between the groups for any of the functional 
tests in the physical performance task battery (PPTB) at Baseline (Table 4-12).  
 
Table 4-12: Performance of the PPTB for PL and TR group at Baseline (N = 49) 
 Participants Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Significance test 
Baseline N = 45 n = 26 n = 19  
     Walking at   
     preferred  
     speed (min) 
18.55 ± 3.2 
(14.09 – 28.66) 
 
18.96 ± 3.49 
(14.09 – 28.66) 
17.97 ± 2.8 
(14.43 – 24.59) 
 
t = 1.02; p = 0.32 
     Walking at    
     fastest speed   
     (min) 
12.48 ± 2.1 
(8.78 – 18.25) 
12.53 ± 2.38 
(8.78 – 18.25)  
12.41 ± 1.72 
(8.78 – 15.22) 
t = 0.19; p = 0.85 
     6-minute walk   
     (m) 
357.19 ± 74.79 
(90 - 466) 
352.25 ± 80.05 
(90 – 465) 
363.95 ± 68.48 
(188.5 – 466) 
t = 0.51; p = 0.61 
 N = 49 n = 26 n = 23  
     Unloaded    
     forward reach    
     (cm) 
107.82 ± 9.11 
(81 – 125) 
 
107.88 ± 9.79 
(81 – 125) 
107.74 ± 8.49  
(90 – 123) 
t = 0.06; p = 0.96 
     Loaded   
     forward reach   
     (cm) 
88.63 ± 10.58 
(65-120) 
 
88.5 ± 10.71 
(65 – 120) 
88.78 ± 10.66 
(68 – 109) 
t = 0.09; p = 0.93 
 N = 48 n = 26 n = 22  
     Timed, repeat   
     sit-to-stand (s) 
5.92 ± 1.35 
(3.81 – 10.81) 
 
5.92 ± 1.26 
(3.81 – 8.82) 
 
5.91 ± 1.49 
(4.21 – 10.81) 
t = 0.01; p = 0.99 
     Timed,   
     repeated  
     reach-up (s) 
4.25 ± 1.41 
(2.09 – 9.31) 
3.89 ± 1.48 
(2.09 – 9.31) 
4.68 ± 1.21 
(3.14 – 7.59) 
t = 2.01; p > 0.05  
     Timed belt-tie   
     (s) 
5.5 ± 1.72 
(3.15 – 9.54) 
5.19 ± 1.58 
(3.15 – 9.22) 
5.87 ± 1.84 
(3.5 – 9.54) 
t = 1.38; p = 0.17 
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4.8.1 Walking at preferred speed, walking at fastest speed, six-minute walk test   
Changes in speed over time for the walking at preferred speed and walking at fastest 
speed are presented in Figure 4-14 and Figure 4-15 respectively. There was no 
reason to do mixed-model analysis as the graphical presentation of data indicated no 
clear changes across time or between groups. Four participants from the TR 
intervention group chose not to walk at Baseline and therefore were not represented 
in the tests which included walking (Figure 4-2; p.106). 
 
 
Figure 4-14: Change in speed in walking at preferred speed test 
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Figure 4-15: Change in speed over time in walking at fastest speed test 
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For the six-minute walk test (6MWT), Figure 4-16 presents the changes in distance 
over time. Analysis on the 6MWT was done using a linear mixed-model regression on 
data transformed by squaring due to left-skewed data. Compared with the null 
model, models for the effect of time, group and time and group and time with 
random intercepts and slopes were significant. After family-wise p-value correction 
the models for the effect of time, and group and time remained significant. There 
was no significant difference between the models, resulting in the simplest model 
being chosen as the best model, which included time. There was a positive significant 
relationship between time and six-minute walk distance (6MWD) over the 24 weeks 
of the study (p < 0.001). No significant difference existed between groups and there 
was no significant effect of the group and time interaction according to this model. 
Therefore, over the 24 weeks of the study there was a significant increase in the 
distance walked in six minutes in both intervention groups, indicating that both 
groups improved over time.  
 
 
Figure 4-16: Change in six-minute walking distance over time 
139 
 
4.8.2 Unloaded and loaded forward reach tests 
Change in distance over time in the unloaded and loaded forward reach tests are 
presented in Figure 4-17 and Figure 4-18. A linear mixed model regression was done 
to analyse the distance over time of the unloaded forward reach test. Models, which 
included the effect of time, group and time, and group and time with random 
intercepts and slopes were significant compared with the null model and remained 
significant with correction for multiple comparisons. As no significant differences 
were found in comparing the models, the best model included the effect of time, as 
it was the simplest model. This model found a significant positive relationship 
between time and distance of the unloaded reach test (p < 0.001). There was no 
effect of group or group and time interaction found in this model. Both intervention 
groups were able to reach further over the 24 weeks of the study, however there 
was no difference between the groups in the distance reached. 
 
The analysis of the loaded forward reach test had the same findings. There was a 
significant positive relationship between time and distance of the loaded reach test 
(p < 0.001). No effect of group or group and time interaction existed in this model. 
Therefore, both groups were able to reach further, whilst holding a weight, over the 
24 weeks of the study.   
 
140 
 
 
Figure 4-17: Change in distance over time for unloaded forward reach 
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Figure 4-18: Change in distance over time for loaded forward reach test 
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4.8.3 Timed repeated sit-to-stand, repeated reach-up and belt-tie tests 
Attempts to model the data for the timed, repeated sit-to-stand, repeated reach-up 
and belt-tie tests failed. Therefore, regression analysis was not used for these tests. 
Changes over time, analysed by one-way ANOVA tests, are presented in Figure 4-19 
for the timed, repeated sit-to-stand test, Figure 4-20 for the timed, repeated reach-
up test and Figure 4-21 for the timed belt tie test.  
 
There were no differences, analysed by t-tests, between groups at Week 24 (Table 
4-13) for any of the three timed tests. A significant difference between groups was 
found for the timed, repeated reach-up test at Week 8 (t = 2.6; p = 0.02) (Table 4-13). 
For the participants (both intervention groups) there was a significant effect of time, 
over the 24 weeks of the study, for the timed, repeated sit-to-stand test (F(4-28) = 
19.19; p < 0.001), the timed, repeated reach-up test (F(4-32) = 15.23; p < 0.001) and 
timed belt tie test (F(4-28) = 7.01; p < 0.01). The results indicated that the time taken 
for performing these three tests decreased over the 24 weeks of the study, meaning 
that both groups showed improvement in their timed performance of these tasks. 
One participant from the TR intervention group chose not to do any of the timed-
tests at Baseline and therefore the change in timed-tests represent one less 
participant than was present at data collection (Figure 4-2; p.106).  
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Figure 4-19: Change in seconds over time for timed, repeated sit-to-stand test 
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Figure 4-20: Change in seconds over time for timed, repeat reach-up test 
  
All participants 
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Figure 4-21: Change in seconds over time for timed belt-tie test 
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Table 4-13: Performance of timed tests of the PPTB for PL and TR group over time (N 
= 49) 
 Participants 
 
 
Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Significance 
test 
Baseline N = 48 n = 26 n = 22  
     Timed, repeat   
     sit-to-stand (s) 
5.92 ± 1.35 
(3.81 – 10.81) 
5.92 ± 1.26 
(3.81 – 8.82) 
5.91 ± 1.49 
(10.81 – 1.62) 
t = 0.01; p = 
0.99 
     Timed,   
     repeated  
     reach-up (s) 
4.25 ± 1.41 
(209 – 9.31) 
3.89 ± 1.48 
(2.09 – 9.31) 
4.68 ± 1.21 
(3.14 – 7.59) 
t = 2.01; p > 
0.05  
     Timed belt-tie   
     (s) 
5.5 ± 1.7 
(3.15 – 9.54) 
5.19 ± 1.58 
(3.15 – 9.22) 
5.87 ± 1.84 
(3.5 – 9.54) 
t = -1.38; p = 
0.17 
     
Week 4 N = 24 n = 16 n = 8  
     Timed, repeat   
     sit-to-stand (s) 
5.67 ± 1.32 
(3.49 – 8.91) 
5.83 ± 1.33 
(3.87 – 8.91) 
5.4 ± 1.33 
(3.49 – 7.92) 
t = 0.73; p = 
0.47 
 N = 25 n = 16 n = 9  
     Timed,   
     repeated  
     reach-up (s) 
2.89 ± 0.93 
(1.87 – 6.17) 
2.89 ± 1.07 
(1.87 – 6.17) 
4.68 ± 1.21 
(2.09 – 3.87) 
t = 0.02; p = 
0.98 
 N = 24 n = 15 n = 9  
     Timed belt-tie   
     (s) 
4.86 ± 1.1 
(2.31 – 7.44) 
5.04 ± 0.99 
(3.47 – 7.44) 
4.55 ± 1.26 
(2.31 – 6.71) 
t = 1.06; p = 
0.3 
     
Week 8  N = 24 n = 11 n = 13  
     Timed, repeat   
     sit-to-stand (s) 
5.42 ± 1.02 
(3.63 – 7.47) 
5.45 ± 1.02 
(3.74 – 6.96) 
5.39 ± 1.05 
(3.63 – 7.47) 
 
t = 0.13; p = 
0.9 
     Timed,   
     repeated  
     reach-up (s) 
2.56 ± 0.55 
(1.69 – 3.49) 
2.27 ± 0.37 
(1.69 – 2.8) 
2.8 ± 0.58 
(1.91 – 3.49) 
t = 2.6; p = 
0.02* 
     Timed belt-tie   
     (s) 
4.37 ± 1.03 
(2.7 – 6.96) 
4.29 ± 1.12 
(2.7 ± 6.59) 
4.44 ± 0.98 
(3.17 – 6.96) 
t =-0.35; p = 
0.73  
     
Week 12 N = 21 n = 12 n = 9  
     Timed, repeat   
     sit-to-stand (s) 
3.32 ± 0.6 
(1.71 – 4.71) 
3.43 ± 0.32 
(3.04 – 4.1) 
3.17 ± 0.85 
(1.71 – 4.71) 
t = 0.98; p = 
0.34 
     Timed,   
     repeated  
     reach-up (s) 
2.26 ± 0.4 
(1.54 – 3.26) 
2.36 ± 0.39 
(1.88 – 3.26) 
2.14 ± 0.39 
(1.54 – 2.71) 
t = 1.28; p = 
0.22  
     Timed belt-tie   
     (s) 
3.44 ± 0.52 
(2.45 – 4.72) 
3.61 ± 0.47 
(3.15 – 4.55) 
3.2 ± 0.36 
(2.45 - 
3.71) 
t = 1.91; p = 
0.07 
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 Participants 
 
 
Positive Living 
intervention 
group 
Therapeutic 
relationship 
intervention 
group 
 
 Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Mean ± SD 
(Range) 
Significance 
test 
     Timed, repeat   
     sit-to-stand (s) 
4.49 ± 0.57 
(3.36 – 5.47) 
4.64 ± 0.49 
(3.93– 5.47) 
4.27 ± 0.65 
(3.36 – 5.38) 
t = 1.25; p = 
0.23 
     Timed,   
     repeated  
     reach-up (s) 
2.31 ± 0.75 
(1.36 – 3.46) 
2.41 ± 0.81 
(1.36 – 3.44) 
2.16 ± 0.7 
(1.58 – 3.46) 
t = 0.62; p = 
0.54 
 N = 14 n = 9 n = 5  
     Timed belt-tie   
     (s) 
3.4 ± 0.65 
(2.2 – 4.55) 
3.65 ± 0.47 
(3.15 – 4.55) 
2.94 ± 0.71 
(2.2 – 3.82) 
t = 2.29; p = 
0.4  
*Indicates a significant difference between groups 
 
4.9 Participants’ responses to post-study structured interviews 
The participant responses to the series of open-ended questions, which were asked 
to participants of both intervention groups during a cellular phone call after the final 
data collection point, are presented here. The responses were analysed for recurring 
topics, which arose from more than two participants. These topics and the responses 
which matched them are presented in Table 4-14 and Table 4-15. Twelve participants 
in the PL intervention group and thirteen participants in the TR intervention group 
were reached for the post-study structured interviews.     
 
4.9.1 Participants’ responses from the Positive Living intervention group   
Participants found the sessions of the PL programme and the workbook helpful. 
Responses were grouped into topics of learning, pain alleviation, exercise and 
improving wellness (Table 4-14). No suggestions for additional information to be 
included in the sessions or in the workbook were made. Three participants 
(participant 30, 36 and 46) expressed satisfaction with the content and 
comprehensiveness of the PL programme, while three other participants (participant 
15, 26 and 34) were unsure if there was more information which should be added. 
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Many participants read the workbook, however a few participants reported that they 
did not. Topics of pain alleviation, exercise and improving wellness emerged again in 
response to questions on the helpfulness of the workbook, as emerged with the 
usefulness of the PL programme (Table 4-14). There were mixed responses to 
whether participants shared or discussed the information gained in the PL 
programme with others. Five participants (participant 2, 6, 9, 26 and 36) expressed 
that they did not share the information from the PL programme with anyone else, 
while five participants (participant 3, 5, 15, 30 and 34) did share information from 
the PL programme in order to support others and share their experience.  
 
In an opportunity to share anything further, many participants had nothing more 
they wished to voice. Two participants expressed gratitude and a wish for more 
PLWHA to have opportunity to participate in the PL programme. 
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Table 4-14: Positive Living intervention group responses (n = 12) 
Topic Question: Did you find the group useful? Please explain. 
Pain alleviation  Participant 2: “Yes, I had a backache and it got better.” 
Participant 3: “And when you are doing the exercises you don’t 
feel any pain.” AND “…I feel relieved…”  
Participant 9: “Yes, because since I have been going to the group 
I feel alright, I don’t feel any pain.” 
Participant 26: “…because there was a pain that I used to feel on 
my legs but I can’t feel it anymore.” 
Exercise Participant 2: “[What helped the pain] was doing the exercises.” 
Participant 3: “Yes, a lot, because we were always doing the 
exercises. And when you are doing the exercises you don’t feel 
any pain. And when I wake in the morning I do the exercises and 
I feel relieved.”  
Participant 6: “It is interesting because of the exercising we were 
doing…” 
Participant 26: “Yes, …because of the exercises.” 
Participant 30: “Yes, because I was lazy to do the things like 
going to the river, when I got the exercises I found it easy to go 
to the river and my life changed.” 
Participant 34: “A lot … if I have a headache I must just take a 
bucket and go to the river. Even if I have pain, I just do the 
exercises then after I feel better.” 
Improving 
wellness 
 
 
Participant 15: “A lot. I felt alright because of the things she said 
we must do.”  
Participant 36: “Yes. Because it made me to stop regretting 
myself. I felt alright and strong.  It made me accept my 
situation.”  
Participant 42: “Yes, it was helpful because when I don’t feel well 
I does the things that she said we must do.” 
Participant 46: “Yes, it was helpful a lot. Because when you are 
doing the exercises you don’t feel any stress, you feel happy all 
the time you always healthy.” 
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Topic Question: Did you read the workbook given to you or have 
somebody read it to you? Please explain. 
Learning Participant 15: “…teaches us…” AND “the book tells us how to 
live when you are HIV positive.” 
Participant 26: “The book was telling us…” 
Participant 30: “…It teaches us…” 
Pain alleviation Participant 26: “…if you suspect anything you go the clinic, 
example…when you have pain you have to go the nurse and ask 
for help.” 
Participant 30: “…what to do when you have pain behind the 
neck.” 
Exercise Participant 3: “It’s about the exercises we’ve been doing in the 
group.”  
Participant 9: “…you have to do the exercises...” 
Improving 
wellness  
Participant 26: “…if you suspect anything you go the clinic, 
example when you have non-stop diarrhoea…you have to go the 
nurse and ask for help.” 
Participant 30: “…how to eat and what we should eat…” 
 
Topic Question: Did you find the information in the workbook 
useful? Please explain. 
Learning Participant 5: “…it gives me important information...” 
Participant 9: “…it shows us exercises…” 
Participant 36: “…there were things that I didn’t know that the 
book taught me.” 
Pain alleviation 
and exercise 
Participant 3: “…I had pain in the legs and in the morning, my 
legs would be very stiff, but now that we’ve been doing different 
exercise the stiffness and the pain got better.”  
Participant 9: “…after the exercises I feel relieved.” 
Improving  
wellness 
Participant 2: “…are helpful for example when you are sick. I 
used to feel tired all the time.” 
Participant 5: “…how to take care of yourself.” 
Participant 15: “…you feel alright emotionally…” AND 
“…after I have done the things…I felt helped.” 
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Topic Question: Did you share or discuss any of the information with 
anybody else? Please explain. 
Sharing and 
support 
Participant 3: “…I go to the support group…” AND “…she’s also 
HIV positive so I used to share the book with her and explain to 
her what’s the book about.” 
Participant 5: “I discuss with the other people” AND “…I also 
make an example about myself.” 
Participant 15: “…I explain to them about the things that I read 
in the book.”  
Participant 26: “…I used to discuss with my group mates.” 
Participant 30: “There is one person I discuss with…” 
Participant 34: “I discuss a lot…” 
 
Topic Question: Is there anything else that you would like to share? 
Please explain. 
Expanding Participant 3: “…I wish you can also go the clinics and do the 
group…because there are people who also want to join the 
group, those who are also using treatment.” 
Gratitude Participant 5: “…I can say I thank the group because it brought 
us important information.” 
 
4.9.2 Participants’ responses from the therapeutic relationship intervention 
group   
The TR intervention group had been exposed to a therapeutic relationship over the 
24 weeks of the study, but did not participate in the PL programme or receive any 
information from it. Despite this, the responses in the post-study interviews for the 
TR intervention group implied that participants had independently identified ways to 
help manage symptoms. For example, many participants reported that exercise 
helped alleviate symptoms. Although participants in the TR intervention group were 
not given exercise as an intervention, it appeared that the exercise performed in the 
PPTB outcome measure, which was part of the assessment at the data collection 
points, became identified as an intervention by the participants.  
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Participants in the TR intervention group, when asked if they had received any 
information during the study, which helped with symptom management, or if they 
discussed this with anyone else, brought up comments on the topic of improved 
wellness, sharing and support and hopefulness and encouragement (Table 4-15). 
Despite not participating in the PL programme, the participants had learnt some 
generic knowledge on how to manage symptoms. 
 
No hints of contamination were found during analysis of the interview responses. 
Similar generic knowledge, with regards to finding support and eating healthily, was 
known, which appears to be taught during routine care for PLWHA. However, no 
knowledge particular to the PL programme appears to have been shared with the TR 
intervention group. One participant in the TR group expressed that within the group 
people shared their own experiences with fellow participants. Individuals also 
expressed noticing the positive effects of exercise. 
 
The responses of two participants (participant 13 and 24) indicate that these 
participants identified the TR intervention group as a group within which to bond 
with others and attend together. This may have occurred naturally as participants 
from the TR intervention group shared the same day for follow-up dates with the RA. 
It is also possible that participants identified those who saw the RA on the same 
follow-up date as a group because the informed consent form expressed that 
participants would be put in a group, an intervention group, for the study. However, 
no effort was made on behalf of the RA to facilitate participants in the TR 
intervention group to act as a group as this was not the intention of the intervention. 
The RA met individually with participants for the most part, with the exception of 
participants who requested to be seen alongside another participant, as explained in 
Chapter 3.8 (p.98), to complete the interview-administered questionnaires and the 
PPTB. Despite this, participants appeared to form a group outside of the RA follow-
up interview while attending the data collection points, in which they shared 
information and offered one another support and encouragement. 
 
153 
 
Table 4-15: Participants’ responses from the TR intervention group (n = 13)  
Topic Questions: Did you receive any information during the study 
about HIV/AIDS that helped you to manage your symptoms? 
Please explain. 
Symptom 
alleviation  
Participant 12: “…I felt better and alright…” 
Participant 23: “I used to feel weak but now I am strong.” 
Participant 24: “…and that helped me…” 
Participant 29: “…I felt better after that.”  
Participant 31: “…I feel alright…” 
Participant 38: “…I don’t have stress anymore…” 
Participant 48: “…I noticed that my legs were very weak but now 
they are strong…” AND “…because others were very worse and 
were very weak but I noticed that they are active now, that group 
is very helpful.” 
Exercise Participant 12: “I do the exercises.” 
Participant 13: “And I mustn’t always sleep all the time I must do 
something to move my body.” 
Participant 24: “… [The group] even taught us how to do 
exercises…” 
Participant 25: “…give us exercises…”  
Participant 29: “…walking exercises really helped me and the belt 
we were using to exercise…” 
Participant 31: “…after doing the exercises…” 
Participant 38: “…do my household chores…” 
Sharing and 
support 
Participant 48: “And being in the group with other people, sharing 
information you get more experience and I feel happy when I’m in 
the group with other people because we laugh and chat.” 
Hopefulness 
and 
encouragement 
Participant 13: “…I was always sad but I felt happy because I was 
encouraged and they told me that it’s not the end of life…” AND “I 
would love to encourage other people…” 
Participant 16: “…it’s not the end of life and you can live for more 
than 30 years. It doesn’t mean you are unique from other people 
you are not different but you must take care of yourself.” 
Participant 23: “…the questions [the RA] asked us like do we regret 
ourselves, questions like that are the ones that made me feel 
strong.”  
Participant 25: “… [the RA] makes it easy for us to manage 
everything like telling us that we must not undermine ourselves.” 
Participant 35: “… [the RA] tell us that we must not feel different 
from other people.” 
Participant 38: “…I was really encouraged. And I don’t have any 
complaints because everything is going well.” 
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Topic Questions: Did you discuss ways to manage symptoms with 
others? Please explain. 
Support and 
acceptance 
Participant 13: “If next year the group is still continuing I would 
love to encourage other people, I would tell people that this 
disease is not different from the other diseases and it’s not the end 
of life.” 
Participant 48: “Yes with my [family]. I tell them that this is not the 
end of life and if they take care of themselves they will not be 
different from other people; they will live for a long time…” 
Participant 29: “If someone is not alright I discuss with them like 
my sister–in-law…she used to hide her tablets and…I advised her 
and now she’s alright…” 
Participant 35: “The only person I discuss with is my father. He 
couldn’t accept this disease; he is also HIV positive.” 
Participant 24: “We discussed in the group about how to take care 
of ourselves.” 
Participant 23: “Yes, …I discuss with [my friend] because she didn’t 
want to accept she is HIV positive so I advised her and now she’s 
alright.” 
Participant 38: “Yes, with my sisters.” 
 
 
4.10 Summary of results 
Forty-nine participants took part in the study, with 26 in the PL intervention group 
and 23 in the TR intervention group. Attendance of the PL programme and the data 
collection points was often poor in both groups. There were no statistical differences 
between groups at Baseline in socio-demographic characteristics, which included 
age, employment, highest level of education and health literacy. No statistical 
differences between groups were found at Baseline for clinical characteristics of 
years since diagnosis, recent CD4 T-cell count, HIV management, medical history of 
opportunistic infections, co-morbidities or use of analgesics. A statistical difference 
was only found for the CD4 T-cell count at diagnosis between groups at Baseline.  
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4.10.1 Changes in pain 
The PSS and PIS reduced significantly in the participants in the PL and TR groups over 
the 24 weeks of the study, indicating an improvement in these outcomes in both 
groups, both of whom received a therapeutic relationship. The reduction in PSS an 
PIS in both groups were indicative of clinically meaning changes in pain severity and 
pain interference224. The percentage of participants who had a clinically meaningful 
improvement in PSS was 67% for both the PL and TR intervention groups at Week 24. 
Further, there was no significant difference between groups in the number of 
participants having successful reduction in pain severity (p = 1), which is in 
agreement with the results of the multiple regression analysis for PSS and indicates 
that a therapeutic relationship appears to be sufficient to bring about these 
improvements in PSS. 
 
The prevalence of pain in the sample reduced from 100% at Baseline (all participants 
reported pain) to a pain prevalence of 57% at Week 24. Further, there were no 
significant differences between groups at any time points in the study. Along with all 
the other improvements in outcomes for pain, the PMI was significantly improved 
over time in the 24 weeks of the study with no significant differences between 
groups.  
 
4.10.2 Changes in secondary outcomes measures 
There was a significant decrease in BDI scores over the 24 weeks of study for both 
groups and no significant differences between groups. This indicated reduced 
symptoms of depression reported in the BDI, and improvement with regards to this 
in the participants in the sample.  
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The results from the EQ-5D VAS and EQ-5D Index, which were used to measure 
HRQoL, were both significantly higher in the PL intervention group compared to the 
TR intervention group at Baseline. For the EQ-5D VAS there was a significant effect of 
time, improving the score over the 24 weeks of the study for both groups. Between 
intervention groups there was no significant difference for the EQ-5D VAS according 
to regression analysis and the EQ-5D VAS did not remain significantly higher than the 
TR intervention group. For the EQ-5D Index an appropriate model could not be found 
to analyse the data using mixed-model regression. The results of t-tests and a one-
way ANOVA indicated that no differences were found between groups at Week 24, 
despite the difference at Baseline and the EQ-5D Index score improved significantly 
over the 24 weeks of the study for the study’s participants.  
 
Self-efficacy was the only outcome which was significantly higher in the PL 
intervention group than the TR intervention group over the 24 weeks of the study. 
The difference in self-efficacy between the intervention groups possibly occurred 
around Week 8, and therefore there may not be a significant difference between 
groups for self-efficacy at Week 24. Further, self-efficacy improved significantly in 
both groups over the 24 weeks of the study and there was no significant effect of the 
group and time interaction, indicating that by Week 24 both groups had significantly 
improved in self-efficacy. 
 
There was an effect of time on function in the sample, with significant improvements 
on the 6MWT, forward reach tests and timed tests over the 24 weeks of the study. 
No significant differences existed between the groups in these tests at Week 24.  
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By means of the open-ended questions posed to participants in the PL and TR 
intervention groups at the end of the study the responses to the study were further 
understood. Participants from both intervention groups reported benefits in pain 
and symptom reduction, improved wellness, increased exercise and support. 
Additionally, participants from the PL intervention group gained knowledge from the 
PL programme and workbook.  
 
The interventions received by each group were therefore successful in significantly 
reducing pain severity and pain interference, the primary outcome measures, over 
time. Further, the secondary outcomes of symptoms of depression, HRQoL, self-
efficacy and physical function also significantly improved over the 24 weeks of the 
study. No differences were found between the groups for outcomes, with the 
exception of self-efficacy, indicating that the therapeutic relationship alone was 
effective in bringing about improvement in pain severity and interference, symptoms 
of depression, HRQoL and physical function. 
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5 Chapter Five: Discussion 
5.1 Introduction 
The present study set about to determine the effect of the PL programme combined 
with a therapeutic relationship, in comparison to a therapeutic relationship alone on 
pain severity and pain interference amongst rural amaXhosa women LWHA. The 
effects of both interventions on symptoms of depression, HRQoL, self-efficacy and 
physical function were evaluated as secondary objectives. 
 
The main results of the study were that the interventions of the PL group and the TR 
group were both effective in significantly reducing pain severity and pain 
interference over time and no differences existed between the groups for pain 
severity or interference.  
 
Initially this discussion will review the attendance, demographic and clinical 
characteristics of the participants. This will be followed by discussion on the results 
of the primary outcome of pain, covering pain prevalence, pain severity and pain 
interference. Thereafter, the secondary outcome measures of symptoms of 
depression, HRQoL, self-efficacy and physical function will be discussed. The 
discussion will be completed by exploring the study strengths, limitations, clinical 
implications and implications for future research.  
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5.2 Sample and attendance 
Low attendance was a consistent feature in both the PL and TR intervention groups 
in the present study as indicated in Figure 4-2 (Chapter 4.1: p.104). Participation was 
limited in the six-week PL programme, with the lowest percent of participants 
attending a session being at Week six of the programme, where only ten participants 
were able to attend (38%). Low attendance was also common for data collection 
with data collection being least attended at Week 24 when only 15 participants of 
the PL group (57%) could attend and 12 participants of the TR group (52%) could 
attend. The reduced participation possibly limited the effects of the programme and 
the effect of therapeutic relationship over the 24 weeks of the study respectively. 
Therefore, sample sizes of studies in rural communities should account for the 
possibility of poor attendance. 
 
It was expected that the 26 participants in the two PL intervention groups, of optimal 
size for facilitation47, would still allow for attrition, based on the results of the study 
on the effect of the PL programme amongst urban amaXhosa women by Parker and 
colleagues46. However, present study attendance was poorer than the attendance of 
the PL programme and data collection points in the study by Parker and colleagues46. 
The highest percentage of non-attendance at a PL programme session was 25% in 
the study by Parker and colleagues46 and 62% in the present study. For data 
collection the attendance was also better in the study by Parker and colleagues46 
(92% and 80% for the experimental and control group respectively) compared with 
the present study (43% and 47% for the PL and TR intervention group respectively). 
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It was not apparent if non-attendance was due to the study itself or for the reasons 
given for non-attendance alone. However, the majority of participants who were 
unable to attend one week were able to attend the following date for data collection 
in the study. Further, no participants officially withdrew from the study, although the 
low health literacy of the participants may have made it unlikely for an official 
withdrawal to occur. Participants expressed that transport, family and community 
responsibility, working or visiting family in urban environments were barriers for 
attendance (Chapter 4.1: Figure 4-2; p.104); the same reasons given for other rural 
amaXhosa LWHA declining participation in the study during recruitment.  
 
The barriers to attendance suggest that change is indicated in this rural area to make 
health care more accessible58,59,274. At times participants expressed not having 
available finances for transport to the clinic despite having costs paid for by the study 
at the previous follow-up date or data collection point, indicating the financial 
burdens of some participants. Further, as using the public transport system is time 
consuming (inferred by a study in rural KwaZulu-Natal)275, as is waiting at the clinic 
for a turn with a HCP, these factors make attending health care more challenging 
when also taking into account family responsibility, work and finances. For many who 
live away from the tar road in the surrounding areas of Zithulele, accessing health 
care in the area is made more challenging by the hilly terrain and dirt roads, which 
means making further effort, by walking, or expense, by taking a private vehicle58,59. 
 
Similar barriers appear to extend to the attendance of routine care (C. Young, email 
communication, November 2016), although attendance of routine care may be 
better as it was expressed to participants that the study dates should not interfere 
with or take precedence over their routine care. In light of this, offering health care 
over and above what is regarded as essential may be burdensome for individuals in 
this rural context and could be contributed to aspects of the participants’ 
demographics such as unemployment. 
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5.3 Demographic characteristics 
In light of the biopsychosocial nature of pain, differences in pain and its management 
are expected in individuals35–39,48,61. Unemployment, low HLOE and limited health 
literacy were common demographics in the study participants, which may have 
contributed to the effect of the study interventions on pain, as these demographics 
are linked to increased risk of pain and increased severity of pain7,18,27,74,81,95,96,108,110.   
 
Unsurprisingly, close to 50% of participants were not looking for work, as according 
to many studies work is one of the most common domains affected by pain in 
PLWHA4,17,25. Apart from pain, participants may have family responsibilities which 
prevent work, or may perceive their work capacity as reduced as has been found in a 
large South African study with over 600 PLWHA living in the Eastern Cape276.  
 
The high unemployment rate in the study sample (82%) was much higher in 
comparison to the unemployment rate reported in the district within which Zithulele 
and the surrounds areas are (38%)45. However, the higher unemployment rate may 
be normal for PLWHA with pain in comparison with the general population or 
PLWHA in the district7. Additionally, the participants have a higher HLOE, with more 
participants having attended high school, than in the population of the district in 
which Zithulele and the surrounding areas are45. The differences in demographic 
characteristics between the participants and the district suggest that the 
participants’ demographics may affect the generalisability across the district, 
however the demographics of PLWHA in the district remain unknown. 
 
5.4 State of health assessed by clinical characteristics 
The cohort appeared to be relatively healthy according to the clinical characteristics. 
Despite the relatively healthy state, all participants were experiencing pain at 
Baseline of the study, with moderate pain intensity and pain interference87,227. 
However, the presence of pain among relatively healthy participants is not unusual 
as pain is commonly reported amongst PLWHA irrespective of CD4 T-cell count or 
stage of disease24.  
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The study participants had lived with a known HIV diagnosis for a 3.96 years (± 3.25) 
and had fairly good health, inferred from the mean recent CD4 T-cell count of 
461.27cell/µl (± 238.62) of the participants277 and the majority of participants being 
on first line HIV management and being largely unaffected by OIs. Participants also 
appeared to have good disease management, with considerably better CD4 T-cell 
count in the recent cell count compared to the initial CD4 T-cell count. In addition, as 
expected for people between 18 to 40 years old, very few comorbidities were 
reported, bringing about the desired effect in the study design of keeping the effect 
of co-morbidities on the results to a minimum. 
 
The rural amaXhosa study sample appeared to have better health, with regards to 
the biomedical factors discussed in this section, in comparison to the urban 
amaXhosa cohort in Parker and colleagues7,46. How the participants’ health 
compared to the health of PLWHA in the areas around Zithulele and the Eastern 
Cape with regards to HIV management and especially CD4 T-cell count is unknown. In 
light of this, it should be recalled that the relationship between pain and HIV 
management or CD4 T-cell count is unclear8,24,54,73,82,101,112. There was a much higher 
percentage of study participants receiving ARVs compared to PLWHA in rural 
informal localities across South Africa and Black African PLWHA51. This was not 
unexpected as recruitment took place on ARV clinic days but this discrepancy 
indicates that the results may be more generalisable to PLWHA receiving first line 
ARVs.  
 
The presence of pain in the relatively healthy study sample, and presence of pain in 
the urban amaXhosa participants in Parker and colleagues7,46, appears to be a further 
testament to the knowledge that pain is complicated in nature, is biopsychosocial, 
and is contributed to by many biomedical and psychosocial aspects32,33,35–39,48,60,67.  
  
163 
 
5.5 Prevalence of pain  
A notable reduction, of more than 50%, occurred in the prevalence of pain over the 
24 weeks of the study. Despite the possible effect of regression to the mean on the 
prevalence of pain as a result of 100% prevalence of pain at Baseline278,279, repeated 
measures reduce the effect280. The consistency of reduction in pain prevalence over 
the period of study during which the interventions occurred, in both the present 
rural cohort and urban amaXhosa cohort in Parker and colleagues46, as well as the  
improvements seen in the secondary objectives, further validates that the 
prevalence of pain appears to have reduced in response to the interventions. 
However, this does not fully eliminate the effect of the regression to the mean, 
particularly as the prevalence could not increase given a baseline of 100%. As both 
intervention groups received the TR intervention, the results suggest that a TR 
intervention is sufficient for reducing the prevalence of pain when compared with a 
combination of a therapeutic relationship with the PL intervention. 
 
5.6 Sites of pain 
The present study found an average of 3 (± 1) sites of pain per participant, which falls 
above the range of number of pain sites found in the systematic review on pain in 
PLWHA24 and is much closer to the number of pain sites experienced by a sample in 
the USA (2.5)24,54 than by participants from another rural South African cohort (1)8,24. 
That multiple sites of pain are common is not surprising as there are many sources 
and influences of pain due to the biopsychosocial influence of pain60,61. As discussed 
in the literature review (Chapter 2.3.3.2; p.23), numerous pain sites could indicate 
the presence of more than one pathological process occurring simultaneously, or 
that the person LWHA may be suffering from a central sensitisation disorder24,117. 
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The percentages of participants reporting the head and the abdomen as sites of pain 
in the present study were higher than the rural cohort in the study by Mphahlele and 
colleagues8. Of particular note is the large percentage of participants in the PL 
intervention group (85%) and TR intervention group (48%) of the present study who 
reported pain in the head, which differs from another rural cohort of PLWHA in the 
study by Mphahlele and colleagues8 (19%). 
 
5.7 Pain severity and pain interference: primary outcome measure 
The moderate PSS and PIS87,227 at Baseline in the present study are consistent with 
the finding that pain and its management is a problem for PLWHA who experience 
pain8,46 and requires better attention and management. As expected, pain severity 
was more similar to that of other outpatients cohorts than to inpatients cohorts24. 
 
5.7.1 Changes in pain severity and pain interference over time 
The main results in the present study indicate that a therapeutic relationship appears 
to be sufficient for significantly reducing PSS and PIS over time. A significant 
reduction in PSS and PIS occurred in the participants over the 24 weeks of the study, 
with both intervention groups, whilst receiving a therapeutic relationship, achieving 
the same outcome. Therefore, either intervention, the PL programme and 
therapeutic relationship combined, or therapeutic relationship alone, appears to be 
adequate to achieve a reduction in pain severity over time. As the PL programme 
was not necessary to establish a significant reduction in PSS and PIS, the present 
study supports the use of the therapeutic relationship for effective pain 
management in rural amaXhosa LWHA.  
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The empathetic therapeutic relationship, which developed between the study 
participants and the RA during data collection in the present study, appears to be 
sufficient to result in a significant reduction in PSS and PIS over time. The results 
support the suggestion in the study on urban amaXhosa women LWHA by Parker and 
colleagues46 that a care factor may have existed which contributed to the 
improvements in PSS and PIS observed in both those participating in the PL 
programme and those who only received the PL workbook.  
 
The results of the present study are supported by many studies which have 
established that a therapeutic relationship is essential for optimising patient 
outcomes156–159,195. This study supports the notion that the therapeutic relationship 
has its own effect on outcomes and should therefore be regarded as a treatment 
itself and that more value and attention should be given to interactions between 
patient and HCP156. The results indicate, as other studies have done so 
previously156,197,207,218,219, that the therapeutic relationship has a positive effect on 
both psychological and physical outcomes, including pain.   
 
In a meta-analysis by Kelley and colleagues156, the effect size of the therapeutic 
relationship alone on physical outcomes in people with various conditions, including 
asthma, fibromyalgia, diabetes and cancer, was small but similar in effect to many 
other medical treatments. The similarity of the effect of the therapeutic relationship 
to another intervention (the PL intervention) was seen in the present study too, as 
both intervention groups had the same outcomes. The trials in the systematic review 
and meta-analysis analysis by Kelley and colleagues281 manipulated the therapeutic 
relationship in various means, including emphasising communication skills and 
empathy, which were purposeful strategies also used in the present study. The 
control groups of the studies in the meta-analysis made use of minimising positive 
effects of the therapeutic relationship and were, therefore, able to determine that 
an effect size for the therapeutic relationship exists.  
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A systematic review by Jensen and Kelley156, on the effect of therapeutic 
relationships, mentioned that a poor therapeutic relationship could have a negative 
effect on outcomes in the same way that a good therapeutic relationship has a 
positive effect on outcomes. Most literature supporting the effect of the therapeutic 
relationship on outcomes is in the field of psychotherapy156. Of interest is that the 
differences in the therapeutic alliance and empathy in psychotherapy have been 
found to account for the majority of differences in outcomes, compared with the 
differences in the other factors which are specific to psychotherapy treatments282. 
This verifies the importance in health care of purposely building good and beneficial 
therapeutic relationships, as the present study has done.  
 
The role of the therapeutic relationship, which was used as an intervention in the 
present study, has been validated by numerous research studies, as reported in the 
review by Jensen and Kelley156, as an important contributor to the outcomes of 
psychotherapy. The findings from Jensen and Kelley156 supported that the 
therapeutic relationship is predictive of physical and psychological changes, as did 
the study by Tufekiglou and Muran194. The association between a better therapeutic 
alliance and positive outcomes of psychotherapy was found to be significant and 
have a medium effect size according to a meta-analysis published in 2011, which 
supported the findings of three previously published meta-analyses195,283–285. It 
should be noted, as pointed out by Jensen and Kelley156 that the medium effect size 
of the therapeutic alliance in psychotherapy is a larger effect than many medical 
treatments.  
 
Flückiger and colleagues159 were able to show that the results indicating the medium 
effect of the therapeutic relationship on outcomes in psychotherapy were robust and 
reliable by re-analysing the data from a previous meta-analysis and taking into 
account some variables. The data were moderated for variables such as RCT trials, 
specific disorders, treatment of specific outcomes related to a specific disorder, CBT 
treatment and an interest in the therapeutic relationship by the therapist.  
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One of the challenges with discussing the effects of the therapeutic relationship  and 
comparing it to other research is that to date, no set way of quantifying the 
therapeutic relationship has been developed158. The therapeutic relationship is 
considered a non-specific element partly characterised by empathy198,208. While no 
measurement of the therapeutic relationship was made in the present study, the 
empathetic therapeutic relationship was generated in a purposeful manner by the 
RA as described in the methods (Chapter 3.6.2; p.87). 
 
The natural ability of the RA to show empathy in addition to the training received, 
appears to have been successful in establishing an empathetic therapeutic 
relationship between the RA and participants, contributing to a reduction in pain. 
Communication, both verbal and non-verbal, is a key aspect of the therapeutic 
relationship in establishing participants’ perception of care, which has been indicated 
in many studies198,208–210. In the present study, the RA behaved with valued 
interpersonal skills such as being friendly, confident, empathetic, encouraging and 
respectful198,211. 
 
As discussed, it is primarily the care as well as the trust and attention received as a 
response to participating in a trial which impacts the outcomes positively197,221. Being 
in a clinical trial also improves researchers’ and HCPs’ behaviour towards 
participants, in comparison to routine care given222. The impact that care has on an 
individual is illustrated in the present study, where pain and secondary outcomes 
were significantly improved as a response to perceiving care220. 
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Proposed mechanisms for the effect of care, generated through the therapeutic 
relationship, on pain include placebo analgesia physiological changes. The release of 
endogenous opioids and neurophysiological changes have been reported in the 
presence of an empathetic therapeutic relationship, and reduce pain156,199–201,286,287. 
Three studies in the review by Jensen and Kelley156 found that the same areas of the 
brain are activated in two people when there is joint attention and mutual 
understanding of an individual’s state of mind, which enhances the therapeutic 
relationship by facilitating social cognition288–290. Further, the anterior cingulate 
cortex and the anterior insula both play a role when individuals empathise with a 
person experiencing pain286. In a study by Sarinopoulos and colleagues287, patients 
experiencing pain had less pain-related brain activity when a HCP focused an 
interview on the patient and showed empathy compared to when a HCP focused the 
interview around diagnosis. Therefore, as the RA in the present study focused on the 
participant and showed empathy in the interviews. This behaviour may have 
contributed to the overall effect of the reduction of pain in both groups of 
participants, who received the therapeutic relationship. 
 
It is important to note that the therapeutic relationship appears to develop over time 
and with consistency and is not merely about empathetic behaviour but the ongoing 
nature of it197,204,221. The continuous interaction develops trust204, and together with 
care facilitates improved outcomes197,221. In both the study by Parker and 
colleagues46 and the present study, participants were given a consistent message of 
being cared for by having regular contact and follow-ups with a consistent 
interviewer. The consistency of person as well as empathetic behaviour the RA 
portrayed is a contrast to the fragmented care patients commonly experience in the 
South African public health care system and the impression of the clinic as a hostile 
environment291. The fragmented care, which arises due to high staff turnover and 
mobile patients53 combined with the sometimes disrespectful health-professionals, 
results in dissatisfaction of patients with routine health care291. 
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The provision of consistent care through a consistent HCP, which may contribute to 
the development of an ongoing therapeutic relationship, in which patients are 
treated well and with care, appears to be an effective pain management strategy for 
rural amaXhosa women LWHA. In addition to being effective, this approach may well 
be more sustainable than running an intervention such as the PL programme, which 
requires peer-leaders and extended patient participation. The appointment of 
‘named’ HCP to allow for the development of therapeutic relationships needs to be 
prioritised in the platform on which treatment is built for PLWHA experiencing pain. 
Further, the impression of the clinic as a hostile environment291 needs to be replaced 
by an empathetic environment. 
 
5.7.1.1 The influence of self-efficacy on pain 
The PL programme, being a self-management intervention, was expected to facilitate 
changes in self-efficacy, which would result in improvement in outcomes of 
pain76,77,142,162. As discussed in the literature review, previous studies have shown 
that self-management programmes are effective in significantly reducing pain76,77,162, 
and that these changes in pain can be predicted by change in self-efficacy over 
time77. Despite a significant difference between groups during the 24-week study, 
both groups’ self-efficacy improved significantly over time. Although a difference 
between groups occurred, which was most likely at Week 8, in the study, the 
outcome suggests that the therapeutic relationship is sufficient to generate change 
in self-efficacy and pain over time.  
 
5.7.1.2 Clinical significance 
The purposeful development of a therapeutic relationship between participants in 
this study and the RA appears to have been sufficient for bringing about a clinically 
meaningful reduction in pain severity. Clinically significant reductions in PSS and PIS 
were found in both intervention groups224,263. In the PL and TR intervention group 
67% of participants met the clinical meaningful change in PSS263.  
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It appears that for rural amaXhosa women LWHA the therapeutic relationship is an 
essential platform for pain management and alone can bring about a significant 
improvement in pain severity and interference. Therefore, HCPs who work with rural 
amaXhosa women LWHA should place more emphasis on developing better 
therapeutic relationships to facilitate improved pain management for their patients.   
 
5.8 Pain Management Index 
On the PMI, inadequate pharmacological management of pain was found at Baseline 
in all participants. These findings are consistent with the cohort of urban amaXhosa 
women in a previous study by Parker and colleagues46. The results of the present 
study and those of Parker and colleagues46 concur with the findings of the systematic 
review by Parker et al.24 that indicate that inadequate pain management is common, 
with 66-100% of participants in the reviewed studies had PMI values below zero24. 
Furthermore, the findings on pain management in the present study are consistent 
with research on women, and people with low levels of education LWHA, for whom 
inadequate pain management exists18,20,26,27. 
 
5.8.1 Change in Pain Management Index over time 
The PMI scores in the present study significantly improved in both intervention 
groups, over the 24 weeks of the study. These results are similar to those from the 
study by Parker and colleagues46 over 16 weeks. The PMI measures pain severity 
against pharmacological pain management87,88. In the present study, the PMI 
improved simultaneously with or following the improvement in PSS. Since change of 
pharmacological pain management is likely to be negligible in routine care46,114 and 
pharmacology is known to have limited effectiveness for reducing pain in PLWHA22,80, 
it is likely that the change to PMI occurred as a result of the reduced PSS.  
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Therefore, the change in PMI in the present study may not be indicative of any 
change in pharmacological pain management. Rather, participants may have 
benefited from the therapeutic relationship and improved communication with HCPs 
to facilitate better pain management. Given the inconsistent availability of pain 
medication in resource poor settings53 and the limited efficacy of pharmacological 
management for pain in PLWHA22,80, the results of the present study support a shift 
in focus towards the purposeful development of therapeutic relationships to 
facilitate reductions in PSS and PIS.  
 
5.9 Self-efficacy: secondary outcome measure 
5.9.1 Change in self-efficacy over time 
The therapeutic relationship appeared to be sufficient to bring about significant 
improvements in self-efficacy over time in both intervention groups. There was an 
effect of group over the 24 weeks of the study where the PL intervention group had 
significantly better self-efficacy compared to the TR group. However, since no group 
and time interaction existed and the significant difference between groups seem to 
be around Week 8, the overall result suggests that the therapeutic relationship is 
sufficient for improving self-efficacy.   
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Improvements in self-efficacy are a target outcome of participating in a PL 
programme77. The significant increase in self-efficacy in the PL programme reflects a 
success of the programme for this variable. These findings are consistent with the 
study by Lorig and colleagues77 on people living with osteoarthritis, in which a 
significant decrease in pain and increase in self-efficacy existed at four months in the 
experimental group, who participated in a self-management programme for six 
weeks, compared to the control group77. However, in the present study these 
improvements in self-efficacy were not limited to the participants in the PL group, as 
participants in the TR group had similar improvements in pain and self-efficacy. It 
may be that the difference between groups would be more apparent over a longer 
follow up periodc. However, at this stage the therapeutic relationship appears to be 
equally effective in improving self-efficacy in rural amaXhosa women LWHA without 
the need for participation in the PL programme. 
 
The therapeutic relationship has been shown to improve health behaviours207, with 
results similar to CBT160,165. Since self-efficacy is integral to positively changing 
thought patterns and behaviours, which has an impact on health behaviours and 
outcomes77,160–163, it is plausible that self-efficacy amongst other health outcomes 
can be improved as a result of a therapeutic relationship.  
  
                                                     
c The long-term effects of the interventions at one year are being monitored as part 
of a larger study on pain in PLWHA and will be reported on in publication. 
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5.10 Symptoms of depression: secondary outcome measure 
No significant difference existed between the intervention groups for BDI at Baseline. 
BDI scores were higher at Baseline amongst rural amaXhosa women in the present 
cohort compared with the mild to moderate scores in urban amaXhosa women in 
Parker and colleagues7,46. However, despite the positive correlation between pain 
and depression16,73,74, the PSS and PIS for the urban cohort was higher than the rural 
cohort. Taking this interaction into account, the comparison between the cohort of 
urban amaXhosa women in the study by Parker and colleagues7,46 further illustrates 
the effect of the biopsychosocial nature of pain and the complexity of the 
relationships between pain, depression and other psychosocial elements292. 
 
5.10.1 Change in symptoms of depression over time 
As a significant reduction in the BDI took place over time for the sample, the 
therapeutic relationship appears to be sufficient in reducing symptoms of depression 
in rural amaXhosa women LWHA and experiencing pain. Over the 24 weeks of the 
study, all participants had reductions in depression from moderate depression to 
minimal depression on the BDI237. The PL programme did not significantly increase 
the improvement in BDI above that of the therapeutic relationship alone, despite 
previous research indicating the worth of self-management programme participation 
in reducing depression76,77,162. The present study is consistent with previous authors 
who have reported and demonstrated the beneficial effects of the therapeutic 
relationship on psychological symptoms, including depression156,158,293. 
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With observations of the graphs for PSS (Chapter 4.4.3: Figure 4-7; p.118), PIS 
(Chapter 4.4.4: Figure 4-8; p.123) and BDI (Chapter 4.5: Figure 4-10; p.128), the BDI 
scores had a more gradual descent than the PSS and PIS in the present study. Similar 
to the results from the urban cohort treated with the PL programme, it is likely that 
the reduction in pain in the present study occurred before improvements in 
depression. Thereafter, it is probable that these two symptoms were inter-related 
and affected each other74 as expected in a biopsychosocial framework of pain35–39. 
This is likely to be the case with HRQoL, which also effects pain16 and therefore 
influences the biopsychosocial framework of pain60. 
 
5.11 Health-related quality of life: secondary outcome measure 
5.11.1 Health-related quality of life at Baseline 
Consistent with other South African cohorts the present study found that rural 
amaXhosa women LHWA have a reduced HRQoL compared to their urban 
counterparts7,17,46,72,98. The baseline EQ-5D VAS of the rural cohort was lower (59.9% 
± 16.6) than the baseline EQ-5D VAS of two urban cohorts of PLWHA (66.67% & 
62%)7,46,106.  
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HRQoL was the only outcome which was significantly different at Baseline in the 
present study. The PL intervention group had a significantly higher EQ-5D VAS and 
EQ-5D Index than the TR intervention group. Participants from the PL intervention 
group all attended Pumalanga clinic, while the participants from the TR intervention 
group attended Ngcwanguba CHC. The differences in the two communities in which 
participants lived, which are two distinct areas, each with its own clinic, road 
networks and tribal authority may have affected the perception of HRQoL despite 
there being no significant difference in age, employment and education58–62. 
Interestingly, there was no difference between groups in pain at Baseline. Previous 
studies have emphasised the links between pain and HRQoL41,72, however this link at 
Baseline was not apparent in the present study’s participants. This suggests that 
there are complex mechanisms at work in the interactions between pain and HRQoL, 
which would be expected considering the biopsychosocial framework of pain35–39.  
 
5.11.2 Change in health-related quality of life over time 
The significant improvements in EQ-5D VAS in all participants (who were all receiving 
a therapeutic relationship), over the 24 weeks of study, differed to the study with 
their urban counterparts by Parker and colleagues7,46, which found no significant 
difference over time from Week 0 to Week 16. The shorter time period of the study 
in Parker and colleagues7,46, may have limited the effect of time on HRQoL. However, 
this difference could also occur as a result of the psychosocial differences in 
communities58–62 or more intentional emphasis being placed on the development of 
an empathetic therapeutic relationship in the present study. The improvement in 
HRQoL in the present study may additionally suggest that a greater potential for 
improvement in the EQ-5D VAS in rural amaXhosa PLWHA exists compared with 
urban amaXhosa PLWHA7,46. 
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The present study found no significant difference for the EQ-5D VAS and EQ-5D Index 
between groups at 24 weeks of the study, as is the case with most other outcomes, 
and the participants of the study significantly improved in both these measurements. 
This indicates that the therapeutic relationship appears to be sufficient to improve 
EQ-5D VAS and EQ-5D Index amongst this rural amaXhosa sample of women LWHA. 
 
5.12 Function: secondary outcome measure 
In comparison to a healthy cohort, the functional performance amongst rural 
amaXhosa women LWHA was reduced at Baseline, similarly to other cohorts of 
PLWHA78,79,294. 
 
There was a positive effect of the study interventions on function. In the present 
study both intervention groups improved significantly over the 24 weeks of the study 
for the 6MWT, forward reach tests, timed repeated sit-to-stand test, timed repeated 
reach-up test and timed belt-tie test. Despite only the participants of the PL 
programme having formal exercise sessions and being encouraged to increase their 
active exercise behaviour47, the only significant differences between groups was for 
the timed, repeated reach-up at Weeks 8 (the PL intervention group was significantly 
quicker) but by Week 24 no significant difference between the groups existed. 
Another study, which compared an experimental group, participating in a similar self-
management intervention for people with osteoarthritis awaiting arthroplasty, to a 
control group, who received routine care, found no significant differences in function 
between groups either192. In the present study both interventions, the PL 
programme and the therapeutic relationship combined or the therapeutic 
relationship alone appear to have the same limited effect on function. 
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The limited effect on function may partly be a result of the type of tests performed in 
the PPTB. The PPTB was chosen as it was a valid and reliable objective measurement 
of function, which had previously been used with people in pain and PLWHA living in 
the USA78,253. In light of the biopsychosocial nature of pain, future studies amongst 
rural amaXhosa women might consider modifying the PPTB to assess function by 
including functional tasks with more relevance to women living in rural areas. This 
would give more meaning to the functional tasks60. For example, walking tests could 
be modified by incorporating carrying wood or water on one’s head during the test43. 
 
As physical tests in the PPTB can be evaluated as individual tests254, each test will be 
discussed in more detail in the following section. 
 
5.12.1 Physical performance task battery – change in 6MWT over time 
The baseline 6MWD for the sample (357.19 metres ± 74.79) was, as expected, under 
the normative values for functional performance from a healthy cohort, despite 
having a lower sample mean age294. In both intervention groups pain and the 6MWD 
improved together, which is consistent with the biopsychosocial nature of pain 
within which the inter-relationship between pain and functional performance can be 
better understood48,61,78,79. However, as no evidence was found on the clinically 
important difference in distance for the 6MWD relevant for PLWHA, the change in 
6MWD, although significantly better, is difficult to interpret. 
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5.12.2 Physical performance task battery – change in forward reach tests over time  
As with the 6MWT, participants in both the PL and TR intervention groups 
significantly improved in the forward reach tests over time, indicating that there was 
an improvement in balance and strength in the sample254,295. Improvement occurred 
in both groups despite only the participants in the PL intervention group taking part 
in structured exercise sessions, which may have improved their balance and 
strength47.  
 
Although improved balance may have been a benefit of the therapeutic relationship, 
it is more plausible that a learning effect may have occurred. The gradual consistent 
improvement in the performance of this test in comparison to the faster initial 
improvement in the 6MWD implies that a learning effect existed. Repeating the test 
twice in one session did not alter the intraclass correlation coefficient (ICC) during 
testing of the validity of the forward reach tests in people with lower back pain253 
and in the original development of the tool (ICC = 0.81295). However, in studies of 
people with Parkinson disease the test re-test ICC was not consistent296. No studies 
reporting on a learning effect in the forward reach test could be found. In addition, 
no literature reporting on the clinically important difference in distance reached on 
the forward reach in PLWHA could be found, limiting interpretation of the difference 
recorded.  
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Although a learning effect may have existed, there is also a contextual possibility that 
may have contributed to the improvement in forward reach. Rural amaXhosa women 
need particularly good dynamic balance to allow them to carry wood and water on 
their heads as they walk. All participants had moderate pain interference with 
function at Baseline but over the course of the study pain improved in both 
intervention groups. It is possible that as pain improved, participants started to 
participate in the activities of carrying wood and water. These activities may then 
have resulted in improvements in balance. Carrying water is the woman’s role in 
traditional family life and vital for survival, as water is a basic necesssity43. Therefore, 
it is likely to be one of the first things women would return to doing as soon as they 
increased in physical performance. 
 
5.12.3 Physical performance task battery – change in timed, repeated sit-to-stand, 
timed, repeated reach-up and timed belt-tie tests over time  
Each timed test improved significantly in both groups, although the reality of the 
improvement is marginal due to the brevity of the tests. The marginal improvement 
found in the present study suggests that the appropriateness of these tests may be 
limited in an outpatient study cohort who are ambulant and independent in many 
tasks. Further, a learning effect may have come into play as with the forward reach 
tests.  
 
Previous research suggests that a learning effect occurs with repeated measures over 
time for the timed, repeated sit-to-stand test297. No evidence regarding the effect of 
repeated measures over time on the timed, repeated reach-up and the timed belt-tie 
test could be found. However, it is possible that a learning effect occurred with these 
timed tests too. Further, the belt-tie test was the least stable of the functional tasks 
in a study on the development of the PPTB in terms of reliability, which is most likely 
due to the task’s complexity252. This also suggests that it is possible that repeated 
measures may lend themselves to mastery of the tasks and improve over time due to 
a learning effect298.  
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5.13 Post-study structured interviews 
The responses to the post-study structured interviews offer similar stories to the 
quantitative results of the study, further validating the effect of the therapeutic 
relationship on pain, depression, HRQoL, self-efficacy and physical function. Pain or 
symptom alleviation, improved function, reduced symptoms of depression and 
supportive community each emerged as benefits to participants from both groups. 
 
The one topic not shared between groups related to pain alleviation. Despite the 
improvements in PSS and PIS in both groups, the topic of pain alleviation was only 
made explicit by participants from the PL group. Comments in the TR group indicated 
symptom relief by stating that they felt “alright” or “better”, which may refer to 
either pain alleviation or other symptoms.  
 
The topic of pain, or in the case of the TR intervention group, symptom alleviation, 
frequently arose in conjunction with exercise and being active. This was 
surprising as only the PL intervention group were explicitly given knowledge 
regarding exercise, partook in exercise classes and were encouraged to do 
exercise through goal setting and action planning. Nevertheless, the TR 
intervention group, who were not educated about exercise, used exercise as 
a tool to improve symptoms. It may be argued that the TR group were 
exposed to exercise by performing the PPTB at each follow-up. Participants 
may have come to regard these exercises as treatment. One participant said 
“…give us exercises…” possibly referring to the RA, although it is unclear. This 
may have helped improve the function of the TR intervention group146,148,149. 
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Consistent with the reduction in BDI scores, participants in both groups made 
comments which implied that reduction in symptoms of depression and anxiety was 
as a result of support. The support mentioned by the participants in the TR group 
mostly appeared to be in relation to other family and community. However, one 
participant mentioned being asked questions about whether she “regrets” herself, 
which resembles questions asked in the BDI. These questions if asked by an 
interviewer in a caring nature have the potential to increase the patients’ trust and 
effect of the therapeutic relationship237,299. The topic of support, contributed to the 
finding that the therapeutic relationship influences psychological and physical health 
outcomes156–159,197,207,218–220 and may be sufficient to significantly decrease pain 
severity and the impact of pain on function. 
 
Further, two participants in the TR group made comments which appear to imply 
that they perceived the follow-up data collection sessions as a group. This perception 
could be contributed to by several factors including participants in an intervention 
group sharing the same interviewer, appointment day and all being women, LWHA 
and of similar age. At times, participants in the study, in both intervention groups, 
requested to do the questionnaires simultaneously with one or two others. The RA 
obliged them, as discussed in Chapter 3.8 (p.98), if adequate consent from each 
participant was given and no hesitancy was observed. Participants were happy to 
share their experiences and were not reluctant to do so in front of others. Being able 
to initiate this as a setting in which to share in a group, may have contributed to 
improved health outcomes in the TR group. This suggests that rural amaXhosa 
women in this cohort are able to create self-initiated groups and find support this 
way, which is a shared ability with their urban counterparts who also set up their 
owns groups46. 
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Interestingly, participants in both groups gave the impression of having gained some 
knowledge of how to manage some symptoms. The sources of information on how 
to manage symptoms appeared to differ.  In the PL group, the source of information 
was primarily through facilitation and the PL workbook, whereas in the TR group, 
information appeared to be shared amongst fellow participants and were suggestive 
of being learnt from routine care.  
 
Although there was no apparent inter-group contamination, there may have been an 
element of intra-group contamination. Research indicates that pain can be 
modulated by expectations, which can cause a placebo or nocebo effect300. As 
participants in the TR group expressed that exercise appeared helpful for symptom 
management, and one participant expressed that participants in the TR group shared 
information with fellow participants, results of the TR intervention group may have 
been affected if participants shared this learnt information that exercise was helpful 
for managing symptoms300.  
 
Participants of the PL programme expressed the usefulness of the group and benefit 
from the exercises which they participated in. Additionally, a suggestion was made 
by one participant to run more groups at clinics for people who wished to join. 
Participants from both groups appeared to accept exercise as beneficial and were 
open to being part of groups. The responses from the interviews in both groups were 
suggestive that interventions of this type are acceptable to rural amaXhosa women 
LWHA. 
 
5.14 Effectiveness of the interventions 
The therapeutic relationship intervention was feasible in this cohort and the 
significant improvements in pain, depression, HRQoL, self-efficacy and function in 
both groups are indicators of its effect. Despite low attendance at data collection 
dates, significant differences in the primary and secondary outcomes occurred. 
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Although the efficacy of the PL programme independent from the therapeutic 
relationship is difficult to ascertain, it does not appear more effective than the 
therapeutic relationship alone as an independent intervention. It appears that the PL 
programme is accepted amongst rural and urban amaXhosa LWHA. It’s feasibility, 
however, is questionable. The poor attendance of the PL programme, particularly in 
one of the two PL groups (which was consistently very poor), suggests that the PL 
programme may not be feasible for many rural amaXhosa women in this area.   
 
The efficacy of the PL programme may differ if it were therapist-led. Both the study 
sample and the urban amaXhosa cohort in Parker and colleagues46 had a lower HLOE 
compared with two studies in the USA, which endorsed peer-led self-management 
programmes, both of which had a mean HLOE of over 13 years in school76,162. A 
South African study of participants who had mostly attended high school (eight to 12 
years of education) indicated that a therapist-led self-management programme, with 
education and exercise, was more effective than usual care for people living with 
osteoarthritis192. However, the self-management programme for people with OA was 
not compared with peer-led self-management in this cohort and the impact of HLOE, 
in South African contexts, has not been established for self-management 
programmes.  
 
Furthermore, regarding the HLOE of the cohort, the PL workbook was pitched for 
people with at least seven years of education7. For the urban amaXhosa cohort for 
whom it was developed, this was appropriate. However, in the present study a large 
percentage of the PL intervention group stopped attending school before completing 
seven years of education. The efficacy of the PL programme may therefore partly be 
affected by the PL workbook being tailored for a higher HLOE than that of a large 
percentage of the rural amaXhosa cohort. A modified version of the workbook may 
need to be developed if the self-management intervention is to be enhanced. In 
addition, developers of modified editions of the PL workbook may need to consider 
that the Flesch-reading scores may not be suitable for use in rural South Africa, when 
comparing reading skills with international standards301.   
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5.15 Strengths and limitations 
The CONSORT guidelines, drawn up to facilitate quality of randomised controlled 
trials, were used to evaluate the strengths and limitations of the present study 
(Appendix K; p.374)302.  
 
5.15.1 Strengths 
The main findings of this study were unexpected. Finding something unexpected 
reduces the likelihood of bias and also provides a platform for a new perspective and 
for best-practice to be better informed by current research and not on assumptions 
or hypotheses298.   
 
The therapeutic relationship intervention has been thoroughly described in the 
methods (Chapter 3.6.2; p.87) with regards to how the RA was chosen, which 
qualities the assistant needed to possess, the training the RA received and the 
procedure of the intervention itself. Showing empathy was vital to the intervention 
and therefore how it was fostered in the RA has been explained in detail. Future 
research using a therapeutic relationship intervention could therefore be modelled 
on this method. Further, comparisons between results of the present study and 
other studies, using a therapeutic relationship, can take into account the method in 
which the therapeutic relationship was developed. 
 
Using clinics as the setting for the implementation of the study interventions meant 
that the research could study the efficacy of the interventions in a realistic setting, as 
clinics are the most accessible place of health care and the primary source of HIV 
care in the areas around Zithulele53. Evaluating the interventions by intention to 
treat strengthens the study’s ability to be realistic, by allowing for usual occurrences 
and challenges, such as the low attendance, to contribute to outcomes. The main 
finding of the study, which found the therapeutic relationship in this rural setting 
amongst amaXhosa women LWHA to be effective in significantly improving pain, 
independent of the PL programme, is therefore a realistic outcome in clinical health 
care. 
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The shared isiXhosa language between participants and the RA or peer-leader 
reduced misinterpretations and increased the participants’ feeling of being 
understood by the RA303. This would have been important for establishing a better 
therapeutic relationship, especially as the presence of an interpreter creates an 
intermediary, whom the attention is diverted towards, reducing the direct 
interaction of a therapeutic relationship304.  
 
This study contributed to research which aids better pain management for PLWHA, 
which is valuable as pain is generally poorly managed in PLWHA internationally24. 
Further, as HIV/AIDS has become known as a chronic debilitating disease9, and 
pharmacological interventions available in South Africa have limited efficacy22,80, it is 
imperative that more research is done to determine effective non-pharmacological 
interventions for pain in PLWHA, which the present study was able to contribute to.  
In particular, it adds to the few studies on pain management in PLWHA in rural South 
Africa6,8,34,41,114,276, which is of importance, as between 10.4%-13.4% of the rural 
population in South Africa are PLWHA51. Furthermore, it was the first study to 
address pain amongst rural amaXhosa women LWHA. In doing so, this study 
establishes more literature specific to vulnerable groups, such as women and people 
in poverty, who commonly receive poor pain management18,20,26–28.  
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Further, the findings of the study frequently complemented other research. The pain 
characteristics found in the present study were in line with those in the systematic 
review in the paper by Parker and colleagues24, highlighting that pain is a problem for 
rural amaXhosa women LWHA as well. Secondly, the finding that the therapeutic 
relationship was sufficient as an intervention, independent from the PL programme, 
to significantly reduce pain in rural amaXhosa women LWHA, complements many 
papers indicating the positive effect of the therapeutic relationship on physical and 
psychological outcomes, including pain156,197,207,218,219. It also offers a plausible idea, 
although not a definite one, that the therapeutic relationship may be partly 
responsible for the reason the workbook in the previous study amongst urban 
amaXhosa women LWHA was as effective in significantly reducing pain as the PL 
programme coupled with the workbook46. 
 
5.15.2 Limitations 
The following limitations should be taken into account with interpretations of the 
results and main findings of the study.  
 
Low attendance was a major limitation of the study, which may have limited the 
effect of the PL programme by restricting the development of self-efficacy164. 
Additionally, the low attendance at data collection dates may have restricted the 
development of the therapeutic relationship despite efforts being made to aid 
attendance.  
  
187 
 
Consistent effort was made to aid attendance, through appointment cards, 
coinciding study dates with follow-up dates for routine care, regular cellular phone 
call reminders of follow-up appointments and giving participants the monetary value 
of transport before the follow-up date. However, contacting participants was difficult 
at times due to the lack of electricity for charging phone batteries45 and poor cellular 
phone signal. As there were few participants in formal employment, and grants are 
the main income for many households in the Eastern Cape, it is likely that poverty 
may have contributed to the low attendance (Chapter 4.1: Figure 4-2; p.106)6. 
Further, there were reasons for non-attendance, which had to do with family 
responsibility and work. 
 
If it were feasible for participants to attend the clinic for the data collection on any 
day of the week the attendance may have been better. However, there are few 
rooms at the clinics and a room was not available daily. Therefore, if participants 
were unable to attend data collection on the first day, a second day in the following 
week was given as an option. Despite attempts to improve attendance at data 
collection in this way, attendance remained limited.  
 
Secondly, transport problems, one of the common reasons for non-attendance in the 
study, are difficult to reduce. Despite providing money for transport, transport 
remained a problem, and participants may have used the money on other pressing 
needs before the next follow-up. If participants transport was organised by the study 
it may create suspicion in the community as to why individuals were given this 
attention. Home visits create the same problem of suspicion and have the potential 
to reduce privacy if other family members are present. The bigger problem with 
home visits is that it changes the intervention, changing it from an intervention that 
can be implemented in a clinic into an intervention which requires more resources. 
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The limitation of low attendance should be highlighted as it indicates that there are 
many barriers to receiving health care in this rural area in South Africa. As far as the 
author is aware, no research exists for comparing non-attendance of scheduled clinic 
appointments in rural versus urban areas in South Africa. Participants from the 
present study appear to have had more barriers for attending the clinic than the 
urban cohort46. In the research setting, there is limited access to clinics due to 
distances between clinics, few public transport routes and high costs of public 
transport, which might have contributed to the low attendance of follow-ups in the 
present study45,58,59,275. Additionally, the higher employment rate and participants 
receiving disability grants in the study by Parker and colleagues7,46, compared with 
the demographics of the participants in the present study, may have financially aided 
better attendance amongst the urban cohort than the present study’s rural cohort. 
 
The most significant limitation of this study is the large amount of missing data. 
Despite having a limited data set, appropriate statistical models were found for 
analysis. To reduce the bias in the interpretation of results, instead of using an 
ANOVA, which may have distorted the results, model regression analysis was 
performed. Further, conservative findings were maintained in the regression 
analysis, where the best model or, failing to find a best model, the most conservative 
one was chosen from models with significance. Corrections for error in significance 
were also conducted. If appropriate, no modelling was done and other statistical 
methods were used.   
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There was reduced power at Week 24 to detect a difference between groups due to 
very low attendance, 12 participants, in Week 24 in the TR intervention group 
(Chapter 4.1: Figure 4-2; p.106). To attain adequate power, 13 participants in each 
intervention group was necessary, as calculated prior to recruitment (Chapter 3.2; 
p.77). The large amount of attrition was unexpected, considering the attrition rate in 
the study by Parker and colleagues46 amongst urban amaXhosa women LWHA. Due 
to the reduced power at Week 24, a reduced probability exists for the significant 
effects of time on pain and many secondary outcomes over the 24 weeks of the 
study in the TR group. There is also less probability that no significant differences 
existed between the efficacy of the PL group and the TR group. 
 
Another limitation which arises from the low attendance is that it is unknown 
whether, apart from the reasons given for non-attendance, the participants who did 
not return were doing well and improving in the outcomes or the opposite. 
Therefore, the study results which indicate improvement in outcomes might be 
biased due to the amount of non-attendance. Fourteen participants of the sample 
(29%) were unable to attend Week 12 and Week 24, of whom nine participants 
additionally were unable to attend Week 8. 
 
The participants were all amaXhosa women living in the areas around Zithulele, a 
rural area in the Eastern Cape, and managed by the Zithulele ARV programme. The 
study results showing a main effect of time on reducing pain in the presence of a 
therapeutic relationship, are not generalisable to all rural amaXhosa women LWHA 
but to women of similar living conditions to the areas around Zithulele and similar 
health. The study results may also not be applicable to amaXhosa men, urban 
amaXhosa women or to other cultural groups. Further studies, using randomisation, 
are indicated across more districts, for example in the Eastern Cape, and between 
gender, to understand the effect of the therapeutic relationship in rural amaXhosa 
women and men.  
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As a sample of convenience was used, the generalisability of results may be reduced. 
The study used two clinics, which were in the Zithulele ARV programme and 
identified as suitable, and all participants at one clinic were stratified into an 
intervention group. Although this study design decreased the chance of 
contamination, the sample populations in these two clinic areas may not be 
homogenous, as demonstrated by different EQ-5D VAS and Index scores. Therefore, 
the generalisability of results across participants in these two intervention groups 
may be reduced.  
 
With further regard for the study design, maintaining the RA as a single-blind in this 
setting was challenging especially since the study avoided participants having two 
hospital visits in a week for the study. For Week 4, the data collection date and the 
Week four PL group session at Pumalanga clinic was set up on the same date. It was 
important, due to limited space and a small clinic area that the participants were not 
seen attending the PL programme. Participants were asked to be discrete in arriving 
at the group session and, as it was in another section of the clinic, participants were 
able to maintain this. The communities in the areas around Zithulele have close 
relationships due to the structure and nature of the community, which shares tribal 
authority, has traditional ties to the land and years of history with neighbouring 
families. It was also possible that the RA could hear reports of participants taking 
part in the PL programme from the community if this information was not managed 
well. Participants were explicitly told to keep the intervention group they 
participated in unknown to the RA, however it was unclear whether blinding was 
maintained throughout the study. The RA was asked to report if the intervention 
group of any participant was revealed to her or was suspected by her. No reports of 
this kind were made but the potential for contamination cannot be ruled out. 
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Other objective tests for function may be more applicable in future studies on 
ambulant PLWHA. The results of change over time for the forward reach tests and 
the timed tests of sit-to-stand, reach-up and belt-tie in the PPTB may have been 
subject to a learning effect over time297 or appear to be negligent or of unknown 
clinical meaningfulness in function. For assessing function objectively, accelerometry 
appears to be a good alternative to the PPTB as it is measures ongoing physical 
measure of general function, including sedentary behaviour and physical activity251. 
 
Finally, the results of the present study indicate the effects of the PL programme and 
the TR over 24 weeks of study. Although this is a longer time period compared to the 
study by Parker and colleagues46 on the effects of the PL intervention on women 
LWHA, 24 weeks is not long enough to show long term effects of the 
interventions141,165. Long-term effects are being monitored at one year, as 
mentioned earlier, to determine the effect of the PL programme and the therapeutic 
relationship over longer periods.   
 
5.16 Clinical implications 
The results of this study suggest that a purposively developed empathetic 
therapeutic relationship is sufficient to significantly reduce PSS and PIS over time. 
The results do not appear to justify the implementation of the PL programme for 
rural amaXhosa women LWHA. Asking participants to attend more appointments at 
the clinics than necessary for quality care is unethical due to the financial burden 
created by transport, and possible absenteeism from work. Additionally, it adds 
burden to the health care system unnecessarily. In response to this research, the 
health care system should address barriers to the development of better therapeutic 
relationships and implement systems that facilitate therapeutic relationships. These 
systems would include addressing staffing levels, training in empathetic 
communication and increasing consultation times. 
  
192 
 
As mentioned previously, patients experience a mix of committed, empathetic staff 
and disrespectful staff in the South African health care system291,305 and in rural areas 
a high-turnover of staff is common53. Appointing a sufficient number of staff who are 
dedicated long-term HCPs to ARV clinics, incentivising long-term commitment in a 
clinic for HCPs and implementing training in empathetic communication may 
improve the development of therapeutic relationships over follow-ups212–214.  
 
It appears to be important that the therapeutic relationship was developed with the 
same consistent RA, acting in the place of a HCP. Allocating PLWHA to consistent 
‘named’ HCPs, who remain committed over time may be necessary to help to reduce 
pain in PLWHA.  
 
Although the RA in the present study showed a natural ability to develop and 
improve a therapeutic relationship with others, research shows that formal training 
in communication improves the therapeutic relationship157,212–214. Heath care 
professionals and other workers involved in patient care should be trained to foster a 
beneficial therapeutic relationship and learn about the impact of the therapeutic 
relationship on health outcomes. The perspective of the therapeutic relationship as 
an intervention, which can be beneficial or harmful, and therefore has ethical 
implications, needs to be adopted among HCPs as a platform for further intervention 
to take place156,194. Further, fostering the therapeutic relationship ties in with the 
patient-centred approach and biopsychosocial approach endorsed by HCPs157.  
 
The follow-up interview took 30 to 45 minutes to complete, and may mean that 
participants may need regular visits with dedicated time to develop a therapeutic 
relationship. As time is a scarce resource, due to low staff numbers in the health care 
system it may continue to be a barrier for improving the therapeutic relationship53. A 
TR intervention programme, which is similar to that used in the present study in 
involving interviewing PLWHA on health outcomes including pain, depression and 
HRQoL by a trained and purposively empathetic non-HCP, could be adopted, if time 
is found to be a factor for HCPs and funds exist for training non-HCPs.  
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Further research is indicated in order to better understand the therapeutic 
relationship and self-management programmes, in order to enhance its use in 
practice with PLWHA.  
 
5.17 Research implications 
Being limited to 24 weeks of study, a study which continues with follow-up until one 
year is necessary to determine long-term effects of the therapeutic relationship in 
comparison with the PL programme combined with the therapeutic relationship. As 
mentioned previously, ethical approval has been obtained to continue to follow the 
participants to one year to further evaluate the effects of the intervention. These 
results will be reported on in publication. 
 
In the present study, no structured measurement of the therapeutic relationship was 
made. Although difficulties arise in quantifying the therapeutic relationship, in future 
research it would be worthwhile to quantify aspects of it, in order to study whether 
there is a correlation between the degree of trust or empathy and the change in 
outcomes. Measures such as the consultation and relational empathy (CARE) 
measure306, the Wake Forest physician trust scale (which measures patient’s trust in 
HCPs)307 and a valid and reliable measure of the trust HCPs have in their patients308 
could all be used to measure empathy and trust in the physician-patient therapeutic 
relationship. Additionally, as the experience of HCPs by patients is mixed291,305, 
understanding any negative effects of poor therapeutic relationships is valuable.  
 
Having regular consultations with a consistent HCP appears to be necessary to build 
a sufficiently effective therapeutic relationship for alleviating pain, as found in the 
present study. Future research could compare the efficacy of having regular 
consultations with a consistent HCP in comparison to the usual setting where 
patients frequently see different HCPs on pain and other health outcomes in PLWHA. 
This would determine whether long consultations, as were used for interviews in the 
present study, was necessary for significant pain improvement or whether regular 
meetings with a ‘named’ HCP is sufficient for the significant change in pain. 
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Although there were no significant differences between the intervention groups, 
except for self-efficacy, the efficacy of these interventions has only been studied 
broadly in PLWHA between 18 and 40 years old. Further research into whether there 
are subgroups for whom participation in the PL programme yields significantly 
different results to the TR intervention should be done. The PL programme, which is 
based on the self-efficacy theory160, has many similarities to self-management 
programmes, in which developing self-efficacy is integral to improving health 
outcomes77,160–163. Research suggests that people with pain and low self-efficacy are 
of particular interest when identifying subgroups for whom the PL programme may 
benefit the most. If the PL programme is significantly more beneficial for a subgroup 
of PLWHA, guidelines for indication of participating in the PL programme could be 
developed.  
 
Further, clarifying the most effective way of facilitating the programme, whether 
peer-led or therapist-led, in cohorts in South Africa may be valuable for future 
comparisons of the PL programme to other interventions, such as the therapeutic 
relationship. Previous research, in the USA, indicated that neither HCP-led or peer-
led self-management programmes were superior for PLWHA76,162. However, the 
contextual differences, including education as discussed earlier in this chapter 
(Chapter 5.14; p.182), between South Africa and the USA may influence the effect of 
a peer-led self-management programme. A South African study assessing a self-
management programme for people with osteoarthritis similar to that of the present 
study showed that participation in a physiotherapist-led programme significantly 
improved pain compared to participants in the control group192. In contrast, the 
significant improvements in pain in South African participants who participated in 
the peer-led PL self-management programme in Parker and colleagues46 and the 
present study appear not to be better than the therapeutic relationship alone or 
workbook alone. If comparison between peer-led or therapist-led programmes are 
studied, the running of future PL programmes should take the poor attendance into 
account during planning its design. 
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As a dearth of research is performed in rural areas, limiting comparisons between 
urban and rural areas, future studies should be considered in rural areas as well as 
urban areas. For further research in rural areas, it is recommended that possible 
poor attendance is well accounted for in the sample size calculation. 
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6 Chapter Six: Conclusion 
Pain is one of the most common symptoms of PLWHA2–5. The high prevalence of pain 
in South Africa amongst urban amaXhosa women LWHA, is likely to also exist in rural 
amaXhosa women LWHA7,8. As pain is a biopsychosocial construct35–39,60,61, culturally 
appropriate and effective interventions which manage pain are needed6,8,32–39. 
Further, the need for better pain management has increased as HIV/AIDS has 
become recognised as a chronic debilitating disease9 and as the prevalence of HIV in 
South Africa continues to rise, resulting from successful ART rollout30.  
 
The PL programme, which was identified as an effective non-pharmacological 
intervention for managing pain in urban amaXhosa women LWHA46, was tested 
amongst rural amaXhosa women LWHA to determine its effectiveness amongst their 
rural counterparts. This was done in light of the biopsychosocial differences between 
rural and urban amaXhosa people40–45,49,51,52. Further, as initial research on urban 
amaXhosa women LWHA who participated in the PL programme suggested that an 
empathetic therapeutic relationship may have added to the improvement in pain, 
the extent of the effect of the therapeutic relationship on pain in rural amaXhosa 
women LWHA needed to be determined46. 
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This study aimed to determine the efficacy of the PL programme combined with a 
therapeutic relationship in comparison to the therapeutic relationship alone in rural 
amaXhosa women LWHA. There were no significant differences between groups for 
the primary outcomes, pain severity and pain interference. Most other health 
outcomes, specifically symptoms of depression, HRQoL and function were not 
significantly different between groups, although a significant difference was found 
between groups for self-efficacy. Significant improvements in pain severity and pain 
interference were found over time for both groups. Additionally, significant 
improvements were found for symptoms of depression, HRQoL, self-efficacy and for 
most functional tasks of the PPTB. Therefore, the therapeutic relationship, and the 
PL programme combined with the therapeutic relationship, are both beneficial for 
managing pain in rural amaXhosa women LWHA. As significant improvements 
occurred in both groups, it appears that the therapeutic relationship is sufficient to 
manage pain in rural amaXhosa women LWHA. A study which continues to follow the 
participants to one year is needed to further evaluate the effects of the interventions 
in the long term, which the larger study will address as mentioned previously and will 
report on in publication.   
 
Currently, the results do not justify the implementation of the PL programme for 
managing pain in rural amaXhosa women LWHA. However, further research to 
determine whether the PL programme is more effective for subgroups, such as 
PLWHA with low self-efficacy is indicated. 
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Finally, the therapeutic relationship needs to be recognised as an intervention by 
HCPs. A therapeutic relationship should act as a platform for further health care in 
order to provide effective and adequate pain management amongst rural amaXhosa 
women LWHA. The development of empathetic therapeutic relationships in health 
care for rural amaXhosa women LWHA needs to be prioritised. Further, emphasis on 
training HCPs to establish and improve empathetic therapeutic relationships with 
rural amaXhosa women LWHA is indicated for this population. In addition, health 
care systems which facilitate a more empathetic environment, where patients can 
have regular consultations with a consistent ‘named’ HCP should be established. 
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8 Appendices 
Appendix A: Demographic questionnaire 
Allocated no: ________________ 
Date of birth: ________________ (day/month/year) 
Village and directions: 
_____________________________________________________________________
_____________________________________________________________________ 
Closest clinic: ________________ 
Contact numbers:  1.   Mark with a * if this is a personal number 
2. 
3. 
HIV status (tick): 
□ Stage 1     □ Stage 2 
 
□ Stage 3    □ Stage 4 
 
Date of diagnosis: ________________ (day/month/year) 
CD4 at diagnosis: ________________ 
Most recent CD4+:________________ Include date:________________  
(day/month/year) 
 
HIV management: 
□ Monitoring 
 
□ First-line ARVs  Date initiated ________________  
(day/month/year) 
 
□ Second-line ARVs   Date initiated ________________  
(day/month/year) 
 
Opportunistic Infections: 
□ Tb - Pulmonary    □ Tb - Extra-Pulmonary 
 
□ Oral Candidiasis    □ Syphilis 
 
□ PCP      □ Human Papillomavirus/Genital Warts 
 
□ Toxoplasmosis    □ Molluscum Contagiosum 
 
□ Cryptococcal Meningitis   □ Seborrhea 
 
□ Genital herpes    □ Folliculitis 
 
□ Vaginal Candidiasis (thrush) □ Pelvic Inflammatory Disease     
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Co- Morbid Diseases (eg. Diabetes Mellitus, Hypertension): 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Type and number of analgesic medications: 
□ Paracetamol   □ NSAID’s 
 
□ Mild opioids    □ Strong opioids 
 
□ Adjunctives                                          □ Other: ________________  
 
 
How long have you been taking the above mentioned medications? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Highest level of education reached:   ___________(grade at school) 
 
___________(higher level of education-define)   
                        
Occupation: 
□ Student    □ Employed 
 
□ Temporary employment   □ Unemployed- looking for work 
 
□ Unemployed- not looking for work  
 
□ Unable to work- Disability Grant 
 
Other (please specify): 
_____________________________________________ 
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Appendix B: The “SOS” health literacy screening tool Instrument 
 
The “SOS” health literacy screening tool Allocated no: _________ 
 
1. What is your highest level of education? 
 
□ School    Indicate highest grade achieved: ________________  
 
□ Higher level of education  Indicate highest level achieved: ________________  
 
 
2. How would you rate your ability to read? 
 
□ Excellent or Very Good (Kakuhle kakhulu)    
 
□ Good   (Kakuhle) 
 
□ Okay     (Ndiyakwazi njee) 
 
□ Poor    (Kakubi) 
  
□ Terrible or Very Poor (Kakubi kakhulu) 
 
3. How often do you need to have somebody help you read instructions, pamphlets 
or other written material given to you by your doctor or pharmacy? 
 
□ Never   (Andidingi ncedo)     
 
□ Rarely   (Manqaphanqapha) 
 
□ Sometimes    (Ngamanye amaxesha) 
 
□ Often    (Ixesha elininzi) 
  
□ Always   (Lonke ixesha) 
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Appendix C: Outcome measures 
Appendix C/1: Brief Pain Inventory English and Xhosa versions 
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Appendix C/2: Beck Depression Inventory English and Xhosa versions 
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Appendix C/3: EQ-5D English and Xhosa versions 
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Appendix C/4: Self-efficacy for Managing Chronic Disease 6-Item Scale English and 
Xhosa versions 
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Appendix C/5: Physical performance task battery  
 
Physical Performance Task Battery Allocated no: _________ 
Date: _______________ 
 
 
 
1 
 
15 metres (m) walking at preferred speed. For this test, 
subjects are timed as they walk 7.5m turn around, and 
walk back to the starting position at their preferred 
walking speed. 
 
 
Time:  
 
2 
 
15 m walk at fastest speed. Subjects are again timed as 
they walk 7.5m, turn around, and walk back to the start as 
fast as they can. 
 
 
Time: 
 
3 
 
Unloaded forward reach. For this test, subjects stand 
adjacent to a wall on which a tape measure is positioned 
horizontally at shoulder height. Subjects reach forward as 
far as they can and the distance reached is measured in 
centimetres (cm). 
 
 
Cm: 
 
4 
 
Timed, repeated sit-to-stand. Subjects sit in a standard 
chair and are then timed as they stand up and then sit back 
down, twice. The test is repeated after a brief rest and the 
average time of the two trials is used.  
 
 
Time 1:  
 
Time 2:  
 
 
 
256 
 
 
5 
 
Loaded forward reach.  For this test, subjects stand 
adjacent to a wall on which a tape measure is positioned 
horizontally at shoulder height.  They hold a weighted bar 
(4.46 kg) with both hands close to their body and at 
shoulder height. They then reach forward as far as they 
can with the bar in a horizontal position, maintaining their 
hands at shoulder height. The reach distance is recorded in 
centimetres.  
  
 
Cm: 
 
6 
 
Timed, repeated reach-up. For this test, subjects stand 
facing a wall and reach up as high as they can with both 
hands. A mark is placed on the wall at the reached 
distance. Subjects then reach up and return their hands to 
their sides three times, as fast as they can. 
 
 
Time:  
 
7 
 
Distance walked in 6 minutes. Subjects walk as far and as 
fast as they can for 6 minutes. The distance walked is 
measured in metres at 6 minutes. (Subjects are allowed to 
rest if and as necessary during the 6-minute period.)  
 
 
Metres: 
 
8 
 
Timed belt tie. Patients sit in a standard chair and are 
timed as they wrap a standard wrap bandage 
(approximately 1 meter long) around their waist and tie it 
in front of them. 
 
Time:  
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Appendix D: The ‘Positive Living’ workbook 
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Positive Living 
 
 
  
 
 
 
 
 
 
 
 
 
 
Name:      
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Positive Living 
 
Welcome to “Positive Living”. This is a workbook designed to be used over 6 weeks which aims to help people 
develop self-management skills for living with HIV/AIDS. Using this workbook is not about sitting and reading or 
listening. In order to get the most out of this course you will be asked to share your experiences, you will need to 
set goals and share those goals with others and you will need to take part in activities. This workbook is NOT a 
substitute for any other medical care that has been recommended for the treatment of your condition. 
 
You will benefit most from this workbook if you commit yourself to completing all the sessions within a 6 week 
period of time. Scientific research tells us that these courses are of great benefit to people living with chronic 
diseases such as diabetes, arthritis and HIV/AIDS.  But to benefit from the course, using the workbook regularly 
over 6 weeks and participating in activities is essential. The workbook is divided into six sections: 
1. Week 1: Self-management and Exercise 
2. Week 2: Managing common symptoms of HIV/AIDS 
3. Week 3: Stress Management 
4. Week 4: Pain 
5. Week 5: Eating Well 
6. Week 6: Continuing as a successful self-manager 
 
Your course leader is                       . She/he has been trained in all the information you will be going through. 
She/he has also been trained by a physiotherapist or occupational therapist who specializes in HIV/AIDS in safe 
ways to exercise and in relaxation techniques.  
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Week 1: Self-Management and Exercise 
 
What do we mean by the term “self-management”? Self-management does not mean that you are expected to 
look after your health on your own with no help. No, someone who is a successful self-manager takes 
responsibility for their health. This means that they choose to work with the health team, with their drugs and with 
themselves to live a healthy life (just like a manager in a business – they don’t do everything themselves, they 
work with a team).  
 
There are lots of things you can learn to do which will help you to be a successful self-manager. First of all it is 
important to understand HIV and AIDS. You need to understand about the virus and the disease, how it is 
transmitted, how it can affect you and about the medications used to treat it.  
 
The next step in being a self-manager is being able to think about this information in terms of how it affects you. 
The final step in being a self-manager is to think about what it is that you want to be able to do, decide how you 
are going to do it and then to learn and practice the skills you need to be able to do it. Some of the things you will 
learn about and practice every day when you do this course include exercising, relaxation techniques and 
healthy eating. 
 
Using this workbook you will learn about exercise and its benefits, in the second section you will learn a bit about 
the common symptoms of HIV/AIDS and how to manage these. The third section will focus on stress 
management, the final sections focus on pain, and eating well. Some people using this workbook may already 
know a lot about these topics, others may not know very much. It is important to share information and make 
sure that everyone has the knowledge they need to become a self-manager, even if you think you know a lot 
about these topics it is still worth your going through the workbook to make sure you have not missed out on any 
information. Scientific research tells us that people who are well informed about their health manage better and 
have a better quality of life. Using this workbook, you will also learn about and discuss the steps that are needed 
to become a good self-manager. Let’s look at these steps here.  
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Self-management steps 
Step 1: 
To be good at self-management you need to learn and practice several skills which you will practice through this 
course. The first step is to decide what it is you want to be able to do. This can be the hardest step to think 
about. For example you might be feeling very sad and depressed. First you need to think about why you are 
feeling that way. Perhaps one of the reasons you are feeling that way is that you have lost touch with your 
friends. Your first step might be to decide that you need to meet people to make friends. This will help you to feel 
less sad and depressed.  
 
Write down here three things that you want to be able to do:  
1)          
          
2)         
          
3)         
          
 
Step 2: 
But deciding that you are going to meet people and make friends doesn’t mean it will happen. You have to make 
it happen. The second step in being a self-manager is to decide how you are going to do it. Sometimes the 
thought of doing something new can seem too much and we don’t even try. If you want to meet people to make 
friends you need to think about all the different options you have to do this. For example you could invite your 
neighbours for tea, or you could decide you would meet people by going to church, by joining a support group or 
an exercise group. Never assume that what you want to be able to do is impossible. Always look for every option 
and look at it from every angle.  
 
Write down here three different ways that you could try to achieve what you want to do: 
1)             
2)             
3)             
 
Now that you have decided on how you can try to achieve what you want, you need to make an action plan. It is 
important that this plan is realistic otherwise it is likely you will not succeed. How do you do this? 
 First decide what you are going to do this week 
 Now make a specific plan  
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Saying that this week I’m going to try to meet some people is NOT a specific plan. To be specific, the plan must 
have different parts. It is useful to ask yourself some questions to help develop a specific plan. Questions like: 
 What? 
Exactly what are you going to do? For example you could decide that to meet people you are going to invite 
your neighbour for tea. 
 How much?  
Then you must decide how much you are going to do. For example are you going to invite one neighbour for 
tea or are you going to invite lots of neighbours over. Lots of people are much more tiring than one person. 
Or do you want to invite your neighbour for lunch? But lunch means a lot more preparation and time and will 
make you more tired. So you have to decide how much you can do. 
 When will you do it? 
Then you must decide on exactly which day you are going to do the activity and at what time of the day. 
Maybe it is better to invite your neighbour for tea in the morning because you get tired in the afternoon. Or if 
you feel sick in the morning from your medicines maybe it is better to invite your neighbour for afternoon tea. 
Or maybe your neighbour works and you need to invite them for tea at the weekend.  
 How often? 
This is always the hardest part. We all would like to be able to do more things every day. But we are human 
and this is not always possible. When people want to start exercising, we often say we are going to do it 
every day. But this is often just not possible and if we then miss a day we feel that we have failed and we 
give up. How often will you invite your neighbour for tea? Not every day but maybe once a week. You know 
that you won’t become friends immediately and that it will take time.  
 Is it a good plan? 
To test whether you have come up with a good plan you need to ask yourself this question: 
“If I give myself a score from 0 -10 for how confident I am that I will achieve my plan this 
week, where 0 is not at all confident, and 10 is totally confident. What score will I give to 
show how confident I am that I can complete this plan?” 
If your answer is 7 or more out of 10 then this is probably a very good plan. If your score is 
less than 7 you need to think about why you are not confident. What are the problems or 
barriers? Can you change the plan or solve the problems to make yourself feel more 
confident? 
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Step 3: 
Now, write your plan down and put it somewhere you will see it every day. There is an action plan form at the 
end of this section and 5 more at the back of this book. Use them every week you are doing this course. You can 
always draw more of them to keep working on your plans in the future.  
 
 
 
 
 
 
 
 
 
Now you need to carry out your action plan. If it is a good plan then doing it is usually fairly easy. It helps to tell 
family or friends what your plan is and to report back to them on how you are doing. On this course you are going 
to make a plan every week and record how you get on. It helps to report back on things because you can then 
have an idea on how well you are doing. If you haven’t been able to keep to the plan you can discuss the 
problems you might have had and make plans to cope with them.  
 
Step 4: 
Always check your results and give yourself a reward for having achieved your plan. Also think 
about how achieving your plan is making you feel. In the example we talked about, you could 
congratulate yourself for having invited your neighbour for tea, you would also think about how you 
now feel. Is the plan helping you to achieve what you want?  
 
What about problems? 
What if your plan doesn’t work? Are you going to give up and decide you had a bad plan? There are seven steps 
to solving problems. These are: 
1. Deciding what the problem is (you might need friends and family to help here) 
2. List ideas to solve the problem 
3. Select one idea to try 
4. How did it go? 
5. If it didn’t work, try another idea 
6. If your ideas don’t work, ask friends, family, counsellors, professionals for ideas 
7. Finally you might have to accept that you can’t solve the problem now. 
 
A good action plan is: 
 Something I want to do 
 Something I can expect to do this week 
 Is specific 
 Answers the questions: What? How much? When? How often? 
 I am confident that I can achieve with a score of at least 7 out of 10. 
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At the end of each section and at the back of the workbook there are “Action Plan Forms”. Use these forms to 
plan what you want to do and how you are going to do it. We are now going to discuss exercise – use the “Action 
Plan Form” at the end of this section to plan what exercise you are going to do this week. 
 
 
 
 
 
 
 
 
 
 
 
 
  
A successful self-manager is someone who: 
 Sets goals 
 Makes a list of ways to achieve those goals 
 Makes action plans to achieve the goals 
 Carries out the action plans 
 Checks on their progress every week 
 Can change the action plan if there are problems  
 Gives themselves a reward for achieving their goals 
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Exercise 
 
Exercise is a very important way to keep healthy. Scientific research tells us that exercise has a lot of good 
effects on our bodies like helping our digestive system absorb and process food; it trains our 
hearts so that they are strong and healthy and keeps our lungs working well. Exercise makes our 
muscles and bones strong and our joints flexible so that we can keep moving. Exercise also helps to 
make us feel happy, improves concentration and memory, improves sleep and exercise helps to 
decrease the chances of developing chronic illnesses like high blood pressure and cancers.  
 
In the past, when people became ill with a chronic illness like high blood pressure or diabetes or HIV/AIDS, 
medical care focused on helping them when their symptoms became worse. Treatment focused on using drugs 
and people were often advised to rest or decrease their activity. Today we know that if we teach people who 
develop chronic illnesses about their disease and encourage them to do exercise we can prevent a lot of the 
problems which used to be treated with medicines. We also know that exercise can help to treat a lot of the 
symptoms which people with chronic diseases develop. Symptoms which may be caused by the disease or by 
the drugs used to treat the disease.  
 
You may be wondering if it is safe for you to exercise when you have an illness like HIV/AIDS. Research tells us 
that it is safe for people living with HIV/AIDS to do exercise. Not only is it safe, it also stimulates the immune 
system, improves endurance and decreases fatigue, improves strength and decreases body fat. We also know 
that strengthening exercises seem to help prevent or decrease lipodsytrophy in people who are taking ARVs 
(Lipodystrophy means that your body stops storing fat in places where it normally stored it - like in your buttocks, 
and begins to store the fat in places like your chest or your stomach). We know that people who are physically fit 
get fewer colds and take fewer days off work because of illness. One of the biggest benefits of exercise is that 
exercising regularly makes you feel more in control of your life.  
 
Although exercise is good for you and safe for you to do, sometimes your body will 
give you clues that you need to cancel your exercise. If you have a fever, feel 
dizzy, have vomiting or diarrhoea, if your joints have suddenly become swollen, or if 
you have a pain which is new and you are not sure what is causing it, it is better to 
miss an exercise session until you can speak to a nurse or doctor.  
  
266 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Exercise is good for: 
 Improving mood 
 Strength 
 Improving sleep 
 Concentration and memory 
 Heart and lung health 
 Decreasing body fat 
 Digestion 
 Increasing confidence to self-manage chronic illness. 
Do not exercise if: 
 You have a fever 
 You are dizzy 
 You have been vomiting 
 You have diarrhoea 
 Your joints have suddenly become swollen 
 You have a new pain which you don’t know the cause of 
Miss one exercise session if you have one of these problems until you can speak to a nurse or 
doctor. This does not mean you should never exercise but you need to make sure you are not 
becoming ill. 
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What kind of exercise should you do? 
You do not have to join a gym or a club to get exercise. There are lots of ways of exercising from formal sports 
like running, playing football or netball, swimming or playing tennis. But, walking is also a very good way to 
exercise. Any activity which makes your heart beat faster and makes you breathe a little harder is exercise. 
Dancing is exercise, walking up the stairs is exercise, gardening is exercise. There are lots of ways that we can 
exercise every day without having to go to a class or join a club. You could walk a little further before catching 
the bus or the taxi or you could play with your children!  
 
There are three general kinds of exercise you can do. Endurance exercise; like walking, running, dancing or 
swimming. Endurance exercise is sometimes called aerobic exercise which means that you will be breathing 
faster and your heart will be beating faster too. We know that this kind of exercise is very important to keep 
healthy and we need to do 30 minutes of this kind of exercise three times a week to keep healthy. The second 
kind of exercise is strengthening exercise. This kind of exercise focuses on making us stronger. To make 
muscles stronger we have to do exercises which make the muscles work hard against a resistance, like weight 
training but you can also do strength training by working with heavy bags of shopping! The last kind of exercise is 
stretching exercise. Stretching exercises focus on keeping us mobile and flexible.  
 
 
 
 
 
 
 
 
 
 
 
Endurance   Strengthening   Flexibility 
 
  
Types of exercise: 
 Endurance exercise which makes you breathe harder (sometimes called aerobic) 
 Strengthening exercise which makes you stronger 
 Stretching or flexibility exercise which makes you more mobile and supple 
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There is an extra reason for people living with HIV/AIDS to do strengthening exercise. Scientific research tells us 
that strengthening exercises seem to help to prevent or limit lipodystrophy. Lipodystrophy means that your body 
stops storing fat in places where it normally stored it (like in your buttocks) and begins to store the fat in places 
like your chest or your stomach. Lipodystrophy doesn’t just change the shape of the body, we also know that 
people who develop lipodystrophy tend to have high cholesterol and low insulin meaning that there is a bigger 
chance that they will have heart problems or develop diabetes. The exact cause of lipodystrophy is not clear but 
it seems to occur with certain HIV drugs, in older people and in people with a low T cell count who have been 
HIV+ for a long time. The most recent research tells us that if you do weight training (which builds up more 
muscle) you can limit lipodystrophy. This is a very good reason to make sure you do strengthening exercises in 
your exercise routine. 
 
We know one of the hardest things about exercise is not doing it once, but doing it again and again. There are 
several steps we can follow to make sure that when we start to exercise we stick to it. We all make lots of 
excuses why we can’t exercise. Let’s look at the most common excuses. 
 
“I don’t have time” 
It doesn’t take a lot of time to start exercising. Five minutes a day is a good start. We make 
time to take medicine because we know without it we would become ill. Exercise is as 
important as medicine to help us remain healthy (remember it can never replace your 
drugs). If we know that it is that important we can make time for it. 
 
“I’m too tired” 
When people become ill they often become less active. As you become less active, your body loses fitness and 
you become weaker, you may feel stiffer and you tire more easily. This means that 
exercising might feel harder and so you exercise less. This often results in a downward 
spiral of activity and people often get to the point where even walking down the street to visit 
the neighbour can feel like too much. Being active or doing exercise when you are feeling tired 
will give you more energy and make you feel less tired. 
 
“I’m too sick” 
You may be too sick to undertake very vigorous exercise but you can still aim to be more active. 
You can even break your exercise into one minute sessions which you repeat several times 
through your day. The fitter you get, the better you will be able to cope with your illness  
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“I get enough exercise already” 
You may be getting a lot of exercise already in your job or simply walking around doing your daily 
chores. But for most people if we add this time up, it still isn’t enough exercise to keep them fully 
fit. This kind of exercise also doesn’t include one of the most important components that make 
exercise good for us – fun!  
 
“Exercise is boring” 
You don’t have to do the exercises that everyone else does if they are boring. Choose something 
that is fun, exercise with a friend or with your favourite music or listen to the radio. You can also 
keep your exercises fun by changing them regularly. 
 
 
“Exercise is painful” 
Exercise may be uncomfortable but it shouldn’t be painful. If you have pain before you start to exercise, it should 
not get worse while you are exercising. If you do not have pain before you start to exercise and you start to feel 
pain while you exercise you need to stop exercising and evaluate your pain using the guidelines in Week 4: Pain. 
If you have muscle or joint pain for more than two hours after you exercise then you have probably done too 
much. Next time do a little less, either exercise for less time or less vigorously. 
 
 
“It’s too dangerous, it’s too hot, it’s too cold” 
There are always reasons like this not to exercise. Remember that exercise can be done 
anywhere and anytime. You can put on music in your home and dance, if its too hot you 
could walk around shops which have air-conditioning. Finding a group of people to exercise 
with will not only make it safer but also more fun! 
 
 
“I know I won’t stick to it so there is no point in starting” 
First review the steps we discussed on how to be a successful self-manager. If you set your 
exercise goals using these steps you have more chance of sticking to your exercises. Remember 
too the important step of rewarding yourself for achieving your goals, this makes it easier to move on 
to your next goal. We are now going to have a look at the important steps to take to be successful at 
putting your exercise plan into action. 
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Your exercise programme: 
An exercise programme should include the three different types of exercise; remember they were endurance, 
flexibility and strength exercise. Following the steps in the box “Steps to success with exercise”, you need to 
decide on what you want to be able to do and what exercise you would like to do. Now that you know what 
exercise you are going to do, you need to decide how much to do. The amount of exercise you are going to 
begin with will depend on a lot of different things. If you have not done any exercise for a long time or have been 
feeling unwell, have had difficulty breathing or been short of breath, if you have had stiffness or pain or weakness 
that interferes with your daily activities then you need to start your exercise slowly. You can begin slowly by 
starting with some flexibility and strengthening exercises. Do these exercises every other day for 5 minutes. 
Once you can do that comfortably and without feeling stiff or sore the next day, increase it to 10 minutes. Once 
you can do 10 minutes comfortably, you can start doing the exercises every day (when we say exercise every 
day, we usually mean exercise for 5 days of the week; it can be very hard to keep a routine to exercise on 
weekends when activities are different). Once you can do at least 10 minutes every day then you are ready to 
begin endurance exercises. Choose your exercises from the ones set out in the sections below. Follow the 
instructions in the box to make sure you get the most out of the exercises and do them safely. 
  
Steps to success with exercise: 
 Set a clear goal using the steps outlined in “How to be a successful self-manager” 
 Choose exercise or activity that you want to do and that is fun 
 Set a specific time and place to do your exercise 
 Decide how long you are going to stick to the plan before you think about changing it (6 to 8 
weeks is a good time to work on things) 
 Keep an exercise diary to keep track of how you are doing (there is one at the back of this 
booklet for you to use) 
 Keep track of your progress using the exercise diaries in this workbook. 
 Start – don’t wait, start now. Begin gradually and proceed slowly 
 Revise your programme. At the end of the 6 – 8 weeks make a new plan for the next 6 weeks 
 Reward yourself. It is a reward to feel better and healthier but also give yourself a 
reward for achieving your goal, like eating a favourite meal, or visiting a friend or 
taking a walk somewhere special. 
 
271 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Flexibility Exercises: 
Remember, these exercises are aimed at improving your ability to move. There is a long 
list of exercises that could be included here and you might not be able to do them all 
every time you exercise. Try to ensure that you do flexibility exercises at least once a 
week.  
 
Strengthening Exercises: 
You do not need to go to a gym to do strength exercises, the exercises described here can 
be done at home. To make muscles stronger you must make them work against a 
resistance or a force – they have to push or pull. You should not do strength exercises every 
day, rather they should be done every second day. Your muscles need a day of rest to adapt and 
get stronger. To make a muscle stronger you need to repeat each exercise 5 times to start with. 
Once you can do an exercise 10 times you will not get stronger by doing more exercises. Now you will need to 
add more resistance to the exercise to get stronger.  
 
  
Getting the most out of your flexibility and strength exercises: 
 Move slowly and gently. Do not use jerking or bouncing movements as these will make your 
muscles shorter and tighter.  
 Stretch to the point of tension in a muscle and hold for 20 seconds before you relax 
 Don’t push until it hurts, stretch to tension not pain 
 Start off with 5 repetitions of each exercise. After 1 week increase it to 7, after another week 
increase to 10.  
 Always do the same number of exercises on the left side and the right side of your body 
 Keep breathing; do not hold your breath when you exercise. Think about breathing out as you 
move to make sure you do not hold your breath. 
 Use the two hour rule. If you have increased symptoms for more than two hours after you 
exercise you have probably done too much. Don’t stop doing the exercises but decrease how 
much you do next time. 
 If you find an exercise difficult this does not mean you should not do it at all. You should adapt 
it, do it as completely as you can. 
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Endurance Exercises: 
The most difficult thing for most people is deciding how much exercise to start with. The easiest starting point is 
to ask yourself the question: “how much do I think I can do without suffering for it tomorrow?” If you feel you can 
do 5 minutes, then do 5 minutes. Remember that any exercise is better than none. You don’t have to do 30 
minutes from the first day. It is important to start slowly and increase very gradually. It is better to start off by 
doing less than you think you can and increase it from there.  
 
There are three things you need to think about when you do endurance exercise. 
These three things are frequency (how often am I going to do this exercise); 
duration (how long am I going to exercise for when I do exercise) and intensity 
(how hard am I going to work when I exercise).  
 
 
Frequency: 
Try to do endurance exercise 3 or 4 times a week. By doing this you can rest every second day and allow your 
body to recover. All athletes have at least one day a week when they rest. Rest does not mean that they lie in 
bed all day though, it means that they do not do their exercises. 
 
Duration: 
How much can I do without suffering for it tomorrow? That is your starting point. If you are starting with just a few 
minutes you can gradually increase it over time until you can do 30 minutes at a time. The easiest way to 
increase the time is to use intervals of exercise. For example to walk hard for 3 minutes, then walk slowly for 2 
minutes, then walk hard again for another 3 minutes. Slowly over time cut down the slow walking and increase 
the hard walking. You could also break your exercise into separate sessions. You could walk for 10 or 15 
minutes in the morning and do it again in the evening. This would still count as 30 minutes of exercise.  
 
Intensity: 
How will you know that you are exercising hard enough to be doing some good? How will you know if you are 
exercising too hard? When doing endurance exercise the easiest way to check the intensity is to use the “Talk 
Test”. When you are doing moderate intensity exercise you should be able to talk comfortably but if you tried to 
sing it would be a little difficult and you would have to stop singing to take bigger breaths. Moderate intensity 
means you should feel that you are breathing a little faster and a little harder but you can still talk. It may take 
you a while to find the right intensity for you for the whole of your exercise session. This is normal; take your time 
to get to know how your body will respond.  
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How will you know you are improving in your exercises? For the flexibility and strength exercises it is easy to feel 
the improvements as you will feel that moving is easier and you are stronger and can lift heavier items. For some 
people it is harder to know if you are improving with the endurance exercises. One way to see if you are 
improving is to do a test. One of the easiest tests to do is a timed test. Decide on a route that you can walk near 
your home. Walk this route at a moderate intensity and time how long it takes. After several weeks of exercise 
walk the route again and time it again. You may see that you can walk the same route faster within 4 weeks, but 
it may take 8 to 12 weeks before you see that you can do the route in a faster time. The goal is to complete the 
same route faster or in the same time but at a lower intensity (breathing much easier).  
 
Use the exercise diary at the end of each section to record your goals and your progress in achieving them. 
 
Exercise Routine 
This is a 20 minute exercise routine which is safe for people living with HIV. This routine includes exercises 
which make you stronger (strength exercises), more flexible (stretching exercises) and fitter (endurance 
exercises). 
 
1. Start by standing up straight and tall, feel your weight across your feet, relax your 
shoulders and open your chest, hold your head straight. Take a deep breath in 
and breathe out.  
 
2. March on the spot for 2 minutes. March at a steady pace – that is a pace which 
you can maintain for 2 minutes. Do not start fast and get slower or start slowly and get faster. Pace yourself, 
start and finish at the same speed. You should be marching so that you can feel you are breathing a little bit 
harder than normal, you should be able to talk but not be able to sing. 
 
3. Now stretch your neck – keep your shoulders relaxed and turn to look over your 
right shoulder – hold it for 20 seconds. Bring your head back to the middle, then 
turn to look over your left shoulder – hold it for 20 seconds and then bring your 
head back to the middle. Now put your left ear on your left shoulder - hold it for 
20 seconds and then bring your head back to the middle. Repeat to the right. 
Now put your chin on your chest - hold it for 20 seconds and then bring your 
head back to the middle. Roll shoulders forwards 5 times, then roll your 
shoulders backwards 5 times.  
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4. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your knees up as high as you can. Keep 
changing every 30 steps. 
 
5. Stretch your body – with your feet shoulder width apart, slide your right 
hand down your right leg so that you bend sideways. Bend as far as you 
can - hold it for 20 seconds and then stand up straight again. Repeat this to 
the left. Put your hands on your bottom; bend your body backwards as far 
as you can. Now bend forward and try to touch your toes.  
 
6. Sit on a chair – now stand up, keep sitting down and standing up for 2 minutes. 
Stand up and sit down at a steady pace – that is a pace which you can maintain 
for 2 minutes. Do not start fast and get slower or start slowly and get faster. 
Pace yourself, start and finish at the same speed. 
 
7. Lie down on the floor with your knees bent and your arms crossed on your 
chest. Lift your head to put your chin on your chest, now lift your shoulders 
off the ground. Slowly lower down. Keep going for 2 minutes.  
 
8. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your feet up as high as you can (try to kick 
your buttocks). Keep changing every 30 steps. 
 
9. Stand up straight. Take one big step forward with your right foot and bend your 
knees so that your left knee almost touches the ground (lunge). Push back with 
your right leg to bring your feet back together again. Repeat on the left. Do 10 
lunges on each leg.  
 
10. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your knees up as high as you can. Keep 
changing every 30 steps. 
 
Finish by standing up straight and tall, feel your weight across your feet, relax your shoulders and 
open your chest, hold your head straight. Take a deep breath in and breathe out.  
 
 Action Plan Form - Exercise 
 
Use this form to develop an action plan on exercise. What exercise would you like to do? 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
  
       ____________________________ 
Not at all     |     |     |     |     |     |     |     |     |      |       Totally 
confident    1    2      3     4     5     6    7    8    9    10    confident 
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Week 2: Managing Common Symptoms of HIV 
 
When something that is happening to our bodies that is unusual or not right, we develop symptoms. Symptoms 
include things like having a fever or temperature, feeling nauseous, vomiting, feeling tired, having pain, having a 
skin rash, coughing or struggling to breathe, feeling depressed and many, many more. People living with 
HIV/AIDS are likely to have many different symptoms which need to be managed. In this section, you will learn 
about some of the more common symptoms which people living with HIV/AIDS experience. You will also learn 
how to manage these symptoms. If you start feeling a symptom which is not described in this section then it is 
best for you to go to your clinic to get your symptom checked by a doctor or nurse.  
 
The symptoms that people living with HIV/AIDS get can be put into one of three groups. The symptoms may be a 
side-effect of the medicines that you are using. Information on the side-effects of medicines can be obtained from 
your clinic and from other support and treatment literacy groups such as the Treatment Action Campaign (TAC). 
The second possible cause of symptoms is HIV-related infections. You might have a cough because you have 
developed pneumonia or TB. The third possible cause of symptoms may be the HIV itself. People with chronic 
illnesses like diabetes, high blood pressure, arthritis and HIV will all get symptoms related to the illness. These 
symptoms tend to increase and decrease over time. Research tells us that all symptoms can be managed better 
by following a good programme for living well as using the steps described in this workbook.  
 
Symptom Management 
All of the different activities described in this workbook will help you to live well and manage different symptoms. 
Exercise, eating well, using relaxation techniques and managing stress are all important to help prevent new 
symptoms from developing. Before we go through the most common symptoms which people with HIV/AIDS 
experience, there are a few principles to keep in mind when you experience a new symptom. If it is a new 
symptom, it could be a sign that you are developing an infection or it might be a side effect of a drug. Use the 
information in this section to help you decide on what action you need to take for the new symptom. It might be 
something that is safe for you to manage to home, or it might be something that you need to go to the clinic for, 
or you might manage at home for a while but if it doesn’t get better then go to the clinic. Use the charts in this 
section to help you decide on how to deal with some of your symptoms 
 
If you start experiencing a symptom you need to take time to think about it. Is this a new symptom, one you have 
experienced before or a symptom you have had for a while which is getting worse? You can do a FAST check 
(as described in the box below) on any new or worsening symptoms.  
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Once you have done your FAST check you can then use the action charts in this section to help you decide what 
to do next. When you read the action charts, you need to start at the top and follow the arrows depending on 
your answers to the questions. Do not jump around the chart as this will lead to mistakes. You will see on the 
chart that some symptoms mean that you need to go to your clinic straight away (now), some symptoms you 
need to go to the clinic today, and some symptoms you can manage yourself at home until your next routine 
clinic appointment. If you have more than one symptom, check the charts for all the symptoms and follow the 
most conservative (safest) advice. If your symptom is not described in this workbook then go to the clinic today to 
get it properly assessed. We will now discuss some of the symptoms in alphabetical order. 
  
FAST check for new or worsening symptoms: 
 
Fever Do you also have a fever which 
started with the new symptom?  
(temperature of more than 
38°C) 
Having a temperature or fever can be a 
chronic symptom of HIV/AIDS. But if a 
fever starts with another symptom it can 
be an important clue that you have 
developed an infection. 
Altered 
mental 
status 
Have you also noticed a change 
in your mental state with the 
new symptom?  
 
The brain is a very sensitive part of the 
body. Altered mental status is the term 
used to describe feeling confused, dizzy, 
and very sleepy. It can also mean more 
severe problems like coma or 
experiencing seizures or fits. You may 
need your friends or family to help you 
assess this. 
Severe 
Is this symptom much more 
severe (worse) than anything 
you have had before? 
Symptoms come and go but if it is much 
worse than ever before you need to 
have it checked. 
Typical 
Is this symptom not typical for 
you? 
Anything that is totally new and you 
have never had before, it is best to 
discuss it with a health care practitioner. 
You can use the charts in this workbook 
to decide whether you need to go to the 
clinic immediately or if you can wait until 
your next planned visit.   
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Breathing problems and coughing 
Your body uses coughing to protect your lungs and to remove abnormal things from your 
lungs. Anything that irritates your lungs can cause you to cough. Coughing might bring up infected pus or 
mucous from the lungs which is useful. Coughing can be a side effect of medication used for high blood pressure 
too. 
 
Smoking is one of the most common causes of coughing as the smoke kills cells in the breathing tubes to the 
lungs. This can happen even in people who are not smoking themselves but are breathing in other people’s 
smoke. Other common causes of coughing are “colds” and “flu” which often cause yellow or white mucous. 
Infections of the sinuses (the passages of the nose), can cause coughing because 
the mucous drips down from the back of the nose into the throat and lungs which 
irritates them and makes you cough. This is usually worse at night. Another 
common cause of coughing is hay fever. Hay fever is more common in spring and 
when it is windy. Dust from tree flowers (pollen) and plant seeds in the air make it 
worse. If you are coughing because of hay fever, you will also have either itchy, red eyes and / or a bit of a sore 
throat with sneezing. The clinic can provide you with anti-histamine medicine to help with this.  
 
  
Cough Action Chart: 
Are you also short of breath at rest or 
short of breath with walking around? 
Yes 
→ 
Go to the clinic now 
No ↓   
Is your cough dry and do you also have 
a fever? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you also have a fever and pain in 
your chest with your cough? 
Yes 
→ 
Go to the clinic today 
No ↓   
When you cough do you cough up 
thick, bad-smelling brown or green 
mucous? 
Yes 
→ 
Go to the clinic today 
No ↓   
Have you had a fever for more than 4 
days or has your cough lasted for more 
than 10 days? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat your cough at home   
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People living with HIV/AIDS are also vulnerable to developing lung diseases which cause coughing. The first 
serious cause of coughing in people living with HIV/AIDS is TB. Tuberculosis of the lungs (TB) causes a cough 
which lasts a long time with a fever. If you have a cough which lasts for more than 10 days then TB should be 
suspected and you should go to the clinic. The second serious cause is Pneumocystis pneumonia (PCP). PCP 
causes a dry cough (there is no mucous) with a fever and shortness of breath. Take a look at the “cough action 
chart” and you will see that any cough that also has a fever means you need to go to the clinic straight away.  
 
Home treatment for a cough: You can treat your cough at home by making sure you are not dehydrated. If you 
do not have enough fluid in your body it will make the mucous in your lungs dry and sticky and more difficult to 
cough out. Drinking a lot of water will help with this. If you have a shower then having a hot steamy shower may 
also help, or steaming with hot water or rooibos tea will help. If you have a dry cough with tickling in your throat, it 
may help to suck on cough lozenges or on a hard sweet.  
 
Depression: 
It is common for people living with HIV/AIDS to become depressed but this is often not picked up by the nurses 
and doctors at the clinic. It is important for you to tell your nurse or doctor if you 
think you have depression. Depression is an illness, it is not simply the shock, 
scared, lonely and stressed feelings you probably experienced when you first 
heard your HIV status. Those feelings are a normal reaction to learning about 
your status. Depression develops over a few weeks and is a general feeling of 
depressed mood which happens with physical symptoms. This is caused by an 
imbalance of chemicals in the brain. See the depression checklist below – if you think 
you have depression and you have many of these symptoms then you probably have 
some degree of depression. This can be treated with medicine and psychological support. It is not something to 
be ashamed of. Go to the clinic and tell the nurse or doctor how you are feeling so that they cans start you on 
treatment.  
 
Dementia is very different from depression. With dementia your thinking is affected so that you struggle to 
communicate, you may struggle to pay attention and forget things a lot. You may also find it hard to move, be 
clumsy, lose your balance or even find that you can’t move at all (paralysed). Your personality might also 
change. People who develop dementia generally do not feel depressed as they are usually not aware that they 
are unwell. Dementia is treated with ARV’s.  
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Home treatment for Depression: There are many things you can do to help manage depression. Make sure 
that you get help straight away if you feel like hurting yourself or someone else. Often talking to a person who 
understand or to a health professional will help you through this mood. Cut back on alcohol, although it might 
make you feel better in the short term. In the long term it affects the way your brain works and you will not be 
able to escape the depression. Keep active, make you sure you get up every day, get dressed and get out of the 
house. Even if you don’t feel like doing things, it’s important to keep active, visit friends, and join a group. If you 
start to lose contact with people and withdraw your mood will only get worse. Make plans for the future, for 
tomorrow, for next week, for next month. Make sure you do 20 to 30 minutes of exercise every day. As we said in 
Week 1, exercise is very important to keep us healthy and help our moods. Depression feeds on depression, 
when you believe that things will get better, they will start to change. Use the suggestions in the section on Week 
3: Stress Management to help you manage your symptoms.  
Depression Check List: 
 Do you feel down most of the time?  
 Do you lack enjoyment with fun things like music, soccer or chocolate? 
 Do you try to find peace by overeating? 
 Or do you lack appetite and lose weight? 
 Do you sleep badly at night? 
 Do you struggle to get up in the mornings? 
 Do you feel angry and agitated very quickly? 
 Do you feel very passive?  
 Do you lack energy every day? 
 Do you struggle to concentrate? 
 Is it difficult to make decisions about simple matters? 
 Do you feel guilty? 
 Do you feel worthless sometimes? 
 Do you think of death a lot? 
 Do you think of killing yourself? 
If you answer yes to many of these questions, then you may have some degree of 
depression. Speak to the doctor or nurse at the clinic about how you are feeling. 
If you answer yes to one or two of these questions then you may have depressed mood 
which you can manage with some of the techniques described in the section on stress 
management. 
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Diarrhoea (Running tummy) 
Diarrhoea can affect anyone. Diarrhoea means you have to go to the toilet often and / or your stool is watery or 
slimy. Sometimes diarrhoea comes with stomach pains or with vomiting or both. When you have diarrhoea your 
body is losing water all the time. Losing water is called dehydration and can be dangerous, especially for 
children.  
 
Diarrhoea can be because of infections, as a side effect of medicines or caused by poor absorption of food. 
Diarrhoea can be prevented by making sure that you are using clean drinking water, that you prepare food 
carefully (see the section for Week 5) and make sure that you wash your hands every time after going to the 
toilet.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diarrhoea Action Chart: 
Do you have? 
 Black or bloody stools 
 Severe, steady stomach pain 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have any signs of dehydration? 
 Extreme thirst 
 Very dry mouth 
 Dark urine 
 Lightheadedness 
Yes 
→ 
Go to the clinic today 
No ↓   
Are you taking antibiotics? 
Yes 
→ 
Go to the clinic 
No ↓   
Has the diarrhoea lasted for more than 5 days 
without improving? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat your diarrhoea  at home   
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Home treatment for diarrhoea: The most important thing with diarrhoea is to make sure that you are getting 
enough fluids so that you do not become dehydrated. Try to 
avoid drinks with caffeine in them as they can cause more 
dehydration (coca-cola, coffee and tea all have caffeine). Drink 
your fluids at room temperature, hot drinks or cold drinks can 
make your diarrhoea worse. Making a glucose drink is the most 
effective treatment for diarrhoea. Make this by filling a clean one-
litre bottle with clean water from a tap or boiled water if you are 
not sure that the water is clean. Add 8 teaspoons of sugar and 
half a teaspoon of salt to the water and mix it well.  You can add 
half a cup of orange juice if you find you don’t like the taste. Try 
to drink one to two cups (200ml) after each loose stool (bout of 
diarrhoea). Take small sips and drink it slowly. 
 
If you have diarrhoea you might not feel like eating but skipping food is not a good idea. Try plain foods like dry 
toast white rice noodles, mashed potatoes or white bread. Eat any food that doesn’t 
make you feel sick. Make sure you wash your hands before and after handling food. 
Usually diarrhoea will go away on its own within a week.  
 
 
 
Fever 
Fevers or having a high temperature are most commonly caused by infection. In people living with 
HIV/AIDS the fever can be caused by the HIV itself but it can also be caused by other infections or 
even by medications. If you have a fever you need to check that you do not have any other 
symptoms of serious illness warning you to take action straight away. Use the fever action chart to 
check for these. 
  
8 
teaspoons 
of sugar 
½ teaspoon of 
salt 
1 litre 
of 
water 
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Home treatment for fever: A high fever can be treated by sponging the body down to cool it down, or by using 
medicine. Sponging the body down with luke-warm water (not cold water) helps to bring the temperature down. 
Paracetomol (Panado) can also be used to lower a temperature.   
Fever Action Chart: 
 
Do you have a fever and? 
 Neck stiffness (you can’t bend your neck to 
put your chin on your chest) 
 Extreme tiredness or feel confused 
 Fitting or seizures 
 Severe irritability 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a fever with a dry cough and severe 
shortness of breath? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a new skin rash or skin sores with 
this fever? 
Yes 
→ 
Go to the clinic 
No ↓   
Do you have any of the following with your 
fever? 
 Headache 
 Sore throat 
 Cough 
 Diarrhoea 
 Urinary problems 
Yes 
→ 
See the action plan for 
that problem 
No ↓   
Treat your fever  at home   
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Headaches: 
Headaches are one of the most common symptoms experienced by people both with and 
without HIV/AIDS. Headaches can be caused by muscles becoming tense, they can also be 
caused by medication. Headaches with fevers can be more serious. If you have a headache 
with a fever and stiff neck – a neck so stiff that when you bend it forward you can’t put your 
chin on your chest, you may have meningitis. This is a serious infection of the lining of the brain 
which needs to be treated immediately. Use the headache action plan to decide how to manage your headaches.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment for Headaches: Paracetomol is very effective to treat a simple headache. This 
medicine works better if you take it as soon as you feel the headache rather than waiting until the 
pain is so bad you can’t take it anymore. If the headache is due to muscle tension and stress then 
rubbing the neck muscles and putting something warm on the neck (a hot water bottle wrapped 
in a towel) can help. Relaxation techniques and resting is also very effective to manage 
headaches.  
 
 
Headache Action Chart: 
Do you have a fever and neck stiffness with your 
headache? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have any of these with your headache? 
 Difficulty moving your arms or legs 
 Difficulty with seeing 
 Difficulty speaking (slurring) 
Yes 
→ 
Go to the clinic now 
No ↓   
Has your headache lasted more than 3 days? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat your headache  at home and discuss it at 
the clinic at your next routine appointment 
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Eye problems: 
People living with HIV/AIDS can get many eye problems. All eye problems should be 
checked at the clinic. Eye problems can be caused by infection (CMV), but, eye problems 
can also be caused by medicines, high blood sugar (diabetes), headaches, eye strain and 
normal changes with ageing. If you develop eye problems suddenly then it is likely that this 
is caused by an infection and you need to go the clinic straight away. If your eye problems 
have come on slowly then you need to get your eyes checked the next time you go to the clinic.  
 
 
 
 
 
 
 
 
 
 
 
Nausea and Vomiting: 
Many of the worries about nausea and vomiting are the same as for diarrhoea. Medicines are 
the most common cause of nausea in people with HIV/AIDS but this can also be caused by 
viral infections. Dehydration is the biggest risk. Signs of dehydration may be dizziness, severe 
thirst, dry mouth and tongue, decreased and very dark urine, wrinkled and dry skin. Black or 
bloody vomit can be a sign that there is bleeding in the stomach.  
 
 
 
 
Eye Problem Action Chart: 
Did blindness (part or total) come on suddenly in 
one or both eyes or is the loss of vision severe?  
Yes 
→ 
Go to the clinic now 
No ↓   
Is your CD4+ count more than 200 
Yes 
→ 
Go to the clinic 
No ↓   
Have you had gradual loss of vision equally in 
BOTH eyes 
Yes 
→ 
Go to the clinic 
No ↓   
Go to the clinic NOW   
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Home treatment of Nausea and Vomiting: It is important to get as much fluid into your body as possible 
without vomiting again. Sipping the glucose drink described for diarrhoea is important. Don’t try to drink a whole 
glass all at once, sip it slowly so that you do not vomit again.   
Nausea and Vomiting Action Chart: 
Do you have any of these? 
 Black or bloody vomit 
 Severe steady stomach pain 
 Headache with a stiff neck (you can’t 
put your chin on your chest) 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have any signs of dehydration? 
 Extreme thirst 
 Very dry mouth 
 Dark urine 
 Lightheadedness or dizziness 
Yes 
→ 
Go to the clinic now 
No ↓   
Has this started after starting new medicines? 
Yes 
→ 
Go to the clinic 
No ↓   
Are you pregnant or do you think you might be 
pregnant? 
Yes 
→ 
Go to the clinic 
No ↓   
Have you been vomiting for more than 3 days 
without improvement? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat vomiting at home   
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Shortness of Breath: 
It is normal to feel short of breath when you do strenuous activity or exercise. If you get short of breath when you 
are resting or when you do very little activity or if you wake up at night feeling short of breath then you need to go 
to the clinic urgently. The main cause for this kind of problem in people with HIV/AIDS is PCP. Shortness of 
breath can also be caused by lung infections you have had in the past and smoking. 
 
 
 
 
 
 
 
 
 
 
Home treatment for Shortness of Breath: If you are busy with something when you become short of breath 
you should not stop straight away or try to hurry up to finish. It is best to slow down what you are doing and see if 
your breathing settles down. Sometimes when we feel short of breath we worry about it which makes us afraid 
and can make our breathing even worse. If you have not been very active for a while, your shortness of breath 
might be a sign that you need to get fitter. You need to slowly increase your activity over time as discussed in the 
section on exercise. If you smoke and you are getting short of breath you need to try to stop smoking. If you are 
struggling with stopping smoking then speak to the nurse on your next visit to the clinic. If people smoke near 
you, try to avoid their smoke or ask them to smoke away from you. If you are short of breath it is helpful to 
practice the deep breathing exercises described in the section on relaxation. This kind of deep breathing helps to 
train the muscles for breathing and also helps your mind to manage your symptoms. 
 
  
Shortness of Breath Action Chart: 
Do you have shortness of breath at rest or with 
very little activity? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a dry cough or fever with your 
shortness of breath? 
Yes 
→ 
Go to the clinic now 
No ↓   
Treat at home and go to the clinic   
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Sore Throat and mouth: 
Sore throats are common in people with and without HIV. The most common causes of a sore throat are the cold 
viruses but a sore throat can also be caused by other infections. Most sore throats can be treated safely at 
home. A sore mouth and sore ears are also common. Patches in the mouth, white patches on the tongue or 
mouth or red burning patches which are itchy and sores in the mouth or down your throat 
can all be caused by thrush.  Pain in the mouth can be caused by teeth with holes. 
Teeth can get holes because of bacteria in the mouth. You can prevent these by 
brushing your teeth twice a day and after very meal. It does not take much toothpaste (a 
drop the size of a pea is enough) to keep your teeth clean. It is also important to cut down on 
sweets and fizzy drinks which cause teeth to rot. Use the sore throat and mouth action chart to 
decide on what you need to do. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment for a sore throat and mouth: Drinking cool liquids and taking painkillers like paracetomol can 
help. You can also treat a sore throat by gargling with salt water. It may also help to suck on ice cubes if you 
have access to ice.  
Sore Throat and Mouth Action Chart: 
Do you have severe difficulty breathing or 
swallowing? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a fever or pus in the back of your 
throat? 
Yes 
→ 
Go to the clinic 
No ↓   
Do you have pain in your teeth or swelling in 
your cheek? 
Yes 
→ 
Go to the dental clinic 
No ↓   
Do you have sores or white patches in your 
mouth, on your tongue or on your lips? 
Yes 
→ 
Go to the clinic 
No ↓   
Has your sore throat lasted more than 10 days? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat at home   
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Skin Problems: 
There are many skin problems which can affect people living with HIV/AIDS. Very few of these 
problems are dangerous but because they can be seen they can be very upsetting. Being able 
to see these might make you feel unattractive or have low self-confidence, they often last a long 
time and can constantly remind you of your HIV status. The most common skin problems people with 
HIV/AIDS have are shingles, chicken pox, bacterial infections, warts, fungal infections and rashes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment for skin problems: It is important to keep the skin clean to prevent any infections developing. 
Wash your whole body with soap and water every day. Keep your fingernails short and clean. If you are 
scratching in your sleep, you can sleep with socks over your hands so that you do not damage your skin. If your 
skin is dry and itchy, it helps to wash with aqueous cream instead of soap.   
Skin Problems Action Chart: 
Do you have a rash which is painful on one side 
of your body or on your face? 
Yes 
→ 
Go to the clinic today 
No ↓   
Has the rash started after starting new 
medicines? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you have a rash or blisters on your body and 
a fever? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you have warts on your skin which are a 
different colour to your skin? 
Yes 
→ 
Go to the clinic 
No ↓   
Do you have a rash in a circle on your skin or 
white dying skin between your toes, in your 
groin, around your private parts or under your 
arms or is there pus in the rash? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat at home   
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Urination problems: 
Urinary infections happen more often in women than in men, but men with HIV/AIDS are more likely to 
get these infections too. The most common symptom of a urinary infection is pain or burning when you 
pass water, frequent need to pass water and blood in the urine. These symptoms are not always 
caused by an infection; they can also be caused by too much caffeine (tea, coffee, cola); bladder 
spasms (when the bladder becomes overactive) and even anxiety. Bladder infection in women can 
also be caused by sexual activity. If you also have a fever, vomiting, back pain or teeth-chattering or body-
shaking chills it is likely that the infection has spread from the bladder to the kidneys. Use the Urination Problems 
Action Chart to help you decide how to manage your symptoms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment of urination problems: The first step in managing these problems is to drink a lot of water. 
Drink several litres (4 to 5 litres) of water in the first 24hours after these symptoms start. This helps to wash out 
anything which might be causing the problem. Drinking fruit juices can also help as these change the chemical 
content of the urine. If you have a new vaginal discharge or pain in the abdomen it is important to go to the clinic 
as this means that the symptoms may not be coming from the bladder but from the vagina which needs medical 
treatment.  
  
Urination Problems Action Chart: 
Do you have a fever, vomiting, back pain, 
shaking chills as well as painful or frequent or 
bloody urination?  
Yes 
→ 
Go to the clinic today 
No ↓   
Could you be pregnant? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you also have a new irritating vaginal 
discharge? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you have pain in your stomach (abdomen) as 
well as a vaginal discharge? 
Yes 
→ 
Go to the clinic today 
No ↓   
Treat at home and go to the clinic if it does not 
clear up in 2 days. 
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A final word on symptoms: 
Remember the steps described in this section and the action charts do not replace nurses and doctors. The 
information in this section is to help you work with your health team. Use 
the action charts to help with thinking about any symptoms you 
experience and to help you decide what you need to do about them. 
As you have read, some symptoms it is perfectly safe for you to 
manage at home. Some symptoms you need to go to the clinic 
straight away for. If you have any doubt or any worries about any of 
the symptoms you experience then it is best to go to the clinic to get 
them fully assessed. Remember what you learnt in the first section on 
how to be a good self-manager. Use the information in that section to help you get 
the most out of any visit to the clinic about any symptoms you experience.  
 
When you do visit the clinic for a symptom you may be treated by the nurse or doctor. Or may be referred to 
someone who specialises in the problem you are experiencing. In the next section, we will discuss how to 
communicate well with your health carer. No matter who you are seeing at the clinic, it is useful to use the steps 
on communication to get the most out of your clinic visit.  
 
Use the “Action Plan Form” at the end of this section to plan how you will manage a symptom which you 
experience. Use the “Exercise Diary” to keep track of the exercise plan you started last week. Remember these 
charts are designed to help you become a successful self-manager!  
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Action Plan Form – Managing Symptoms 
 
Think about a common symptom which you experience. Use this form to draw up an action plan of how you plan 
to manage this symptom the next time it occurs. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did, when I feel sick: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
  
       ____________________________ 
Not at all     |     |     |     |     |     |     |     |     |      |       Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
 
293 
 
Exercise Diary 
 
Use this exercise diary to keep track of the exercise goals and plan you drew up in week one. 
Start off by writing down your goal.  
Write down here what you want to be able to do:         
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three 
times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for this 
week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 3: Stress Management 
 
In our society, we talk about stress a lot. We might say that it is stressful to live in South Africa. 
That it is stressful to worry about our children or our families, it is stressful to worry about money 
or it is stressful worrying about getting a job or coping with my job. We use the word stress a lot, 
but what does it mean? Stress is a feeling; it is a combination of feeling tense and worried. When 
we feel stressed we may be irritable, and find it difficult to concentrate or remember things, stress can affect our 
sleep, our appetite and our relationships. 
 
The most common reason why we feel stressed is a lack of control. We tend to feel that things are stressful if we 
don’t have any control over them. We feel stressed if we are going to be late for work because the trains are late 
– this is out of our control. We feel stressed about where we live if we don’t feel safe 
there – those who commit crimes against us are also out of our control. In the same 
way, we may feel stressed when we have a chronic illness like HIV/AIDS or diabetes 
or high blood pressure. If you feel that your illness is out of your control and there is 
nothing you can do to affect it, this makes you feel stressed.  
 
Stress is not always bad. We know that stress can be useful too. For many people if we feel some stress, we 
might feel under pressure to perform better. You might feel stressed because your family is coming to visit, but 
this stress makes you tidy up your home – a good effect of the stress. Students who are studying will only 
complete their studies if there are exams and deadlines for assignments, without the stress of the deadline, the 
students would not complete the work.  
 
Sometimes we wish for a “stress-free” life. But, we know that if there was no stress in our lives, if we did not have 
to do anything all day long, this would not be good for us either. If I lay in bed all day and did not do anything, my 
muscles would get weak, my joints would get stiff and I would become ill. We need some stress in our lives to 
keep us healthy. The important thing is to keep the amount of stress at a level that we feel we can manage. This 
is why we talk about stress management, not stress elimination! 
 
There are many different things we can do in our lives to manage stress. The first step is to understand why we 
are feeling stressed. There are usually three things which affect how stressed we feel. 
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1. The stressful situation:  
Usually the less you expect the situation and the less familiar you are with a situation, the more 
stressful it will be. If you needed to take the taxi to work but you knew the day before that the taxi would 
come late, this would be less stressful than finding out while you are waiting for the taxi that it would 
make you late. If you think about having pain, if you know the cause of the pain is it more or less 
stressful? If you don’t know what is causing your pain and you are worrying that there is something 
seriously wrong, is this more or less stressful? 
 
2. How you see the situation and how you cope with it: 
If the situation you are in is not important, you are likely to feel less stressed about it. If you 
are in a taxi which is going to be late, but you are going shopping on your own, then you are 
likely not to get so stressed about it. If you are in a taxi which is going to be late and you are 
going to work this might be more stressful, but if you have a cell phone with you and you 
have airtime on the cell phone and you telephone your boss to explain why you will be late, then this might be 
less stressful. Your ability to cope with the situation, affects the amount of stress you feel. While it is stressful to 
live with a chronic disease like HIV/AIDS, diabetes or high blood pressure, if you thought you could cope with it 
and it would not interfere with your job and your life would it be more or less stressful? Having knowledge about 
your condition allows you to think about it in a different way and will change the way that you cope. 
 
 3. Support from family and friends: 
Friends and family who understand and support you will affect your levels of stress. Feeling alone and 
like you have no support will probably make you feel more stressed. If you think about living with 
HIV/AIDS, would it be more or less stressful if there were no one to support you? But, we do need to be 
careful about support from family and friends. If they take over doing everything for us (because they 
care about us and are trying to help), we might feel useless and like we don’t have a purpose. Support 
does not mean doing everything for me. 
 
 
Stress is not just the things that happen to us. The amount of stress that we feel depends on a lot of different 
things which can change every day. There are many different things we can do to manage stress every day. You 
can ask for assistance at a clinic or you could discuss what options there are at the Jabulani ARV clinic 
or with your doctor. If you can afford to get transport you can go to an NGO like FAMSA who specialise 
in family and relationship counselling.    
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Managing Stress: 
1. Dealing with the cause of the stress 
The first step in dealing with stress is to identify why you are feeling this way. Use the self-
management steps to help you identify the problem. Once you know why you are feeling 
this way then you need to decide what you can do about it. Sometimes dealing with the 
things that stress us is easy, if you are friends with your neighbours and the noise from their 
television is irritating you it might be easy to ask them to turn down the volume. If you are not 
friends with your neighbours, or you are very shy it might be quite difficult to ask them to turn 
down the volume. Sometimes we can identify the things that stress us and do something about it. But, often we 
either cannot deal with it or it is out of our control. If you cannot deal with it or it is out of your control, the next 
step is to change the way you are looking at the problem. 
 
The second step is to look at the problem in a different way. Think about how you are feeling. Are your thoughts 
and feelings about the problem inaccurate? Maybe you are very worried about your health, this is stressing you. 
Are you worried that you will be very ill and unable to work soon? Are these thoughts and feelings accurate? On 
what information are you basing these thoughts and feelings? Have you spoken to experts about your health or 
are you basing your thoughts and feelings and stress on poor information? 
 
Step three is - plan your life. Do you get stressed by the same things over and over again? Or do you find 
yourself getting stressed because there are times when your life is very busy? If you are doing 
the same things over and over and getting stressed, you might want to look at how you are 
dealing with it and see if you can try a different plan. What about a busy life? This is also 
about planning, being very busy and having no time for ourselves, can be very stressful. Plan 
things over time carefully, make sure you have time to at least do some relaxation or exercise even when you 
are very busy. Do not leave things for the last minute.  
 
The last step to deal with stress is to get help. Family and friends and support groups are a 
great way to decrease stress. If we want support from people though, we have to tell them 
clearly what the problem is and what we would like from them. Often we do not communicate 
clearly and this might make the stress worse! If you find your family or friends are not very 
helpful or supportive, it might be worth sitting down with them when you are not feeling stressed 
to talk about these things. It might be that they see things differently to you, this does not mean they are right and 
you are wrong, or that you are right and they are wrong. It just means that you see things differently and you can 
discuss how to handle things better. If having a discussion like this is difficult, it might be useful to ask a 
counsellor to help with the conversation. You can ask for assistance at a clinic or you can go to an NGO like 
FAMSA who specialise in family and relationship counselling. 
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2. Relaxation 
When we feel relaxed, we feel calm. Sometimes if we are relaxed and we are tired, we might feel sleepy. At other 
times we might feel relaxed and alert and be able to concentrate calmly on tasks. Relaxation can help us to 
concentrate and it can help us to unwind and go to sleep. Relaxation is a very useful way to manage stress and 
some of the symptoms of chronic diseases such as pain. 
 
If we are stressed, this can make our muscles tense, our hearts beat faster and we breath faster, if we are also 
feeling unwell and have pain we will feel worse. Relaxation can decrease the tension in muscles and slow down 
our hearts and breathing and help to make us feel better. If we are stressed we often become irritable and 
moody, relaxation helps to calm you and make you feel more in control of your life. When we are 
stressed sometimes it is difficult to fall asleep as we are worrying about things out of our 
control, if you are also unwell, not sleeping will make you feel worse. Relaxation will 
help you get to sleep, this will help manage your stress and improve your health.  
 
Just like learning to play a new sport or doing exercise, relaxation takes practice. The specific way that you relax 
doesn’t matter; we are all different and might relax in different ways. The important thing is to practice it regularly. 
There are two different ways of relaxing described at the end of this section. You can do these at home in a quiet 
and comfortable safe place to begin with. But, once you get good at relaxation, you can relax in a crowded 
waiting room, on a train or a taxi. You can do relaxation anywhere! 
 
 
 
 
 
 
 
 
 
  
Good times to practice relaxing are when: 
 You feel you are getting tense or irritable or you are worried 
 You feel you are in pain 
 You want to go to sleep 
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3. Sleep 
People with chronic illnesses often struggle to sleep because they are stressed and worried about their condition, 
they worry about what this means for them, for their family, for their future. People also often struggle to sleep 
because of the illness itself, perhaps you have pain, you feel sick or you may even be so tired 
you can’t sleep. Some people find it difficult to get to sleep and only fall asleep very late at 
night, others find that they fall asleep but then wake up during the night and can’t get back to 
sleep. Some people find it difficult to sleep at all at night and sleep during the day.  
 
Sleep is very important to keep healthy. We all need different amounts of sleep. Some people need 8 hours of 
sleep a night, some may need 10 hours and some people only need 5 hours of sleep. We are all different. We 
have been learning how to fall asleep and sleep well since we were babies. If you do not sleep well, following 
these steps will help you to learn how to fall asleep and sleep well. Remember that like learning anything new, 
this will take time. It might take up to 3 months to learn to sleep well if you have been struggling with sleep for a 
while. 
 
Suggestions for Improving Sleep 
1. Have a bedtime routine: try to go to bed at around the same time every night and always do 
the same things before getting into bed. A bedtime routine could be to lock the house, get 
undressed, wash your face, clean your teeth, get into bed and do a relaxation session. 
2. You can’t sleep because of worrying: write down your problems or the things that are 
worrying you, then write down the next step that you think could help sort out the problem. If you 
wake up during the night worrying about the problem, remind yourself that you’ve gone over it and you have 
a plan. If you wake up with a new worry, write down that problem to deal with in the 
morning. Practice your relaxation to take your mind off the worry. If you still can’t 
sleep, it may be better to get up and do something relaxing like reading, watching 
TV, listening to relaxing music or doing relaxation.  
3. Your bed and bedroom are for sleeping: try not to use your bedroom during the day. Do not watch TV in bed. 
If you are not asleep within 30 minutes of going to bed, get up and do something else. Do not lie in bed and 
worry that you have not fallen asleep. This will only make you feel stressed and lessen the 
chance of falling asleep. 
4. Have a morning routine: get up at the same time every day, even if you don’t feel like it. 
Our bodies like to work on regular patterns to fall asleep and get up at the same time every 
day. 
5. Avoid drinks containing caffeine for at least 4 hours before going to sleep (drinks like coke, tea or coffee). 
6. Never use alcohol to help you sleep. It might make you feel relaxed at first, but once this wears off it is likely 
to make you feel jumpy and you are likely to wake up during the night. 
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4. Exercise 
Exercise is a very effective way of managing stress. People who exercise regularly doing at 
least 20 to 30 minutes of exercise, 3 times a week have less risk of suffering from stress 
related illnesses. Go back to the section on exercise for more on how to exercise safely 
and effectively. 
 
 
 
  
 
 
 
 
 
 
 
  
Good sleep habits: 
 Go to sleep at the same time every day 
 Have a bedtime routine 
 Do relaxation before going to sleep 
 Use your bed only for sleeping or relaxing 
 Have a morning routine 
Exercise: 
 Decreases stress 
 Helps us sleep better 
 Decreases pain 
 Makes us healthy and decreases our chances of developing other 
illnesses 
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5. Communicating with your health carer 
Anyone living with a long term health problem, whether it is HIV or high blood pressure 
or diabetes will have to visit their clinic regularly. Visiting the clinic regularly can be 
stressful because it takes time, you have to plan ahead, you might not be sure how 
long you are going to have to wait, you might be worrying about what the health carers 
are going to tell you. One of the most important ways of managing the stress associated with visiting clinics and 
seeing health carers is to think about and plan how to communicate with them.  
 
 When visiting the clinic to see a health care practitioner it is important that you feel comfortable asking questions 
(any questions, even if you feel they are “silly” or “stupid” questions) and comfortable expressing how you feel. It 
is also important that you feel you can negotiate your treatment with your health care provider so that both you 
and the carer feel that you are receiving the best care for you. It is important that you not 
feel that your health care provider is ignoring you, “puts you down” or treats you like a 
child. We know that doctors and nurses have a lot of patients to see and they have little 
time to spend with each person. One helpful way to make sure that you get the most 
out of your appointments with the doctor or nurse is for you to take PART – Prepare, 
Ask, Repeat, Take action. 
 
Take PART: 
Prepare: 
Before your appointment at a clinic it is important to prepare. Think about the reason for your appointment and 
whether there are any issues in particular that are worrying you. Write down your questions or the things that are 
worrying you. You need to be realistic about the list you write down, there will probably only be time to answer 
one or two of the things on your list. Make sure the most important problems are at the top of the list. Take your 
list with you to your clinic appointment, then when the doctor or nurse asks if there is anything you want to ask, 
you can use your list.  
 
If there are particular symptoms or health issues you want to discuss, prepare for your appointment by writing 
down specific information the doctor or nurse will want to know. Things that are helpful are: 
when did it start, how long do the symptoms last, where are they in your body, what makes 
you feel better or worse, have you had a problem like this before and how was it treated; 
have you changed anything such as your diet, exercise, medicines. If you have already 
received treatment for a problem, be ready to report back on how well it has worked, or on 
whether it has not worked at all.  
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Be open about how you are feeling and about the things that are worrying you. The more open you are, the more 
the health care provider can help you. Finally, give feedback. If you don’t like the way you have been treated you 
can tell the doctor or nurse. If you do not want to tell them directly then you can speak to someone else in the 
clinic or to someone in a support group. Remember too that doctors and nurses and other health care 
providers also appreciate being complimented. If you feel that you have been treated well and are 
happy with your treatment, it is acceptable to compliment the health carer. 
 
Ask: 
Another important step in having good communication and decreasing stress is to ask questions. Having good 
information is essential to you being successful in self-managing your health. Ask questions about your diagnosis 
such as what is wrong, what has caused it, is it contagious and what is going to happen now? Then ask 
questions if you have had tests, what is the test for; what if I don’t have the test and what will the test involve? 
Remember to ask questions about your treatment options, what are the benefits of treatment and what are the 
risks and side effects? Finally ask questions about follow-up, when should you return to the clinic, what should 
you watch out for and what should you do next? 
 
If you find you have difficulty remembering information it is a good idea to write things down 
during your visit. Or you could ask someone you trust to come to the appointment with you to 
help with remembering.  
 
Repeat: 
One of the important things to do to help with remembering things is to repeat it. So if the nurse or doctor 
explains something to you, repeat back to them in your own words what you have understood. This is very useful 
to make sure there are no misunderstandings.  
 
Take Action: 
At the end of your appointment, it is important that you know exactly what you will need to do next. It might be 
that you need to make another appointment, or that you need to go home and change something or get new 
medicine from the pharmacy. Make sure that you are clear about what you need to do next, and then do it! 
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Relaxation 
Long relaxation: 
Find a comfortable position. Lie on your back or sit in a chair with your back supported. 
Place your hands at your sides, palms up. 
Close your eyes if you wish. 
Now begin to become aware of your breathing..... Focus on slowing down the rhythm of your breathing..... 
Your chest and tummy will expand outward with each breath, like a balloon gently filling with air.... 
Imagine your ribcage moving out to the sides when you breathe in.... and gently inward as you breathe out.... 
Slowly take a deep breath in.... Pause for a moment.... and then slowly breathe out. Let the tension melt away as 
you relax more deeply with each breath... 
Continue breathing slowly and gently.... 
Now think about the top of your head. Feel the skin on the top of your head beginning to relax, and spreading 
slowly downwards.... 
Even your ears are becoming relaxed and heavy.... Feel your eyebrows resting....  
Your forehead is becoming relaxed and smooth....all the lines on your face are becoming smooth.. 
Let your jaw relax by allowing your mouth to be slightly open.... Allow your tongue to relax... 
Feel your throat relaxing.... relax your cheeks, nose, and eyes.... Feel your eyelids becoming very heavy.... and 
very relaxed.... more and more relaxed.... 
Enjoy the feeling of relaxation you are experiencing. 
Now think about your neck.... allow a feeling of relaxation to begin at the top of your neck, and flow downward... 
Feel the relaxation as your shoulders become relaxed and loose.... Let your shoulders gently sink downward.... 
as they become relaxed.... and heavy.... very heavy.... and very relaxed.... deeper and deeper.... relaxed.... 
Feel your collar bones becoming relaxed as your shoulders move gently back, and your chest widens slightly.... 
Allow all the muscles in your shoulders to feel smooth... and relaxed.... as the muscles give up their hold 
completely... 
Notice your breathing once again... see how regular it has become... continue to take slow.... smooth.... deep 
breaths... Breathe in the feeling of relaxation... and breathe out any tension... your breathing allows you to 
become more and more relaxed.... deeply relaxed..... Now turn your attention to your right arm..... Feel the 
relaxation flowing down from your right shoulder.... allow your upper arm to relax... your elbow.... lower arm... and 
wrist become loose and relaxed.... 
Enjoy the feeling of relaxation as the muscles of your right arm give up their hold.... Feel the relaxation flowing 
into your hand... Let all the tension drain out of each finger tip and flow away.... the relaxation spreads to your 
thumb... index finger.... middle finger... ring finger... and little finger.... 
Feel the relaxation flowing down your left arm... Let the muscles of the left upper arm relax.... Relax your 
elbow.... lower arm.... and wrist....  
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Enjoy the feeling of relaxation you are experiencing. 
Let the tension melt away.... imagine the tension flowing right out of your finger tips... Allow your left hand to 
relax completely.... relax your thumb... index finger.... middle finger... ring finger... and little finger.... 
Both of your arms are now totally relaxed... allow them to be free and limp... pleasantly relaxed... 
Enjoy the feeling of relaxation you are experiencing...  
Allow the feeling of relaxation to continue to your chest and stomach....feel the relaxation there... becoming 
deeper with each breath.... 
Now turn your attention to your upper back... Feel the relaxation flow down your spine... Let all the muscles give 
up their hold.... relax your upper back... middle and lower back.... allow your back to relax completely..... Feel the 
relaxation in your whole upper body .... 
Relax more deeply with each breath.... more and more relaxed.... deeply relaxed and calm.... 
Let your hip muscles relax.... Relax all the way from your buttocks (bottom), down the back of your thighs... relax 
the muscles on the front of your thighs...Feel the relaxation in your upper legs moving down to your knees... your 
calves and shins.... your ankles.... and your feet.... allow all the muscles to relax and go limp.... 
Allow any last bits of tension to flow right out of the soles of your feet....Feel the relaxation flowing through your 
body... From the top of your head... down to the bottoms of your feet.... become more relaxed with each breath.... 
enjoy the feeling of total relaxation..... 
You are now as relaxed as you want to be.... Experience the feeling of deep relaxation... enjoy the feeling.... 
relaxed.... calm..... at peace 
Focus on the feeling of relaxation throughout your body.... Notice your breathing.... Your relaxed muscles.... Your 
calm thoughts... Memorize this feeling so you can re-create this relaxed state whenever you wish.... 
Enjoy relaxing for a few moments more.... 
When you are ready to return to your day, reawaken your body slowly... gently move your muscles... roll your 
shoulders slowly forward.... then slowly backward.... lean your head gently to the left... return to centre.... lean 
your head gently to the right... turn your head... 
Wriggle your fingers and toes.... 
Gently open your eyes.... Feeling alert... calm.... and full of energy. 
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Short relaxation: 
Deep breathing not only helps to cure anxiety and stress, it also triggers relaxation. Here's how to breathe 
deeply. 
 
Breathe in slowly to the count of four (count slowly; to the pace of one-one-thousand, two-one-thousand....). 
Pause to the count of three. 
Breathe out slowly to the count of five. 
The breathing process goes like this: 
Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 
Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 
Repeat for a minute or two. 
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Action Plan Form – Stress Management 
 
Think about one thing that is causing you stress. Use this action plan form to come up with a plan of how to 
manage your stress this week. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
  
       ____________________________ 
Not at all     |     |     |     |     |     |     |     |     |      |       Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Exercise Diary 
 
Use this exercise diary to keep track of your exercise goals and activities. 
Start off by writing down your goal.  
Write down here what you want to be able to do:         
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three 
times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for this 
week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 4: Pain 
 
Many people living with HIV/AIDS experience pain and it is very often the symptom which bothers them most. 
We know this from lots of scientific studies conducted across South Africa, Africa and the rest of 
the world. There can be many reasons for someone living with HIV/AIDS to have pain. The pain 
may be caused by the virus, or the pain may be caused by the medicines used to keep you 
healthy or the pain might be for a reason that has nothing to do with HIV/AIDS.  
 
The pain may be caused by the disease, for example if the virus damages nerves you may feel pain. Pain may 
also be caused or made worse by tense muscles. When something hurts we tend to make our muscles tense to 
try and protect ourselves. Pain may also be caused by weak muscles or stiff joints. People with 
HIV/AIDS often become less active and their muscles and joints get weak and stiff. Then when 
they do use their muscles and joints these can hurt because they haven’t been used for a long 
time and they aren’t used to it. Finally stress, fear, anxiety and depression can cause pain and 
make pain worse. We know from research that when you are in pain your brain is very active. If you 
are also stressed, or afraid, worried or anxious, or depressed, your brain becomes even more 
active. This does not mean that your pain is not real, what it does mean is that activity in your brain 
can cause pain or if you are already in pain, it can make it worse.  
 
To properly treat pain we have to make sure that we check and treat all the possible causes of pain. 
 
Checking the cause of pain 
If you develop a new pain which you have not felt before it is important for you to pay attention to it. Pain is your 
body’s way of getting your attention that something might be wrong. It does not always mean that something is 
wrong; it may just be a warning. It’s like when you put your hand on something hot, it hurts and you pull your 
hand away. Often your hand is not burnt, but it was painful, the pain got your attention quickly and you moved 
your hand before you got burnt.  
 
If you have not felt the pain before it is important for a doctor or a nurse to examine you to find the cause of the 
pain. If they find the cause of the pain they may give you medication to treat the cause. If you have TB you might 
have pain, the doctors or nurses might give you medicine for the TB to treat the cause of the pain. They should 
also give you medicine for the pain itself. If they forget to give you pain medicine you must ask 
for it. Sometimes you may only be given pain tablets for a few days, if you know your pain 
lasts for the whole month you must tell the nurse or doctor this and they should give you 
medicine for the whole month.  
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In up to one third of people with HIV/AIDS who have pain, the doctors or nurses might not find any reason or 
cause for the pain. This does not mean that the pain is not real or that it should not be treated. If they do not find 
a clear cause for your pain they should still give you pain medicine. 
 
What can you do for pain? 
There are lots of things you can do for yourself to help manage your pain. Because we know that the brain is 
very involved when someone is in pain, we also know that understanding your illness, being a self-manager who 
understands about their treatment and, having support can help manage your pain. We are now going to talk 
about different things that you can do to help decrease pain. 
 
Exercise 
Doing any kind of exercise, stretching, strengthening or endurance exercise can all help to decrease pain. We 
also know that people who exercise regularly have less pain.  
 
Relaxation 
Managing stress and doing relaxation exercises also helps to decrease pain. This works because it decreases 
the activity in the brain. We also know that if you do regular relaxation it can help you to sleep better. People with 
pain often find that the pain is worse at night and that it is difficult to sleep. Bad sleep can also make pain worse. 
Doing relaxation and being able to sleep better will help to reduce the pain and help to prevent it getting worse. 
You can also help your pain by managing stress and anxiety. You can do this by talking to people and getting 
support, either from a nurse, a counsellor or a support group.  
 
Heat 
If your pain is being caused by tense muscles then heat can help to decrease it. You can warm up the muscles 
by having a warm bath or shower with the water on the affected area. If you cannot have a hot bath or shower, 
then keeping the muscles warm with clothes or a blanket can also help. There is one time when you should not 
use heat for pain. If you touch the painful area and it is already hot, this means it is inflamed and you should not 
make it hotter. If the area is infected or the skin is damaged then it is also better not to make it hot. In both these 
situations, it is better to use cold.  
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Cold 
Cold is a very good way to treat pain. When we make nerves that send messages warning us about 
damage cold, they slow down and send fewer messages. This means that we feel less pain. If 
you have a freezer then you could use a packet of ice or of frozen vegetables on the painful area. 
Only leave it on your skin for 10 minutes at a time. If you do not have a freezer then putting a damp cloth on your 
skin (if you have a fridge then use water from the fridge) will also work well.  
 
Massage 
Self-massage is a very simple but very good way to treat pain. You may have even been doing it without 
realising this is what you were doing. If you have ever rubbed a painful arm or leg then you have done some self-
massage. You can use a simple cream or baby powder to do massage. Gentle rubbing of a painful area can 
relieve pain a lot. BUT, as with heat, if the painful area is hot or infected then it is better not to rub it. Rather use 
cold. If you have pain and the painful area is hot, red and swollen this may be a sign of an infection. If you have 
been using ice on this for a day and it is not getting better, visit the clinic. 
 
Support 
As we said before, when we feel pain, our brains become very busy. We often worry about 
the pain, we may feel scared about what is causing the pain or what the pain means (we 
often talk about this as stress – “I feel so stressed!”). We might wonder what we have done to 
be getting pain. The fear and worry we feel when we have pain can make the pain worse. This is why support is 
so important to help pain. It is helpful to talk to people that we trust about how we feel. It is also helpful to be 
reassured by a nurse or doctor about what is causing our pain. It may be that worrying about HIV is making your 
muscles tense and this is causing your neck to pain or causing headaches. It helps if the doctor or nurse can 
reassure you that the pain is caused by stress. This does not mean that you are making it up or that it is not real! 
It means that there is something you can do to help the pain. Talking to people, doing exercise and relaxation all 
help to manage stress and this will help the pain. 
 
Medicine 
If you have medicine to help your pain it is important that you take it regularly. Do not wait for the pain to start 
before you take the medicine, if you wait it will not work as well. If the doctor or nurse has told you to take the 
medicine several times a day then it is important that you do this, even if you are not feeling any pain at the time; 
not feeling pain means that the medicine is working. Do not wait for the pain to come back again before taking 
another pill, it won’t work as well.   
If your medicines are not helping the pain then you must go back to the nurse or doctor. You might need stronger 
medicine or you might need to take two different kinds of medicine at the same time.  
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Common medicines used to treat pain are:  
 Paracetomol (panado, dolorol, painamol, painstop) is a very good, very 
effective and safe medicine for pain. It is important not to take more 
than 10 tablets per day. 
 Aspirin (disprin) is also very good but some people need to be careful 
with this medicine. If you use it for a long time you need to be careful of side-effects like ulcers, asthma or 
kidney problems. 
 Anti-inflammatories like indomethacin (indocid), dicolfenac (voltaren or panamor) or ibuprofen (brufen or 
inza) are good if your pain is being caused by inflamed muscles or joints. These must be taken with food. 
These can also cause side-effects like ulcers. 
 Paracetomol and Codeine is stronger than paracetomol on its own. If you have been using paracetomol on 
its own and taking it as the nurse or doctor told you but your pain is not getting better they may give you 
paracetomol with codeine. 
 Dextropropxyphene (Doloxene) is a stronger pain medicine. This medicine is not easily available at clinics 
and the doctor or nurse would need to arrange for you to get it. 
 Codeine phosphate is much stronger and can only be prescribed by a doctor. This medicine can make you 
sleepy and can cause constipation.  
 Morphine is the strongest pain medicine. It can be taken up to 5 times a day. It also has to be prescribed by 
a doctor. If you are prescribed morphine make sure the doctor also gives you a laxative to prevent 
constipation.  
Remember that the most important thing about the pain medicines is to take them before the pain starts or as 
soon as the pain starts. Don’t wait for the pain to become severe before you take the pain medicine. It won’t work 
nearly as well. 
 
 
 
 
 
 
 
 
  
Pain 
 Pain is one of the most common symptoms people living with HIV/AIDS experience 
 Pain can be caused by the virus, by tense muscles, by weak muscles and stiff joints. 
 Pain can be caused by and made worse by stress and worry 
 Exercise, relaxation, cold, heat and massage are all good ways of treating pain 
 Medication for pain works best if it is taken regularly and before the pain becomes very 
bad. 
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Action Plan Form - Pain 
 
Think about one pain which you commonly experience. Use this action plan form to develop a plan of how you 
are going to manage that pain. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
 When I have pain I plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
  
       ____________________________ 
Not at all     |     |     |     |     |     |     |     |     |      |       Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Exercise Diary 
 
Use this exercise diary to keep track of your progress with your exercise goal which you set in week one. 
Start off by writing down your goal.  
Write down here what you want to be able to do:         
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) 
three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for this 
week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 5: Eating Well  
 
Eating well is important for everyone, eating well helps keep you healthy and if you are sick, either with HIV or 
any other illness, eating well is important to help you feel better. Treatment is not just taking anti-retroviral 
medicines; it is taking anti-retroviral medicines and eating well. When you are living with HIV, your body 
burns more energy than someone who does not have the virus. The virus makes your 
body use 10% more energy even when you are feeling well and between 20% 
and 30% more energy when you are feeling sick. This means that you have to 
eat more just to keep your weight the same. Losing weight is one of the most 
common symptoms of HIV. People with HIV mostly lose muscle weight, 
which makes them thin and also makes them weaker. So, how do you stop losing weight, or if you have already 
lost weight, how do you help your body recover? It is not difficult or complicated to eat well to stay healthy. We 
are going to discuss some simple steps to follow to eat well. 
 
What should I eat? 
Our bodies need energy to be able to do all the things we need to do every day. This energy comes from food 
and the best source of energy is food which has complex sugars in it. Complex sugars are not sweet, they are 
foods that many of us eat every day – the starch foods. Starchy foods like bread, pap, rice, potato and mngqusho 
are high energy foods (complex sugars). When our bodies run out of this high 
energy food, it will start to use energy stored in the body. Before you had HIV, your 
body would use fat to provide energy. But, now with the virus your body uses 
energy stored in muscles – protein energy. If you do not eat enough, your body 
will run out of complex sugars to give it energy and will start using protein from the 
muscles. This means that you will start to lose muscle and not fat – we call this wasting. If you eat foods with 
complex sugars (starchy foods - energy foods) regularly you can stop this happening. If you have already lost 
weight because of the virus, then you need to eat food with protein to help your muscles recover. Try to make 
sure you have high energy food (starchy food) with every meal. 
 
One of the important steps for eating well is to eat small meals or snacks often through the day. It is best to try 
and eat 3 meals a day and have another 2 snacks a day. This means that we should eat 5 times a day; these 
meals do not all need to be big meals, a snack might be some fruit, nuts or sour milk. By eating 5 times a day we 
can make sure that we do not run out of energy. When we run out of energy, our bodies have to work harder, if 
we have pain the pain will get worse, if we are tired we will become more tired, if we are feeling sad we will feel 
sadder when we run out of energy and if are you are trying to concentrate then it is harder to concentrate when 
you run out of energy. Also, if you have HIV and you run out of energy your body starts to use the protein in 
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muscle and you start to develop wasting. For these reasons it is important to eat at least 3 times a day and better 
to eat 5 times a day.  
 
There is no single food which is good or bad. It is important to eat a variety of foods. We will now talk about the 
different food groups which we should be eating from every day. 
 
Starchy Foods (also called carbohydrates or complex sugars) 
Bread-Potatoes-Pasta-Rice-Sweet Potatoes -Samp-Mealies-Sorghum-Pap-Porridge-Cereals 
 We need to have enough energy, so the starchy foods (complex sugars) should be the main part of our diets. 
Starchy foods should make up the main portion of all meals. Starchy foods can give us energy for a long time. In 
the shops or in magazines you might see food labelled “low GI”. “Low GI” foods are starchy 
foods which give us energy for a very long time compared to other starchy foods which 
are “high GI” which don’t give energy for as long. Both these kinds of starchy food are 
important for people living with HIV. 
 
 
Fruits and Vegetables 
Spinach-Morogo-Pumpkin-Green Peppers-Lettuce-Beans-Squash-Carrots-Tomatoes 
Peaches-Apricots-Oranges-Naartjies-Avocados-Paw Paw-Mango-Guavas-Watermelon 
The second most important groups of food which we need are the fruits and vegetables. We 
should eat at least one fruit and one vegetable with every meal and aim to have at least 7 
portions of fruits and vegetables every day. Fruits and vegetables supply vitamins and 
substances which are important for keeping the immune system strong. Try to eat a 
variety of fruits and vegetables and include vegetables which are yellow, orange, red or dark green in colour. 
These fruits and vegetables contain a vitamin (vitamin A) which helps the lining of the 
stomach. Citrus fruits like oranges, lemons, grapefruit and naartjies are also important 
as they contain another vitamin (vitamin C) which helps the immune system to work. You 
can see in the picture below that the starchy foods and fruits and vegetables are the 
biggest sections of food. 
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Protein 
Beef-Pork-Chicken-Fish-Mutton-Lamb-Eggs-Milk products-Beans-Grains-Nuts 
People living with HIV need to eat protein every day. As we said before, this is important for your 
muscles and to help prevent weight loss. Protein is found in meats and milk based foods. You 
can also get protein from dried beans, peas, lentils, peanuts or soya. These foods can be a very 
economical way of getting enough protein, they are often much cheaper than meat or milk products.  
 
Fats and oils 
Butter-Lard-Margarine-Cooking oils-Cream-Mayonnaise 
Fats and oils are also an important part of a healthy diet. These foods provide energy, like the starchy foods. 
This does not mean you can eat as much as you like of these foods, but they should make 
up a portion of your diet. These foods can be used to increase your weight if you have been 
sick with an infection and lost weight. 
 
How do I put it all together? 
A balanced way of eating is for each meal to include two portions of starch + one portion of vegetables + one 
portion of fruit + one portion of protein. The fat portion of the food is included as part of the cooking (if you use 
oil) or if you put butter or oil on your food.   
 
 
 
A balanced meal 
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“I find it hard to eat well!” 
Now that you know what you should be eating let’s talk about why people living with HIV may be struggling to eat 
enough. The reasons for not eating enough could be that they do not want to eat because they just don’t feel 
hungry or because they are too tired to eat or they are too worried to eat or they feel like they will vomit if they 
eat, or they have diarrhoea or they have sores in their mouth which hurt when they eat or food just doesn’t taste 
good any more. The next section gives ideas on ways to manage these problems.  
 
“I’m not hungry” 
On the days when you feel like eating, make sure you eat well to make up for days when you might not be eating 
so well. On the days when you do not feel like eating try to eat small meals more often, maybe 6 times a day. Eat 
in a relaxing place, maybe with a friend. Keep small snacks with you in your bag or next to your bed so that if you 
wake up or suddenly feel hungry you can eat straight away. Make sure these snacks have lots of energy in them 
(are complex sugars). Make sure you have your favourite foods to eat, even if it’s just a little bit it helps.  
 
“I get full too quickly” 
You might be trying to get all your food at one meal. Try to eat five or six times a day. When you do eat, make 
sure its food with lots of energy and protein. Don’t eat foods without energy first and then feel too full for 
important foods. 
 
“Food doesn’t taste so good” 
Infections in the mouth or medicines can change the way food tastes. Sometimes you may have a bitter taste or 
a taste of metal in your mouth. If you have thrush, ask your doctor for medicine for this. You can 
also rinse your mouth with a mixture of 1 teaspoon of baking soda in a glass of water. DO NOT 
swallow this, rinse your mouth and spit it out. Try cleaning your teeth and your tongue before you 
eat. If you have a taste of metal in your mouth, try to drink orange juice or another tart drink.  
 
“Eating makes me want to vomit” 
Wanting to vomit when you eat can be because of an infection or a side effect of the medication. Eating smaller 
meals helps (5 or 6 meals a day) – it is important to know that nausea or the feeling that you are going to vomit is 
often worse when your stomach is empty. Food with lots of spices or fats and food or drink with caffeine can 
irritate your stomach and make you feel sick. Salty and dry food might help (bread or crackers). If the smell of 
food makes you feel sick, ask someone else to cook, and also make sure there is lots of fresh air where the 
cooking is being done so that the smell clears quickly. Don’t eat your favourite foods when you feel sick, you 
don’t want to start thinking that your favourite foods make you feel sick. If you think your medicine is making you 
feel sick, ask your doctor or pharmacist about the best time to take the medicines which might help. You can also 
ask your doctor for medicine which will help to stop the feeling of nausea.  
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“I have diarrhoea”  
Diarrhoea can be caused by the virus, by the medicines or by stress or other infections. When you have 
diarrhoea, your body is not getting the food that it needs, even if you are eating it, your body cannot absorb it. 
When you have diarrhoea, your body is also not getting enough fluids. You need to make sure you are getting 
enough liquid when you have diarrhoea to make sure that you don’t get dehydrated. Go to the section on 
managing symptoms of HIV/AIDS for more information on how to manage diarrhoea. Remember, if you have 
diarrhoea for more than a week, you must go to your clinic for treatment. 
 
“I feel sick if I eat dairy products” 
Some people living with HIV find that drinking milk or eating milk products makes them feel sick. This is because 
the virus can affect a chemical in your intestine which you need to absorb milk. If this 
chemical is not present, you may feel bloated or get diarrhoea after eating milk products. 
This is called lactose intolerance. If this is happening to you, then you need to avoid eating 
milk products. Sometimes this reaction will get better; you might find that in a few months you 
could try a milk product again and not have the same reaction. This would mean that your body now has enough 
of the chemical it needs and you can resume eating milk products.  
 
“My mouth is dry / I have sores in my mouth / chewing and swallowing hurts” 
A dry mouth might be a side effect of medications. Sores and pain in the mouth can be from infections. You can 
help this by avoiding smoking and drinking alcohol as these irritate your mouth and throat. Eat softer food, if you 
mash your food or make soup as this will be easier to swallow. Try not to eat food with a lot of spices or drink 
fizzy drinks if your mouth is sore. These can make your mouth burn more. Eating cold food like ice cream or 
sucking on an ice block can help to numb your mouth. If your mouth is sore, try to drink through a straw. Rinse 
your mouth often and keep a bottle of water next to your bed so that you can rinse your mouth during the night. 
 
 
 
 
 
 
 
 
Now that we have discussed how we should be eating and ways of managing eating problems, let’s look at how 
to keep our food safe.   
 
Managing Eating Problems 
 Try to eat at least 5 times a day – 3 meals and 2 snacks.  
 Eat energy food first. 
 Keep snacks with you to eat as soon as you feel hungry. 
 Drink 6 glasses of juice and water a day. 
 Drink rehydration fluid after every bout of diarrhoea. 
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How do I keep my food safe? 
If we don’t pay attention to our food, where we get it from, how we store it and how we 
prepare and cook it, the food may become contaminated and make us sick. This is very 
important for the person living with HIV because you are more vulnerable to illness. There 
are simple ways to keep your food safe. 
Storing and preparing food safely 
 Read food labels carefully when you are shopping for food. Look for the “sell-by” and the “use-by” dates. 
Do not buy them if the “sell-by” date has already passed, do not buy if you are not sure that you will eat it 
before the “use-by” date. 
 Don’t buy food if the packaging is damaged 
 Storing food properly is important to keep it safe. Food that you buy from the fridge or freezer section of a 
shop needs to be put into a fridge or freezer as soon as possible unless you are going to cook or eat it 
straight away.  
 If a fridge or freezer is not available please buy food more regularly from the shops if this is feasible or buy 
longer lasting fruit and vegetables. 
 Write on the packages of food the date you bought them so that you can keep track of how long you have 
had it. Remember food that can make you sick doesn’t always look or smell bad.  
 If you want to keep leftover food, store it in a container with a tight lid and put it into a fridge or freezer 
immediately (if available).  
 If you have leftovers in the fridge you must eat them within 2 days. Leftovers that have been in the fridge 
for more than 2 days MUST be thrown away - even if they look and smell OK! If you do not have a fridge it 
is better to make fresh food daily. 
 Always wash your hands before preparing food. Wash your hands again after handling any raw food. 
 Wash up all your cutlery and crockery in HOT soapy water.  
 If you have eaten food that has made you sick it is important that you clean all equipment and surfaces in 
the kitchen which that food might have touched. You can clean it using a mixture of 1 tablespoon of 
bleach in a litre of water. 
 Never eat raw meat, chicken or fish of any kind. 
 Make sure all meat is well cooked – no red meat of any kind. 
 When you buy eggs make sure none have cracked shells. Keep them cold. 
 Never eat any dish with raw eggs 
 Use only pasteurized milk and milk products 
 Wash all fruit and vegetables 
 Keep fruit and vegetables in the fridge (or a container to keep longer lasting fruit uncontaminated). 
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Action Plan Form 
 
Think about your eating habits. Use this form to come up with a plan to improve one thing about your nutrition. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
  
       ____________________________ 
Not at all     |     |     |     |     |     |     |     |     |      |       Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Exercise Diary 
 
Keep using the exercise diary to keep track of your exercise goals from week one. You may want to start 
increasing your exercise plan. 
Start off by writing down your goal.  
Write down here what you want to be able to do:         
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before 
lunch (when) three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for this 
week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 6: Continuing as a Successful Self-Manager 
 
Over the last six weeks you have learnt many skills which will help you to live positively with your condition. 
Research tells us that people living with any chronic disease who follow these steps have better quality of life, 
have fewer sick days and have better disease control. This is true for people living with high blood pressure, 
HIV/AIDS, cancer or depression. You have learnt how to be a positive self-manager by being able to solve 
problems and set goals for yourself so that you can move forward with your life. You have learnt about the 
importance of exercise. How exercise can make you feel better, what exercises you should do and you have 
been doing those exercises too! You have learnt about the common symptoms that trouble people living with HIV 
and you have learnt how to manage these symptoms. You have learnt about pain, what might be causing pain 
and how to treat and manage any pain you may have. You have learnt about food and eating well and how to 
make sure that your food is safe. With all of these you have also had the chance to practice doing things 
differently and to think about how this has made you feel.  
 
Action Planning for the Future 
Now it is time to think about the future. People with long term illnesses often worry about what will happen if they 
get very sick, how they will manage their lives; how they will they look after themselves or their families. Worrying 
about these things can also make people feel sad, angry or depressed and helpless. These emotions may make 
everything feel even more difficult than they are. By working through this book you have already started to deal 
with these emotions. You have increased your knowledge and this is one of the main ways that we manage fear. 
If we are afraid of something, knowing more about it helps us to tackle the fear. If you know more about it, you 
can make a plan around it and making a plan helps us to get a sense of control over the very thing that we are 
afraid of.  
 
Planning for the future means thinking about the things that might happen to you in the future and planning for 
them. You may never ever need to use the plan as the things that you worry about may 
not happen, but, having a plan will help you to worry less about these things and stay in 
control should they happen. You can use the action planning forms you have been 
using in this workbook to think about the things which worry you about the future. You 
can then start making a plan about what you want to do if these things happen. If you are 
not sure about making a plan, you may want to talk to different people who might be able to help you with this. 
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Step 1: 
To be able to plan for the future, you need to decide what it is that you are worried about happening. This can be 
the hardest step to think about. For example you might be feeling very sad and depressed. First you need to 
think about why you are feeling that way. It might be that you are worried about not being able to look after your 
family if you become ill, or you may be worried about making someone else ill, or you may be worried about not 
being able to look after yourself, or you may be worried about dying. Once you have identified what it is that 
worries you and makes you feel sad, depressed, angry or afraid then you can start to make a plan to deal with it.  
This will help you to feel less sad, depressed, angry or afraid.  
 
Write down here some of the things that might happen in the future that you worry about:  
1)          
          
2)         
          
 
Step 2: 
Now that you have identified some of the things which worry you, you can start to think about different ways to 
manage these things. If you were worried about becoming ill and not being able to look after yourself, write down 
a list of things that you would need help with. Then write down who you could ask to help you with those things. 
The people who can help might be family, friends, social workers, counsellors, nurses, physiotherapists, 
occupational therapists or doctors. If you are not sure who could help you, you may want to talk to someone you 
trust to help you identify who could help.  
 
Write down here three different things you could do to help plan for the things in the future that you worry about: 
1)             
2)             
3)             
 
There are many organisations and people who you can approach for help in planning for the future. These 
organisations include the Treatment Action Campaign (TAC), the Family and Marriage Society of South Africa 
(FAMSA), your church, the AIDS consortium; the Aids Law Project (ALP), the National Association of People 
living with HIV/AIDS (NAPWA) as well as the health care practitioners at your local clinic. The contact details for 
these organisations are included at the end of this section. 
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Once you have completed Step 2 and written down three different things you could do to help plan for the things 
in the future that you worry about, choose the one which seems to suit you the best (this might be one which is 
easier or is cheaper or you know has worked for someone else). Now use this action plan form to work out what 
you will do if the thing which you worry about happening should happen. You can use this method to plan for any 
of the things which worry you.  
 
Action Plan Form for Future Worries 
 
I am worried that in the future I will not be able to: 
            
             
 
My plan to manage this if it happens is to: 
             
           
         
         
         
          
            
         (what, who, how, when?) 
 
How confident are you that you can complete this action plan? (remember you are aiming for 7 out of 10 on the 
confidence line) 
 
 
 
 
 
  
       ____________________________ 
Not at all     |     |     |     |     |     |     |     |     |      |       Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Changes I have made in my life: 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
           
Moving forward: 
Over the last 6 weeks you have learnt many things about how to live with a chronic illness like HIV/AIDS. You 
have learnt about the disease and how to be a successful self-manager. This does not mean that you should be 
managing your health on your own. What it does mean is that you now have the ability to manage your health 
and your life as part of the health team. Remember you are not alone but are part of a team of people whose aim 
is to help you get the most out of life. We encourage you to keep using the skills you have learnt in this workbook 
to live positively. There are extra “Action Plan Forms” and “Exercise Diaries” in the back of the workbook for you 
to use. Try to keep using these forms to help you remain active and give you a sense of purpose and 
accomplishment in your life. Being active and involved, using the skills you have learnt in this workbook are 
important steps in helping you achieve the best quality of life you can. In the box write down some of the 
important changes you have made in your life over the past few weeks. 
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Things that are still missing in my life: 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
           
Now, your final task is to think about changes you still want to make in your life. Remember, this is about getting 
the most out of life, increasing your quality of life. Are there still some things missing in your life, things that you 
would still like to be able to do? In the box below, write down some of the things that are still missing. You can 
use this list to keep working on your goals from now on.  
 
 
 
  
 
 
 
 
 
 
 
 
You have now completed this workbook. By working through this workbook you made an important commitment 
to yourself. You have chosen to spend time looking after yourself and you 
have taken steps to overcome the many challenges that people living with 
HIV/AIDS face. Do not put this workbook away; keep it somewhere safe 
where you will be able to review it from time to time. We all forget things at 
times and it is useful to be able to look back and remind ourselves of 
things we may have forgotten. We can also look back and see how far we 
have come. We hope that the knowledge and the skills you have learnt by 
using this workbook will continue to have a positive effect on your life.   
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Useful Organisations: 
Zithulele ARV Clinic and Outreach programme (www.jabulanifoundation.org) 
Jabulani Office (Zithulele Village):  081 370 1041 
 
 
Philani - Mentors Mothers Programme (www.philani.org.za) 
Zithulele Office  (Zithulele Village):  0739048243 (Ncedisa) 
0732250751 (Nomsa) 
 
 
Stop Stock Outs – Monitoring Essential Medicines Consortium (www.stockouts.org/index) 
Reporting Stock Outs:   084 055 7867(STOP)  (SMS, Please Call Me, Phone, WhatsApp) 
     (email) report@stockouts.co.za 
  
  
Treatment Action Campaign (TAC) (www.tac.org.za) 
National Office (Cape Town):  021 422 1700 
Eastern Cape Office (Lusikisiki):  039 253 1951 
EC Satellite Office (East London):  073 636 1373 
 
 
Family and Marriage Society of South Africa (FAMSA) (www.famsaorg.co.za) 
East London Office:   043 743 8277 
 
 
AIDS Consortium (www.aidsconsortium.org.za) 
National Office (Gauteng):  011 403 0265 
 
 
National Association of People Living with HIV/AIDS (NAPWA) (www.napwasa.org) 
Eastern Cape Office (East London): 043 760 0333 
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Additional Reading 
 
The information is this workbook is based on several sources of information. If you would like to read more on 
any of these topics we suggest you explore these: 
 
Living Well with HIV & AIDS; Gifford A.L.; Lorig K; Laurent D; Gonzalez V (3rd edition) Bull Publishing Company, 
Boulder Colorado2005 
 
Self-management of Long-term Health Conditions: A handbook for people with chronic disease. Expert Patients 
Programme Community Interest Company . Bull Publishing Company, Boulder Colorado 2007 
 
Manage your pain. Nicholas M, Molloy A, Tonkin L, Beeston L ABC Books, Sydney 2000 
 
HIV in our lives: a book of information sheets for clinics. Treatment Action Campaign, Cape Town, 2007 
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Appendix E: Positive Living Course Participation Agreement English and 
Xhosa versions 
 
 
 
I, __________________________________ , understand that all discussions which 
take place during the ‘Positive Living’ course are confidential and shall not be spoken 
of outside of this group. I agree to maintain the trust of those participating in the 
course with me.  
 
I agree to attend all six (6) sessions of the course. I understand that this is for my own 
benefit. For any reason if I am unable to attend a day of the course I will get in 
contact with my peer-leader (Luleka Caleni - 0736291002) or the researcher (Kirsty 
Jackson – 0826849760). 
 
I understand that this course is aimed at helping me to cope better with living with 
HIV/AIDS. I understand that a major part of the course is setting goals and working 
towards them. I will work towards these goals weekly and share my achievements. 
Working towards my goals and sharing these achievements are of benefit and 
encouragement to me and those participating in the group. Another major part of 
taking part in this group is exercising. I agree to participate in this.  
 
Signed: ___________________________ Date: __________________________  
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Mna,__________________________________, ndiyaqonda ukuba zonke iingxoxo 
ezenzeka ngexesha lesifundo ‘Ukuphila Ngokuqinisekileyo’ ziyimfihlo yaye 
akunakuthethwa ngazo ngaphandle kweliqela. Ndiyavuma ukuthembakala kwabo 
bathatha inxaxheba kwisifundo kunye nam. 
 
Ndiyavuma ukuza kuzo zontandathu(6) iintlangano zesifundo. Ndiyaqonda ukuba oku 
kuyinzuzo kum. Ukuba kuthe kwenzeka, nangasiphi na isizathu, ndingakwazi 
ukubakhona kusuku oluthile lwesifundo, ndiyakuqhagamshelana nenkokheli yam 
(Luleka Caleni-073 629 1002) okanye umphandi-lwazi (Kirsty Jackson-0826849760). 
 
Ndiyaqonda ukuba injongo yesi sifundo kukuba sincede mna ndikwazi ukumelana 
ngcono nokuphila nentsholongwane kagawulayo okanye ugawulayo. 
Ndiyaqonda ukuba eyona nto ingundoqo kwisifundo esi kukuzenzela izicwangciso 
futhi ndilandelele ngokuzifezekisa. Ndiyakusebenza ukuphumelelisa ezi zicwangciso 
qho ngeveki ndakugqiba ndabelane nabanye ngezinto ezithe zayimpumelelo. 
Ukusebenzela ukuphumelelisa izicwangciso  nokwabelana ngempumelelo yam 
kuyinzuzo kum nakwabo bathatha inxaxheba kwiqela. Omnye undoqo ekuthatheni 
inxaxheba kwesi sifundo ngumthambo. Ndiyavuma ukuthatha inxaxheba koku.  
 
 
Isayinwe: _________________________         Umhla: _________________________ 
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Appendix F: ACSM Health/Fitness Screening  
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Appendix G: Information sheets and Informed Consent form  
Appendix G/1: Information sheet – Positive Living Group 
 
Information sheet – Positive Living Group 
 
Study Title: Efficacy of a multimodal approach to managing pain in rural amaXhosa 
women living with HIV/AIDS compared to a therapeutic relationship 
 
Name of researcher: Kirsty Jackson, Masters Physiotherapy Student BSc (Phys) 
Name of supervisor: 
Romy Parker, Bsc(Phys) Bsc(Med)(Hons) Ex.Sci(Phys) Msc(Pain) PhD(Psych) 
Senior Lecturer and Deputy Head of Division (Physiotherapy) 
Institution: 
University of Cape Town, Division of Physiotherapy 
 
 
What are we doing and why? 
I am a student at the University of Cape Town. I’m doing a degree in MSc 
Physiotherapy. I want to learn about what helps amaXhosa women living with 
HIV/AIDS cope better. What helps you enjoy life more? What helps you do more 
activities? What helps you to take part in your family and community more. I want to 
find out whether knowing more about HIV and learning ways to manage symptoms 
of HIV helps you. To learn about this, we are asking some people to take part in this 
study. In the last few years a similar study was done in a South African city. The 
researcher found a useful way of helping amaXhosa women in cities or towns cope 
more with living with HIV/AIDS. We now need more research to find out if this way 
will be useful here. Will this way be useful in rural amaXhosa women living with 
HIV/AIDS.     
 
 
Why have you been asked? 
You have shown interest in the study. You also meet the requirements which are 
needed to take part in the study. We are including people who are: 
- amaXhosa 
- HIV positive 
- aged between 18 and 40 years 
- attend one of the two clinics included in this study 
- answered “yes” to the question: “Throughout our lives most of us have had 
pain from time to time (such as minor headaches, sprains, toothaches). Have 
you had pain other than these everyday kinds of pain during the last week?”.  
We are looking for 24 people from each clinic to take part.  
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What will taking part involve and what will you need to do? 
If you agree to be part of the study you will first be asked questions. Then you will be 
asked to do a few actions or tasks. This should take 30-45 minutes. Your time is 
important and we understand that this is a long time. We will be very thankful for 
your time. It will help us to find out more about how we can help amaXhosa women 
living with HIV to cope better. Hopefully with time it will bring about change.  
 
You have been placed in one of two groups. There was an equal chance of being put 
into either group. Each group will do something different. It doesn’t matter which 
group you are in. We are doing the study to find out if either of the things the two 
groups do is better than the other. At the end of the study if what one group does is 
found to be better than you will have an opportunity to take part in what that group 
did.  
 
You are in the group which takes part in the ‘Positive Living’ intervention. This is a 
treatment where you learn how to manage the symptoms you get from having HIV. 
You will take part in a group to learn these things and will do exercise too. You will 
also be asked to agree to come to six buya-dates to learn the most out of this group. 
The group will be led by a peer-leader and will be run at a venue close by to the clinic 
for two hours every Wednesday morning between 10am and 12am or afternoon 
between 1pm and 3pm for six-weeks. Each person in the group will be asked to sign 
a document/contract to keep what is shared in the group safe and to not allow what 
people said and their secrets to be shared with people outside the group. The peer-
leader, who also has HIV/AIDS, will help the group to talk about different tops and 
make a plan of action and do some gentle exercise that might change how you cope 
with living with HIV. There is a workbook called ‘Positive Living’, which has 
information which will be talked about in the group over six sessions. This workbook 
will be given to each person who takes part in this group and you can have it in 
isiXhosa and English.  
 
During the group and after the group you will be asked to come to the clinic for 
follow-up dates. You will be asked to come after 4 weeks, 8 weeks, 12 weeks, 24 
weeks and 1 year after the study starts. We will need to talk to you and remind you 
of follow-up dates during the year. For this reason, we will ask for your cellphone 
number. During the study, you must not tell anyone else that you are taking part in 
this group. You must not tell anybody what you are doing in the group. You must not 
tell people in the community or the person who sees you for follow-ups on how you 
are doing during the study. 
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What if something goes wrong 
If you have certain health problems, exercise may not be safe for you. Someone 
asked you questions about your health to make sure that it is safe for you to 
exercise. If it is not safe for you to exercise you would not be allowed to take part in 
the study. If it becomes unsafe for you to exercise we will refer you to someone to 
help with your healthcare. 
Being in a group means that you may share personal information. You might not 
want to share this information with people outside of the group. Sharing personal 
information may be something that is unsafe for you to do. For this reason, 
documents (contracts) will be signed by the peer-leaders and group members. These 
documents will try to stop any personal information from being shared outside of the 
group. This will help to make the group safer to share information in. There is a 
chance that if you take part in this study somebody might find out that you have HIV. 
However, steps have been taken to prevent this. You will not meet at the clinic for 
follow-ups and your workbook does not have anything which is associated with 
HIV/AIDS.   
 
We have promised that we will not give anyone your information. We will not share 
what you have told us with anyone else without asking you. There are only a few 
people who may see or hear what we have learnt from you. These people are the 
researcher, the research supervisor and members of the Human Research Ethics 
Committee. The Human Research Ethics Committee are a group of people who keep 
people taking part in studies safe. The researcher will not include your name or 
anything which identifies you when writing about what has been learnt.  
 
You will also be protected if you have an injury during the study by the University of 
Cape Town (UCT). This is the institution behind the running of this study. UCT has 
insurance cover (money) to pay for medical costs if you get injured or have 
unpleasant side-effects because of taking part in this study. This plan has been made 
to follow the South African Good Clinical Practice Guidelines. These guidelines were 
written by the Department of Health in 2006. The ideas in these guidelines come 
from the Association of the British Pharmaceutical Industry Guidelines (ABPI). You 
will not have to show proof that the University is at fault for the injury. UCT will take 
responsibility without proof. You must immediately let the study health professional 
know if any injury happens to you during the study. 
 
However, UCT will not be responsible by law in all situations. This means they do not 
have to pay for medical costs if the following happens:  
Any loss, injuries and/or harm that happens to you because of 
 The use of unauthorised medicine or substances (not having full permission or 
being allowed to use these) during the study 
 Any injury that happens because you have not followed the rules or instructions 
that the study doctor/ health professional gives you 
 Any injury that happens from not responding or acting on a side effect or 
reaction to the study medication as best as one can* 
 An injury that happens from negligence (not taking proper care) on your part* 
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By taking part in the study you are still allowed to go the law/ courts to claim for 
compensation. You can do this if an injury happens which you can prove was because 
of taking part in the study. This right will be protected and made sure of. Please be 
aware that most of the time you will be paid the money for to cover medical costs as 
a full settlement. This means that this will be the total money you will receive even if 
taken to court.  
 
If you want further information about these guidelines you may ask for a copy. 
 
 
What will taking part in this study help you with? 
It is not clear exactly how the study will help you. This is why we are doing the study. 
We want to find out if the ‘Positive Living’ intervention helps amaXhosa women with 
HIV in a rural context. We hope that the information learnt from this study will help 
people living with HIV/AIDS cope better in the future. If the results show how to help 
these people then we would like to tell people who can change how the government 
and health care workers help HIV positive people. These people would include 
organisations, local health institutions, or government. All these people work 
together to help people living with HIV/AIDS. By sharing results, we can help them to 
improve services for people who are HIV positive to cope better. Your name and 
personal information will never be given to these organsations or government. Your 
name will always be kept safe. 
 
Remember that if we find that one of the groups got more help from the study the 
other group will get offered that treatment. Therefore, if the study does have a 
benefit then you will have a chance to benefit from it. 
 
 
Do you get anything if you commit to take part in the study? 
You will not get money or get payed for taking part in the study. However, your 
transport costs to the hospital and back home will be paid for whenever you visit the 
clinic to take part in this study. You will be given biscuits and a juice at each two-hour 
session during the ‘Positive Living’ intervention. At the end of the intervention you 
will get a document (certificate). This document will say to say that you have 
completed the ‘Positive Living’ intervention. 
 
 
Taking part in this study is voluntary 
It is your choice whether you would like to take part in this study or not. Nobody can 
tell you that you have to take part in the study. If you do agree and commit to take 
part in the study you will always have the choice to not answer questions asked. You 
cannot be forced to do tasks asked or come to sessions or follow-up dates. Your 
actions are your choice. Taking part is a choice during the whole study. If during the 
study you choose that you do not want to do something asked of you or you do not 
want to take part any longer you will not be treated any differently. 
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You will not be treated any differently if you decide not to be part of the study at all 
either. Those who take part in the study will not be given any privileges. They will not 
be treated differently in hospital and clinic services. 
 
Will my information be safe? 
The information you give us and what we learn from you will be kept safe. Nobody 
will be able to get that information except the researcher, research supervisor and 
members of the Human Research Ethics Committee. Other than these people 
nobody will know that the information and what we learn comes from you. Your 
name will not be included with information. 
 
What we learn can only be used for making services better for amaXhosa women 
living with HIV/AIDS. You will be contacted and asked to agree and sign (consent) 
should the information be helpful for another use. 
 If you have any questions or worries, please contact Kirsty Jackson (082 684 9760). 
You may use a please-call me to make contact. You make ask questions at any time 
during the study.   
 
You are also welcome to contact the research supervisor or the chairperson of 
Human Research Ethics Committee should you have concerns or questions about 
your rights or welfare as participants.  
 
 
Research supervisor:   Human Research Ethics Committee  
Chairperson: 
Dr. Romy Parker    Professor Marc Blockman 
021 406 6571                                          021 406 6492  
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Iphepha-nkcazelo – Positive Living Group 
 
Isihloko sesifundo: “Isifundo esifuna ukujonga ukuba iindlela ezohlukenenyo 
zokuncedisa ukumelana neentlungu ezifumaneka ngenxa yokuphila nogawulayo 
kwabasethyini bamaXhosa abaphila nentsholongwane kagawulayo okanye 
ugawulayo”.  
 
Igama leresearcher: Kirsty Jackson, Masters Physiotherapy Student BSc (Phys) 
Igama lesupervisor: 
Dr Romy Parker, Bsc(Phys) Bsc(Med)(Hons) Ex.Sci(Phys) Msc(Pain) PhD(Psych) 
Senior Lecturer and Deputy Head of Division (Physiotherapy) 
Iziko: 
University of Cape Town, Division of Physiotherapy 
 
Senzantoni kwaye kutheni?  
Ndingumfundi kwi Dyunivesi yase Kapa. Ndenza imfundo enomsila kwi MSc 
Physiotherapy. Ndifuna ufunda ngezinto ezinceda abasethyini bamaxhosa abaphila 
nentsholngwane kagawulayo ukuba baphile ngcono. Yintoni ekuncedayo ukuba 
wonwabele ubom ngakumbi? Yintoni ekuncedayo ukwazi ukwenza imisebenzi 
ngakumbi? Yintoni ekuncedayo ukwazi uthabatha inxaxheba kusapho lwakho 
nasekuhlaleni ngakumbi? Ndifuna ukufumanisa ukuba ingaba ukwazi ngakumbi 
ngentsholongwane kagawulayo kwaye ukufunda iindlela zokulawula okanye 
ukumelana neempawu zentsholongwane kagawulayo kuyakunceda na? Ukufunda 
ngoku sicela abanye babantu bathathe inxaxheba kolufundo. Kwiminyana embalwa 
endlulileyo ofundo olofana nolu lwake lwenziwa kwisixeko saseMzantsi Africa. 
Umphandi wafumanisa indlela eluncedo yokunceda abasethyini bamaxhosa 
abasezixekweni okanye ezidolophini bamelane ngakumbi nokuphila 
nentsholongwane kagawulayo/ ugawulayo. Sifuna kengoku uphando olumandla 
ukufumanisa ukuba lendlela iyakuba luncedo na apha. Ingaba lendlela iyakuba 
luncedo emaphaandleni kwabasethyini abaphila nentsholongwane kagawulayo/ 
gawulayo.      
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Kutheni uceliwe? 
Ubonakalise umdla kwizifundo. Kwaye unazo zonke izinto eziyimfuneko ezifunekayo 
ukuze uthabathe inxaxheba kwisifundo. Siquka nabantu aba: 
- amaXhosa 
- Abanentsholongwane kagawulayo 
- Abaphakath kweshumi elinesibhozo namashumi amane eminyaka 
- Abake baya kwenye yeekiliniki ezimbini kuquka nolufundo 
- Uphendule “ewe” embuzweni : “Kubo bonke obomi bethu unintsi lwethu sike 
seva iintlungu amaxesha ngamaxesha (njengentloko engabhekelephi 
ebuhlungu, sprains, amazinyo abuhlungu). Uke wanentlungu ngaphandle 
kwezi ntlobo zemihla ngemihla kwezinyanga zintathu zidlulileyo?”.  
Sikhangela abantu abangamashumi amabini anesine kwi kiliniki nganye ukuba 
bathathe inxaxheba.  
 
Oku kwenzekayo kuyawube kuquka ntoni kwaye kuyawfuneka wenze ntoni? 
Ukuba uyavuma ukuba yinxalenye yesisfundo uyawuqala ngokubuzwa imibuzo. 
Kengoku uyawucelwa wenze izinto ezimbalwa okanye imisebenzi.  Oku kungathatha 
amashumi amathathu ukuya kumashumi amane anesihlanu. Ixesha lakho libalulekile 
kwaye siyaqonda lixesha elide eli. Siyawukulibulela kakhulu ixesha lakho. 
Kuyawusinceda ufumanisa ngakumbi ukuba singabanceda kanjanina abasethyini 
bamaxhosa abaphila nentsholongwane kagawulayo baphile bhetele. Ngethemba 
exesheni iyawuzisa utshintsho. 
 
Ubekiwe kwelinye okanye amabini amaqela. Bekukho ithuba elilinganayo lokuba 
ubekwe nakweliphi na iqela. Iqela ngalinye liyawukwenza into eyahlikileyo. 
Akukhathaliseki ukuba ukwelipi na iqela. Senza isifundo ukufumanisa ukuba ingaba 
into eyenziwa ngalamaqela mabini ingcono na kuneyenziwa ngamanye. Ekupheleni 
kwesifundo ukuba okwenziwa lelinye iqela kufunyaniswe kungcono kengoku 
uyawufumana ithuba lokuthatha inxaxheba kokuyawube kusenziwa liqela.  
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Useqeleni elithabathea inxaxheba kwi “Phila Ngokuqinisekileyo” intervention. Olu 
lunyango apho ufunda ngeendlela zokumelana neempawu ozifumanayo ngengxa 
yentsholongwane kagawulayo. Uyawuthabatha inxaxheba eqeleni ukuze ufunde 
ezizinto uyawukwenza nemithambo kananjalo. Kwaye uyawucelwa ukuba uvume 
ukubuya kuzo  zontandatho iideyithi zobuya ukuze ufunde okunintsi kweliqela. Iqela 
liyakukhokelwa ngumcebisi okhokeleyo kwaye iyakuqhutywa kwindawo ekufutshane 
nekiliniki kangangee yure ezimbini qho kusasa ngoMvulo phakathi kwentsimbi 
yeshumi neyeshumi elinambini okanye emva kwemini phakathi kwentsimbi yokuqala 
neyesithathu kangangeeveki ezintandathu. Umntu ngamnye eqeleni uyawukucelwa 
ukuba atyikitye incwadi okanye isivumelwano sokugcina yonke into ebithethwa 
eqeleni iyimfihlo, kwaye kungavunyelwa ukuba okuthethwe ngabantu neemfihlelo 
zabo kwabelwane ngazo nabantu abngaphandle eqeleni.  
 
Umcebisi qela onentsholongwane kagawulayo/ugawulayo naye uyawuncedisa iqela 
ukuthetha ngezihloko ezahlukileyo enze necebo lento emayenziwe enze 
nemithambo elula egathsintsha indlela onokumelana ngayo nokuphila 
nentsholongwane kagawulayo okanye ugawulayo. Umcebisi qela uyawucela umntu 
ngamnye eqeleni ukuba enze umqweno wento acinga ukuba angayenza enomceda 
aphile ngcono. Kukho incwadi yokusebenza ebizwa ngokuba yi“Phila 
Ngokuqinisekileyo” eneenkcukacha ngokuyawuthethwa ngako eqeleni kwezi zifundo 
zithandathu. Lencwadi yokusebenza iyawukunikezwa kuye wonke umntu othabatha 
inxaxheba kweliqela kwaye ungayifumana ngesixhosa nangesingesi. 
 
Ngexesha lendibano nasemva kwendibano kuyawucelwa umntu ngamnye ukuba uze 
ekiliniki ukulandelela iideyithi zokkuphinda ubonwe. Uyawucelwa ukuba uze emva 
kweeveki ezine ezisibhozo, ezilishumi elinambini, ezingamashumi amabini anesine 
kunye nonyaka emva kokuba isifundo siqalile. Kuyawufuneka sithethe nawe kwaye 
sikukhumbuze ngeentsuku zakho zobuya enyakeni. Ngenxa yesisizathu siyawucela 
iinombolo zenu zomnxeba.  
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Ngethuba lesifundo ungamxeleli umncedisi owenza imibuzo novavanyo kuwe ukuba 
ukwekiphi iqela. Ungabaxeleli ukuba ukwiqela le’Phila Ngokuqinisekileyo’.  
 
Ukuba kukho into ehambe ngendlela engeyiyo 
Ukuba uneengxaki ezithile zempilo, imithambo inganobungozi kuwe. Omnye umntu 
uyawukukubuza imibuzo malunga nempilo yakho ukuqinisekisa ukuba ukhuselekile 
ukuba ungenza imithambo. Ukuba awukhuselekanga ukuba wenze imithambo 
awuvunyelwa ukuba uthathe inxaxheba esifundweni. Ukuba kubanokungakhuseleki 
kuwe ukwenza imithambo siyawukukuthumelela kumntu ozakunceda ngokhathalelo 
lwempilo yakho. 
 
Ukuba seqeleni kuthetha ukuba ungabelana ngeenkcukacha zakho eziyimfihlo. 
Ungangafuni ukwabelana ngeenkcukacha nabantu abangaphandle eqeleni. 
Ukwabelana ngeenkcukacha  eziyimfihlo zakho kungayinto engakhuselekanga ukuba 
uyenze. Ngenxa yesosizathu  iifomu (zesivumelwano) ziyakusayinwa ngumkhokeli 
qela (i-peer leader) namalungu eqela elo. Ezimpepha ziyakuzama ukunqanda nayiphi 
na inkcukacha eyimfihlo kungathethwa ngayo ngaphandle eqeleni. Oku 
kuyawukwenza iqela likhuseleke ukuthetha ngeenkcukacha zabo. Usethubeni lokuba 
xa useqeleni omnye umntu angafumanisa ukuba unenstholongwane kagawulayo. 
Sekunjalo amanyathelo athathiwe ukunqanda oku. Anizukuhlanganela kwiikliniki 
zamachiza entsholongwane kagawulayo ngeemini zendibano kwaye nencwadi yenu 
yokusebenza ayinayo kwanto eyayamene nentshlongwane kagawulayo okanye 
ugawulayo. 
 
Sithembisile ukuba asisayi kunika mntu iinkcukacha ngani. Asisayi kwabelana namntu 
ngenithe nasixelela kona ngaphandle koba sicele imvume kuni. Kukho abantu 
abambalwa abanothi babone okanye beve ngesithe sakufunda kuni. Ababantu 
ngabaphandi, ababkhokeli baphandi, namalungu eHuman Research Ethics 
Committee. I-Human Research Ethics Committee liqela labantu abagcina abantu 
abathatha inxaxheba kwizifundo bekhuselekile. Uphando alusayi kuquka igama lakho 
okanye nantoni eyakuchaza  okanye icacise wena xa kubhalwa ngokuthe kwafundwa. 
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Kwaye uyakukhuseleka  ukuba uthe wanomonzakalo ngexesha lesifundo esenziwa 
yidyunivesiti yase Kapa (UCT). Le yimenko esemva kokuqhuba kwesifundo. I UCT 
inengxowa yokhuselo (imali) yokubhatala iindleko zonyango xa uthe walimala okanye 
ubenemiphumela engaqhelekanga ngenxa yothabatha inxaxheba kwesisisfundo. 
Elicebo lenzelwe ukulandela iSouth African Good Clinical Practice Guidelines. 
Lemiqathango yabhalwa lisebe lezempilo ngo2006. Imibono ngalomgaqo isuka kwi 
Association of the British Pharmaceutical Industry Guidelines (ABPI). Akusayi 
kufuneka ukuba ubonise ubungqina bokuba idyunivesiti isengxakini ngenxa 
yomonzakalo. I UCT iyawuthatha uxanduva ngaphandle kobungqina. Kuyawufuneka 
kwangoko wazise ingcali ngemfundo yezempilo eyaziwayo ukuba kuthe kwakho 
ingozi eyenzekayo kuwe ngethuba lesifundo. Kanjalo I-UCT ayisayi kubanxaxheba 
ngokomthetho kuzo zonke iimeko. Oku kuthetha ukuba abasayi kubhatala iindleko 
zonyango ukuba kwenzeke oku kulandelayo: 
 Ukusebenzisa amachiza angavumelekanga okanye izinto (kungekho mvume 
ipheleleyo okanye ube uvunyelwe ukusebenzisa ezozinto) ngethuba 
lesifundo.  
 Umenzakalo owenzeke ngenxa yokuba ungalandelanga imithetho okanye 
imiyalelo oyinikiweyo ngugqirha wesifundo okanye ingcali yezempilo. 
 Nayipi na ingozi eyenzeke ngokungalandeli okanye ukwenza  intshukumo 
ekhawulezileyo xa ubona ukuba amayeza owanikiweyo awakulungeli. 
 Nawuphi na umonzakalo owenzeke ngenxa  yokungakhathali (ukungathathi 
inkathalo eyiyo) kwindima yakho. 
 
Ngokuthabatha inxaxheba kwisifundo usavumelekile ukuba ungaya egqwetheni 
okanye enkundleni uyokwenza ibango lomonzakalo. Ungakwenza oku xa umonzakalo 
othe wenzeka kuwe ungqina ukuba wenzeke ngenxa yothatha inxaxheba kwisifundo. 
Elilungelo liyakukhuselwa kwaye liqinisekiswe. Nceda qaphela ukuba amaxesha 
amanintsi uyawubhatalwa imali  ukuze uhlawule iindleko zonyango ngokupheleleyo. 
Oku kuthetha ukuba le iyawukuba yimali epheleleleyo oyakuyifumana nokuba usise 
enkundleni.  
 
Ukuba ufuna ingcombolo engakumbi ngalemigaqo ungacela ikopi.  
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Kuyakukunceda ngatoni okuyawuqhubeka kwesisifundo? 
Akucacanga ncam ukuba esisifundo siyawkunceda kanjani, yiyo loonto senza 
isifundo. Sifuna ukufumanisa ukuba ngaba I“Phila Ngokuqinisekileyo” intervention 
iyabanceda na abasethyini bamaxhosa abanentsholongwane kagawulayo 
abasemaphandleni. Siyathemba ukuba iingcombolo ezifundwe kwesisisfundo 
ziyakubanceda  abantu abaphila nentsholongwane kagawulayo okanye ugawulayo 
ukuba baphile bhetele ebomini. Ukuba iziphumo zibonakalisa ukuba singabanceda 
njani ababantu, ngoko singathanda ukuba singaxelela abantu abanotshintsha indlela 
urhulumente nabasebenzi bezempilo abanceda ngayo abantu abanentsholongwane 
kagawulayo. Ababantu bayakuquka imibutho, amaziko empilo asekuhlaleni, okanye 
urhulumente. Bonke ababantu bayasebenzisana ukunceda abantu abaphila 
nentsholongwane kagawulayo nogawulayo. Ngokwabelana ngeziphumo 
singabanceda baphuhlise iinkonzo ukwenzela abantu abaphila nentsholongwane 
baphile ngcono. Igama lakho neenkcukacha ngawe azisayi kunikezwa kulemibutho 
okanye kurhulumente. Igama lakho liyakuhlala ligcinwe likhuselekile.  
 
Khumbula ukuba siye safumanisa ukuba elinye leqela lifumene uncedo olukhulu 
kwisifundo, elinye iqela liyakufumana ukunikezwa unyango. Ngoko ke ukuba isifundo 
siye saxhamla ngoko uyawufumana ithuba lokuxhamla kuso. 
 
Kukho into esiyifumanayo ngokuzibophelela ekutheni inxaxheba kwesisifundo? 
Awusayi kufumana mali okanye ubhatalwe ngothabatha inxaxheba kwesisifundo. 
Kodwa ke iindleko zakho zokhwela isithuthi ukuza esibhedlele nobuyela ekhaya 
ziyakubhatalwa ngalo lonke ixesha undwendwela ekiliniki uzothatha inxaxheba 
kwesisifundo. Uyakunikezwa amakhekhe nesiselo kuzo nzonke iiyure ezimbini 
zamahlelo ngexesha le“Phila Ngokuqinisekileyo” intervention. Ekupheleni kwe 
intervension uyawufumana incwadi (isatifiketi). Lencwadi iyawuthetha ukuthi 
uyigqibile I“Phila Ngokuqinisekileyo” intervention.  
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Ukuthatha inxaxheba kwesisifundo kukuzinikela 
Lukhetho lwakho ukuba ungathanda ukuthatha inxaxheba kwesisifundo okanye hayi. 
Akekho umntu onokuxelela ukuba umele  uthathe inxaxheba esifundweni. Ukuba 
uyavuma kwaye uyazibophelela uthatha inxaxheba kwisifundo lonke ixesha 
uyawubanalo ukhetho lokuba ungaphenduli imibuzo ebuzwayo. Awunakunyanzelwa 
ukuba wenze imisebenzi ekuthiwe yenze, okanye uze ezindibanweni, okanye 
kwiintsuku zophinda ubonwe. Iintshukumo zakho uyazikhethela. Uthatha inxaxheba 
kuzikhethela ngalo lonke ithuba lesifundo. Ukuba ngethuba lesifundo ukhetha ukuba 
awufuni ukwenza into oyiceliweyo okanye awusafuni uqhubeka nothatha inxaxheba 
awuyikuphathwa ngokwahlukileyo. 
 
Awuyikuphathwa ngokwahlukileyo ukuba ugqiba ekubeni ungabiyonxalenye 
yesifundo kwawena. Abo bathabatha  inxaxheba kwisifundo ubayi kunikwa 
kwangqwalasela. Abayikuphathwa ngendlela eyahlukileyo esibhedlele nakwiindibano 
zeekiliniki. 
 
Ingaba iinkcukacha ngam zikhuselekile? 
Iinkcukacha osinike zona ngawe nesithe sakufunda kuwe kuyakugcinwa kuyimfihlo. 
Akukho mntu uyawukwazi ukufumana ezonkcukacha ngaphandle komphandi, 
umkhokeli mphandi, namalungu eHuman Research Ethics Committee. Ngaphandle 
kwababantu akukho mntu uyawukwazi ukuba iinkcukacha nesithe sakufunda kusuka 
kuwe. Igama lakho aliyikubandakanywa kwiinkcukacha.  
 
Oku sikufundayo kungasetyenziswa kuphela ukwenza iinkonzo zibengcono 
kwabasethyini bamaxhosa abaphila nentsholongwane kagawulayo nogawulayo. 
Uyakufowunelwa ucelwe ukuba uvume kwaye usayine (isivumo) ukuba iinkcukacha 
zibeluncedo ukusetyenziswa kwezinye izinto. Ukuba unemibuzo okanye inkxalabo 
nceda nxulumana no Kirsty Jackson (082 684 9760). Ungathumela umyalezo othi 
ndicela undifowunele ukunxulumana. Ungabuza imibuzo naninina nguthuba 
lesifundo. 
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Uvumelekile kananjalo ukunxulumana nomkhokeli mphandi okanye usihlalo we 
Human Research Ethics Committee ukuba nje unenkxalabo okanye imibuzo 
ngamalungelo akho okanye ukhuseleko njengabathathi nxaxheba.  
 
 
Research supervisor:   Human Research Ethics Committee Chairperson: 
Dr Romy Parker   Professor Marc Blockman 
021 406 6571                             021 406 6492  
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Appendix G/2: Information sheet – Therapeutic relationship Group 
 
Information sheet – Therapeutic relationship Group 
 
Study Title: Efficacy of a multimodal approach to managing pain in rural amaXhosa 
women living with HIV/AIDS compared to a therapeutic relationship 
 
Name of researcher: Kirsty Jackson, Masters Physiotherapy Student BSc (Phys) 
Name of supervisor: 
Romy Parker, Bsc(Phys) Bsc(Med)(Hons) Ex.Sci(Phys) Msc(Pain) PhD(Psych) 
Senior Lecturer and Deputy Head of Division (Physiotherapy)  
Institution: 
University of Cape Town, Division of Physiotherapy 
 
 
What are we doing and why? 
I am a student at the University of Cape Town. I’m doing a degree in MSc 
Physiotherapy. I want to learn about what helps amaXhosa women living with 
HIV/AIDS cope better. What helps you enjoy life more? What helps you do more 
activities? What helps you to take part in your family and community more. I want to 
find out whether being seen for follow-ups help you with the symptoms of HIV. To 
learn about this, we are asking some people to take part in this study. In the last few 
years a similar study was done in a South African city. The researcher found what 
seems to be a useful way of helping amaXhosa women in cities or towns cope more 
with living with HIV/AIDS. We now need more research to find out if this way will be 
useful here. Will this way be useful in rural amaXhosa women living with HIV/AIDS.     
 
 
Why have you been asked? 
You have shown interest in the study. You also meet the requirements which are 
needed to take part in the study. We are including people who are: 
- amaXhosa 
- HIV positive 
- aged between 18 and 40 years 
- attend one of the two clinics included in this study 
- answered “yes” to the question: “Throughout our lives most of us have had 
pain from time to time (such as minor headaches, sprains, toothaches). Have 
you had pain other than these everyday kinds of pain during the last week?”.  
We are looking for 24 people from each clinic to take part.  
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What will taking part involve and what will you need to do? 
If you agree to be part of the study you will first be asked questions. Then you will be 
asked to do a few actions or tasks. This should take 30-45 minutes. Your time is 
important and we understand that this is a long time. We will be very thankful for 
your time. It will help us to find out more about how we can help amaXhosa women 
living with HIV to cope better. Hopefully with time it will bring about change.  
 
You have been placed in one of two groups. There was an equal chance of being put 
into either group. Each group will do something different. It doesn’t matter which 
group you are in. We are doing the study to find out if either of the things the two 
groups do is better than the other. At the end of the study if what one group does is 
found to be better than you will have an opportunity to take part in what that group 
did.  
 
You are in the group who will be seen by the same person at each follow-up date. 
You will be asked to come after 4 weeks, 8 weeks, 12 weeks, 24 weeks and 1 year 
after the study starts. We will need to talk to you and remind you of follow-up dates 
during the year. For this reason, we will ask for your cellphone number. During the 
study you must not tell anyone else that you are taking part in this group. You must 
not tell anybody what you are doing in the group. You must not tell people in the 
community or the person who sees you for follow-ups on how you are doing during 
the study. 
 
 
What if something goes wrong 
There is a chance that if you take part in this study somebody might find out that you 
have HIV. However, steps have been taken to prevent this. You will not meet at the 
clinic for follow-ups and your workbook does not have anything which is associated 
with HIV/AIDS.   
 
We have promised that we will not give anyone your information. We will not share 
what you have told us with anyone else without asking you. There are only a few 
people who may see or hear what we have learnt from you. These people are the 
researcher, the research supervisor and members of the Human Research Ethics 
Committee. The Human Research Ethics Committee are a group of people who keep 
people taking part in studies safe. The researcher will not include your name or 
anything which identifies you when writing about what has been learnt.  
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You will also be protected if you have an injury during the study by the University of 
Cape Town (UCT). This is the institution behind the running of this study. UCT has 
insurance cover (money) to pay for medical costs if you get injured or have 
unpleasant side-effects because of taking part in this study. This plan has been made 
to follow the South African Good Clinical Practice Guidelines. These guidelines were 
written by the Department of Health in 2006. The ideas in these guidelines come 
from the Association of the British Pharmaceutical Industry Guidelines (ABPI). You 
will not have to show proof that the University is at fault for the injury. UCT will take 
responsibility without proof. You must immediately let the study health professional 
know if any injury happens to you during the study. 
 
 
However, UCT will not be responsible by law in all situations. This means they do not 
have to pay for medical costs if the following happens:  
Any loss, injuries and/or harm that happens to you because of 
 The use of unauthorised medicine or substances (not having full permission or 
being allowed to use these) during the study 
 Any injury that happens because you have not followed the rules or instructions 
that the study doctor/ health professional gives you 
 Any injury that happens from not responding or acting on a side effect or reaction 
to the study medication as best as one can* 
 An injury that happens from negligence (not taking proper care) on your part* 
By taking part in the study you are still allowed to go the the law/ courts to claim for 
compensation. You can do this if an injury happens which you can prove was because 
of taking part in the study. This right will be protected and made sure of. Please be 
aware that most of the time you will be paid the money for to cover medical costs as 
a full settlement. This means that this will be the total money you will receive even if 
taken to court.  
 
If you want further information about these guidelines you may ask for a copy. 
 
 
What will taking part in this study help you with? 
It is not clear exactly how the study will help you. This is why we are doing the study. 
We want to find out if these follow-ups help amaXhosa women with HIV in a rural 
context. We hope that the information learnt from this study will help people living 
with HIV/AIDS cope better in the future. If the results show how to help these 
people, then we would like to tell people who can change how the government and 
health care workers help HIV positive people. These people would include 
organisations, local health institutions, or government. All these people work 
together to help people living with HIV/AIDS. By sharing results, we can help them to 
improve services for people who are HIV positive to cope better. Your name and 
personal information will never be given to these organisations or government. Your 
name will always be kept safe. 
 
347 
 
Remember that if we find that one of the groups got more help from the study the 
other group will get offered that treatment. Therefore. if the study does have a 
benefit then you will have a chance to benefit from it. 
 
 
Do you get anything if you commit to take part in the study? 
You will not get money or get payed for taking part in the study. However, your 
transport costs to the hospital and back home will be paid for whenever you visit the 
clinic to take part in this study.  
 
 
Taking part in this study is voluntary 
It is your choice whether you would like to take part in this study or not. Nobody can 
tell you that you have to take part in the study. If you do agree and commit to take 
part in the study you will always have the choice to not answer questions asked. You 
cannot be forced to do tasks asked or come to follow-up dates. Your actions are your 
choice. Taking part is a choice during the whole study. If during the study you choose 
that you do not want to do something asked of you or you do not want to take part 
any longer you will not be treated any differently. 
 
You will not be treated any differently if you decide not to be part of the study at all 
either. Those who take part in the study will not be given any privileges. They will not 
be treated differently in hospital and clinic services.  
 
 
Will my information be safe? 
The information you give us and what we learn from you will be kept safe. Nobody 
will be able to get that information except the researcher, research supervisor and 
members of the Human Research Ethics Committee. Other than these people 
nobody will know that the information and what we learn comes from you. Your 
name will not be included with information. 
 
What we learn can only be used for making services better for amaXhosa women 
living with HIV/AIDS. You will be contacted and asked to agree and sign (consent) 
should the information be helpful for another use. 
  
If you have any questions or worries, please contact Kirsty Jackson (082 684 9760). 
You may use a please-call me to make contact. You make ask questions at any time 
during the study.   
 
You are also welcome to contact the research supervisor or the chairperson of 
Human Research Ethics Committee should you have concerns or questions about 
your rights or welfare as participants.  
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Research supervisor:    Human Research Ethics Committee  
Chairperson: 
Dr Romy Parker    Professor Marc Blockman 
021 406 6571                                          021 406 6492  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
349 
 
Iphepha-nkcazelo – Therapeutic relationship Group 
 
Isihloko sesifundo: “Isifundo esifuna ukujonga ukuba iindlela ezohlukenenyo 
zokuncedisa ukumelana neentlungu ezifumaneka ngenxa yokuphila nogawulayo 
kwabasethyini bamaXhosa abaphila nentsholongwane kagawulayo okanye 
ugawulayo”.  
 
Igama leresearcher: Kirsty Jackson, Masters Physiotherapy Student BSc (Phys) 
Igama lesupervisor: 
Dr. Romy Parker, Bsc(Phys) Bsc(Med)(Hons) Ex.Sci(Phys) Msc(Pain) PhD(Psych) 
Senior Lecturer and Deputy Head of Division (Physiotherapy)  
Iziko: 
University of Cape Town, Division of Physiotherapy 
 
 
Senza ntoni kwaye kutheni? 
Ndingumfundi kwi dyunivesi yase Kapa. Ndenza imfundo enomsila kwiMSc 
Physiotherapy. Ndifuna ukufunda ngezinto ezingaba zinceda abasethyini bamaxhosa 
abaphila nentsholongwane kagawulayo/ugawulayo baphile ngcono. Yintoni 
ekuncedayo wonwabele ubom ngakumbi? Yintoni ekuncedayo ukwazi ukwenza 
imisebenzi eminintsi? Yintoni ekuncedayo ukwazi ukuthatha inxaxheba kusapho 
lwako nasekuhlaleni ngakumbi. Ndifuna ukufumanisa ukuba ngaba ukubonwa 
ngolandelelo kuyakunceda kwiimpawu zentsholongwane kagawulayo. Ukufunda 
ngoku sicela abanye babantu ukuba bathathe inxaxheba kwesisifundo. Umphandi 
ufumanise into engathi ingayindlela eluncedo yokunceda abasethyini bamaxhosa 
ezixekweni okanye ezidolophini bamelane ngakumbi nokuphila nentsholongwane 
kagawulayo okanye ugawulayo. Kengoku sidinga uphando olungakumbi ukufumanisa 
ukuba lendlela iyawuba luncedo na apha. Ingaba lendlela iyawuba luncedo 
kwabasethyini bamaxhosa abasemaphandleni abaphila nentsholongawane 
kagawulayo okanye ugawulayo.     
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Kutheni uceliwe? 
Ubonakalise umdla kwisifundo. Kwaye unazo zonke izinto eziyimfuneko ukuze 
uthathe inxaxheba kwesisifundo. Siquka abantu aba: 
- amaXhosa 
- Abanentsholongwane kagawulayo 
- Abaphakathi kweshumi elinesibhozo namashumi amane eminyaka. 
- Abake beza kwenye yeekiliniki ezimbini  eziqukwe kwesisifundo.  
- Uphendule “ewe” embuzweni:  “Kubo bonke ubom bethu abanintsi bentu 
bake baneentlungu kumaxesha ngamaxesha” (ezinjengentloko ebuhlungu 
engabhekele phi, Imisipha eqaqambayo, amazinyo aqaqmbayo ).Uke wanazo 
iintlungu ngaphandle kwezi zamihla yonke kwezinyanga zintathu zidlulileyo?.    
Sikhangela abantu abangamashumi amabini anesine kwikiliniki nganye ukuba 
bathathe inxaxheba.  
 
Igaba kuyawuquka ntoni oku kuyawube kusenzeka kwaye kuyawufuneka wenze 
ntoni? 
Ukuba uyavuma ukuba yinxalenye yesifundo uyawuqale ubuzwe imibuzo. Uze 
ucelwe kengoku ukuba wenze iintshukumo ezimbalwa okanye imisebenzi. Oku 
kumele kuthathe imizuzu engamashumi amathathu ukuya kumashumi amane 
anesihlanu emizuzu. Ixesha lakho libalulekile kwaye siyaqonda ukuba lixesha elide eli. 
Siyawukulibulela kakhulu ixesha lakho. Kuyawusinceda sifumanise ngakumbi ukuba 
singabanceda njani abasetyhini bamaxhosa abaphila nentsholongwane kagawulayo 
baphile ngcono. Ethembeni ekuhambeni kwexesha iyawuzisa uthsintsho.  
 
Ubekiwe kwelinye lamaqela amabini. Bekukho amathuba alinganayo okuba ubekwe 
nakweliphi na iqela. Iqela ngalinye liyawukwenza into eyahlukileyo. Akukhathaliseki 
ukuba ukweliphi iqela. Senza isifundo ukufumanisa ukuba ngaba enye yenzinto 
zenziwa ngalamaqela mabini ingcono kunenye.  Ekupheleni kwesifundo ukuba into 
eyenziwa lelinye iqela ifumaniseke ingcono ngoko uyawuba nethuba lokuba 
uthabathe inxaxheba kwinto eyenziwa leloqela.  
Useqeleni eliyawukubonwa ngumntu omnye kuzo zonke iintsuku zodibana. 
Uyawucelwa ukuba uze emva kweeveki ezine, ezisibhozo, ezilishumi elinambini, 
ezingamashumi mabini anesine kunye nonyaka emva kokuba isifundo siqalile. 
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Kuyawufuneka sithethe nawe kwaye sikukhumbuze ngeentsuku zolandelelwa 
enyakeni. Ngenxa yesisizathu siyawucela inombolo yakho yomnxeba.  
 
Ngethuba lesifundo ungamxeleli umncedisi owenza imibuzo novavanyo kuwe ukuba 
ukwekiphi iqela. Ungabaxeleli ukuba ukwiqela leTherapeutic.  
 
Ukuba kukho into ehambe ngedlela engeyiyo? 
Kukho ithuba lokuba ukuba uthabatha inxaxheba kwesisifundo omnye umntu 
angafumanisa ukuba unentsholongwane kagawulayo. Sekunjalo amanyathelo 
athathiwe ukuthintela oko. Anizudibana kwiikliniki zamachiza entsholongwane 
kagawulayo ngeentsuku zokulandelelwa kwaye nencwadi yenu yokusebenzela 
ayinayo kwanto enxulumene nentsholongwane kagawulayo okanye ugawulayo.   
 
Sithembisile ukuba asisayi kunika mntu iinkcukacha zakho. Asisayi kwabelana 
namntu ngothe wasixelela kona ngaphandle kokuba sicele okanye sibuze kuwe. 
Kukho abantu abambalwa abangabona okanye beve ngesithe sakufunda kuwe. 
Ababantu ngabaphandi, umkhokeli phando namalungu eHuman Research Ethic 
Committee. iHuman Research Ethic Committee liqela labantu abagcina abantu 
abathatha inxaxheba esifundweni bekhuselekile. Umphandi akasayi kuquka igama 
lakho okanye nantoni na eyakuchaza wena xa ebhala ngokuthe kwafundwa.  
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Uyawukhuseleka kananjalo ukuba uthe wafumana umonzakalo ngethuba lesifundo 
esenziwa yidyunivesiti yase Kapa (UCT).  Eli liziko elimelene nokuqhuba kwesisifundo. 
I UCT inombutho (wemali)  wokubhatala iindleko zonyango ukuba uthe wafumana  
umonzakalo okanye ubenemiphumela engaqhelekanga ngenxa yothatha inxaxheba 
kwesisifundo. Elicebo lenzelwe ukulandela I South African Good Clinical Practice 
Guidelines.  Lemigaqo yabhalwa  lisebe lezempilo ngo 2006. Iingcamango 
ngalomgaqo yasuka kwi  Association of the British Pharmaceutical Industry 
Guidelines (ABPI).  Awusayi kufuneka ukuba uveze ubungqina bokuba idyunivesi 
isengxakini ngenxa yomonzakalo. I UCT iyawuthatha uxanduva ngaphandle 
kobungqina.  Kuyawufuneka ngokukhawuleza wazise ingcali yezifundo zezempilo 
ukuba kukho umonzakalo owenzeke kuwe ngethuba lesifundo. 
 
Sekunjalo I UCT ayiwubanaxanduva ngokomthetho kuzo zonke iimeko. Oku 
kuthetha ukuba abafanelanga ukuba babhatale iindleko zonyango ukuba kwenzeke 
oku kulandelayo:  
Nakuphi na ukulahlekelwa, Umonzakalo okanye ingozi ethe yenzeka kuwe ngenxa : 
 Yokusebenzisa amachiza angavumelekanga okanye izinto (ukungabinamvume 
epheleleyo okanye ungavumelekanga usebenzise ezonto ngexesha lesifundo. 
 Nawuphi na umonzakalo othe wenzeka ngenxa yokuba ungalandelanga imithetho 
okanye imiyalelo athe ugqirha wesifundo okanye ingcali yezempilo yakunika yona. 
 Nawuphi na umonzakalo othe wenzeka ngokungalandeli okanye wenze. 
 Nayipi na ingozi eyenzeke ngokungalandeli okanye ukwenza  intshukumo 
ekhawulezileyo xa ubona ukuba amayeza owanikiweyo awakulungeli. 
 Nawuphi na umonzakalo othe wenzeka ngenxa 
yokungabinankathalo(ukungakhathali ngokupheleleyo) kwindima yakho.  
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Ngokuthatha inxaxheba kwisifundo usavumelelkile ukuba  uye emthethweni okanye 
enkudleni uyokwenza ibango lomonzakalo. Ungakwenza oku xangaba umonzakalo 
othe wenzeka unganobungqina bokuba wenzeke ngenxa  yothatha inxaxheba 
kwisifundo. Ilungelo lakho liyakukhuseleka kwaye liqinisekiswe.  Nceda qaphela 
ukuba amaxesha amanintsi uyawubhatalwa imali ukuze uhlawule zonke iindleko 
zonyango ngokuphelelelyo. Oku kuthetha ukuba le yimali ephelelyo oyakuyibhatalwa 
noba ungasisa enkundleni. 
 
Ukuba ufuna iingcombolo ezingakumbi ngalemigaqo ungacela ikopi.  
 
Kuyakunceda ngantoni uthatha inxaxheba kwesisisfundo? 
Akucacanga ncam ukuba isifundo siyakunceda kanjani. Yiyo loonto sisenza isifundo. 
Sifuna ukufumananisa ukuba ngaba iindibano ziyabanceda abasethyini bamaxhosa 
abaphila nentsholongwane kagawulayo abakwingingqi zasemaphandleni. 
Siyathemba ukuba iinkcukacha esithe sazifunda  kwesisifundo ziyawukubanceda  
abantu abaphila nentsholongwane kagawulayo baphile ngcono ebomini. Ukuba 
iziphumo zibonisa ukuba singabanceda njani ababantu ngoko singathanda ukuxelela 
abantu abanotshintsha indlela urhulumente nabancedisi bamaziko empilo abanceda 
ngayo abantu abanentsholongwane kagawulayo. Ababantu bayawuquka imibutho, 
amaziko empilo asekuhlaleni, okanye urhulumente. Bonke ababantu 
bayasebenzisana ukuncceda abantu abaphila nentsholongwane kagawulayo 
nogawulayo. Ngokwabelana ngeziphumo singabanceda baphucule iinkonzo kubantu 
abanentsholongwane kagawulayo baphile ngcono. Igama lakho okanye iingcombolo 
ngawe azisayi kunikezelwa kulemibutho okanye kerhulumente. Igama lakho 
liyakuhlala ligcinwe likhuselekile. 
 
Khumbula ukuba sithe safumanisa ukuba elinye lamaqela lifumene lukhulu 
kwisifundo elinye iqela liyakunikezwa  olonyango. Ngoko ke ukuba isifundo sithe 
saxhamla ngoko uyawufumana ithuba loxhamla kubo. 
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Kukho into oyifumanayo ukuba uyazibophelela uthatha inxaxheba kwisifundo 
Awusayi kufumana mali okanye ubhatalwe ngothatha inxaxheba kwisifundo. Kodwa 
ke iindleko zakho zokhwela isithuthi xa usiza esibhedlele nobuyela ekhaya 
ziyakubhatalwa  ngalo lonke ixesha undwendwela ekiliniki uzothatha inxaxheba 
kwisifundo.  
 
Uthatha inxaxheba kwesisifundo kuzinikela 
Lukhetho lwakho ukuba uyawuthatha inxaxheba kwesisifundo okanye hayi. Akukho 
mntu onokuxelela ukuba  uthathe inxaxheba kwisifundo. Ukuba uyavuma kwaye 
uyazibophelela uthatha inxaxheba kwisifundo ngalolonke ixesha uyawuba nokhetho 
lokuba ungaphenduli imibuzo ebuziweyo. Awunakunyanzelwa ukuba wenze 
imisebenzi okanye ukuza kwiintsuku zophinda ubonwe. Iintshukumo zakho lukhetho 
lwakho. Uthatha inxaxheba kuzikhethela ngalo lonke ithuba lesifundo. Ukuba 
ngethuba lesifundo ukhetha ukuba awusafuni ukuthatha inxaxheba awusayi 
kuphathwa ngendlela eyahlukileyo. 
 
Awusayi kuphathwa ngokwahlukileyo  ukuba ugqiba ekubeni ungabiyiyo inxalenye 
yesifundo kwawena. Abo bathatha inxaxheba esifundweni abayi kunikwa 
ngqwalasela. Abayi kuphathwa ngokwahlukileyo esibhedlele nasekiliniki.  
 
Ingaba iinkcukacha  ngam ziyawukhuseleka? 
Iinkcukacha osinike zona ngawe nesithe sakufunda kuwe kuyawugcinwa 
kukhuselekile. Akukho mntu uyawukwazi ukufumana ezonkcukacha ngaphandle 
komphandi, umkhokeli mphandi namalungu e Human Research Ethics Committee. 
Ngaphandle kwababantu akekho omnye oyawukwazi ukuba iinkcukacha ngawe 
nesithe sakufunda kusuka kuwe. Igama lakho alisayi kubandakanywa kwiinkcukacha. 
 
Oku sithe sakufunda kungasetyenziswa kuphela ukwenza iinkonzo ngcono 
kwabasetyhini bamaxhosa abaphila nentsholongwane kagawulayo okanye 
ugawulayo. Uyakutsalelwa umnxeba ucelwe ukuba uvume utyikitye ifomu 
yokuzibophelela ukuba iinkcukacha zithe zalulutho  ukuba zisetyenziselwe okunye.  
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Ukuba unawo nawuphi na umbuzo okanye inkxalabo nceda unxulumane noKirsty 
Jackson (082 684 9760). Ungenza umyalezo ocela ufowunelwa (Please call me) 
ukunxulumana. Ungabuza umbuzo ngalo naliphina ixesha ngethuba lesifundo.   
 
Kananjalo wamnkelekile ukuba unganxulumana nomkhokeli mphandi okanye usihlalo 
we chairperson of Human Research Ethics Committee ukuba unenkxalabo okanye 
imibuzo malunga namalungelo akho okanye ukhuseleko lwakho njengomthathi 
nxaxheba.   
 
Research supervisor:   Human Research Ethics Committee Chairperson: 
Dr Romy Parker   Professor Marc Blockman 
021 406 6571                             021 406 6492  
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Appendix G/3: Informed consent form 
 
  School of Health & Rehabilitation Sciences 
Divisions of Communication Sciences & Disorders ·  
Nursing & Midwifery · Occupational Therapy · Physiotherapy 
Informed consent form 
 
 
 
 
Dear participant 
 
You are invited to take part in the study on: 
 
“Efficacy of a multimodal approach to managing pain in rural 
amaXhosa women living with HIV/AIDS compared to a 
therapeutic relationship”. 
 
Please read or have the information sheet read to you before you choose to sign this form. 
We hope that this study can help us to learn more about how to help rural amaXhosa 
women who are HIV positive cope better with living with HIV.  
 
I, _________________________________, have read and understood all of what is written 
in the information sheet. (And I have been read all of what is written in the information 
sheet by ___________________________). I know why the study is being done and what the 
study involves. I also know what may be unsafe and what may be helpful in taking part. I 
have had all of my questions and worries listened to and answered. I may ask any questions 
or voice any worries I might have in the future. I know that at any time I am allowed to stop 
taking part in the study. This will not change the normal treatment I get at hospital or clinic 
services.  
 
I know that by signing here (giving consent) I am choosing by myself to take part in this 
study. I know that if I do not want to answer questions or do tasks asked of me I do not have 
to. 
 
Signed: 
 
_______________________________  ___________________________ 
Participant (name and signature )   Date and place  
 
_______________________________  ___________________________ 
Researcher (name and signature)   Date and place  
 
_______________________________  ___________________________ 
Witness (name and signature)    Date and place  
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  School of Health & Rehabilitation Sciences 
Divisions of Communication Sciences & Disorders ·  
Nursing & Midwifery · Occupational Therapy · Physiotherapy 
Informed consent form 
 
 
 
 
Mholo mthathinxaxheba 
 
Uyamenywa ukuba uthathe inxaxheba kwesisifundo  singe: 
 
“Isifundo esifuna ukujonga ukuba iindlela ezohlukenenyo 
zokuncedisa ukumelana neentlungu ezifumaneka ngenxa yokuphila 
nogawulayo kwabasethyini bamaXhosa abaphila nentsholongwane 
kagawulayo okanye ugawulayo”.  
 
Nceda ufunde okanye ufundelwe umqulu oneenkcukacha phambi kokuba ukhethe 
ukutyikitya lefomu. Siyathemba ukuba esisifundo siyawusinceda ukuba sifunde ngakumbi 
ngokuba singabanceda kanjani abasethyini bamaxhosa  abasemaphandleni 
abanentsholongwane bamelane ngcono nokuphila nogawulayo.   
 
Mna, _________________________________ , ndikufundile kwaye ndakuqonda konke 
okubhalwe kulomqulu. . (Kwaye ndikufundelwe konke okubhalwe kulomqulu oneenkcukacha 
ndifundelwa ngu ___________________________). Ndiyazi ukuba kutheni isifundo 
sisenziwa kwaye siquka ntoni isifundo.  Ndiyazi kananjalo ukuba yintoni engagakhuseleki 
nokuba yintoni engaluncedo ekuthatheni inxaxheba.  Yonke imibuzo yam neekxalabo 
zimanyelwe kwaye zaphendulwa.  Ndingabuza nayiphi na imibuzo okanye ndivakalise 
inkxalabo endingaba nayo ekuhambeni kwexesha.  Ndiyazi ukuba ndivumelekile ukuba 
nangaliphi na ixesha ndivumelekile ukuba ndinganqumama ukuthatha inxaxheba kwisifundo. 
Oku akusayi kutshintsha indlela eqhelekileyo yonyango endilufumanayo esibhedlele okanye 
ekiliniki.   
 
Ndiyazi ukuba ngokutyikitya apha(unikeza isivumelwano sokuzibophelela) ndiyazikhethela 
ukuthabatha inxaxheba kwesisifundo. Ndiyazi ukuba, ukuba andifuni ukuphendula imibuzo 
okanye ndenze izinto endicelwe ukuba ndizenze andinyanzelekanga.  
 
Isayinwe: 
 
_______________________________  ___________________________ 
Umthathi nxaxheba (Igama nesayinwe)  Umhla nendawo  
 
_______________________________  ___________________________ 
Umphandi (Igame nesayinwe)   Umhla nendawo  
 
_______________________________  ___________________________ 
Ingqina (igame nesayinwe)   Umhla nendawo  
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Appendix H: Post Study Structured Interviews   
Appendix H/1: Post Study Structured Interview for Positive Living Group 
Participants 
Allocated no: ________________ 
 
1. Did you find the group sessions useful? 
□ Yes    □ No 
 
Please explain: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
2. Is there any other information that you feel should have been included in the 
sessions?                                                                                                                                      
□ Yes    □ No 
Please explain: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
3. Did you read the workbook given to you or have somebody read it to you?                                
□ Yes    □ No 
Please explain: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
4. Did you find the information in the workbook useful?                                                             
□ Yes    □ No 
Please explain: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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5. Is there any other information that you feel should have been included in the 
workbook?                                                                                                                                           
□ Yes    □ No 
Please explain: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
6. Did you share or discuss any of the information with anybody else?                                         
□ Yes    □ No 
If yes, then with you. Please explain: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
7. Is there anything else that you would like to share? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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Appendix H/2: Post Study Structured Interview for Therapeutic Group Participants 
 
Allocated no: ________________ 
 
1. Did you receive any information during the study about HIV/ADS that helped you 
to manage your symptoms? 
□ Yes    □ No 
 
Please explain: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
2. Did you discuss ways to manage your symptoms with others? 
□ Yes    □ No 
 
If yes, then with whom? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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Appendix I: Ethics Approval Letters 
Appendix I/1: Letter of approval from the Human Resource Ethics Committee, 
Faculty of Health Sciences, University of Cape Town: HREC REF: 932/2014 
362 
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Appendix I/2: Letter of approval from the Eastern Cape Department of Health 
364 
Appendix I/3: Permission for research from Zithulele Hospital, Eastern Cape, 
Department of Health 
365 
Appendix I/4: Ethics approval renewal (2015 - 2016) 
366 
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Appendix I/5: Ethics approval renewal (2016 - 2017) 
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Appendix I/6: Pan African Clinical Trial Registry: PACTR201410000902600 
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Appendix J: Supplementary results 
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Figure F-1: Pain Severity Scores at Baseline for the PL and TR intervention groups (N = 
49) 
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Figure F-2: Pain Interference Scores at Baseline for the PL and TR intervention groups 
(N = 48) 
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Figure F-3: EQ-5D Index at Baseline  for the PL and TR intervention goups (N = 49) 
 
372 
 
 Mean 
 Mean±SE 
 Mean±1.96*SE PL intervention group                                   TR intervention group
160
180
200
220
240
260
280
300
320
340
C
D
4
 a
t 
d
ia
gn
o
si
s
 
Figure F-4: Results collected at Baseline of CD4 T-cell count at diagnosis for the PL 
and TR intervention groups (N = 39) 
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Figure F-5: Results collected at Baseline of the most recent CD4 T-cell count for the 
PL and TR intervention groups (N = 45) 
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Appendix K: CONSORT Guidelines and indication of chapter where items were addressed  
Section/Topic  Item No  Checklist item  Reported in  
Title and abstract  1b  Identification as a randomised trial in the title 
Structured summary of trial design, methods, results, and conclusions  
Abstract  
Introduction  
Background/objective  
2a  
2b  
Scientific background and explanation of rationale  
Specific objectives or hypotheses  
Chapter 1 and 2.1  
Chapter 1.5  
Methods  
Trial design  3a  
3b  
Description of trial design (such as parallel, factorial) including allocation ratio  
Important changes to methods after trial commencement (such as eligibility 
criteria), with reasons  
Chapter 3.1  
Participants  4a  
4b  
Eligibility criteria for participants  
Settings and locations where the data were collected  
Chapter 3.2  
Chapter 3.4 and 3.7 
Interventions  5  The interventions for each group with sufficient details to allow replication, 
including how and when they were actually administered  
Chapter 3.6 and Appendix B   
Outcomes  6a  
6b  
Completely defined pre-specified primary and secondary outcome measures, 
including how and when they were assessed  
Any changes to trial outcomes after the trial commenced, with reasons  
Chapter 3.5 and Appendix A 
Chapter 3.7  
Sample size  7a  
7b  
How sample size was determined  
When applicable, explanation of any interim analyses and stopping guidelines  
Chapter 3.3  
Randomisation:  
Sequence generation  
8a  
8b  
Method used to generate the random allocation sequence  
Type of randomisation; details of any restriction (such as blocking and block 
size)  
N/A (stratified) 
Chapter 3.1 and 3.7   
Allocation concealment mechanism  9  Mechanism used to implement the random allocation sequence (such as 
sequentially numbered containers), describing any steps taken to conceal the 
sequence until interventions were assigned  
N/A (stratified) 
Chapter 3.1 and 3.7 
Implementation  10  Who generated the random allocation sequence, who enrolled participants, 
and who assigned participants to interventions  
Chapter 3.7  
Blinding  11a  
11b  
If done, who was blinded after assignment to interventions (for example, 
participants, care providers, those assessing outcomes) and how  
If relevant, description of the similarity of interventions  
Chapter 3.7 
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Section/Topic  Item No  Checklist item  Reported in  
Statistical methods  12a  
12b  
Statistical methods used to compare groups for primary and secondary 
outcomes  
Methods for additional analyses, such as subgroup analyses and adjusted 
analyses  
Chapter 3.9 
Results  
Participant flow (a diagram is strongly 
recommended)  
13a  
13b  
For each group, the numbers of participants who were randomly assigned, 
received intended treatment, and were analysed for the primary outcome  
For each group, losses and exclusions after randomisation, together with 
reasons  
Chapter 4.1 and Figure 4-1 
and 4-2 
Recruitment  14a  
14b  
Dates defining the periods of recruitment and follow-up  
Why the trial ended or was stopped  
Chapter 4.1  
Baseline data  15  A table showing baseline demographic and clinical characteristics for each 
group  
Table 4-1 and 4-2 (Chapter 
4.2) 
Table 4-3 – 4-7 (Chapter 4.3) 
Numbers analysed  16  For each group, number of participants (denominator) included in each 
analysis and whether the analysis was by original assigned groups  
Figure 4.1 and Chapter 4 
Outcomes and estimation  17a  
17b  
For each primary and secondary outcome, results for each group, and the 
estimated effect size and its precision (such as 95% confidence interval)  
For binary outcomes, presentation of both absolute and relative effect sizes is 
recommended  
Chapter 4.4 – 4.8 
Ancillary analyses  18  Results of any other analyses performed, including subgroup analyses and 
adjusted analyses, distinguishing pre-specified from exploratory  
Chapter 4.2 – 4.9  
Harms  19  All important harms or unintended effects in each group   
Discussion  
Limitations  20  Trial limitations, addressing sources of potential bias, imprecision, and, if 
relevant, multiplicity of analyses  
Chapter 5.8.2  
Generalisability  21  Generalisability (external validity, applicability) of the trial findings  
 
 
Chapter 5.8.2  
Interpretation  22  Interpretation consistent with results, balancing benefits and harms, and 
considering other relevant evidence  
Chapter 5 
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Section/Topic  Item No 
Other information 
Registration  23 Registration number and name of trial registry Pan African Clinical Trial 
Registry 
(PACTR201410000902600) 
Protocol 24 Where the full trial protocol can be accessed, if available  N/A  
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders Acknowledgements  
